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MS-DOS stands for Microsoft™ Disc Operating System. Every computer 
has an  operating system which is needed to manage the computer memory, in­
terpret what is keyed in on the keyboard and to operate the display screen. Disk 
operating systems do all these things and also provide the user with commands 
and utility programmes to manage the disk files. Though the disk handling rou­
tines add a  substantial am ount to the size of the operating system, parts of DOS 
are held on disk to be brought in as required, thus saving some space in  mem­
ory.
A disk operating system therefore provides a  wide range of functions for 
which otherwise each user would have to write his own special routines. This 
provides a  ’standard interface’ between the programmer and the computer, and 
between the computer and the user.
MS-DOS was first produced under the name of PC-DOS for the IBM Per­
sonal Computers. MS-DOS and PC-DOS are functionally almost identical, the 
principal difference being in the implementation within the computer. MS-DOS 
has rapidly become the standard operating system for 16-bit microcomputers. 
There are some minor differences in the way certain facilities are implemented 
on different models.
Most application programmes now being written for microcomputers 
have, a t the very least, an  MS-DOS version. Most users now learning to use micro­
computers will be learning MS-DOS. The more users that buy MS-DOS, the more 
programmes will be written. The popularity of a  standard is self-generating.
These operating systems are designed for business microcomputers with 
a t least 64K of main memory, one display and keyboard, one or two printers, and 
one or more disk drives. The drives can be for floppy disk (diskettes) or hard  disks. 
These operating systems are not designed to handle more than  one terminal.
Loading MS-DOS: In order order to be able to run, the software m ust be 
loaded from disk into the main memory (RAM) of the computer. The m ain part of 
the operating system is loaded automatically into memory at the beginning of the
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day, when the power is switched on. This is known as ’booting’ the operating sys­
tem, and the ’bootstrap’ programme to do this is on the first sector of every disk 
th a t contains a  copy of MS-DOS. In normal operation the system then rem ains 
resident in memory to control each of the user’s required applications in turn , as 
they are loaded, used and set aside. Other programmes are called into memory 
as and when required, either by the user or by each other.
Reset: The software may also be reloaded a t any time by pressing the 
RESET button. Because a reset will corrupt all the programmes and data cur­
rently in the computer, or any files still open on disk, this function is always 
made difficult to invoke by accident. It may be, for example, a small bu tton  a t 
the rear of the computer. The user will need to reset only:
n To change the operating system 
Q If the system  hangs up
R euse o f memory: After use, the application and utility programmes can 
be overwritten with other programmes. The original copy is kept unchanged on 
disk or future use. Memory is normally volatile; the contents will be lost if the 
power is switched off or if there is even a  momentary interruption of the m ains 
supply.
In common with all maj or items of software, the authors of MS-DOS have 
a  policy of active development. This m eans tha t new versions of the software will 
be made available from time to time. The new version may provide more facilities, 
improve performance or remedy faults. Versions issued purely to remedy faults 
or to cater for a  hardware variation are normally numbered within a version as 
Version 3.10, 3.21 etc.
MS-DOS commands: MS-DOS user functions are of two types: 
a  Internal commands permanently resident in memory
Q External (utility) command programmes held on disk and called in a s  re­
quired.
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Error messages: MS-DOS provides easy-to-understand messages to 
identify errors tha t occur. These messages are usually listed in the m anuals for 
further amplification.
Batch commands: Facilities are available in MS-DOS to set up a  sequence 
of commands for automatic execution. Any commands or programme names, 
with their necessary parameters, may be included in such a  sequence. They m ust 
be in a file with a  .BAT extension. The .BAT sequence file is executed by keying 
the name of the file; the .BAT extension is not keyed.
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Appendix B1 - TEMPRAC interactive screens
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* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Copyright (c) April 1987 by
G. N. Dutton 
A. Wall M. H. zeini
Electronics Department Eye Department
Strathclyde University Glasgow University
No part of this Program may be reproduced or distributed in 
any form or by any means, or stored in database or retrieval system, 
without the prior written permission of the previous writers.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Press any key to start
Enter Hospital Number 
123211
Enter Age Code / 0 for 0 - 9
/ 1 for 10 - 19
/ 2 for 20 - 29
/ 3 for 30 - 39
/ 4 for,40 - 49
/ 5 for 50 - 59
/ 6 for 60 - 69
/ 7 for 70 - 79
/ 8 for 80 - 89
/ 9 for 90 - 99
/ 10 for 100 4
1 2 3 4 5 6 7
I I I  I I I I
6/5 6/6 6/9 6/12 6/18 6/24 6/36
Enter Snellen’s Visual Acuity (Right Eye)
VAR: 4
1 2 3 4 5 6 7
I I I I I I I
6/5 6/6 6/9 6/12 6/18 6/24 6/36
Enter Snellen's Visual Acuity (Left Eye)
VAL: 3
Which Eye Would You Like To Test ?
R ... For Right Eye





T ... To terminate the test
Enter Patient Sex (M/F)
Diagnosis Codes
N o r m a l -------—  (N)
Amblyopia --- -- (A)
Cataract ---- —  (C)
(Cl) — Congenital
(C2) — Nuclear Sclerosis
(C3) — PSCLO
Diabetes ---- -— (D)
(DN) — No retinopathy
(DB) — Background; no visible maculopathy
(DP) — Proliferative; no visible maculopathy
(DO) — Macular oedema
(DI) — Ischaemic maculopathy
(DE) — Exudative maculopathy
Glaucoma (OAl —  (G)
(GO) — Ocular hypertension
(Gl) — Baring of Blind spot
(G2) — Arcuate scotoma
(G3) — Constriction of part of field to <10 deg
(G4) — Constriction of all field to <10 deg
Press Any Key
Diagnosis Code (cont.)
Hypermetropia —  (H)
(HI) — 0-5 DS
(H2) — 6-8 DS
(H3) — 9+ DS
Leber -------- —  (L)
Myopia ------- —  (H)
(Ml) — 0-5 DS
(M2) — 6-10 DS
(M3) — 11 + DS
Optic N / CNS —  (0) (O+number) referring to card file
Retinitis pig —  (R)
S M D ---------- —  (S)
(SI) — Dry
(S 2) — Exudative
Thyroid ------ —  (T)
(TO) — Normal nerve function
(Tl) — Evidence of optic neuropathy
unclassified -—  (U)
Enter Diagnosis Code
For RIGHT Eye
How would you like to run the test ? (M/A)
M ..... For Manual
A ..... For Automatic
RIGHT Eye will be tested
Size of 8 (6/60), Period of 00.01 SECS
To start push the button S
Test Performed was.. RIGHT Eye, Size 8 (6/60)
For the period of 00.01 SECS
Letter shown was X
Enter
S ....... if patient answer is correct / and to try a smaller letter
SPACE ...If patient answer Is Incorrect / and to try a longer time interval
R  to repeat already performed test
T .......to terminate the automatic runlng
LEFT EYE IS TESTED
enter required size (1 - 8):-
8 7 6 5 4 
I I 1 1 1 








LEFT EYE IS TESTED SIZE OF 8 (6/60)







LEFT Eye will be tested
Size o£ 8 ( S / S O ) ,  Period of 00.20 SECS
To start push the button S
ALREADY SHOWN LETTER WAS H
PLEASE,ENTER WHAT HAS BEEN RECOGNIZED BY THE PATIENT 
a l e t t e r .. ............................. enter it
if nothing ................... ..push space button
Test Performed was., l e f t  Eye, 





DO YOU WANT TO PERFORM ANOTHER TEST (ON THE SAME EYE) ? (Y/N)
Appendix B2 - Turbo Pascal & Turbo Graphics Toolbox
Turbo Pascal V 3.0 is a  high-performance integrated programming envi­
ronment. It includes a  full-screen, WordStar- like editor. The compiler locates er­
rors, automatically activates the editor and shows the programmer the location 
of the error in the source code. This provides an  environment which improves the 
productivity of the developers.
Turbo Pascal V 3.0 for the PC-DOS provides window procedures, sound, 
colour and graphics.
Turbo Graphix toolbox lets developer create high-resolution graphics on 
the IBM/PC and true compatibles. It provides a  set of tools to include in the pro­
grammes for complex graphics, windowing and storing screen images to mem­
ory. The tools includes the following facilities:
Q Drawing simple graphics such as circles, squares, rectangles, and a var­
iety of geometric shapes.
a  Procedures for more complex scientific graphics such as bar charts, pie 
charts, and a  variety of curves with optional smoothing.
a  Routines for including graphics into flexible windows.
Q ’Clipping’ option to automatically keep drawings within window boun­
daries or t o ’zoom in’ on some aspects of an  image.
□ Store images in RAM for quick access.
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Appendix B3 - TEMPRAC programme listing
program VisionAcuity;
{$1 typedef.sys} {$1 graphix.sys} {$1 kernel.sys} {$1 windows.sys} {$Iaxis.hgh} {$1 polygon.hgh}
const v60 = 305.00 ; v36 = 508.325; v24 = 762.50 ; vl8 =1016.66; vl2
1525.00; v9 =2033.325; v6 =3050.00; v5 =3660.00; h60 = 404.00 ; h36
673.33 ; h24 = 1010.00; hl8 = 1346.66; hl2 = 2020.00; h9 = 2693.33; h6 =
4040.00; h5 =4848.00;
ty p es  = 1..8 ; r  = 1.. 20 ; regRecord = record ax,bx,cx,dx,bp,di,si,ds,es/lags :integer ;
end; timeString = string[ll];
var
LASTNAME :string[8]; FERSTNAME :string[8]; NUMBER :string[8]; DOB :string[8]; AGE 
:string[2]; SEX :string[l]; DIAGNOSIS :string[4]; VA_RT :string[l]; VA_LT :string[l]; 
OPERATOR ;string[8]; DATE :string[8];
whichEye :string[07]; size :s;visSize :string[09]; resp :r;visResp :string[12]; tas,ts :timestring; 
eye :char; ch :char; letter :string[03]; n,q :integer; c :char; answer :char, acuity :integer; 
result :string[12]; MAWZ :text; printer :text; DBTRE :text; DBTRENM :STRING[12]; line 
:string[250]; L rinteger, {length of Lastname of patient} a :string[250]; tl,t2,time : 
timeString; NrHour,NrMin,NrSec,NrHoSecs rinteger; hl,h2,ml,m2,sl,s2,hsl,hs2 :integer; 
hp,mp,sp,hsp,ht,mt,strhst rinteger; code :integer; hh,vv :real ; I  rinteger; first rinteger ;vbv 
rinteger; laster rinteger; RHast rinteger; LFTlast rinteger; RTJJFT rplotArray; interval rreal ; 
automaticrboolean ; righting .’boolean ; righteringrboolean; lefting rboolean ; lefteringrboolean ;demor 
rinteger ;getsize rreal ; queen rfile ; prince rfile ;
procedure shifter; begin writeln; writeln; writeln; writeln; writeln; writeln; writeln; aid; 
procedure copyright; begin shifter,
writeln(’***************************************************************************’); 
writeln(’* Copyright (c) April 1987 by *’); writeln(’*
*’); writeln(’* G.N. Dutton *’); writeln(’* A. Wail
M. H. Zeini *’); writeln(’* Electronics Department Eye Department *’);
writeln(’* Strathclyde University Glasgow University *’); writeln(’*
*’); writeln(’* No part of this Program may be reproduced or distributed in *’); writeln(’* any 
form or by any means, or stored in database or retrieval system, *’); writeln(’* without the prior written 
permission of the previous writers. *’); writeln(’* *’);
writeln(’***************************************************************************’);
shifter, writeln(*  Press any key to start  ’); read(kbd,ch); end; procedure showDiag 1; begin
writeln; writeln(’ Diagnosis Codes ’);
writeln(*--------------------------------------------------   ’);writeln(’Normal-------(N) ’);
writeln(’ ’); writeln(’Amblyopia------ (A) *); writeln(’Cataract-------(C) *); writeln(*
(C l)- - Congenital ’);writeln(’ (C2)- -Nuclear Sclerosis *);writeln(* (C3)
-  PSCLO ’); writeln(’Diabetes (D) ’);writeln(’ (D N )-N o
retinopathy ’);writeln(’ (DB) -  Background; no visible maculopathy *);writeln(’
(DP) -  Proliferative; no visible maculopathy ’);writeln(* (DO) — Macular oedema ’);
writeln(’ (DI) -  Ischaemic maculopathy ’); writeln(’ (DE) -  Exudative
maculopathy ’); writeln(’Glaucoma [OA] -(G ) ’); writeln(’ (GO) -  Ocular
hypertension ’); writeln(’ (Gl) —Baring of Blind s p o t’);writeln(’ (G2) —
Arcuate scotoma ’); writeln(’ (G3) -  Constriction of part of field to deg*); writeln(*




’); writeln(’ Press Any Key
procedure showDiag2; begin writeln; writeln(’ Diagnosis Code (cont.) ’);
writeln(’--------------------------------------------------------------------- ’);writeln(’Hypermetropia -(H)
’); writeln(’ (HI) -  0-5 DS ’); writeln(’ (H2) -  6-8 DS ’); writeln(’
(H3) — 9+ DS ’); writeln(’Leber (L) ’); writeln(’Myopia--------- (M)
’); writeln(’ (M l)-0 -5  DS ’);writeln(’ (M 2)-6 -10DS ’); writeln(’
(M3) -  11 + DS ’); writeln(’Optic N /  CNS —(O )  (O+number) referring to card file ’);
writeln(’Retinitis pig ~(R) ’); writeln(’SMD------------ (S) ’); writeln(’
(SI) —Dry ’);writeln(’ (S2) -  Exudative ’); writeln(’Thyroid-------- (T)
’); writeln(’ (TO) — Normal nerve function ’); writeln(’ (Tl) -  Evidence of
optic neuropathy ’); writeln; writeln(’Unclassified—(U) ’);
writeln(’------------------------- -------------------------------------------- ’); writeln; write(’ Enter Diagnosis
Code: ’) ; readln(DIAGNOSIS);end;
begin {MAIN PROGRAM) clrscr; copyright; ClrScr; vbv:=l; automatic:=false; righting:=false; 
rightering:=false; lefting:=false; leftering:=false; RTlast:=0; LFTlast:=0;
shifter; writeln(’Enter Hospital Number *); writeln; readln(NUMBER); ClrScr;
shifter; writeln(’Enter Age Code / 0 for 0 - 9 ’); writeln(’ /1  for 10 -19 ’); writeln(’
/  2 for 20 - 29 ’); writeln(’ /  3 for 30-39 ’);writeln(’ /  4 for 40-49 ’); writeln(’
/  5 for 50 - 59 ’); writeln(’ /  6 for 60 - 69 ’); writeln(’ /  7 for 70 - 79 ’); writeln(’
/  8 for 80-89 ’);writeln(’ /  9 for 90-99 ’);writeln(’ /10  for 100+ ’); writeln;
writeln; readln(AGE); ClrScr;
shifter, writeln(’Enter Patient Sex (M/F) ’); writeln; readln(SEX); ClrScr; 
showDiagl; clrscr; showDiag2; ClrScr,
shifter; writeln(’ 1 2 3 4 5 6 7 8 ’); writeln(’ I I  I I I I I I ’);
writeln(’ 6/5 6/6 6/9 6/12 6/18 6/24 6/36 6/60’); writeln; writeln; writeln(’Enter Snellen” s
Visual Acuity (Right Eye) ’); writeln; write(’ VAR: ’); ieadln(VA_RT); ClrScr,
shifter; writeln(’ 1 2 3 4 5 6 7 8 ’); writeln(’ I I I I I I I I ’);
writeln(’ 6/5 6/6 6/9 6/12 6/18 6/24 6/36 6/60 ’); writeln; writeln; writeln(’Enter Snellen” s
Visual Acuity (Left Eye) ’); writeln; write(’ VAL: ’); readln(VA_LT); ClrScr,
assign(queen,’midest.com’); EXECUTE(queen); end.
program VisionAcuity;
{$1 typedef.sys) {$1 graphix.sys) {$1 kemel.sys) {$1 windows.sys) {$1 axis.hgh) {$1 polygon.hgh)
const v60 = 305.00 ; v36 =508.325; v24 = 762.50 ; vl8 =1016.66; vl2
1525.00; v9 = 2033.325; v6 =3050.00; v5 =3660.00; h60 =404.00 ; h36
673.33 ; h24 =1010.00; hl8 =1346.66; hl2 = 2020.00; h9 =2693.33; h6
4040.00; h5 =4848.00;
types = 1..8 ; r  = 1..20 ; regRecord = record ax,bx,cx,dx,bp,di,si,ds,es,flags :integer ;
end; timeString = string[l 1];
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var
LASTNAME :string[8]; FIRSTNAME :string[8]; NUMBER :string[8]; DOB :string[8]; AGE 
:string[2]; SEX :string[l]; DIAGNOSIS :string[4]; VA_RT :string[l]; VAJLT :string[l]; 
OPERATOR :string[8]; DATE :string[8];
whichEye :string[07]; size :s ; visSize :string[09]; resp :r; visResp :string[12]; tas,ts rtimestring;
eye :char; ch :char; letter :string[03]; n,q :integer; c '.char; answer :char; acuity '.integer; 
result :string[12]; MAWZ :text; printer :text;DBTRE :text; DBTRENM :STRING[12]; line 
:string[250]; L rinteger, {length of Lastname of patient) a :string[250]; tl,t2,time :
timeString; NrHour,NrMin,NrSec,NrHoSecs :integer; hl,h2,ml,m2,sl,s2,hsl,hs2 :integer; 
hp,mp,sp,hsp,ht,mt,st,hst '.integer; code '.integer; hh,vv :real ; I :integer; first '.integer; vbv 
:integer; laster rinteger; RTlast rinteger; LFTlast rinteger; RTJJFT rplotArray; interval rreal ; 
automaticrboolean ; righting rboolean ; righteringrboolean; lefting rboolean ; lefteringrboolean ;demor 
rinteger ; getsize rreal ; queen rfile ; prince rfile ;
procedureLetter_A;var dist rinteger ;





for dist:=0 to 68 do Drawline(hh/2-18+dist/2,vv/2-90,hh/2-70+dist/2,vv/2+90); for dist:=0 to 68 
do Drawline(hh/2-18+dist/2,vv/2-90,hh/2+34+dist/2,vv/2+90); 
Drawsquare(hh/2-34,vv/2+14,hh/2+34,vv/2+50,true); end; end;














Drawsquare(hh/2-18,vv/2-91 ,hh/2+18,vv/2+91 ,true); end; end;
procedure Letter_C;
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vardist : integer ;




Drawsquare(hh/2+l 06 ,vv/2-90,hh/2+142, vv/2+90,true);
for dist :=0 to 36 do Drawline(hh/2-70+dist,w/2-91,hh/2+34+dist,vv/2+91); for dist :=0 to 36 do 
Drawline(hh/2+36+dist,w/2-91,hh/2-70fdist,w/2+91); end; end;
procedure Letter_Y; var dist rinteger ; begin if q=l then copyscreen else begin
Drawsquare(hh/2-70,vv/2-162, hh/2+70,vv/2-126, true);
Drawsquare(hh/2-70, vv/2+126 Jih/2+70, vv/2+162,true);
Drawsquare(hh/2-142, w/2-90,hh/2-106, vv/2+90,true);
Drawsquare(hh/2+106,w/2-90,hh/2+142, vv/2+90,true);
for dist :=0 to 36 do Drawline(hh/2-70+dist,vv/2-90,hh/2-17+dist,vv/2+19); for dist r=0 to 36 do 
Drawline(hh/2+36+dist,vv/2-90,hh/2-19+dist,w/2+19);
Drawsquare(hh/2-17,vv/2+19Jih/2+17,vv/2+90,true); end; end;















for dist :=0 to 72 do Drawline(hh/2-70+dist/2,vv/2-90,hh/2-18+dist/2,vv/2+90); for dist :=0 to 72 
do Drawline(hh/2+34+dist/2,vv/2-90,hh/2-18+dist/2,vv/2+90); end; end;









function getTime: timeString; var regs: regRecord; hour ,min ,sec ,hOSecs :string[2]; begin with regs 
do begin ax:= $2c shl 8 ; msDos(regs); str(cx shr 8, hour); if length(hour)=l then hour :=
’0’ +hour; val(hour,NrHour,Code); str(cx mod 256,min); if length(min) =1 then min ' := ’0’
+ min ; val(min,NrMin,code); str(dx shr 8, sec); iflength(sec)=l then sec := ’0’ + sec; 
val(secJMrsec,code); str(dx mod 256,hOSecs); iflength(hOSecs)=l thenhOSecs := ’0’ +hOSecs 
; val(hOSecs,NrHoSecs,code); getTime ;= hour + + min + ’-’ + sec + + hOSecs ; end; end;
procedure TargetTime; begin
hst:=hsl+hsp; if hst=100 then begin hst:=hst-100; si :=sl+l; end; 
st=sl+sp; if st=60 then begin st:=st-60; ml := m l+ l; end; 
mt:=ml+mp; ifmt=60 then begin mt:=mt-60; h l:= h l+ l; end;
ht:=hl+hp;ifht=24then begin hf=ht-24; end;
end;
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procedure sizeOfLet; begin ClrScr; writeln(WhichEye,’EYE IS TESTED’);
writeln(’_______________________________________________ ’); writeln; writeln(’enter required size
(1 - 8):- ’); writeln; writeln(’ 8 7 6 5 4 3 2 1 ’); writeln(’ I I I I I I I I
’); writeln(’6/60 6/36 6/24 6/18 6/12 6/9 6/6 6/5 *);
writelnf_______________________________________________ ’); writeln; readln(size);
writeln(’_______________________________________________ ’); if ((size8) or (size)) then begin
sound(4000); delay(200); nosound; sizeOfLet; end; end;
procedure responce; begin ClrScr,
case size of 1: visSize:=’ 1 (6/5) ’ ; 2 : visSize:=’2 (6/6) ’ ; 3 : visSize:=’3 (6/9) ’ ; 4 :  visSize:=’4 
(6/12)*; 5 : visSize:=’5 (6/18)’ ; 6 : visSize:=’6 (6/24)’ ; 7 : visSize:=’7 (6/36)’ ; 8 : visSize:=’8 (6/60)’ 
;end;
writeln(WhichEye,’EYE IS TESTED ’,’SIZE OF * ,visSize);
writeln(’___________________________________________ ____________ ’); writeln; writeln(’enter
required time period (1 - 20):- ’); writeln; writeln(’ 20..19..18........... 10....................3...2...1 ’);
writeln(’ I I I ’); writeln(’0.95................. 0.50..........................0.01 sec ’);
writeln(’_____________________________________________________________ ’);ieadln(iesp);
writeln(’__________________________________________ ’); if ((resp20) or (resp)) then begin
sound(4000); delay(40); nosound; responce; end else
end;
procedure sounding; begin sound(3000); delay(100); nosound; delay(100);
sound(3000); delay(100); nosound; sound(3000); delay(100); nosound;
I:=random(9); writeln(I); delay(600);
case I of 0: begin letter:=’F’; c:=T end; 1: begin letter:=’H’; c:=’h’ end; 2: begin letten=’I’; 
c:=*i* end; 3: begin letter:=’C’; c:=’c* end; 4: begin letter:=’T’; c:=’t’ end; 5: begin letten=’E’; 
c:=’e’ end; 6: begin letter:=*A’; c:=’a’ end; 7: begin letter:=’X’; c:=’x’ end; 8: begin letter:=*Y’; 
c:=’y’ end; 9: begin letter:=’V’; c:=’v’ end; end;
end;
procedure start; begin ClrScr,
case size of 1: visSize:=’l (6/5) ’ ; 2 : visSize:=’2 (6/6) ’ ; 3 : visSize:=’3 (6/9) ’ ; 4 :  visSize:=’4 
(6/12)’ ; 5: visSize:=’5 (6/18)’ ; 6 : visSize:=’6 (6/24)’ ; 7 : visSize:=’7 (6/36)’ ; 8 : visSize:=’8 (6/60)’ 
; end;
case resp of
1 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=01 ;visResp:=’00.01 SECS ’ ; end; 2 :begin hp:=00 
;mp:=00 ;sp:=00 ;hsp:=05 ;visResp:=’00.05 SECS ’ ; end; 3 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=10 
;visResp:=’00.10 SECS ’ ; end; 4 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=15 ;visResp:=’00.15 SECS ’ ; 
end; 5 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=20 ;visResp:=’00.20 SECS ’ ; end; 6 :begin hp:=00 
;mp:=00 ;sp:=00 ;hsp:=25 ;visResp:=’00.25 SECS ’ ; end; 7 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=30 
;visResp:=’00.30 SECS ’ ; end; 8 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=35 ;visResp:=’00.35 SECS ' ;  
end; 9 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=40 ;visResp:=’00.40 SECS ’ ; end; 10 :begin hp:=00 
;mp:=00 ;sp:=00 ;hsp:=45 ;visResp:=’00.45 SECS ’ ; end; 11 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=50 
;visResp:=’00.50 SECS ’ ; end; 12 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=55 ;visResp:=’00.55 SECS ’ ; 
end; 13 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=60 ;visResp:=’00.60 SECS ’ ; end; 14 :begin hp:=00 
;mp:=00 ;sp:=00 ;hsp:=65 ;visResp:=’00.65 SECS ’ ; end; 15 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=70 
;visResp:=’00.70 SECS ’ ; end; 16 rbegin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=75 ;visResp:=’00.75 SECS ’ ;
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end; 17 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=80 ;visResp:=’00.80 SECS *; end; 18 :begin hp:=00 
;mp:=00 ;sp:=00 ;hsp:=85 ;visResp:=’00.85 SECS ’ ; end; 19 .‘begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=90 
;visResp:=’00.90 SECS ’ ; end; 20 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=95 ;visResp:=’00.95 SECS ’ ; 
end;
end; writeln; writeln; writeln; writeln; writeln(whichEye,’Eye will be tested ’); writeln; writeln(’ Size 
of \visSize,\ Period of \visResp);
writeln(*______________  ’); writeln; writeln(’To
start push the button S ’); read(Kbd,ch); if((ch=’S’)or(ch=’s’)) then sounding else start; end;
procedure prepare; begin selectscreen(2); DrawBorder; DefineWindow(l,4^,XMaxGlb-4,YMaxGlb-6); 
case size of 8 : begin defineWorld( 1,0,v60,h60,0); hh:=h60 ;w:=v60 ;end; 7 : begin 
defineWorld( 1,0,v36 Ji36,0); hh:=h36 ;vv;=v36 ;end; 6 : begin defineWorld(l,0,v24,h24,0); hh:=h24 
;w:=v24 ;end; 5 : begin defineWorld( 1,0,v 18 ,h 18,0); hh:=hl8 ;vv:=vl8 ;end; 4 :  begin 
defineWorld(l,0,vl2,hl2,0); hh:=hl2 ;w:=vl2 ;end; 3 : begin defmeWorld(l,0,v9 ,h9 ,0); hh:=h9 
;w:=v9 ;end; 2 : begin defineWorld(l,0,v6 J i6 ,0); hh:=h6 ;w:=v6 ;end; 1: begin defineWorld(l,0,v5 
,h5,0); hh;=h5 ;w:=v5 ;end;end;
SelectWorld(l); SelectWindow(l); SetBackground(255); DrawBorder; SetColorblack;
q:=0; case I of 0: Letter_F; 1: Letter_H; 2: Letter_I; 3: Letter_C; 4: Letter_T; 5: Letter_E; 6: 
Letter_A; 7; Letter_X; 8: Letter_Y; 9: Letter_V; end;
end;
procedure measure; begin if vbv=l then InitGraphic else EnterGraphic; drawborder; vbv:=vbv+l; 
prepare; selectscreen(l); DrawBorder, DefineWindow(l,4,2,XMaxGlb-4,YMaxGlb-6); case size of 8 : 
begin defineWorld(l,0,v60,h60,0); hh:=h60 ;vv:=v60 ;end; 7 : begin defineWorld(l ,0,v36 Ji36,0); 
hh:=h36 ;vv:=v36 ;end; 6 : begin defineWorld( 1,0,v24,h24,0); hh:=h24 ;vv:=v24 ;end; 5 : begin 
defineWorld(l,0,vl8,hl8,0); hh:=hl8 ;vv:=vl8 ;end; 4 : begin defineWorld(l,0,vl2,hl2,0); hh:=hl2 
;w:=vl2 ;end; 3 : begin defineWorld(l,0,v9 J n 9 ,0); hh:=h9 ;vv:=v9 ;end; 2 ; begin defineWorld(l,0,v6 
,h6,0); hh:=h6 ;w:=v6 ;end; 1: begin defineWorld(l,0,v5 ,h5,0); hh:=h5 ;vv:=v5 ;end; end; 
SelectWorld(l); SelectWindow(l); SetBackground(255); Drawborder; delay(1000); selectscreen(2) ; 
copyscreen;
if respl then begin
tl :=getTime ;ts:=tl; h i ;=NrHour ; m l :=NrMin ; si :=NrSec ; hsl:=NrHoSecs; targetTime; n:=l 
; q:=l; SetColorBlack;
repeat
case I of 0: begin LetterJF; end; 1: begin Letter_H; end; 2: begin Letter_I; end; 3: begin 
Letter_C; end; 4: begin Letter_T; end; 5: begin Letter_E; end; 6: begin Letter_A; end; 7: 
begin Letter_X; end; 8: begin Letter_Y; end; 9: begin Letter_V; end; end;
tl :=getTime; hi :=NrHour ; ml :=NrMin ; si :=NrSec ; hsl:=NrHoSecs; if n=l then begin tas:=tl 
end; n:=n+l; q:=q; until ((h 1 =ht)and((m 1 =m t) OR (hlht))and((sl=st) OR (mlmt)) and((hsl=hst) OR
(slst))); {until keypressed;} end;
t2 :=getTime; selectscreen(l); SelectWorld(l); SelectWindow(l); SetBackground(255); DrawBorder; 
delay(500); leaveGraphic; end;
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procedure recording; begin writeln(’ ALREADY SHOWN LETTER WAS ’ .letter);
writelnr __________________________________________  ’); writeln;
writeln(’PLEASE,ENTER WHAT HAS BEEN RECOGNIZED BY THE PATIENT ’); writeln(’if a
letter.............................enter it ’); writeln(’if nothing...................push space button ’); read(kbd,ch);
if ch= ’ ’ then begin result:=’UNRECOGNIZED’; end else if ch=c then begin
result:=’CORRECT ; end else begin result:=’WRONG’ ; end;
writeln(MAWZ,visSize,’ I ’.visResp,’ I ’.result);
writeln(MAWZ,’_____________________________________________________   ’);end;
procedure previous; begin clrScr; writeln;writeln; writeln;writeln;
writeln(’Test Performed was..’,whichEye,*Eye, ’.’Size ’.visSize ); write(’For the period of \visResp ); 
end;
procedure manual;
procedure continue; begin write(’ WAS ’.result); writeln;
writelnO------------     ’); writeln(’DO YOU WANT TO PERFORM
ANOTHER TEST (ON THE SAME EYE) ? (Y/N) ’); read(Kbd,answer); if ((answer=’Y’) or 
(answer=’y’)) then manual else if ((answen=’N’) or (answer^ ’n’)) then writeln (’O. K. ’) else continue; 
end;
begin sizeOfLet; responce; start; measure; recording; previous; continue; end; 
procedure auto; 
procedure update; begin
case size of 1: visSize:=’l (6/5) ’ ; 2 : visSize:=’2 (6/6) ’ ; 3 : visSize:=’3 (6/9) ’ ; 4 :  visSize:=’4 
(6/12)’ ; 5 : visSize:=’5 (6/18)’ ; 6 : visSize:=’6 (6/24)’ ; 7 : visSize:=’7 (6/36)’ ; 8 : visSize:=’8 (6/60)’ 
; end;
case resp of
1 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=01
2 .-begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=05
3 :begin hp;=00 ;mp:=00 ;sp:=00 ;hsp:=10
4 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=15
5 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=20
6 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=25
visResp:=’00.01 SECS ’ ; interval:=00.01 end;
visResp:=’00.05 SECS ’ ; interval:=00.05 end;
visResp:=’00.10 SECS ’ ; interval:=00.10 end;
visResp:=’00.15 SECS ’ ; interval:=00.15 end;
visResp:=’00.20 SECS ’ ; interval:=00.20 end;
visResp:=’00.25 SECS ’ ; interval:=00.25 end;
7 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=30; visResp:=’00.30 SECS ’ ; interval:=00.30 end;
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8 rbegin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=35; visResp:=’00.35 SECS ’ ; interval:=00.35 end;
9 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=40; visResp:=’00.40 SECS ’ ; interval:=00.40 end;
10 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=45; visResp:=’00.45 SECS ’ ; interval:=00.45 end;
11 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=50; visResp:=’00.50 SECS ’ ; interval:=00.50 end;
12 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=55; visResp:=’00.55 SECS ’ ; interval:=00.55 end;
13 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=60; visResp:=’00.60 SECS ’ ; interval:=00.60 end;
14 -.begin hp:=00 ;mp:=00 ;sp;=00 ;hsp;=65; visResp:=’00.65 SECS ’ ; interval:=00.65 end;
15 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=70; visResp:=’00.70 SECS ’ ; interval:=00.70 end;
16 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=75; visResp:=’00.75 SECS ’ ; interval:=00.75 end;
17 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=80; visResp:=’00.80 SECS ’ ; interval:=00.80 end;
18 :begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=85; visResp:=’00.85 SECS ’ ; interval:=00.85 end;
19 .-begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=90; visResp:=’00.90 SECS ’ ; interval:=00.90 end;
20 .-begin hp:=00 ;mp:=00 ;sp:=00 ;hsp:=95; visResp:=’00.95 SECS ’ ; interval:=00.95 end;
end;
case acuity of 1: result;=’ UNRECOGNIZED ’; 2: result;=’ CORRECT ’; 3: result:^’ WRONG ’; 
end; end;
begin
update; previous; first:=l; writeln; writeln(’ Letter shown was ’detter);
writeln(’. .’); writeln;
writeln(’Enter ’); writeln(’ S if patient answer is correct /  and to try a smaller letter’); writeln;
writeln(’SPACE ...if patient answer is incorrect /  and to try a longer time interval’); writeln; writeln(’
R to repeat already performed test ’); writeln; writeln; writeln(’ T to terminate the automatic runing
’); read(kbd,ch); clrscr; if ch=’ ’ then begin result:=’UNRECOGNIZED’;
writeln(MAWZ,visSize,’ I ’,visResp,’ I ’.result);
writeln(MAWZ,*______________________________
ifresn20then begin resn:=resm-l: size:=size: sounding: measure;
auto; end: end else if ch=V then begin re,sult:=’CORRECT* :
laster:=laster+l; if righting then begin RT[laster,l]:=interval;
RT[laster^]:=size; end; if lefting then begin LFT[laster,l]:=interval; 
LFT[laster^]:=size; end;
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writeln(MAWZ,visSize,’ I ’,visResp,’ I ’.result);
writeln(MAWZ,’______________________________________________________________ ’);
if sizel then begin size:=size-l; resp:=resp; sounding; measure; 
auto; end; end else if ch=’r’ then begin sounding; measure; auto; end
else if ch=’t’ then begin sound(2500); delay(40); nosound; end else auto
end;
procedure manauto; begin clrScr, writeln; writeln; writeln; writeln; writeln(’For \whichEye,’ Eye ’);
writeln(’ How would you like to run the test ? (M/A) ’); writeln; writeln(’M  For Manual ’);
writeln; writeln(’A  For Automatic ’);
writeln(’_______________________________________________________ ’); read(kbd,ans wer); if
answei^’m’ then manual else if answer=’a’then begin First:=0; lasten=0; size:=8 ; resp:= l; 
automatic:=true; sounding; start; measure; auto; end else begin sound(4000); delay(lOO); 
nosound; manauto; end; end;
begin manauto; end;
procedure EyeChoice; begin clrScr; if righting then RTlast:=laster; if lefting then LFTlast:=laster, 
writeln; writeln; writeln; writeln; writeln(’Which Eye Would You Like To Test ? ’); writeln;
writeln(’ R ... For Right Eye ’); writeln; writeln(’ L ... For Left Eye ’); writeln; writeln; writeln; 
writeln; writeln(’ T ... To terminate the test ’);
writeln(’  -’); read(kbd,eye); if ((eye=’L’) OR (eye=T))
then begin whichEye := ’ LEFT ’;
lefting:=true; righting:=false; leftering:=true;
writeln(MAWZ,’ ’); writeln(MAWZ,’ ’); writeln(MAWZ,’ ’); writeln(MAWZ,
whichEye,’EYE TEST’);
writeln(MAWZ,’= = = = = = = = = = = = = = = = = = = = = = = = = =
writeln(MAWZ,’ SIZE I PERIOD I RESULT’);
Wliteln(MAWZ,’= = = = = = = = = = = - .......  -----------I--!-:--::. L .-■== = =
generator, EyeChoice; end else if ((eye =’R’) OR (eye=’r’)) then begin whichEye := ’ RIGHT’;
righting:=true; lefting:=false; rightering:=true;
writeln(MAWZ,’ *); writeln(MAWZ,* *); writeln(MAWZ,* ’); writeln(MAWZ, whichEye,
’EYE TEST’);
writeln(MAWZ,’= = = = = = = = = = = = = = = — = = = = = = = = = = = = = = = ’);
writeln(MAWZ,’ SIZE I PERIOD I RESULT’);
writeln (MAWZ,’= = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = ’);
generator, EyeChoice; end else if ((eye =’T’) OR (eye=’t’)) then begin clrScr; writeln; writeln(’TEST 
IS TERMINATED ’); end else EyeChoice; end;




if RTlastO then begin for demor :=1 to RTlast do write(DBTRE,’,” ,(RT[demor,l]):5:2,’,”); end;
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if RTlast then begin for demor :=RTlast to 7 do {7 not 8 to have correct output} 
w r i t e ( D B T R E , —’,’"’); end;
if LFTlastO then begin for demor :=1 to LFIlast do write(DBTRE,’"’,(LFT[demor,l]):5:2,’"’); end;
if LFTlast then begin for demor :=LFTlast to 7 do {7 not 8} write(DBTRE,’"’,’ ’,’"’); end;
close(DBTRE); end;
begin {MAIN PROGRAM} assign(MAWZ,NUMBER); rewrite(MAWZ); writeln(MAWZ,’
* * * * . *  ’); writeln(MAWZ,’HOS.NUM.r ’.NUMBER); writeIn(MAWZ,’ ’);
writeln(MAWZ,’AGE CODE: \AGE,’ ’:(25-length(AGE)),’SEX: \SEX); writeln(MAWZ,’ ’); 
writeln(MAWZ,’DIAGNOSIS CODE: ’.DIAGNOSIS); writeln(MAWZ,’ ’); writeln(MAWZ,’VAR 
CODE: \VA_RT,’ ’:(24-length(VA_RT)),’VAL CODE: ’,VA_LT); EyeChoice; writeln(MAWZ,’ ’); 
writeln(MAWZ,’ ’); writeln(MAWZ,’ ’); writeln(MAWZ,’ * * * * *  »);
close(MAWZ); FACER; assign(prince,’final.com’); EXECUTE(prince); end.
program printTest;
{$1 typedef.sys} {$1 graphix.sys} {$1 kemel.sys} {$1 windows.sys} {$Iaxis.hgh} {$1 polygon.hgh}
305.00 ; v36 = 508.325; v24 = 762.50 ; vl8 = 1016.66; vl2
= 2033.325; v6 =3050.00; v5 = 3660.00; h60 = 404.00 ; h36 =
= 1010.00; hl8 = 1346.66; hl2 = 2020.00; h9 = 2693.33 ; h6 
= 4848.00;
types  = 1..8 ; r  = 1..20 ; regRecord = record ax,bx,cx,dx,bp,di,si,ds,es,flags rinteger ;
end; timeString = stringfll];
var
LASTNAME :string[8]; FIRSTNAME :string[8]; NUMBER :string[8]; DOB :string[8]; AGE 
:string[2]; SEX :string[l]; DIAGNOSIS :string[4]; VA_RT :string[l]; VA_LT :string[l]; 
OPERATOR :string[8]; DATE :string[8];
whichEye :string[07]; size :s; visSize :string[09]; resp :r, visResp :string[12]; tas,ts :timestring;
eye :char, ch :char; letter :string[03]; n,q :integer, c :char, answer :char; acuity :integer; 
result :string[12]; MAWZ :text; printer :text; DBTRE :text; DBTRENM :STRING[12]; line 
:string[250]; L rinteger; {length of Lastname of patient} a :string[250]; tl,t2,time : 
timeString; NrHour,NrMin,NrSec,NrHoSecs rinteger; hl,h2,ml,m2,sl,s2,hsl,hs2 rinteger; 
hp,mp,sp,hsp,ht,mt,st,hst rinteger; code rinteger; hh,w rreal ; I rinteger; first rinteger; vbv 
rinteger; laster rinteger; RTlast rinteger; LFTlast rinteger; RTJLFT rplotArray; interval rreal ; 
automaticrboolean ; righting rboolean ; righteringrboolean; lefting rboolean ; leftering:boolean ; demor 
rinteger ; getsize rreal ; queen rfile ; prince rfile ;
procedure polydem; begin
setColorwhite; setBackground(0);




673.33 ; h24 
4040.00; h5
if rightering then begin
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if RTlast2 then begin
defineWindow(l,Of10 * Ymaxglb div 100, Xmaxglb ,55 * Ymaxglb div 100);
defineWorld(l,0,9.999,1.08,0); selectWorld(l); selectWindow(l); Draw Axis(9,-8,0,0,25,0,0,0,true);
Drawpolygon(RT,l ,RTlast,2,2,0);
end else begin gotoxy(4,7); writeln(’ curve is not drawn if points less than 3 ’); end; 
for demon=l to RTlast do begin interval:=RT[demor,l]; getsize:=RT[demor,2]; 
size:=trunc(getsize);
case size of 1: visSize:=’l (6/5) ’ ; 2 : visSize:=’2 (6/6) ’ ; 3 : visSize:=’3 (6/9) ’ ; 4 :  visSize:=’4 
(6/12)’ ; 5 : visSize:=’5 (6/18)’ ; 6 : visSize:=’6 (6/24)*; 7 : visSize:=’7 (6/36)’ ; 8 : visSize:=’8 (6/60)’ 
; end;
casedemorof 1 .'begin gotoxy(58,3); writeln(visSize,’ ...\interval:5:2,’ SECS’); end;
2 : begin gotoxy(43,4); write(’ RIGHT EYE ’); gotoxy(58,4); writeln(visSize,’
...’4nterval:5:2,’ SECS ’); end;
3 : begin gotoxy(58,6); writeln(visSize,’ ...’4nterval:5:2,’ SECS ’); end;
4 : begin gotoxy(58,7); writeln(visSize,’ ...’4nterval:5:2,’ SECS ’); end;
5 : begin gotoxy(58,9); writeln(visSize,’ ...*4nterval:5:2,’ SECS ’); end;
6 : begin gotoxy(58,10); writeln(visSize,’ ...’,interval:5:2,’ SECS ’); end;
7 : begin gotoxy(58,12); writeln(visSize,’ ...’,interval:5:2,’ SECS *); end;
8 .'begin gotoxy(58,13); writeln(visSize,’ ,..’,interval:5:2,’ SECS ’); end;
end; end; end;
gotoxy(56,14);writeln(’...........................’);
if lettering then begin 
if LFTlast2 then begin
defineWindow(2,0,55 * Ymaxglb div 100, Xmaxglb, Ymaxglb); defineWorld(2,0,9.999,1.08,0); 
selectWorld(2); selectWindow(2); Draw Axis(9 ,-8,0,0,25,0,0,0,true); Drawpolygon(LFT, 1 ,LFTlast,2,2,0);
end else begin gotoxy(4,19); writeln(’ curve is not drawn if points less than 3 *); end;
for demor:=l to LFTlast do begin interval:=LFT[demor,l]; getsize:=LFT[demor,2];
size:=trunc(getsize);
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case size of 1: visSize:=*l (6/5) ’ ; 2 : visSize:=’2 (6/6) ’ ; 3 : visSize:=’3 (6/9) ’ ; 4 :  visSize:=’4 
(6/12)’ ; 5: visSize:=’5 (6/18)’ ; 6 : visSize:=’6 (6/24)’ ; 7 : visSize:=’7 (6/36)’ ; 8 : visSize:=’8 (6/60)’ 
; end;
casedemorof 1 : begin gotoxy(58,15); writeln(visSize,’ ...’,interval:5:2,’ SECS’); end;
2 :  begin gotoxy(43,16); write(’ LEFT EYE’); gotoxy(58,16); writeln(visSize,’
...’4nterval:5:2,’ SECS ’); end;
3 : begin gotoxy(58,18); writeln(visSize,’ ...’,interval:5:2,’ SECS *); end;
4 : begin gotoxy(58,19); writeln(visSize,* ...*,interval:5:2,’ SECS ’); end;
5 : begin gotoxy(58,21); writeln(visSize,’ ...\interval:5:2,’ SECS ’); end;
6 : begin gotoxy(58,22); writeln(visSize,’ ...\interval:5:2,’ SECS ’); end;
7 : begin gotoxy(58,24); writeln(visSize,’ ...’,interval:5:2,’ SECS ’); end;
8 : begin gotoxy(58,25); writeln(visSize,* ...’,interval:5:2,’ SECS ’); end;
end; end; end; 
end;
procedure DMSTR; begin
clrScr; writeln; writeln; writeln; writeln; writeln(’Do you want to draw the test results ? (Y/N)’); 
read(Kbd,answer); case answer of ’Y’.’y’ : begin entergraphic; polydem;
repeat until keypressed; leavegraphic; end; ’N \ ’n’ :writeln(’O.K. ’); else begin
sound(4000); delay(200); nosound; DMSTR; end; end; end;
procedure print;
begin clrScr, writeln; writeln; writeln; writeln; writeln(’Do you want to print the test results ? (Y/N)’); 
read(Kbd,answer); case answer of *Y\*y* : begin reset(MAWZ);
assign(printer,’PRN’); rewrite(printer); clrScr, writeln(’THE TEST IS
PRINTED’); while not eof(MAWZ) do begin readln(MAWZ,a);
writeln(printer,a); end; close(MAWZ); close(printer); end;
’N’,’n’ : writeln(’O.K.’);
else begin sound(4000); delay(200); nosound; print; end; end; end;
begin
if automatic then DMSTR; print;
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Appendix B4 - Automatic Chart Reader programme listing
#include .h ftinclude alloc.h ti include .h















































































































mainO { intm .r = 60, f = 30 , x = 320, y = 200; static char monitorO = "HALOIBME.DEV"; static char 
scannerD = "HALOCANN.SCN"; static int scanl[18] = {-1,3710, -13250, -1,-1, -1,1,0,-1, -1,-1, -1,-1, -1,-1, 
*1,-1}; static charphotoO = {"try4.pic"}; static charphoutD = {"try5.pic"}; int mode = 5; intmaxcolor; 
int index = 9; int c, a, b, g, h; int n; int x_centre, y_centre; int hold[639]; int z; int col; int o,p; int shift; int
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q,w; int xx,yy,c_up,c_down; int black = 0; int white = 15; int xl_rel, yl_rcl, x2_rel, y2_rel; int qq.ff; 
float &•'/***************************************************/ int xl = 100; intyl = 100; 
int x2 = 300; int y2 = 300; int delta_x, delta_y, bytes, buffer_size; unsigned char s_airay[40006]; int
int x3 = 0, y3=450; int md
x_adjust,y_adjusq int curve_qt,c_check; int pilot; intcurve_temp[6][3]={ {0,0,0}, {0,0,0}, {0,0,0}, 
{0,0,0}, {0,0,0}, {0,0,0} };intpre_filled = 0;intpre_flag;intpre_pilot,pre_p;intpre_ray[6][3]={ 
{0,0,600}, {0,0,600}, {0,0,600}, {0,0,600}, {0,0,600}, {0,0,600} }; int currJilled = 0; int curr_flag; int 
curr_pilot ,curr_p; int curr_ray[6][3]={ {0,0,600}, {0,0,600}, {0,0,600}, {0,0,600}, {0,0,600}, {0,0,600}
}; int next_filled = 0; int next_flag; int next_pilot, next_p; int next_ray[6}[3}={ {0,0,600}, {0,0,600}, 
{0,0,600}, {0,0,600}, {0,0,600}, {0,0,600} }; int observer; intcompare_ray[18][7]; int compare_pilot; int 
pre_diff ,next_diff; int tolerance = 23; /********* allowed tolerance between curve points ***/ int 
next_point; int curve_keep[30][6J; int total_qt; int actual_cur_qt; int user_qt = 3; int row; int temp_place; 
int logic = 0; int firsusecond,third; int compare_curr, int keep_or_not; int xarray[10],yarray[10];
initgraphics(&mode); /* setscan(scanner); setscattr(scanl); gscanQ; gwrite(photo); */ gread(photo);
flood(&index); movabs(&x,&y); inqclr (&x, &y, &index); c = index; while (c != 9) {inqclr (&x, &y,
&c); x - ; } movabs(&x,&y); f* cir(&f);*/a = x; x = 320; movabs(&x,&y); /*cir(&f):*/c = 3; while (c != 
9) { inqclr (&x, &y, &c); x++;} movabs(&x,&y); /*cir(&f);*/b = x; movabs(&a, &y); index = 6 ; 
setcolor(&index); x = b; y = 200; lnabs (&x, &y); /*cir(&r);*/ x = ((a + b)/2) + 1; x_centre = x; 
movabs(&x,&y); /*cir(&r);*/ c = 3; while (c != 9) { inqclr (&x, &y, &c); y--;} g = y; movabs(&x,&g); 
/*cir(&r);*/ y++;y++; /* WHY ? ???????????? */ movabs(&x,&y); c = 3; while (c != 9) { inqclr (&x,
&y, &c); y++;} h = y; movabs(&x,&h); /*cir(&r);*/ setcolor(&index); lnabs(&x,&g); y = (g + h)/2; 
y_centre = y; x = x_centre; movabs(&x,&y); /*cir(&r);*/ c = 3; while (c != 9) {inqclr (&x, &y, &c); x—;
} movabs(&x,&y);/*cir(&f);*/o = x;p = x + 2* (x_centre- o); x = p ; lnabs(&x,&y); 
box(&o,&g,&p,&h); n = 450; scroll(&n); delta_y = (h - g)/2; delta_x = (p - o)/2; shift = 20; q = h + shift 
; w = q + delta_y; index = 0; setcolor(&index); bar(&o,&q,&p,&w); =x_centre.
200; yl = y_centre - 200;
x2 = x_centre; y2 = y_centre;
movefrom(&xl, &yl, &x2, &y2, s_array);
x3 = x_centre - 200; y3 = (h + 20 + ((h - g)/2)) - 200;
for(q q = y3-l; aa (V3+T): -H-oalf forfff=x3-l: ff(x3+ 2):+ + ff) f m ovetof& ff .&ao ,s array .&md1: } 
x2 =  x._ centre - 200; v2 =  v centre - 200: m ovefrom f& xl. & v l. &x2. &v2. s array'); x3 =  o; v3 = o:
for(q q = y 3 -l; aa fv3+l): -h-qqM forfff=x3-l: ff fx3+2): -H-ffl f m ovetof& ff .&aa ,s array .&md): ) 
- 2 0 0 : v l  = e : x 2  =  x centre:v2 =  v centre-200: m ovefrom f& xl. & v l, &x2. &v2. s array}:
x3 =  x_centre - 200; y3 =  q;
for(qq=y3-l; aa fv3+1): + + aa)f forfff=x3-l: f f  fx3+2): -H-fO f m ovetof& ff .&qq .s array .&md): ) 
v_centre - 200: x2 =  x centre - 200: v2 =  v centre: m ovefrom f& xl. & v1. &x2. &v2. s array): x3 =  o: v3 
= jw ^200: fo rfa a = v 3 -l: qq fv3+1): -H-ao)f forfff=x3-l: ff fx3+2): -H-ffl f m ovetof& ff .&aa .s array 
.&md): ) 1
scrollf&n'): index = 6 : setcolorf&indexl: for fvy = Q: yv delta v : - h w H  forfxx = 0 ;x x  delta x: 
±±21201__________M iS l r J i  ggntrg + 7>X\___________ v l rel = v centre+ vv :x 2  rel =  x cen tre-xx: v2 rel =
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inqclr(&xl_rel, &yl_rel, &c_up); inqclr(&x2_rel, &y2_rel, &c_down); 
else */ if((c_up =  white) &(c_down =  white)) ptabs(&xl_rel,&yl_rel);
/* else if c_up = white and c_down = black leave it */ ) )
/* n = -450; scrollf&n);*//* gwrite(phout); */ r_index = 0; a_index = 0; index = 9; setcolor(&index); 
/********************** new *********/ nionoQ; next_point = 0; observer = 1; for (a_index = 0; 
ajndex 10: a index++)f curve ot = 0 :r index =0: c check = 0: while (fr index 83) && fcurve at 5)
) f x adiust =  fx index fa indexlfr indexD + x centre: v adjust = v centre 
fv indexfa indexlfr indexl) - 350):
inqclr(&x_adjust,&y_adjust,&c_check); /*printf("c_check = %d write c_check, r_index =
%dSn",c_check,(50 + (3 * r.index)));*//* c.check = (getchQ - 48) ;*/ if ( (c.check =
83) ) f Dtabsf&x adiust.&v adiust): curve temnfcurve atlF0)=x adiust: curve te
v adiust: curve temDfcurve atlf21= f50+f3  * r index-)): curve at++: while f fc ch eck = = 15)& &
fr index 8 3 ) )(  r index++: x adiust =  fx indexfa indexlfr indexl) + x
fv indexfa indexlfr indexl) - 350): f* nrinrff'write c check, r index = %d\n"/50 +
/* c check = feetch f> -4 8 ):* / inaclrf&x adiust.&v adiust.&c check):
r index++; /* Drintff'r index =  %dW'.r index):*/ 1/* w h ile* /
/*printff"curve qt = .curve qt): for fnilot = 0: Dilot fcurve at -1 ):  Dilot++ )f Drintff"curve ten 
x_=%d.v=%d.r=%d\n".curve temDfDilotlfOl.curve ternDfDilotlfll. curve temt>fnilotlf21): )* /
if  ( (pre.filled  != 1) && ( o b serv er=  1 ) ){  
ore ravrm'lotlfOl =  curve temnfDilotirOl:
for fnilot =  0: Dilot fcurve ot - 1 ): nilot++ ) f 
ore ravfnilotim  = curve tem nfnilotlfll:
ore ravfDilotlf21 = curve temr»fr)ilotir21: )/* for */ ore filled = 1 :  Dre Dilot = curve at:
/*printff"pre pilot =  %d\n".pre pilot): for fDilot = 0: Dilot. fDre Dilot -1 ):  D ilot++)f Drintff"Dre ravx  
% d .\ = % ds=  %d\n".Dre ravfDilotlfOl.Dre ravfDilotim . Dre ravFnilotlf21): ) * / ! /*
i f  ( (curr.filled != 1) && ( ob serv er=  2 ) )f 
curr ravfDilotirOl = curve temnfDilotirOl:
for fnilot =  0: Dilot fcurve at -1 ):  Di1ot++)f 
curr ravfDilotim  =  curve temDfDilotini:
curr ravfDilotir21 =  curve temDfDilotir21: ) /* fo r * /  curr filled =  1: curr i
/*printf("curr_pilot =  %d\n",curr_pilot);
= %d.v =  %d.r= %d)n".curr ravfnilotlfOl.
for fnilot = 0: Dilot fcurr nilot - 1):D ilot++)f nrintff'curr rav 
curr ravfoilotlfll.curr ravfnilotlf21): 1 * /)/*
i f  ( (next.filled  1= 1) && ( ob serv er=  3 ) ){ 
next ravfDilotirOl =  curve temnrnilotirOl:
for fDilot =  0: Dilot fcurve at - 1): nilot++ )f 
next ravfDilotim  = curve ternDfDilotlfll:
next ravfDilotim  = curve temDfDilotir21: 1 f* for */ next filled = 1; next j
/*printf("next_pilot = %d\n",next_pilot); for (pilot = 
x = % d.v=% d.r=  % d V .n ex t ravrDilotirOl.
0: nilot fnext nilot -1 ):  nilot++ ) f  nrintffnext rav
next ravfnilotlfll.next ravfnilotlf21): )* /
)/*  i f * /
=  %d\n",pre_filled,curr_filled,
 ^ c u r r .
next.filled);*/
if ( (pre.filled = 1 )  && (currjilled = 1 )  && (next.filled == 1)) {total.qt = prejpilot + curr_pilot + 
next_pilot;
for (col = 0; col 17:co1++)f for (row = 0: row 6:row-H-)f compare Tavrcolirrowl = 0: 1 V 
/*printf("total_qt = %d, I am in the sorting loopNn ",total_qt);*/
compare_pilot = 0;
pre_p = 0; curr_p = 0; next_p = 0; 
while(compare_pilot (total o t- PM
first = pre_ray[pre_p][2]; second = curr_ray[curr_p][2]; third = next_ray[next_p][2];
if (pre_p =  (pre_pilot)) first = 600; /* dummy */ if (curr_p =  (curr_pilot)) second = 600; f*
dummy */ if (next_p =  (next_pilot)) third = 600; /* dummy */ if ( first second 1 f temp place =
UlSL__________ ore flag = 1: curr flag = 0: next flag = 0: logic. = 1:____ ]__ else, if (first second) f
second: ore, flap =0: curr flag = 1: next flag = 0: logic =1:1
/*printff''pre ravf%dir21=%d.cuiT ravr%dir2i=%d.temo place =%cNi ".pre p. 
first.cnrr n.second.temn place):*/
if ( (third temp place) && (logic =  1)) f temn place = third: pre. flac = 0:___ curr flag = 0:
next flag= 1: 1 /*printfr— next ravr%dir21=%d. temp place =%d\n". next p.third.temo place):*/
/*printf("pre_flag =  %d, curr_flag = %d, next_flag =  %dNn",pre_flag,cun_flag, next_flag);*/
compare_ray[compare_pilot] [0] =  temp_place; /* r value * / i f  ( (pre_flag =  1) &.& (pre_p
(pre_pilot) ) ) {  ++pre_p; }
i f  ((curr_flag =  1 ) )  { compare_ray[compare_pilot][l] = 1; compaie_ray[compare_pilot][5] =
curr_ray [curr_p] [0]; /*x value*/ compare_ray[compare_pilot][6] = curr_ray [ curr_p] [ 1 ]; /*y value*/
i f  (curr_p (cuir_pilot)) +4curr_p; }
if  ( (next_flag =  1) && (next_p (next_pilot) ) )  { ++next_p; }
logic =  0; pre_flag =  0; curr_flag =  0; next_flag = 0; ++compare_pilot; ] /*for (pilot =  0; pilot (total Qt 
-1): -H -pjlotlf printffcom pare rav
r01=%d.nl=%d.r2~l=%d.r31=%d".compare ravfpilotirOl.compare ravrpilofim .com pare ravfr>ilotir21.
compare ravroilotlRlVnrintff". f4)=%dJ51=%d.r61=%(ftn''.compare ravroilotir41. 
compare ravrpilotir51 .compare ravrpilotir6T):_______ I ! /
************** * * * * * * * * * * * /compare pilot = 0: for (compare pilot = 0: compare pilot (total ot-
] ) :  -H-compare pilot) f
compare_curr= compare_ray [compare_pilo t] [ 1 ]; 
if (compare_curr =  1){
if (compare_pilot 0)( pre_diff = compare_ray[compare_pilot][0] - compare_ray[compare_pilot-l][0]; 
if (pre_diff 0) (pre_diff = - pre_diff); compare_ray[comparejpilot] [2] = pre_diff; ]
if (compare_pilot (total_qt- 1)){ next_diff = compare_ray[compare_pilot][0] - 
comparc_ray[compare_pilot+l][0]; if (next_diff 0) (next_diff = - next_diff);
compare_ray[compare_pilot][3] = next_diff; } } } /* for *//*printf("\n,\n,Nn,\n");
printf("********difference********\n,\n,\n");
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for (pilot = 0; pilot (total at -1): nilot-H-1 f PrintfC'compare rav
mi=%d.ni=%d.r2lg%d.ni=%d".compare ravfpilotlfOl.compare. ravrpilotirn.comparc ravfpilotir21.
 compare ravrnilotir31):printfr.l41=%d.r51=%d.r61=9fdSn"-xompare ravfp ilotim .
 compare- ravfpilotim.compare- ravfpilotim i; LI/
TOLER ANCE*******»»»»****\n\n\nlnn:V  compare pilot =  0: for (compare pilot = 0: compare pilot 
(total ot - 1 ) :  ~H~compare pilot) f compare curr=com pare ravlcompare pilotir.ll:
if  (compare_curr =  1) {
if (compare_pilot =  0) { if (compare_ray[compare_pilot][2] tolerance-1 f* 5 pixel */
(compare- ravrcompare pilotlf41 = 11:_________________________________ I
if ( (compare_pilot 0) && (compare_pilot total_qt) )  ( if ( (compare_tay[compare_pilot][2],
tolerancel &&_________________________ _  (compare- ravrcompare pilot1f31 tolerancel 1_________ (comp;
if (compare pilot =  total o tlf i f  (compare ravfcompare- p ilo tim  tolerance)
(compare ravfcompare pilot1141 = 11:________________________________ }_____1 f* if  » /1  /*for*/ /*for (pilot = 0: pilo
Pilot-H-K prim fr compare rav
f01=%d.ni=%d.[21g%d.r31=%d".compare ravrpilotirOl.comnare T avfp ilotim .com nare r a v fp ilo tm
 compare- ravfpilotir311:printf(". f41=%d J5l=%d.r6l=%d\n".compare ravrpilotir41.
 compare- ravfpilotim .com pare ravfpilotim i:_______ L I/
(compare pilot =  0: compare pilot (total ot - 1 1 : -H-compare pilot) f
if (compare_ray[compare_pilot][4] =  1) actual_cur_qt = actual_cur_qt + 1; }/* for */
tNn^ .N i i  ****** CHECK USER 
(actual_cur_qt — user_qt){ row = 0; for (compare_pilot = 0; 
compare pilot (total ot -11: -t-tcompare pilot) f keep or not = compare ravfcompare pilotir41:if
(keep or not = 1 1 1 / * ___________ curve keepfnext pointirrowl = 0; to initialise- - /c u r v e  keepfnext pointlfrowl.
compare ravfcompare p ilotirsi:/*  curve keepfnext pointlfrowl = Q: to initialise. *//*printf("oddrow  
=%d^i"jow1:*/ -M-row: curve keepfnext pointlfrowl = compare ravfcompare pilotir61:
H _______________printf("even row =%dVn"jow1:*/ -H-row: 1 1 f* for * / (*printf("curve keepfnext poi)
curve keepfnext pointiril = %d". curve keepfnext point!f01 .curve- keepfnext poin tlflll:  
printf("curve keepfnext point1f21=%d. curve keeplnext PointlOl =  %d".
curve keepfnext pointlf21 .curve keepfnext noint1f311:printffncurve keepfnext point1f4f=%d. 
curve keepfnext pointir51 =  %d". curve keepfnext point1f41.curve keepfnext point! f511:*/ 
next noint-H-: 1 filled =  0 ;/*  onlvnext »/pre pilot =
curr pilot: curr pilot =  next pilot: logic =  0: for (pilot =  0; pilot5: pilot-M-1 f pre ravfpilotirOl = 0: 
pre ravfpilotin i =  0: pre ravfpilotlf21 =  600:1 for (pilot =  0: pi1ot5: pjlot++l f for (row = 0: row
2UQw-H-).f pre Tavfpilotlfrow^curT ravfpilotlfrpwl: 1 I
curr ravfpilotlfOl =  0: curr ravfp ilotin i = 0: curr ravfpilotir21 =  600; 1 for (pilot =  0: pilot5:
Dilot+4-1 f „ for (row = 0: row 2: row-n-1 (________ curr ravfpilotlfrowl = next ravfpilotlfrowl: 11
next ravfpilotirOl =  0: next ravfp ilotin i = 0: next ravfpilotin i =  600; 1
^ * * * * * * * * * * * * * * * * * * ^
f for (row = Q: row 2: row-f+1 f printfCpre ravfpilotirrowl = %d V .nre ravfpilotlfrowl): 1 1
printf(,’\n>n.\n.\n.\n.****** AKER SWAPPlNO***************\n\nVi\n',l: for (nilot = 0: nilot5: 
pilot-H-1 f for (row = 0: row 2: row-f+1 f DrintfTcurr ravrpilotirrowl = %d W.curr ravfnifotlfrowlf:
) 1 for (pilot = 0: pjlot5: pilot-M-1 f for (row = 0: to w  2: row-M-1 f printfCnext ravfpilotlfrowl = %d 
NnLnext ravrnilntirmwll: 1 1 */?> ■*•••**************•*•*****/) /* h in if  * //*  next noint-M-r ♦/
observer++: i f  (observer =  41 observer =  3:1  f* big for » / /*printff observer =  % dn".observer1:*/ index
r J ;  gttT O lorfftinflw );
for(ajndex = 0 ;aJndex (next point-11:a index++lf x = curve keepfa indexir01:x =
xarravfa indexl: v = curve keenfa indexlfU: v = varravfa indexl:ptabsf&x.&v):/*printf("xl= %d.vl =
%d\n".x.v1:*/x = curve keenfa indexlf21: v = curve keepfa indexlf31:ptabs(&x.&vV. /*printf("x2=
%d. v2 = %d Vn".x.v1:*/ x = curve keenfa indexir41:v = curve keepfa indexlFSI; Dtabsf&x.&vl:
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/*printfT"x3= %d. v3 = % d\n".x.vV */1 movabs(&x centre.&v centre): r - 3 0 0 :  a l = -0.3926991: a2 =
0.0: index = 9 :  setcolorf&index): pie(&r.&al.&a2.&index): x = x centre+5: v = v centre+1: 
movabsf&x.&v): s = 9: index =  9: flood2(&index.&s): index = 0: setcolorf&indexV. 
pie(&r.&al.&a2.&index):
index = 15; setcolor(&index);
for (a_index = 0; a_index (next m in t -1): a index-H-)f xarravfa index) =  curve keenfa indexlfOl: 
varravfa index) =  curve keenfa in d e x lf l l : ) f* s =  next p ilo t- l : x  = xarravf01: v =  varravf01: 
movabs(&x.&v): for (a index = 0: a index (next p o in t-1 ): a index++)f x =  xarravfa index): v =  
varravfa index): ptabs(& x.& v.& s):) ♦ /
for (a_index = 0; a_index (next n o in t-1 ): a index++)f x = curve keepfa indcxlfOl: v = 
curve keepfa indexlfll: ntabs(&x.&v): /*printf("xl= %d. v l =  %d V -x .y l-* /x  = 
curve- keenfa indexlf21: v =  curve keenfa indexlf31:ptahs(&x.&v): /*printf("x2= %d. v2  =  %d 
Vi".x.v):*/x =  curve keenfa indexlf41:v =  curve keenfa indexlf51: ntabs(&x.&v):/*printf(''x3= %d. v3 
=  % d \n \x .v ):* /1
gwrite(phout); closegraphicsQ: }/* main * /
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0 0 1 .  SEX:
1 MALE 2 FEMALE
0 0 2 .  GEOGRAPHICAL DISTRIBUTIO N:
0 OUTSIDE GLASGOW 1 
0 0 3 .  CONSULTANT:
■85 G 1-G 85
0 DATA NOT AVAILABLE
1 DR. CANT 2 PROF
3 DR. DUDGEON 4 DR. ,
5 DR. DUTTON [ SENIOR LECTURER ]
. AGE OF ONSET ( IN IT IA L ) : I  N
, DURATION OF THYROID D ISEA SE: I  N
. VISUAL ACUITY ( R ) :
00 DATA NOT AVAILABLE
01 NPL 10 6 /6 0
02 PL 11 6 /3 6
03 HM 12 6 /2 4
04 CF 13 6 /1 8
05 1 /6 0 14 6 /1 2
06 2 /6 0 15 6 /9
07 3 /6 0 16 6 /6
08 4 /6 0 17 6 /5
09 5 /6 0 18 6 /4
VISUAL ACUITY ( L ) :
00 DATA NOT AVAILABLE
01 NPL 10 6 /6 0
02 PL 11 6 /3 6
03 HM 12 6 /2 4
04 CF 13 6 /1 8
05 1 /6 0 14 6 /1 2
06 2 /6 0 15 6 /9
07 3 /6 0 16 6 /6
08 4 /6 0 17 6 /5
09 5 /6 0 18 6 /4
LIE! LAG ( R ) :
0 DATA NOT AVAILABLE
NO
0 0 9 .  LID  LAG (L)
YES
M O N T H E S
0 DATA NOT AVAILABLE
1 NO YES
0 1 0 .  LID  RETRACTION ( R ) :
0 DATA NOT AVAILABLE
1 NO
0 1 1 .  LID  RETRACTION ( L ) :
0 DATA NOT AVAILABLE 
' 1 NO
0 1 2 .  LID  OEDEMA ( R ) :
0 DATA NOT AVAILABLE
1 NO
0 1 3 .  LID  OEDEMA ( L ) :
0 DATA NOT AVAILABLE
1 NO
0 1 4 .  CHEMOSIS ( R ) :
0 DATA NOT AVAILABLE
1 NO
0 1 5 .  CHEMOSIS ( L ) :
0 DATA NOT AVAILABLE
1 NO
0 1 6 .  PTO SIS ( R ) :
0 DATA NOT AVAILABLE
1 NO
0 1 7 .  PTO SIS ( L ) :
0 DATA NOT AVAILABLE
1 NO
0 1 8 .  CORNEA ( R ) :




0 1 9 .  CORNEA ( L ) :




0 2 0 .  DISK OEDEMA ( R ) :















0 2 1 .  D ISK  OEDEMA ( L ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 2 2 .  CHOROIDAL FOLDS ( R ) :
0 DATA NOT AVAILABLE
1 NO YES
0 2 3 .  CHOROIDAL FOLDS ( L ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 2 4 .  I . O . P  STRAIGHT ( R ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 2 5 .  I . O . P  STRAIGHT ( L ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 2 6 .  I . O . P .  UP ( R ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 2 7 .  I . O . P .  UP ( L ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 2 8 .  EXOPHTHALMOMETRY ( R ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 2 9 .  EXOPHTHALMOMETRY ( L ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 3 0 .  SYMPTOM OF D IP L O P IA :
0 DATA NOT AVAILABLE
1 NONE 2 MILD
3 MODERATE 3 SEVER
0 3 1 .  D IPLO PIA  ON EXAMINATION:
0 DATA NOT AVAILABLE
1 ABSENT 2 ON ELEVATION/DEPRESSION
3 ON ADDUCTION/ABDUCTION 4 CLOSE TO MID LINE
5 IN EXTREME GAZE 6 AFTER SURGERY
0 3 2 .  EXTRA-OCULAR MOVEMENTS & HESS CHART ( R ) :
0 DATA NOT AVAILABLE
1 NORMAL 2
3 RESTRICTED ON DOWN GAZE 4
5 RESTRICTED ON ADDUCTION 6
7 RES. ADD & ABD 8
9 FIXED EYE
RESTRICTED ON UP GAZE 
RES. UP & DOWN GAZE 
RESTRICTED ON ABDUCTION 
COMBINATION OF RESTRICTIONS
0 3 3 .  EXTRA-OCULAR MOVEMENTS & HESS CHART ( L ) :
0 DATA NOT AVAILABLE
1 NORMAL
3 RESTRICTED ON DOWN GAZE 
5 RESTRICTED ON ADDUCTION 
7 RES. ADD & ABD 
9 FIXED EYE
0 3 4 .  FIELD S c o r e  ( R ) :
0 DATA NOT AVAILABLE 
S c o r e
0 3 5 .  FIELD S c o r e  ( L ) :
0 DATA NOT AVAILABLE 
S c o r e
0 3 6 .  FIELD LOSS PATTERN ( R ) :
2 RESTRICTED ON UP GAZE 
4 R ES. UP & DOWN GAZE 
6 RESTRICTED ON ABDUCTION 
8 COMBINATION OF RESTRICTIONS
0 DATA NOT AVAILABLE
1 NO LOSS
3 ONLY PERIPHERAL 
5 MORE THAN ONE QUADRANT
0 3 7 .  FIELD LOSS PATTERN ( L ) :
0 DATA NOT AVAILABLE
1 NO LOSS
3 ONLY PERIPHERAL 
5 MORE THAN ONE QUADRANT
0 3 8 .  FM -100 HUE S c o r e  ( R ) :
0 DATA NOT AVAILABLE 
S c o r e
0 3 9 .  FM -100 HUE S c o r e  ( L ) :
0 DATA NOT AVAILABLE 
S c o r e
0 4 0 .  AXIS FM -100 HUE ( R ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 4 1 .  AXIS FM -100 HUE <L) :
2 ONLY CENTRAL LOSS 
4 PERIPHERAL IN ONE QUADRANT 
6 CONCENTRIC CONTRACTION
2 ONLY CENTRAL LOSS 
4 PERIPHERAL IN ONE QUADRANT 
6 CONCENTRIC CONTRACTION
0 DATA NOT AVAILABLE 
R e a d in g
0 4 2 .  FLUORESCEIN ( R ) :
0 DATA NOT AVAILABLE
1 NOT DONE 
3 ABNORMAL
2 NORMAL
0 4 3 . FLUORESCEIN ( L ) :
0 DATA NOT AVAILABLE
1 NOT DONE 
3 ABNORMAL
2 NORMAL
0 4 4 . ORBITAL X -  RAYS ( R ) :
0 DATA NOT AVAILABLE
1 NOT DONE 
3 ABNORMAL
2 NORMAL
0 4 5 . ORBITAL X -  RAYS ( L ) :
0 DATA NOT AVAILABLE
1 NOT DONE 
3 ABNORMAL
2 NORMAL
0 4 6 . ORBITAL U /S  ( R ) :
0 DATA NOT AVAILABLE
1 NOT DONE 
3 ABNORMAL
2 NORMAL
0 4 7 . ORBITAL U /S  ( L ) :
0 DATA NOT AVAILABLE
1 NOT DONE 
3 ABNORMAL
2 NORMAL
0 4 8 . THYROID STATUS (AT ONSET) :






TH YRO ID ITIS
0 4 9 . GOITRE:
0 DATA NOT AVAILABLE
1 NO 2 YES
0 5 0 . PRETIB IA L DERMOPATHY:
0 DATA NOT AVAILABLE
1 NO 2 YES
0 5 1 . THYROID ACROPACHY:
0 DATA NOT AVAILABLE
1 NO 2 YES
0 5 2 . MYOPATHY:
0 DATA NOT AVAILABLE
1 NO 2 YES
0 5 3 .  CARDIAC FAILURE:
0 DATA NOT AVAILABLE
1 NO 2 YES
0 5 4 .  SERUM P . B . I . :
0 DATA NOT AVAILABLE 
R e a d in g
0 5 5 .  T3 RESIN UPTAKE :
0 DATA NOT AVAILABLE 
R e a d in g
0 5 6 .  RESIN UPTAKE RATIO:
0 DATA NOT AVAILABLE 
R e a d in g
0 5 7 .  "FREE THYROXIN IN D EX ":
0 DATA NOT AVAILABLE 
R e a d in g
0 5 8 .  RADIOIODINE UPTAKE:
0 DATA NOT AVAILABLE 
R e a d in g
0 5 9 .  TOTAL T 4:
0 DATA NOT AVAILABLE
R e a d in g
0 6 0 .  TOTAL T 3 :
0 DATA NOT AVAILABLE
R e a d in g
0 6 1 .  TSH :
0 DATA NOT AVAILABLE
R e a d in g
0 6 2 .  R x . CARBIMAZOLE ONLY:
0 DATA NOT AVAILABLE 1 NO
0 6 3 .  Rx_. PROPRANOLOL:
0 DATA NOT AVAILABLE 1 NO
0 6 4 .  RXj. T 4 :
0 DATA NOT AVAILABLE 1 NO
0 6 5 .  Rx_. T 3 :





0 6 6 .  R x . RADIOIODINE:
0 DATA NOT AVAILABLE 1 NO
0 6 7 .  PARTIAL THYROIDECTOMY:
0 DATA NOT AVAILABLE 1 NO









0 7 3 ,
0 DATA NOT AVAILABLE 
HISTOPATHOLOGY ( T h y r o i d )  
0 DATA NOT AVAILABLE 
DIABETES:
0 DATA NOT AVAILABLE
HPERTENSION:
0 DATA NOT AVAILABLE
DATA NOT COMPLETE:
COMPLETE 1













0 7 4 .  DURATION ( FINAL ) : Y E A R S
0 7 5 .  VISUAL ACUITY (R) ( FINAL ) :
00 DATA NOT AVAILABLE
01 NPL 10 6 / 6 0
02 PL 11 6 / 3 6
03 HM 12 6 / 2 4
04 CF 13 6 /1 8
05 1 / 6 0 14 6 /1 2
06 2 / 6 0 15 6 / 9
07 3 / 6 0 16 6 / 6
08 4 / 6 0 17 6 / 5
09 5 / 6 0 18 6 / 4
VISUAL ACUITY (L) ( FINAL ) :
00 DATA NOT AVAILABLE
01 NPL 10 6 / 6 0
02 PL 11 6 / 3 6
03 HM 12 6 / 2 4
04 CF 13 6 / 1 8
05 1 / 6 0 14 6 /1 2
06 2 / 6 0 15 6 / 9
07 3 / 6 0 16 6 / 6
08 4 / 6 0 17 6 / 5








0 7 7 .  L ID  LAG (R) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 7 8 .  L ID  LAG (L) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 7 9 .  LID  RETRACTION (R) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 8 0 .  L ID  RETRACTION (L) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO
0 8 1 .  LID  OEDEMA (R) ( FINAL
0 DATA NOT AVAILABLE
1 NO
0 8 2 .  L ID  OEDEMA (L ) ( FINAL
0 DATA NOT AVAILABLE
1 NO
0 8 3 .  CHEMOSIS (R) ( FINAL )
0 DATA NOT AVAILABLE
1 NO
0 8 4 .  CHEMOSIS (L ) ( FINAL )
0 DATA NOT AVAILABLE
1 NO
0 8 5 .  PTO SIS (R) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO
0 8 6 .  PTO SIS (L) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO
0 8 7 .  CORNEA (R) ( FINAL ) :













S TIPPL IN G
NECROSIS, PERFORATION
0 8 8 .  CORNEA (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NORMAL 2 STIPPLIN G
3 ULCER 4 NECROSIS, PERFORATION
5 SCARRING
0 8 9 .  DISK OEDEMA <R> ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 9 0 .  DISK OEDEMA (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 9 1 .  CHOROIDAL FOLDS (R) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 9 2 .  CHOROIDAL FOLDS (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2 YES
0 9 3 .  I . O . P  STRAIGHT (R) ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
0 9 4 .  I . O . P  STRAIGHT (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
R e a d in g
0 9 5 .  I . O . P .  UP (R)  ( FINAL ) :
0 DATA NOT AVAILABLE
R e a d in g
0 9 6 .  I . O . P .  UP (L)  ( FINAL ) :
0 DATA NOT AVAILABLE
R e a d in g
0 9 7 .  EXOPHTHALMOMETRY (R) ( FINAL ) :
0 DATA NOT AVAILABLE
R e a d in g
0 9 8 .  EXOPHTHALMOMETRY (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
R e a d in g
0 9 9 .  SYMPTOM OF D IPLO PIA  ( FINAL ) :
0 DATA NOT AVAILABLE
1 NONE 2 MILD
3 MODERATE 3 SEVER
100. DIPLOPIA ON EXAMINATION ( FINAL )
0 DATA NOT AVAILABLE
1 ABSENT 2 ON ELEVATION/DEPRESSION
3 ON ADDUCTION/ABDUCTION 4 CLOSE TO MID LINE
5 IN EXTREME GAZE 6 AFTER SURGERY
1 0 1 .  EXTRA-OCULAR MOVEMENTS & HESS CHART (R) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NORMAL 2
3 RESTRICTED ON DOWN GAZE 4
5 RESTRICTED ON ADDUCTION 6
7 RES.  ADD & ABD 8
9 FIXED EYE
1 0 2 .  EXTRA-OCULAR MOVEMENTS & HESS CHART (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NORMAL
3 RESTRICTED ON DOWN GAZE
5 RESTRICTED ON ADDUCTION
7 RES.  ADD & ABD
9 FIXED EYE
1 0 3 .  FIELD S c o r e  (R) ( FINAL ) :
0 DATA NOT AVAILABLE
S c o r e
1 0 4 .  FIELD S c o r e  (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
S c o r e
1 0 5 .  FIELD LOSS PATTERN (R) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO LOSS 2 ONLY CENTRAL LOSS
3 ONLY PERIPHERAL 4 PERIPHERAL IN ONE QUADRANT
5 MORE THAN ONE QUADRANT 6 CONCENTRIC CONTRACTION
1 0 6 .  FIELD LOSS PATTERN (L ) ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO LOSS 2 ONLY CENTRAL LOSS
3 ONLY PERIPHERAL 4 PERIPHERAL IN ONE QUADRANT
5 MORE THAN ONE QUADRANT 6 CONCENTRIC CONTRACTION
1 0 7 .  FM -100 HUE S c o r e  (R) ( FINAL ) :
0 DATA NOT AVAILABLE
S c o r e
1 0 8 .  FM -100 HUE S c o r e  (L ) ( FINAL ) :
2 RESTRICTED ON UP GAZE 
4 RES. UP & DOWN GAZE 
6 RESTRICTED ON ABDUCTION 
8 COMBINATION OF RESTRICTIONS
RESTRICTED ON UP GAZE 
RES. UP & DOWN GAZE 
RESTRICTED ON ABDUCTION 
COMBINATION OF RESTRICTIONS
0 DATA NOT AVAILABLE 
Score
109. AXIS FM-100 HOE (R) ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
110. AXIS FM-100 HUE (L) ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
111. FLUORESCEIN (R) < FINAL ) :
0 DATA NOT




1 1 2 . FLUORESCEIN (L ) ( FINAL ) •'
0 DATA NOT




1 1 3 . ORBITAL X - RAYS ( R ) ( FINAL ) :
0 DATA NOT




1 1 4 . ORBITAL X - RAYS (L ) ( FINAL ) :
0 DATA NOT




1 1 5 . ORBITAL U /S (R ) ( FINAL ) ’•
0 DATA NOT




1 1 6 . ORBITAL U /S (L ) ( FINAL ) :
0 DATA NOT



















1 2 0 .  DECOMPRESSION (L ) ( FINAL )
0 DATA NOT AVAILABLE
1 NO 2
1 2 1 .  MUSCLE SURGERY (R) ( FINAL
0 DATA NOT AVAILABLE
1 NO 2
1 2 2 .  MUSCLE SURGERY (L ) ( FINAL
0 DATA NOT AVAILABLE
1 NO 2
1 2 3 .  GUANETHIDINE ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2
1 2 4 .  SYSTEMIC STEROIDS ( FINAL )
0 DATA NOT AVAILABLE
1 NO 2
1 2 5 .  THYROID STATUS ( FINAL ) :
0 DATA NOT AVAILABLE
1 HPERTHYROID 2
3 EUTHYROID 4
1 2 6 .  GOITRE ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2
1 2 7 .  PR ETIB IA L ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2
1 2 8 .  THYROID ACROPACHY ( FINAL )
0 DATA NOT AVAILABLE
1 NO 2
1 2 9 .  MYOPATHY ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2
130. CARDIAC FAILURE ( FINAL ) :
0 DATA NOT AVAILABLE
1 NO 2
1 3 1 .  SERUM P . B . I .  ( FINAL ) :
















1 3 2 .  T3 RESIN UPTAKE ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
1 3 3 .  RESIN  UPTAKE RATIO { FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
1 3 4 .  "FREE THYROXIN INDEX" ( FINAL )
0 DATA NOT AVAILABLE 
R e a d in g
1 3 5 .  RADIOIODINE UPTAKE ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
1 3 6 .  TOTAL T4 ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
1 3 7 .  TOTAL T3 ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
1 3 8 .  TSH ( FINAL ) :
0 DATA NOT AVAILABLE 
R e a d in g
1 3 9 .  Rx^ CARBIMAZOLE ONLY ( FINAL )
0 DATA NOT AVAILABLE 1 NO 2 YES
1 4 0 .  Rj^. PROPRANOLOL ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO
1 4 1 .  Rx_. T4 ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO
1 4 2 .  Rx .  T3 ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO
1 4 3 .  RXj. RADIOIODINE ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO
1 4 4 .  PARTIAL THYROIDECTOMY ( FINAL ) 






1 4 5 .  TOTAL THYROIDECTOMY ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO 2
1 4 6 .  HISTOPATHOLOGY ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO 2
1 4 7 .  DIABETES ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO 2
1 4 8 .  HPERTENSION ( FINAL ) :
0 DATA NOT AVAILABLE 1 NO 2
1 4 9 .  DATA NOT COMPLETE { FINAL ) :
1 MICROFICHE 2 CASE NOTE NOT
3 INFORMATION NOT WRITTEN
1 5 0 .  PATIENT ALIVE ( FINAL ) :
1 NO 2 YES
1 5 1 .  APPOINTMENT SENT ( FINAL ) :
1 NO 2 ATTENDED 3 D.N
1 5 2 .  FOR DETAILED DISEASE PATTERN :
1 NO 2 YES
1 5 3 .  CALL THE PATIENT :






Appendix C2 - SPSS/PC+
SPSS/PC+ is a data analysis software family which consists of a  base 
package plus a  num ber of add-on options. It has been adapted for the IBM/PC 
and compatible computers from the original SPSSx which has been w ritten for 
Mainframe computers.
SPSS/PC DATA ENTRY n  MODULE is an  integrated data entry, cleaning 
and editing tool with user-defined skip logic, rules and input screens. It creates 
a spread sheet format or custom designed forms for entering data into SPSSx, or 
other leading software such as Lotus 1-2-3 and dBase, and translates any of 
these files directly into another.
The SPSS/PC+ BASE MODULE contains all data and file handling rou­
tines; descriptive, categorical, correlation, regression, and analysis of variance 
procedures; in addition to full report writing and plotting functions. This module 
is necessary to running the other options.
SPSS/PC ADVANCED STATISTICS MODULE contains sophisticated 
statistical procedures such as factor, discriminant analyses, and multivariate 
analysis of variance.
SPSS/PC TABLES displays results in any tabular form, from complex 
stub  and banner cross tabulations and display of multiple response data to fre­
quency counts and descriptive statistics.
SPSS/PC+ DATA ENTRY n  runs under PC or MS DOS 2.0 or later on IBM 
PC’s and m any compatibles with 512 memory. A hard disk is highly recom­
mended. The SPSS/PC+ family runs under PC or MS DOS 2.0 or later on IBM 
PC/XTs or ATs and many compatibles. Minimum requirements ranges from 384 
to 640 KB depending on the modules available.
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Appendix C3 - Selected summary statistics and conten- 
gency tables of dysthyroid ophthalmopathy patients.
LIST OF TABLES
A.1 Follow-up peroid.
A.2 Duration of thyroid eye disease.
A.3(a) Age.
A.3(b) Sex.
A.4 Thyroid status by decompression.
A.5 Diplopia by muscle surgery.
A.6(a) Diplopia on examination by muscle surgery.
A.6(b) Muscle surgery by ocular motility.
A.7 Final thyroid status.
A.8 Age group by sex.
A.9 Frequency of age groups.
A.10 Frequency of groups of follow-up peroid.
A.11 Thyroid status.
A.12 Treatment of hyperthyroidism prior to onset.
A.13 Thyroid myopathy by diplopia on examination.
A.14 Relation between thyroid and ocular myopathy.
A.15 Treatment of thyroid dysfunction by severity.
A.16 Duration of thyroid dysfunction by severity.
A. 17 Duration of thyroid dysfunction of the series.
A.18 Duration of thyroid dysfunction by thyroidectomy.
A.19 Duration of thyroid dysfunction by radioiodine.
A.20 Initial and final acuity by severity.
A.21 Mean age by sex by severity.
A.22 Extraocular muscle surgery by severity.
A.23 Mean age by sex by severity.
A.24 Mean duration of thyroid dysfunction by sex.
A.25 Mean duration of thyroid dysfunction by age.
A.26 Mean follow-up by sex by severity.
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A.27 Mean follow-up by severity by sex.
A.28 Intraocular pressure by severity.
A.29 Intraocular pressure (final) by severity.
A.30 Intraocular pressure ‘up’ by severity.
A.31 Intraocular pressure ’up’ (final) by severity.
A.32 Exophthalmos by severity.
A.33 Exophthalmos (final) by severity.
A.34 Tarsorrhaphy by severity.
A.35 Guanethidine treatment by severity.
A.36 Age group by severity.
A.37 Duration category of dysthyroidism by severity.
A.38 Follow-up period category by severity.
A.39 Lid lag by severity.
A 40 Lid lag (final) by severity.
A.41 Lid retraction by severity.
A.42 Lid retraction (final) by severity.
A.43 Lid oedema by severity.
A.44 Lid oedema (final) by severity.
A.45 Chemosis by severity.
A.46 Chemosis (final) by severity.
A.47 Ptosis by severity.
A.48 Cornea by severity.
A.49 Cornea (final) by severity.
A.50 Disc oedema by severity.
A.51 Choroidal folds by severity.
A.52 Diplopia by severity.
A.53 Diplopia (final) by severity.
A.54 Diplopia on examination by severity.
A.55 Diplopia on final examination by severity.
A.56 Ocular motility by by severity.
A.57 Ocular motility (final) by severity.
A.58 Thyroid status by severity.
A.59 Thyroid status (final) by severity.
A.60 Goitre by severity.
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A.61 Goitre (final) by severity.
A.62 Pretibial dermopathy by severity.
A.63 Pretibial dermopathy (final) by severity.
A.64(a) Thyroid acropachy by severity.
A.64(b) Thyroid acropachy (final) by severity.
A.65 Thyroid myopathy by severity.
A.66 Thyroid myopathy by severity.
A.67 Cardiac failure by severity.
A.68 Carbimazole by severity.
A.69 Carbimazole (final) by severity.
A.70 Propranolol treatment by severity.
A.71 Propranolol (final) by severity.
A.72 Thyroxine treatment by severity.
A.73 Thyroxine treatment (final) by severity.
A.74 Triiodithyronine by severity.
A.75 Triiodothyronine (final) by severity.
A.76 Radioactive iodine treatment by severity.
A.77 Radioactive iodine treatment ( final) by severity
A.78 Partial thyroidectomy by severity.
A.79 Parital thyroidectomy (final) by severity.
A.80 Diabetes by severity.
A.81 Diabetes (final) by severity.
A.82 Hypertension by severity.
A.83 Hypertension (final) by severity.
A.84 Decompression by steroids.
A.85 Sex by mean age by treatment.
A.86 Sex duration of thyroid dysfunction treatment
A.87 Sec by follow-up peroid by treatment.
A.88 Visual acuity by treatment.
A.89 Visual acuity (final) by treatment
A.90 Decompression by lid lag.
A.91 Decompression by lid lag (final).
A.92 Decompression by lid retraction.
A.93 Decompression by lid retraction (final).
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A.94 Cornea by lid lag.
A.96 Cornea (final) by lid lag (final).
A.97 Cornea by lid retraction.
A.98 Cornea (final) by lid retraction (final).
A.99 Treatment by lid oedema.
A. 100 Treatment by lid oedema (final).
A.101 Treatment by chemosis.
A.102 Treatment by chemosis (final).
A. 103 Treatment by cornea.
A.104 Treatment by cornea (final).
A. 105 Treatment by disc oedema.
A. 106 Treatment by choroidal folds.
A. 107 Treatment by diplopia.
A. 108 Treatment by diplopia (final).
A. 109 Mean intraocular pressure by treatm ent
A.110 Mean intraocular pressure (final) by treatment.
A.111 Mean Intraocular pressure 'up' by treatment.
A.112 Intraocular pressure ’up* (final) by treatm ent
A.113 Exophthalmos by treatment
A.114 Exophthalmos (final) by treatm ent
A.115 Tarsorrhaphy by treatm ent
A.116 Muscle surgery by treatm ent
A.117 Guanethidine treatm ent
A.118 Treatment by goitre.
A.119 Treatment by goitre (final).
A. 120 Treatment by carbimazole.
A.121 Treatment by carbimazole (final).
A. 122 Treatment by propranolol.
A.123 Treatment by propranolol (final).
A.124 Treatment by Thyroxine.
A. 125 Treatment by Thyroxine (final).
A.126 Treatment by Triiodothyronine.
A.127 Treatment by Triiodothyronine (final).
A. 128 Treatment by radioiodine.
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A.129 Treatment by radioiodine (final).
A.130 Treatment by partial thyroidectomy.
A.131 Treatment by partial thyroidectmoy (final).
A.132 Treatment by diabetes.
A.133 Treatment by diabetes (final).
A. 134 Treatment by hypertension.
A.135 Treatment by hypertension (final).
A. 136 Diplopia on examination by treatm ent
A.137 Diplopia on examination (final) by treatm ent
A.138 Ocular motility by treatment
A.139 Ocular motility (final) by treatment.
A.140 Thyroid status by treatm ent
A.141 Thyroid status (final) by treatment.
A.142 Pretibial dermopathy by treatm ent
A.143 Pretibial dermopathy (final) by treatment.
A. 144 Muscle surgery by treatment
A.145 Signs of optic nouropathy by treatment.
A.146 Sex by mean age of decompression group.
A. 147 Sex by mean duration of thyroid dysfunction.
A.148 Sex by mean follow-up of decompression group.
A.149 Distribution of visual acuity (decompression).












Follow-up peroid in years 











Duration (in months) from the date of diagnosis of 
thyroid dysfunction to the onset of ophthalmopathy 

































































The relationship of thyroid status at presentation to 
the'need for surgical orbital decompression
Muscle surgery




























































The relationship between diplopia as a presenting 
symptom and the need for muscle surgery.
Muscle surgery


































































The relationship between diplopia as elicited 
at onset and the need for muscle surgery.
Muscle surgery
Muscle surgery R. Row
total
No Yes















































































The relationship between extraocular muscle 
dysfunction at onset on orthoptic assessment 












Age collapsed into 
categories 








3 0 -  39 years
5 25
16.7% 83 . 3%
10. 0% 14.4%












70 - 79 years
2 5
28. 6% 71.4%
4.0% 2 . 9%






22 . 3% 77.7%
100.0% 100.0%
TABLE A.8
Age group frequencies of males and females.
Age groups
Frequency Percent
Age collapsed into 
categories 
10 - 19 years 5 2.2%
20 - 29 years 17 7.6%
30 - 39 years 30 13 .4%
40 - 49 years 63 28.1%
50 - 59 years 66 29.5%
60 - 69 years 32 14.3%
70 - 79 years 7 3.1%
80 - 89 years 4 1.8%
TOTAL 224 100.0%
TABLE A.9 





< 5 years 46 20.5%
6 - 10 years 105 46.9%
11 - 15 years 31 13.8%
16 - 20 years 36 16.1%
21 - 25 years 3 1.3%
> 25 years 3 1.3%
TOTAL 224 100.0%
TABLE A.10
Frequencies of groups of follow-up peroid in years.
Thyroid status
Frequency Percent



















Treatment recieved for hyperthyroidism 
before the onset of ophthalmopathy.






No diplopia 91 91
100.0% 100.0%
50.0% 49.5%
Up / down 8 1 9
88.9% 11.1% 100.0%
4.4% 50. 0% 4.9%
Add / abd 23 23
100.0% 100.0%
12.6% 12.5%
Close to midline 21 21
100.0% 100.0%
11.5% 11.4%
Extreme gaze 39 1 40
97.5% 2.5% 100.0%
21.4% 50.0% 21.7%




Thyroid myopathy in relation to 
extraocular muscle dysfunction at onset.























Extreme gaze 10 1 11
90.9% 9.1% 100.0%
9.8% 50.0% 10. 6%




Thyroid myopathy in relation to final 
extraocular muscle dysfunction.
Mild and severe groups
Severity of Disease Rt.
mild severe
Frequency Percent Frequency Percent
Radio Iodine Rx
No 98 48.0% 28 13 .7%
Yes 55 27. 0% 23 11.3%
Partial thyroidectomy
No 125 60.7% 41 19.9%
Yes 29 14.1% 11 5.3%
Carbimazole Rx only
No 84 42.4% 27 13. 6%
Yes 63 31.8% 24 12.1%
■ TABLE A.15 
Treatment of thyroid dysfunction 
in relation to severity of ophthalmopathy.
Duration of thyroid dysfunction
Duration collapsed into categories 1








8 - 10 1 
years 1




























































Duration categories of thyroid dysfunction (in years) 
before the onset of ophthalmopathy
(continue
Duration of thyroid dysfunction
Duration collapsed into categories Row 1 
total 1
11 - 15 
years
1 6 - 2 0
years
21 - 25 
years
26 - 30 
years





5 4 2 2 1 114 1
4.4% 3.5% 1.8% 1.8% .9% 100.0% 1
71.4% 66.7% 66.7% 100.0% 100.0% 70.4% 1
severe
2 2 1 48 1
4.2% 4.2% 2.1% 100.0% 1
28.6% 33.3% 33.3% 29.6% 1
Column total
7 6 3 2 1 162 I
4.3% 3.7% 1.9% 1.2% . 6% 100.0% 1
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% j
TABLE A.16
Duration categories of thyroid dysfunction (in years) 
before the onset of ophthalmopathy
Thyroid dysfunction
Frequency Percent
Duration collapsed into 
categories 
< 6M 46 24.2%
6m - 1 year 38 20. 0%
2 - 3 years 27 14.2%
4 - 5 years 35 18.4%
6 - 7 years 10 5.3%
8 - 10 years 7 3.7%
11 - 15 years 10 5.3%
16 - 20 years 9 4.7%
21 - 25 years 4 2.1%
26 - 30 years 2 1.1%
Over 30 years 2 1.1%
TOTAL 190 100.0%
TABLE A . 17
Duration categories of thyroid dysfunction in years.







mild severe mild severe


















Effect of partial thyroidectomy prior to the onset 
of ophthalmopathy on the time (in months) from the 
onset of thyroid dysfunction to the presentstion 
with ophthalmopathy in the mild and severe forms.







mild severe mild severe


















The relationship of previous radioiodine treatment to 
the time (in months) from the onset of thyroid dysfunction 
to the development of ophthalmopathy.













6/18 8 3.9% 6 2.9%
6/12 5 2.4% 5 2.4%
6/9 33 15.9% 12 5.8%
6/6 68 32.9% 17 8.2%
6/5 31 15.0% 9 4.3%
6/4 3 1.4%









6/18 6 4.5% 2 1.5%
6/12 6 4.5% 9 6.7%
6/9 19 14.2% 10 7.5%
6/6 38 28.4% 16 11.9%
6/5 10 7.5% 6 4.5%
TABLE A.20
The frequency distribution of varoius levels of 
visual acuity in the mild and severe groups at 
the onset of ophthalmopathy.
Mild and Severe Ophthalmopathy groups
Patient sex 1
Male Female 1
Patient age Patient age 1
Mean age Count Percent Mean age Count Percent 1
Severity of Disease
Rt.
mild 47.7 34 68.0% 49.1 133 76.4% 1
severe 53.3 16 32.0% 45.9 41 23.6% 1
Column total 49.5 50 100.0% 48.3 174 100.0% j
TABLE A.21
The mean age (in years) of males and females 







































The relationship of extraocular muscle 
surgery and the severity of ophthalmopathy.
Mild and Severe Ophthalmopathy groups
Severity of Disease Rt.
mild severe 1
Patient age Patient age 1
Mean age Count Percent Mean age Count Percent 1
Patient sex
Male 47.7 34 20.4% 53 .3 16 28.1% 1
Female 49.1 133 79.6% 45.9 41 71.9% 1
Column total 48.8 167 100.0% 48.0 57 100.0% |
TABLE A.23 
The mean age (in years) of mild and severe 
ophthalmopathy groups for males and females.
Mild and Severe Ophthalmopathy groups
Severity of Disease Rt.
mild severe 1
Duration of thyroid 
dysfunction






















Column total 47.8 167 100.0% 44 .5 57 100.0% j
TABLE A.24
The mean duration (in months) of thyroid dysfunction before 
the onset of ophthalmopathy in mild and severe 
groups for male and female patients.
Mild and Severe Ophthalmopathy groups
Patient sex 1
Male Female 1
Duration of thyroid 
dysfunction









mild 21.4 34 68.0% 54 .5 133 76.4% I
severe 26.3 16 32.0% 51.4 41 23.6% 1
Column total 23.1 50 100.0% 53 .8 174 100.0% |
TABLE A.25
The mean duration (in years) of thyroid dysfunction 
before the onset of ophthalmopathy in mild and severe 
groups for males and females.
Mild and Severe Ophthalmopathy groups
Severity of Disease Rt.
mild severe 1







Male 10.8 34 20.4% 8.2 16 28.1% I
Female 10.6 133 79. 6% 10.3 41 71.9% 1
Column total 10.6 167 100.0% 9.7 57 100.0% j
TABLE A.26
The mean follow-up time (in years) of mild and 
severe groups for male and female patients.
Mild and Severe Ophthalmopathy groups
Patient sex 1
Male Female 1






















Column total 10.0 50 100.0% 10.5 174 100.0% j
TABLE A.27
The mean follow-up time (in years) for males 

























Intraocular pressure in the mild and severe 





IOP straight R. final 
Mean IOP st. 16.2 16.2






Intraocular pressure at final assessment 

























Intraocular pressure on up gaze at the onset 





IOP up R. final 



















Intraocular pressure on up gaze of the 

























Exophthalmometric reading in mm. at the onset 

























Exophthalmometric reading in mm. of mild 






































The relationship between the severity of ophthalmopathy 






































The relationship of Guanethidine therapy 







Age collapsed into 
categories 


























































































TABLE A . 3 6 
Age groups of mild and severe groups.
































































































The time (in years) from the diagnosis of thyroid dysfunction 
to the onset of ophthalmopathy.
(continue



































The time (in years) from the diagnosis of thyroid dysfunction 
to the onset of ophthalmopathy.












































































Follow-up peroid in years.





































The relationship of lid lag at presentation 
to the severity of ophthalmopathy.






































The relationship between severity of ophthalmopathy to
lid lag at final assessment.






































The relationship between lid retraction at presentation 
to the severity of ophthalmopathy.







































The relationship between severity of ophthalmopathy
to lid retraction at final assessment.






































The relationship between lid oedema 
at onset and severity of ophthalmopathy.






































The relationship between severity of ophthalmopathy
to lid oedema at final assessment.






































The relationship between chemosis at onset 
to severity of ophthalmopathy.



































The relationship between severity of ophthalmopathy
to chemosis at final examination.



































The relationship between ptosis at presentation 
to severity of ophthalmopathy.























































The condition of the cornea at onset 
in mild and severe groups.
















































Final corneal condition in mild and severe groups.



































Disc oedema at onset in mild and severe groups.




















Choroidal folds at presentation 
in mild and severe groups.


























































Diplopia as a presenting symptom 
in mild and severe ophthalmopathy groups.





















































The relation of severity of ophthalmopathy 
to symptom of diplopia on final assessment.

































Diplopia elicited on initial examination 
in relation to mild and severe groups.



























































The relationship between of severity of ophthalmopathy 
to diplopia elicited on final assessment.

























50.0% 50. 0% 100.0%
.6% 1.8% .9%













Ocular motility (orthoptic assessment) 
at onset in mild and severe groups.









































































Orthoptic assessment at final examination 
for mild and severe ophthalmopathy groups.

















































Thyroid status of mild and severe 
ophthalmopathy groups at onset.






Thyroid status final 
Hyperthyroid
1 1 2















final thyroid status in mild as severe groups.







No goitre 76 32 108
70.4% 29.6% 100.0%
55.5% 66.7% 58.4%
Goitre 61 16 77
79.2% 20.8% 100.0%
44.5% 33.3% 41.6%




Goitre at presentation in relation to 
severity of ophthalmopathy.





































Severity of ophthalmopathy in relation 
to goitre at final assessment.








dermopathy 132 48 180
73.3% 26.7% 100.0%
97.1% 94.1% 96.3%
Pretibial dermopathy 4 3 7
57.1% 42.9% 100.0%
2.9% 5.9% 3.7%




Pretibial dermopathy at presentation 
in relation to severity of ophthalmopathy.









dermopathy 89 41 130
68.5% 31.5% 100.0%
97.8% 95.3% 97.0%
Pretibial dermopathy 2 2 4
50.0% 50. 0% 100.0%
2.2% 4.7% 3.0%




Severity of ophthalmopathy in relation 
to pretibial dermopathy at final assessment.


































The relationship between thyroid acropachy at 
presentation and the mild and severe groups.







No thyroid acropachy 90 44 134
67.2% 32.8% 100.0%
98.9% 97.8% 98.5%
Thyroid acropachy 1 1 2
50. 0% 50.0% 100.0%
1.1% 2.2% 1.5%




The relationship between severity of ophthalmopathy and 
thyroid acropachy at final assessment.




















The relationship between thyroid myopathy 
at onset and the severity of ophthalmopathy.


































The relationship between thyroid myopathy at
final assessment and the severity of ophthalmopathy.







No cardiac failure 138 53 191
72.3% 27.7% 100.0%
97.9% 98.1% 97.9%
Cardiac failure 3 1 4
75.0% 25.0% 100.0%
2.1% 1.9% 2.1%




Cardiac failure as the mode of presention of thyroid 
dysfunction in relarion to severity of ophthalmopathy.





































Carbimazole treatment before onset 
in relation to severity of ophthalmopathy.






































Carbimazole treatment received 
during the course of ophthalmopathy 
in relation to its severity.





































Propranolol treatment received before onset 
in relation to the severity of ophthalmopathy.





































Propranolol treatment received during the course 
ophthalmopathy in relation to the severity of the disease.







No 92 26 118
78. 0% 22.0% 100.0%
61.3% 52.0% 59. 0%
Yes 58 24 82
70.7% 29.3% 100.0%
38.7% 48.0% 41.0%




Thyroxine treatment received prior to the 
onset of ophthalmopathy in relation to its severity.





































Thyroxine treatment received during the course 
of opthalmopathy in relation to its severity.







No 111 41 152
73.0% 27.0% 100.0%
76.0% 82.0% 77.6%
Yes 35 9 44
79.5% 20.5% 100.0%
24.0% 18.0% 22.4%




Relation of Triiodothyronine treatment received prior
to the onset of ophthalmopathy to its severity.






T3 Rx final 
No 103 46 149
69.1% 30.9% 100.0%
94.5% 93.9% 94.3%
Yes 6 3 9
66.7% 33.3% 100.0%
5.5% 6.1% 5.7%




The relationship between Triiodothyronine treatment received during 
the course of ophthalmopathy to its severity.





































The relationship between radioiodine received proir
to the onset of ophthalmopathy to its severity.





































The relationship between radiiodine received during the 
course of ophthalmopathy to its severity.





































The effect of partial thyroidectomy proir to 
the onset of ophthalmopathy on its severity.






































Partial thyroidectomy performed during the course of 
of ophthalmopathy in relation to its severity.







No 148 53 201
73.6% 26.4% 100.0%
96.1% 96.4% 96.2%
Yes 6 2 8
75.0% 25. 0% 100.0%
3.9% 3.6% 3.8%




The relationship between diabetes at the onset of
ophthalmopathy to its severity.







No 113 50 163
69.3% 30.7% 100.0%
97.4% 96.2% 97. 0%
Yes 3 2 5
60.0% 40.0% 100.0%
2.6% 3.8% 3.0%




The relationship between diabetes at final assesment 
and the mild and severe ophthalmopathy groups.





































Hypertension prior to the onset of 
ophthalmopathy in relation to its severity.





































The relation of hypertension at final 


































The relationship of treatment either with systemic
steroids or orbital decompression in the severe group.
Severe Ophthalmopathy Group
Decompression R. 1
Steroids only Surgical decompression 1
Patient age Patient age 1
Mean age Count Percent Mean age Count Percent 1
Patient sex
Male 52.5 8 42.1% 54.1 8 21.1% 1
Female 45.5 11 57.9% 46.0 30 78.9% 1
Column total 48.5 19 100.0% 47.7 38 100.0%
TABLE A.85
The mean age (in years) of males and females in 
steroids and decompression subgroups.
Severe Ophthalmopathy Group
Decompression R. 1
Steroids only Surgical decompression 1
Duration of thyroid 
dysfunction








Male 17.6 8 42.1% 35.9 8 21.1% 1
Female 28.7 11 57.9% 59.7 30 78.9% 1
Column total 24.1 19 100.0% 54.7 38 100.0% j
TABLE A.86
The mean duration (in months) from the time of diagnosis of thyroid 
dysfunction to the onset of ophthalmopathy in males and females 
in subgroups treated with steroids or decompression.
Severe Ophthalmopathy Group
Decompression R.
Steroids only Surgical decompression 1







Male 9.8 8 42.1% 6.6 8 21.1% 1
Female 10.2 11 57.9% 10.3 30 78.9% I
Column total 10.0 19 100.0% 9.5 38 100.0% j
TABLE A.87
Follow-up peroid (in years) of males and females in subgroups 























































































Visual acuity distribution at presentation in subgroups 

















Visual acuity distribution at presentation in subgroups 













































Visual acuity distribution at final assessment in subgroups 





































Visual acuity distribution at final assessment in subgroups 
treated with steroids or decompression.
Severe group


































Lid lag at presentation in the steroid 
and decompression subgroups.
Severe group





































Lid lag at final assessment of the steroids
and decompression subgroups.
Severe group





































Lid retraction of the steroid and decompression 
subgroups at presentation.
Severe group










































Lid retraction of the steroids and decompression 
subgroups at final assessment.









































The relationship between lid lag and the condition
of the cornea at presentation in the severe group.


























The relationship between lid lag and the condition
of the cornea at final assessment in the severe group.












































The relationship between lid retraction and corneal
condition at onset in the severe group.

















































The relationship between lid retraction and corneal
condition at final assessment in the severe group.






































The relationship between lid oedema at onset 
and different treatment subgroups.








































Lid oedema at final assessment in cases







































The relationship between chemosis at persentation 
and the steroid and decompression subgroups.
Severe group


































Chemosis at final assessment





















































Corneal condition at presentation 
of both steroid and decompression 
treated subgroups.















































Corneal condition at final assessment in relation
to steroid and decompression subgroups.
Severe group







































The relation between presentation with disc 








































Choroidal folds at presentation in steroid 
and decomression treatment subgroups.
Severe group












6 6 6 1 19
31.6% 31.6% 31.6% 5.3% 100.0%
23.1% 37.5% 46.2% 50.0% 33.3%
Surgical decompression
20 10 7 1 38
52.6% 26.3% 18.4% 2.6% 100.0%
76.9% 62.5% 53.8% 50.0% 66.7%
Column total
26 16 13 2 57
45.6% 28.1% 22.8% 3.5% 100.0%
100.0% 100.0% 100.0% 100.0% 100.0%
TABLE A.107 
Diplopia at presentation in steroid 
and decompression subgroups.
Severe group














































Diplopia at final assessment in




























Mean intraocualr pressure at presentation 








IOP straight R. final 



















Mean intraocular pressure at finalassessment




























Mean intraocualr pressure on up gaze at 








IOP up R. final 



















final intraocular pressure in upgaze




























Exophthalmometry (in mm.) at presentation 




























Exophthalmometry (in mm.) at final assessment










































Cases required tarsorrhaphy in 









































The relationship between extraocular muscle 









































The relationship between treatment with Guanethidine 







































The presence of Goitre at presentation in relation 







































The presence of Goitre at final assessment in relation







































The relationship of treatment with Carbimazole 







































The distribution of patients who received Carbimazole 
during the course of ophthalmopathy in the steroid 





































The relationship between Propranolol treatment 







































The relationship between treatment with Propranolol 
during the course of disease and the steroid or 





































The relationship between Thyroxine treatment and 
the steroid and decompression subgroups.
Severe group



































The distribution of patients who were receiving Thyroxine at





































The relationship between Triiodothyronine treatment 
before the onset of ophthalmopathy and the steroid 
and orbital surgical decompression subgroups.
Severe group



































The relationship between Triiodothyronine treatment 
during the course of ophthalmopathy and the steroid 
and orbital surgical decompression subgroups.
Severe group



































The effect of radioiodine treatment received before 
the onset of ophthalmopahty on the final 
treatment modality in the severe group.
Severe group





































The relationship of radio-iodine treatment during the 
course of ophthalmopathy and the choice of 







































The effect of partial thyroidectomy prior to 









































The relationship of partial thyroidectomy performed during 





































































Diabetes on final assessment in relation





































Hypertension at onset in relation to







































Hypertension at final assessment in relation 




































The relationship between persentation with diplopia





























28. 6% 71.4% 100.0%
100.0% 100.0% 100.0%
TABLE A.137
The relationship between treatment modality and




















50. 0% 50.0% 100.0%
5.3% 2.7% 3.6%





















The relationship between persentation with ocular muscle







































The relationship between treatment modality and extraocular




















































The relationship between of thyroid status at onset
















































The relationship between thyroid status at final











dermopathy 15 33 48
31.3% 68.8% 100.0%
93.8% 94.3% 94.1%
Pretibial dermopathy 1 2 3
33.3% 66.7% 100.0%
6.3% 5.7% 5.9%




The relationship between pretibial dermopathy at 







































The relationship between pretibial dermopathy at final





































The relationship between extraocular muscle 























75.0% 25. 0% 100.0%




















The relationship between the indications 
























The relationship between the indications 
























25.0% 75. 0% 100.0%






























The method of diagnosis of optic neuropathy 
























The method of diagnosis of optic neuropathy 
in subgroups treated with steroids or decompression.
Orbital decompression Rt.
Patient age
Mean age Count Count
Percent
Patient sex
Male 54.1 8 21.1%
Female 46.0 30 78.9%
Column total 47.7 38 100.0%
TABLE A.146 
Mean age (in years) of males and females 
in the decompression subgroup.
Orbital decompression







Male 35.9 8 21.1%
Female 59.7 30 78.9%
Column total 54.7 38 100.0%
TABLE A. 147
Mean duration (in months) from the time of disgnosis of 
of thyroid dysfunction to the onset of ophthalmopathy 
in males and females in the decompression subgroup.
Orbital decompression






Male 6.6 8 21.1%
Female 10.3 30 78.9%
Column total 9.5 38 100.0%
TABLE A.148 
Mean follow-up peroid (in years) for females 



































Distribution of visual acuity



































Disrtibution of final visual acuity
levels in the decompression subgroup.
Appendix C4 - Discriminant function analysis print out
C4-1
2. 3 K > B Y T E S of w a r k s p a c e -Thi s D i scriminant An a 1ysi s requires 2360 (
Page /O SPSS/PC'!-
- - - - - - - -  D I S C R I M I  W A N T  A N A L Y S I
On groups def ined by SEVERE Severe ophthaImcpathy
224 (unweighted) cases were processed.
107 of these were ex eluded from the analysis.
14 had missing or put-af-range group codes.
76 had at least one missing discriminating variable. 
17 had both.
117 (unweighted) cases will be used in the analysis.












Number of Cases 
U n w e i g hi t e d W e i q h t e d L a b e 1
40 
1 17
77. 0 M i 1 d o p h t h a 1 m a p a t h y 





















































1.39581T o t a 1










































































-. 06383 -. 04776 -.. 04994
.30202 -.0-490 .22431 .30562
Correlations which cannot be computed are printed as ’ .
Page 74 SPSS/PC+
W i 1 k s ’ Lambda (U-st at ist i c ) and un i vari at e F—r at i o 
with 1 and 115 degrees of freedom
1 - 00000 
.07537 1.00000
.24253 -.00366 1








































































Covariance Matrix for Group 2, Severe ophthalmopath
AGE CORF: EXOF; RAIX
AGE 1. 968590
CDRR .1051282 .2666667
EXOR .5897436E—01 46153S5E-01 14.40000
RAIX .1493590 .7692308E-02 -.1307692 .2557692
THYR -.1121795 -. 3846.154E-01 .1153846 .1121795
DIPEX .4160256- -.5384615E-01 -.3410256 7243590E-0!
DU 5.369872 4.761538 94.79744 9.994231
THYR DIPEX D'J
THYR .6250UOO
DIPEX .352564 IE-01 1.763462
DU 6.573713 -22.67756 4709., 437
Page 77 SPSS/PC+
Total Covariance Matrix with 116 degrees of freedom
AGE CDRR EXDR RAIX
AGE 1.976717
CDRR -.736811 IE-02 .3043030
EXOR .1763926 .1425729 11.12732
RAIX .1858238 .2203065E-01 -.1465517 .2490421
THYR .2778515 .1525199E-01 .4515915 .1120690
DIPEX .5229885 3735632E-01 .9482759E-01 -.2873563E-01




DU 12.41114 -1.376437 5753.723
Page 78 SPSS/PC+
_ _ _ _ _ _ _ _ _  D I S C R I M I N A N T A N A L Y S I S  - - - _
On groups defined b y  SEVERE ' Severe ophthalmopathy
Analysis number 1
Stepwise variable selection
Se 1 ec t i on r u 1 e : Mi n i mi z. e W.i I k s ’ La<nb d a
Maximum number of steps..  ........    14
M i nimum Tolerance Level............ 0 010 0
Minimum F to enter..........   1.0000
Maximum F to remove.......   1.0000
Canonical Discriminant Functions
Maximum number of functions......  1
Minimum cumulative percent of variance... 100.00
Maximum significance of Wilks' Lambda.... 1.0000
Prior probability for each group is .50000
Page 7? SPS3/PC+















































was included in the anal'/sis.
Degrees o-f Freedom Sign if. 
.36830 1 1 115.0
17.3667 1 115.0 .0001
Between Group
Variables in the analysis after step 1
Vari abl< 
EXQF;








































F statistics and significances between pairs of groups after step 




2 Severe o 17.367
phthalmopath .0001
Page 82




was included in the analysis.
Degrees of Freedom Giqnir. 
.83245 2 1 115.O
1 1.4722 2 114.0 .0000
Burvjeon Group
nr iables in the analysis after step
Vanabl o Tol erancc F to remove 






------------------- Variables not in the analysis after step 2 -----------.------
Minimum
Variable Tolerance Tolerance F to enter Wilks' Lambda 
AGE . 9245090 .9164904 .51973 .82364
CDRR .9971025 .9872927 .30359 .83022
RAIX .8383755 .3333755 .314133-0 3 .83222
DIPEX .99 3.2237 .9534056 3.0928 .31023
DU .9006151 .9006151 3.7731 ..30556
F statistics and significances between pairs of groups after step 2 




2 Severe o 11.472
phthalmopath .0000
Page 84 SPSS/PC+
At step 3, DU was included in the analysis.
Degrees of Freedom Signif. Between Groups 
Wilks' Lambda .80556 3 1 115.0
Equivalent F 9.09189 3 113.0 .0000
-----------   Variables in the analysis after step 3 -------------
Variable Tolerance F to remove Wilks' Lambda 
EXOR .9471900 16.499 .92317
THYR .9339267 6.7083 .85333
DU .9006151 3.7731 .93245
P ag e 85 SPSS/PC+-
  Variables not.in the analysis after step 3 ---
Minimum
Variable Tolerance Tolerance F to enter Wilks' Lambda 
AGE .3641152 .34 3,7321 . 5.1699E—01 .30513
CDRR .9931795 .8970713 .17734 .80428
RAIX .8126426 .3126426 .53098 .30140
DIPEX .9910958 .90049=9 2.8928 .73527
F statistics and significances he-tween pairs of groups after stop 
Each F st.aitist.ic: has 3 and 113.0 degrees of freedom.
Group 1
Mild opn 
Group tha1 mop athy
2 Severe o 9.0919
p h t h a1 mopat h .0000
Page S6 SPSS/PC+
At step 4, DIPEX was included in the analysis.
Degrees o-f Freedom Signif. Between Groups 
Wilks-’ Lambda .78527 4 1 115.0
Equivalent F 7.65633 4 112.0 .0000
Variables in the analysis after step
Variable Tolerance F to remove Wilks-’ Lambda 
EXOR .9446051 16.700 .90237
THYR .9327432 5.7003 .82524
DIPEX .9910958 2.8923 .80556
DU .9004989 3.5661 .81028
Page 87 SPSS/PC+
Variables not in the analysis after step
Minimum
Variable Tolerance Tolerance F to enter
AGE .7996982 .7996982 .49955
CDRR .9891681 .8968603 .2716B





F statistics and significances between pairs of groups after step 




2 Severe o 7.6563
phthalmopath .0000




Step Entered Removed In Lambda Sig. Label
1 EX DR 1 .86880 .0001 Exophthalmos R.
2 THYR .83245 .0000 Thyroid status at onset
3 DIJ 3 .80556 .0000 Duration of thyroid dysfunction
4 DIPEX 4 .73527 .0000 Diplopia on examination
Classi f ica tion Function Coef:f ici ents
(Fi sher -’s Linear Discriminant Functions)
SEVERE = 1 2
Mild oph Severe o
thalmopathy phthalmopath
EX OR 2.153705 2.433647
THYR 2.144206 2.890815
DIPEX 1.277797 1.550274




Pet of Cum Canonical After W i l k s 7 
Fen Ei genva1us Vari ance Pet Corr Fen Lambda Chisquare DF S .
: 0 .7853 27.315 4 .<
1t  .2734 100.00 100.00 .4634 ;
t marks the 1 canonical discriminant functions remaining in the anal vs:
Standardised Canonical Discriminant Function Coefficients
FUNC 1 






:'ocl ed-wi ttvi n-groups correlations between di scr i mi nati ng variables
and canonical discriminant functions 








:o r r « 04653
:'age 91 5ppg/pr+
Instandard ized Canonical Discriminant Functi
FUNC 1
:x o r .2561361
HYR .6831180
IIPEX • .2493058
'U -.5251142 E —02
c o n s t a n t ) -6.877228




Page 92 SPSS /PC~
Test o-f equa.lic> of group covariance matrices using Bo:: ■’ s M
The ranks and natural logari thms of determin ants printed are those
o-f the group covariance matrices.
Group Label Rank Log Determi nant
1 Mild ophthalmcpathy 4 10.509918
2 Sever e ophthalmcpath 4 1C.995S59
Pooled Within—Groups
Ccvari ance Matrix 4 10.303390
Box ■' s M Approximate F Degrees of freedom Significance
14. 974 1.4227 16, 2976 _• • 2 . 1629
Page 93 SPSS / P c+
Case Mis Actual Hi ghest Probsbi lity 2nd Highest Di scrim
Number Val Ssl Group Group p n /1 3 p (G / D) Group P(G/D) Scenes
1 1 1 . 3099 . 532S 2 .4 172 —.1331
2 1 1 _ r / 3 c Z .5013 2 .“-82 . i 662
er 1 1 . 9202 . 6697 2 .3303 -.473 ?
6 2 2 . 7907 1 .2133 1.3348
7 1 1 . 7S63 . 7096 2 .2904 —.c447
a i 1 1094 .9127 2 .0373 — 1. 9743,
IJngrpd 2 . 75S5 .5649 1 .4351 . 41 19
12 Ungrpd 1 . SO 13 .5798 2 .4202 -.121?
13 t 1 . 2006 . 8904 2 .1196 -1.6535
16 2 ' 2 - .8726 .6841 1 .3159 . 8796
IS Ungrpd 2 .6165 . 7535 1 .2415 1.2201
19 2 2 .5126 . 7830 1 .2120 1.3742
23 Ungrpd 2 .3314 .6963 1 .3037 . 9322
25 o 2 . 3068 . 8474 1 .1526 1.7413
26 1 1 . 6090 . 7606 2 .2394 -.9951
23 Ungrpd 1 . 6951 5385 2 .4615 .0319
29 -> -> . 9892 . 6416 1 .3594 . 70)59
30 2 2 . 4213 .8140 1 .I860 1.5235
32 2 t t 1 . 5955 . 5042 2 .4959 . 1573
33 Ungrpd 1 .4599 8030 2 .19 70' - 1.112?
34 2 . 7940 .7103 1 .2997 . 9934
Page 94 SPSS 'PC+ .
Case Mi s Actual Highest Probabi lity 2nd Highest Di. scri m
Number Val Sel Group Group =(D/G* P CG/D) Group PiG/D) Scores
35 1 t v 2 _ C5P9 .6573 1 .3422 _ -— po
36 i 1 .2197 8742 2 .1258 — 1.6010
37 1 t v 2 . 3240 .5976 1 '.4124 . 4-6?
33 Ungrpd 2 . SS23 6912 1 .3139 • 3 w 7* •!
39 1 t t 2 . 9340 6655 1 .3345
40 Ungrpd 1 . 6501 7490 2 .2510 -«E273
41 2 2 . 7597 5654 1 .4346 . 4174
44 1 1 . 6079 .5091 2 .490? • 1394
46 1 1 .9331 6944 2 .3056 — a 3TS0
47 2 V V 1 . 6603 5294 2 .470)6 . 03 32
49 ■ 2 Y.V 1 . 6C79 7353 2 .2647 — • 7 j 3
51 2 . 0209 .9578 1 .0422 3.0239
52 i 1 . 6751 5347 2 .4653 ' . 0 455
33 Ungrpd 2 . 7745 5706 1 .4294 . 432 =
54 1 1 . 73°6 7232 2 .2769 —•7031
36 1 1 . 2908 9552 2 .1449 -1.4322
57 1 1 . 7770 571 4 2 .4236 —.0904
39 Ungrpd 2 . 7656 7157 1 .2843 1.0175
60 2 2 . 1037 91 43 1. . 0857 2 - 33*9 c
i i 1 . 3352 6952 2 .3048 . u  •:? 1
4 7 i 1 . 937"^ 65«4 ?  . 3 4 0 . f - .
Page 95 SPSS/PC+
Case Mi s Actual Hi ghest Pr ob ab ilit y 2nd Hi ghost Di sen ni
Number Val Sel Group Group P-D/G) P (G/D ■ Group P •G/D5 Scores.
c  — 1 1 .9070 .6153 2. . 3c! 4 7 -.2568
64 2 #*: 1 . 9077 . O  ■- Zs 2 . 3265 -.4 896
66 1 1 * 2ZZ257 . S~24 2 . 1276 -3.5364
63 . 2 2 .3811 . 3256 1 . 1 744 1.5952
69 1 1 . 8009 .5787 2 . 4203 - .1214
70 1 1 . 3462 . 8357 2 . 1643 -1.3157
71 1 1 . 1707 . 3904 2 . 3 0°6 -1.74 35
75 1 1 .2177 . 3743 2 . 1 252 -1.6062
76 2 1 . 3860 . 6800 2 . 3200 -.5170
“7*7 1 1 .2197 . 8742 *■? . 1 258 -1.60'0
79 2 #* .1 . 8393 . 684 0 2 . 3060 -.5764
81 1 1 . 9952 .6465 - 2 .3535 -.379"
83 1 1 . 0674 . 9306 2 . 0694 —2.2025
84 1 1 . 1793 . 3874 2 . 1 1  26 -1.716?
85 2  * * 1 . 6636 . 7437 2 -.8017
86 2 2 . 2164 . 8753 1 .1247 1.9555
87 2 n . 9545 . 6306 1 .3694 . 6622
83 2  * * 1 . 8971 . 676’’ 2 -.5030
89 1 ** 2 . 1785 . 8877 1 . 1 123 2.064 6
90 1 # * 2 . 4292 .8117 1 . 1833 1.5098
91 1 1 . 8235 .5875 2 . 4 125 -.1506
Page 96 SPSS/PC+
Case Mis Actual Highest Probabi1i tv 2nd Highest Di scrim
Number Val Sel Group Group PCD/G) P(G/D.) Group P (G/D) Scores
92 1 1 . 6425 .7511 2 .24 89 -.8378
94 -> 2 .7637 . 5668 .1 . 4 332 . 4187
95 2 %*. 1 . 9745 . 6370 2 . 3630 -.3417
97 1 1 .7294 . 554 6 2 .4454 -.0278
100 1 ** 2 . 8349 .6953 1 . 3047 . 9277
103 1 1 .9969 . 6460 2 . 3540 —.3776
104 1 1 .6664 . 7443 2 > n w3 / -.8043
106 1 1 . 8397 . 6939 2 . 3061 -.5760
109 1 1 . 9755 . 6373 2 .3627 -.342°
113 i i . 6372 . 7526 2 . 2474 -.84 53
114 1 1 . 8053 .5812 2 . 4 1 38 -.1272
115 1 1 ..8053 .5812 2 .4188 -.1272
116 1 i .8513 . 5969 2 . 4031 -.1362
117 2 % % 1 .8352 .6952 . 2 . 304 8 -.5317
118 1 1 .7847 .5741 2 . 4259 -.1004
119 1 1 .4617 . 8025 2 . 1975 -1.1097
120 2 2 . 7307 . 55?!.' 5 . 44 50 . 3751
122 2 2 . 7071 . 7326 1 . 2674 1.0950
. 126 2 2 . 3266 . 6973 1 . 3022 . 9383
127 . 2 2 . 7670 .7153 1 . 2347 1.0156
128 1 1 . 6738 . 5342 2 . 465S . 0473
)«r 97 SPSE/FC+
\E- S' Ml £ Actual Hi ghest Probability 2nd Hi 9host Di per 1 fi
iber Val Sel Group Group F■' C D / G) PC G/D) Group PCG/D) Scorer.
129 1 ** 2 . 9633 .6565 3 . 34 35 . 7653
1 30 1 1 . 8434 . 692S 2 . 3072 "". 12
131 . 2 2 . 9293 . 666 1 . 8073
■r 1 1 . 9905 . 6421 2 . 3579 -.36 3 B
133 1 1 .7151 . 7303 2 . 2697 - . 73B"7
134 1 1 .4035 . 8177 2 . 3 223 -1.2002
136 1 1 . 5894 .5013 2 . 4 932 . 3 66 3
139 1 1 . 2986 . 3498 2 . 1502 -3.4133
142 1 X X 2 . 7647 .5671 1 .4729 \ . 4 OQ
14S 1 1 . 9725 . 6364 2 . 3 213 6 __ ——op
3 49 2 -> . 6565 . 7473 3 . 2579 3.1640
150 1 1 . 3737 . 8277 X'. 3 — np - i.2632
152 -> -> . 9353 . 6653 3 . 374 9 . 3'"■05
154 1 1 .6151 . 7539 2 .24 1 1 -.8765
155 1 1 . 6152 . 5120 2 . 4830 . 1289
1 r^“7 2 X X 1 . 8494 .5962 2 . 4038 -.1837
159 2  X X 1 . 7766 . 5713 2 . 4287 — _ 1*1000
160 1 X X 2 .6339 . 53B0 3 . 4620 .312 3
161 1 1 . 0740 . 9276 2 . 0724 -2. .1605
162 1 1 .7932 .7076 . 2924 -.6358
164 ~> —> .6339 . 5330 3 . 4620 .3123
e 98 
se Mi 5 Actual
SPS5/PC+
Highest Probability 2nd Hi ghost Di scri m
ber Val Sel Group Group PCD/G) P CG/D) Group P CG/D) Scores
165 1 X X 2 . 1137 . 93.10 3 . 0890 2.3009
3.06 Ungrpd 2 . 9039 .6746 3. .3254 .8403
167 1 X X 2 . 6426 . 753 1 3 .74 89' 1 . 1834'
168 ' 1 X X n . 9465 .6281/ 3 .3719 . 6522
169 1 1 . 8623 • 6005 2 . 3995 -.2002
171. 2 2 .4669 . 803 0 1 . 3 890 1.44 69
L 72 1 1 . 4122 . 8166 2 . 3 834 -1.3 937
173 1 1 . 6659 . 5313 2 .4 637 . 0582
L 74 2 X X 1 .4113 . 8169 2 . 1833 -1. 3 953
L75 2 X X 1 . 84-27 . 5940 2 . 4060 -.3 752
i76 1 1 .3441 . 8363 2 . 1637 -1.33 98
L77 2 r> . 0945 .9187 1. . 0813 2.3914
.79 Ungrpd 0 .6946 ,.5419 1 . 458 3 . 3266
1 30 2 X X 1 . 8233 . 6987 2 . 303.3 -.5969
.82 1 1 .9538 ,. 6304 2 . 3696 -. 3158
.83 ' 1 X X 2 . 9620 . 6330 1 . 3670 . 6717
.88 1 1 .6313 . 7543 2 .2457 -.8536
.89 1 1 .3184 . 5857 2 . 4 3 43 -.3 440
90. ' 1 X X O .8163 . 5850 1 . 4 150 . 4870
.91 1 1 .4964 .7926 2 . 2074 -1.0539
92 p r> -. 022B ., 9563 1 . 0437 2.9958
F‘ a g £■ 10 2! S F' S S / F’ C a
Hi stogram for Group 2 Severn ophthai mopath
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Cl ass 11111111111111111111112222222222222222222 
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Hi s t o g r a f T i  -for ungrouped cases
Canonical Discriminant Function 1
4 +
3 + it ir +
: it #
! it it :
1 # # i
2  + it it# +
: #■ i t# '
! it it i t !
i # ## !
1 + # it it it i t# # it it# +
! # # it it it# it # # # !
! # it it it i t# it i t # # !
! # #  it # ## # i t # # !
>;•--------- 4__--------_i------------•---- — +---- +— -------¥---------x
Out -3. 0 —2 .0 -1.0 . 0 1.0 2 . 0 3.0 Out
Cl ass 1111111111111111111111222222222:
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Case Mis Actual Hi ghest Probability 2nd Highest Di scr i m
Humber Val Sel Group Group P(D/G) P(G/D) Group P(G/D) Scores
194 Ungrpd 2 . 7479 . 7208 1 . 2792 1 0407
195 Ungrpd 1 . 1999 . 8806 2 .1194 -.1 6554
197 Ungrpd 1 . 0010 .9852 2 . 0 3 43 _3 6659
19G 2 2 . 0947 .9186 I . OS 14 2 3905
199 1 1 • ■—* 1 . 8454 2 . 1546 -1 3316
200 1 ** 2 . S312 .5901 1 . 409? 5061
201 1 1 . 1694 . 8908 2 1 092 7476
206 1 1 .7610 .5658 2 . 4342 - 0694
207 1 1 . 9339 . 6640 2 .3360 - 4504
208 1 ** 2 . 9833 . 6399 1 . 360 5 6990
212 1 #* n . 9936 . 6446 1 . 3554 7175
214 2 2 . 2079 . 3780 1 . 1220 i 9786
Page 100
Symbols used in Plots 
Symbol Group Label 
1
SPSS/PC+
1 Mild ophthalmopathy 
2 2 Severe ophthalmopath
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! 1 11 ;
11111 !
! 11 Hill !
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! 1111 111111111 {
! 1 1111 111111111 !
! 111111111111111111 1 1 1 !
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Out -3.0 -2.0 -1.0 .0 1.0 2.0 3.0 Out
Centroi ds , 1
Page 104 SPSS/PC+ 
All-groups stacked Histogram
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#
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Out -3.0 -2.0 -1.0 .0
Class 1111111111111111111111 
Centroids 1












Group 1 81 64 17
Mild ophthalmopathy 79. 07. 21.07
Group 2 42 15 27
Severe ophthalmopath 35.77 64 .37
Ungrouped Cases 15 6 9
40. 07 60.07
Percent of "grouped" cases cor rectly class ified: 73.987
Classification Processing Summary 
224 Cases were processed.
0 Cases were excluded for missing or out—cf-rango group codes. 
86 Cases had at least one missing discriminating variable.
138 Cases were: used for printed output.
Page 106 SPSS/PC+
This procedure was completed at 0:41:19
SPSS/PC+
_ _ _ _ _ _ _ _  D I S C R I M I N A N T  A N A L Y S I S  - - -
On groups defined by DCMF'R Decompression R.
224 (unweighted) cases were processed.
137 of these were excluded from the analysis.
8 had missing or out-of-range group codes.
106 had at least one missing discriminating variable. 
23 had both.
87 (unweighted) cases will be used in the analysis. 
Number of Cases by Group
DCMPR
1


































































































































DCMPR CHFLDR IOPSTR EXOR SYMDIP
1 .00000 3.54558 2.94175 . .8538
2 .27689 3.62767 3.64097 . 8524!
total .15074 3.85399 3.43951 .8487i
DCMPR DIPEX EOMR THYR PTHDMY
1 1.46932 2.92584 .74035 . 3379'
2 1.07703 3.35510 .75719 . 4082!





Pooled Within-Groups Covariance Matrix with 85 degrees of freei









VAR -.6466793E-01 -5.651203 -3.875507 2.181495
LODR -. 2808349E—01 2.038482 4.013738 .2056926E—01
CHEMOR -.3320304E—01 1.590383 .9854194 -.328349IE-01
CORR . 1571157E—01 -.6827628 -4.607985 — .9155218E-01
DODR — .4436433E—01 .4881139 -2.743324 — .4324858E-01
CHFLDR - . 1882353E-01 .3237647 -1.073412 — .2870588E-01
IOPSTR -.1004175 6.692645 31.07763 -.3493890
EX OR -.1693738 -1.931438 21.86967 -.2180342
SYMDIP — .4026565E—01 3.772304 .8972524 — .8176091E—01
DIPEX — .5544592E—01 .7311651 -8.114209 -.1162808E-01
EOMR -.1904364 5.861541 -51.08650 -.3926072
THYR - . 1036053E—01 2.029017 4.918019 .3297154E—01
PTHDMY .7969639E—02 .4003036 10.15537 -.3893738E-01
RAIX .2S72B65E—01 .7816546 6.656767 .3661480E—01









DODR .1335863E-01 .2754459E—01 -.6087287E—02 .6464516E-01‘
CHFLDR .9411765E—02 .1317647E—01 -.6588235E—02 .2070588E—01
IOPSTR .2325617 -.7411006E-01 .188387IE-01 .1227932
EXOR .1876281 .1975180 .4915370E— 01 .54869u7E-Ol
SYMDIP .9366224E-01 .2490323E-01 - . 1842884E—01 .1262239E—01
DIPEX — .8698292E—01 -.340721 IE-01 -.5402657E—01 .1558254E-01
EOMR .2187476 .1373662 .3473245E—01 .8959393E—01
THYR -.2717268E—01 .275521SE-02 .804554IE—03 -.296091 IE-01
PTHDMY -.9867173E—02 .1055028E-01 -.2428843E—02 -.1161290E—01
RAIX -.5540797E-02 — . 7795066E—02' .3233397E—02 - . 1799620E—01





EXOR .4847059E—01 2.233670 9.953495
SYMDIP .7529412E-02 .2993700 .2718027E—01 .7283264
DIPEX .98S2353E-02 -.1897381 .2437192E—01 .4232789
EOMR .837647IE-01 1.483385 -.1093131 1.537427
THYR -.1505382E—01 -.1744516 .3974421 .1101404
PTHDMY -.4705882E-02 -.1834535 .1540038 -.50S53S9E—02
RAIX -.1035294E-01 .325313IE—01 -.1800911 -.1418596E-01
DIPEX EOMR THYR PTHDMY
DIPEX 1.876S65
EOMR 1.975S05 9 .321806
THYR .2109374 2382391 . 555 2410
PTHDMY .1692600E-01 5927894E- 01 .2990512E-01 .129032 3
RAIX -.1471651 9071727E- 01 .7827704E-01 -.1677419E—01
RAIX
RAIX .2479924
Pooled Within-Qroups Correlation Matrix
SEX AGE DU VAR LODR CHEMOR CORR
SEX 1.00000
AGE -.21319 1.00000
DU .05752 .31127 1.00000
VAR — .10684 — .28400 -.03303 1.00000
LODR -.14060 .31044 .10365 .02857 1.00000
CHEMOR — .25077 .30945 .03252 -.05828 .50087 1.00000
CORR .06695 -.08849 -.10128 -.1p823 — .09136 .01827 1.00000
DODR ■ -.42579 .14250 -.13581 ' -.11517 .10779 .28399 -.04181
CHFLDR -.31220 .16334 • -.09183 13210 .13124 .23476 -.07819
IOPSTR — .06866 .13919 .10961 -.06628 .13369 — .05443 .00922
EXOR -.13101 -.04544 .08725 -.04679 .12201 .16412 .02720
SYMDIP -.11513 .32810 .01323 -.06486 .22517 .07649 -.03771
DIPEX — .09876 .03962 — .07455 -.00575 -.13026 -.06519 -.06886
EOMR -.15221 .14250 -.21061 — .08706 .14699 .11794 .01986
THYR -.03393 .20212 .08308 .02996 -.07482 .00969 .00189
PTHDMY .05414 .08272 .35586 -.07339 -.05636 .07699 -.01181
RAIX .14078 .11651 .16826 .04978 -.02283 -.04103 .01134
DODR CHFLDR IOPSTR EXOR SYMDIF DIPEX EOMR
DODR 1.00000
CHFLDR .55351 1.00000
IOPSTR .13532 .10844 1.00000
EXOR .06840 .10442 .19838 1.00000
SYMDIP .05817 . 05997 .09829 .01009 1.00000
DIPEX .04474 .04903 -.03881 .00564 .36203 1.00000
EOMR .11541 .18647 .13613 -.01135 .59004 .47232 1.00000
THYR -.15628 -.13736 — .06560 .16906 .17320 .20663 .10472
PTHDMY -.12715 -.08904 -.14310 .13589 -.01659 .03439 — .05405




RAIX .21095 -.09377 1.00000
Sorrel at i c:>ns which cannot be computed are printed as
Jilks' Lambda (,'U-stat i st i c ) and univariate F-ratio
;ith 1 and 85 degrees of freedom
Variable Wilks’ Lambda F Si gni fi cance
SEX .99988 .9936E—02 . 9208
AGE .99788 . 1807 .6718
DU .98296 1.473 .2282
VAR .89266 10. 22 . 0020
LODR .94964 4. 507 . 0367
CHEMOR .86647 13. 10 . 0005
CORR .99813 . 1595 . 6906
DODR .9B364 1.413 . 2378
CHFLDR .94165 5.267 . 0242
IOPSTR .84758 15.29 . 0002
Var i abl e Wilks' Lambda F Signi ficance
EXOR .83153 17.22 . 0001
SYMDIP .99325 .6354E -01 .8016
DIPEX .99953 .4030E -01 .8414
EOMR .97421 2.251 . 1373
THYR .99564 .3725 .5433
PTHDMY .99189 . 6954 . 4067
RAIX .99886 . 9715E--01 .7560
Covar i anc e Matrix for Gr aup 1, No
SEX AGE DU VAR
SEX .1684294
AGE -1.348228 175.8839
DU 1.976467 323.4566 4051.809
VAR — .8355368E—01 -2.885775 -3.102591 1.744051
LODR -.6345S49E-02 1.670016 2.458488 .7456372E—01
CHEMOR — .2511898E—01 .7511898 -1.506875 .8408250E—01
CORR .1533580E-01 -1.153358 -3.964569 .5341089E-01
DODR 3886B32E—01 .1837652 -1.390534 .4071920E—01
CHFLDR .0000000 .0000000 . 0000000 . 0000000
IOPSTR -.3172924E-01 1.300899 15.39080 -.3976732
EXOR .5579059E-01 -4.844791 39.16790 -.2723427
SYMDIP -.6266526E—01 3.421735 8.709942 .2115283E-01
DIPEX -.1002115 .3545743 1.664463 — .4177684E-01
EOMR — .2030672 3.014278 -10.44315 .89S9952E-02
THYR -.1771549E—01 2.709942 10.06478 — .9307245E-01
PTHDMY .Ill0524E—01 .528B207E—01 7.046007 — .4442094E—01
RAIX .2035960E-01 1.296404 8.199101 -.3225B06E—01
LODR CHEMOR CORR DODR
LODR .2326811
CHEMOR .7403490E—01 .1017980
CORR -.3225806E—01 — .9518773E—02 .3744051
DODR .1533580E—01 .10840S2E-01 -.1110524E—01 .4680063E-01
CHFLDR . 0000000 . 0000000 . 0000000 .0000000
IOPSTR .1470122 -.2035960 .2649392 .9307245E-01
EXOR — .2379693E—01 .1578530 .8619778E—01 .4891592E—01
SYMDIP .5182443E—01 -.6610259E—02 -.1322052E—01 .1824432E-01
DIPEX -.1507139 — .4944474E-01 — .497091SE-O1 .256478IE-01
EOMR .1998942 .9o42834E-Ol - . 1586462E—01 .6451613E—01
THYR -.6081438E—01 .4494976E—02 .8989952E—02 -.9783184E-02
PTHDMY -.3014278E—01 -.1480698E—01 -.1322052E—01 — .6345849E—02
RAIX .2115283E—02 .2908514E-02 .5817028E—02 -.3437335E—02
CHFLDR IOPSTR EXOR SYMDIP
CHFLDR .0000000
IOPSTR . 0000000 12.57113
EXOR . 0000000 1.471179 8.653887
SYMDIP .0000000 .3246959 .129561IE-01 .7289794
DIPEX . 0000000 -.1306187 .3270756 .3989952
EOMR .0000000 1.638815 -.1385510 1.494447
THYR .0000000 -.9095717E-01 .4397144 .1351137
PTHDMY . 0000000 -.2326811 .1359069 — .5288207E—03
RAIX . 0000000 .7615019E-01 -.2535695 .4494976E—02
DIPEX EOMR THYR PTHDMY
DIPEX 2.158911
EOMR 2.013221 8.560550
THYR .2657324 .2998414 .5481227
PTHDMY .793231 IE-01 .6S21787E—01 .2855632E-01 .1142253
RAIX -.2234268 — .9624537E—01 .2776309E—01 -.3701745E-02
RAIX .2445796
Covar i anc e Matrix for Gr oup 2, Yes
SEX AGE DU VAR
SEX .1666667
AGE -.7416567 195.7733
DU 1.608333 357.8033 12054.94
VAR 1666667E—01 -12.68000 -5.840000 3.293333
LODR — .8333333E-01 2.975000 7.966667 -.1166667
CHEMOR -.7500000E—01 r> 7,"C'oo't' 7.320000 — .3300000
CORR .1666667E—01 cr 1 O■ J 1 UUtJvJU -6.243333 -.4600000
DODR -.5S33333E—01 1.261667 -6.181667 -.2566667
CHFLDR — .6666667E-01 1.146667 -3.801667 -.1016667
IOPSTR — .2750000 20.39667 70.94833 -.2266667
EXOR -.7416667 5.473333 —22.U9667 -.8000000E-01
SYMDIP .1666667E-01 4.663333 -18.96000 _ n.nnnn^
DIPEX .5S33333E—01 1.688333 -32.96833 .6500000E-01
EOMR -.1583333 13.09333 -154.3883 -1.413333
THYR .S333333E—02 .2983333 -8.163333 3533333
PTHDMY .0000000 1.283333 IB.05833 -.2500000E-01
RAIX .5000000E-01 -.5266667 2.736667 .2116667
LODR CHEMOR CORR DODR
LODR .2500000
CHEMOR .1416667 .2566667
CORR -.8333333E-02 .3833333E—01 .2100000
DODR .8333333E—02 .7000000E-01 .6666667E—02 .1100000
CHFLDR .3333333E—01 .4666667E—Ol -.2333333E—01 .7333333E-01
IOPSTR .4500000 .2550000 -.6066667 .1983333
EXOR .7250000 .2983333 -.4500000E-01 .7000000E-01
SYMDIP .2000000 .1050000 — .3166667E—01 -.1666667E-02
DIPEX .7500000E-01 .5000000E-02 -.6500000E-01 -.1000000E—01
EOMR .2666667 .2566667 .1633333 .1533333
THYR .5833333E-01 -.1666667E—02 -.2000000E-01 — .8000000E-01
PTHDMY .4166667E—01 .7500000E—01 .2500000E-01 -.2500000E-01
RAIX -.2500000E-01 -. 3500000.E—01 -.3333333E-02 — .5500000E-01
CHFLDR IOPSTR EXOR SYMDIP
CHFLDR ; .7666667E—01
IOPSTR .2016667 13.16000
EXOR .1716667 4.171667 13.25667
SYMDIP .2666667E—01 .2350000 .6333333E—01 .7266667
DIPEX .3500000E-01 -.3400000 -.7450000 .4850000
EOMR .2966667 1.088333 -.3500000E-01 1.646667
THYR — .5333333E—01 -.3866667 .2900000 .4666667E—01
PTHDMY -.1666667E—01 — .5S33333E—01 .2000000 -. 1666667E—01
RAIX — .3666667E—O 1 -.7833333E—01 .6666667E—02 — .6166667E—01
DIPEX EOMR THYR PTHDMY
DIPEX 1.160000
EOMR 1.880000 11.25667
THYR .7166667E—01 .8166667E—01 m J/UUUUU
PTHDMY -.1416667 -.3833333 .3333333E—01 .1666667




Tota1 Covariance Matrix with 86 degrees of freedom
SEX Ab'E DU VAR
SEX .1659984
AGE -1.165998 179.7706
DU 1.896552 322.8593 6346.253
VAR — .6615878E-01 -5.271051 -9.125100 2.415397
LODR 2726544E-01 1.945870 5.127372 — .3648757E-01
CHEMOR -.3809142E—01 1.479952 2.522053 -.1082598
CORR .1563753E-01 -.6900561 -4.297915 -.1030473
DODR — •437U489E—01 .4623095 -2.372494 -.5934242E-01
CHFLDR 1S44427E-01 .2975140 — .6823042 — .4691259E—01
IOPSTR — .92S2229E—01 5.685646 46.36207 -1.111468
EXOR -.1611868 -2.780674 36.29324 -.9342422
SYMDIP — .3969527E—01 3.714114 1.128041 -.9262229E—01
DIPEX -.5493184E-01 .7409783 -8.328254 .360866IE-02
EOMR -.1860465 5.48S372 -45.35659 -.6395349
THYR -.1002406E-01 1.975140 5.370756 .7618284E-02
PTHDMY .8019246E—02 .3757017 10.37316 -.5493184E-01
RAIX .2846832E—01 .7622294 6.753408 .2766640E—01
LODR CHEMOR CORR DODR
LODR .2472601
CHEMOR .1086608 .1659984
CORR -.2245389E-01 .7618284E—02 .3247795
DODR .16B4042E—01 .320769BE—01 — .5212510E-02 .64955S9E—01
CHFLDR . 133654 IE-01 .1844427E—01 -.5613472E—02 .2165196E—01
IOPSTR .3977546 .1507618 .5573376E—01 .1704090
EXOR .3429564 .4053729 .8340016E-01 .1002406
SYMDIP .9516172E—01 .2806736E—01 -.1764234E—01 .1323176E—01
DIPEX -.8928094E—01 -.3809142E-01 -.541299IE—01 .1443464E-01
EOMR .2713178 .2093023 .4651163E—01 .1046512
THYR -.2138466E-01 .1002406E-01 .2004812E—02 — .2766640E—01
PTHDMY -.6148089E—02 .1523657E-01 — .1603849E—02 - . 1042502E—01
RAIX -.360866IE-02 -.5212519E-02 .360866IE-02 - . 1724138E—01
CHFLDR .IOPSTR EXOR SYMDIP
CHFLDR .2272120E—01
IOPSTR .1110666 14.85325
EXOR .9930500E—01 4.331596 11.83026
SYMDIP .8286554E—02 .3307939 .5960973E—Ul .7203956
DIPEX .8687517E-02 -.2321572 -.1777600E—01 .4176691
EOMR .1007752 2.209302 .5891473 1.531008
THYR -.1309810E—01 -.9863673E—01 .4620422 .1099973
PTHDMY — .34750O7E—02 -.1327185 .1978081 -.427693IE-02
RAIX -.9623095E—02 .573376IE-01 -.1543705 - . 1363272E—01
DIPEX EOMR THYR PTHDMY
DIPEX 1.855921
EOMR 1.937984 9.457364
THYR .2070302 .2596899 .5511895
PTHDMY .1577118E-01 — .4263566E—01 .3114141E—01 .1285752




D I S C R I M I N A N T  A N A L Y S I S
On groups defined by DCMPR Decompression R.
Analysis number 1
Direct method: All variables passing the tolerance test are entered.
Minimum Tolerance Level.................... 00100
Canonical Discriminant Functions
Maximum number of functions.............
Minimum cumulative percent of variance...
Maximum significance of Wilks’ Lambda....
Prior probability for each group is .50000
Classification Function Coefficients 







DU -.5984335E—01 -. 5559207E-
VAR 12.29787 11.71575
LODR —.6195367 -.3577006














Pet of Cum Canonical After Wilks'
Fen Eigenvalue Variance Pet Corr Fen Lambda Chi square DF
: 0 .5841 41.130 17






* marks the 1 canonical discriminant functions remaining in the analysis.



















Structure Matr i x:
Pooled-within-groups correlations between discriminating variables
and canonical discriminant functions 













































Test of equality of group covariance matrices using Box's M
The ranks and natural logarithms of determinants printed are those 
of the group covariance matrices.
Group Label









NOT ENOUGH NON-SINGULAR GROUP COVARIANCE MATRICES FOR DSC— At least two 




































































Actual Highest Probabi1ity 2nd Highest Discrim
Gr oup Group PCD/G) PCG/D) G'r oup PCG/D) Scores
Ungrpd 1 . 0502 .9951
•*!> . 0049 -2.4877
Ungrpd 1 . 7596 . 9057 2 . 0943 —.8357
Ungrpd .4476 . 9568 1 . 0432 2.0728
2 ..7812 .7661 1 . 2339 1.0357
.5080 .6173 1 .3827 .6514
Ungrpd 2 . 4915 . 6060 1 . 3940 . 6254
2 ** 1 .6535 . 7050 2 .2950 -.0807
1 .7268 .9123 2 . 0877 -.8790
Ungrpd
1
1 . 5941 . 9359 2 .0641 -1.0626
1 .8587 . 7974 ji . 2026 —.3516
Ungrpd 1 . 7953 .8981 2 . 1019 -.7890
2 ** 1 . 9793 .8515 o . 1485 —.5556
1 .6722 .7147 2 .2853 -.1064
1 1 . 4530 .5782 2 .4218 . 2209
1 . 4297 .9591 2 . 0409 -1.3193
Ungrpd 1 . 4267 . 5581 2 .4419 . 2652
1 ** 2 . 7990 . 8973 1 . 1027 1.5681
1 . 5702 . 9396 2 . 0604 -1.0974
1 1 . 4962 . 9504 '■> . 0496 -1.2101
2 . 1558 . 9868 1 . 0132 2.7329
1 1 .3610 .9671 2 . 0329 -1.4430
1 .7642 . 9048 2 . 0952 -.8296
1 •** 2 .4433 . 5709 1 .4291 . 5469
1 1 . 6449 .9274 2 . 0726 -.9905
1 1 ,9555 .8583 2 . 1417 -.5855
1 .7444 .9088 2 .0912 -.8557
1 1 .7071 . 7322 2 .2678 -.1538
1 1 .8384 .8884 2 .1116 -.7336
1 1 . 2026 . 9828 •o .0172 -1.8038
1 1 . 9859 .8410 2 . 1590 -.5119
2 *•* 1 .6361 . 6956 2 . 3044 -.0565
1 1 .2186 .9814 2 .0186 -1.7598
2 **- 1 . 5690 .6567 2 .3433 .0399
1 ** 2 . 9399 .8263 1 . 1737 1.2381
1 . 5037 . 9493 2 . 0507 -1.1983
2 .8533 .8848 1 .1152 1.4983
2 . 0028 . 9993 1 . 0007 4.3034
2 2 . 9290 .8226 1 . 1774 1.2243
i .8483 .8851 2 .1139 -.7210
1 *■* 2 .4317 . 5620 1 . 43B0 .5272
1 * * 2 .9153 .8179 1 . 1821 1.2071
1 1 . 8260 .7847 2 .2153 -.3098
.3581 .5012 1 . 4988 . 3945
1 1 .7167 .7368 2 .2632 -.1667
1 1 . 9522 . 8592 2 .1408 -.5895
1 1 .4128 .9611 2 .0389 -1.3485
1 1 . 8302 .7864
*7» .2136 -.2151
.7170 .9142 1 . 0858 1.6759
1 1 . 8306 . 8902 jd . 1098 -.7435
.5796 .9382 1 .0618 1.8674
1 1 .6845 . 9204 2 .' 0796 -.9359
. 9643 .8342 i . 1658 1.2687
2 . 2522 . 9783 i .0217 2.4585
1 1 . 5402 .9441 2 . 0559 -1.1421
1 . 7707 .7615 2 .2385 -.2381
1 . 9496 . 8600 2 . 1400 -.5928
2 ** 1 . 5022 .6134 o .3866 ' . 1414
1 •** 2 .6157 .6843 1 .3157 .8115
1 ** 2 . 5769 .6615 1 . j w 8 j .7555
1 1 .8815 . 8059 2 . 1941 -.3805
1 . 9685 .8546 2 . 1454 -.5691
1 1 . 8020 . 8967 2 . 1033 -.7804
c .6625 . 9243 1 . 0757 1.7499
Case Mis Actual Highest




155 1 ** 2










169 1 ** 2
171 2 2
172 1 1



















# All Ungrouped Cases
Probability 2nd Highest
CD/G) PCG/D) Group PCG/D) Scores
. 9636 . B560 2 . 1440 —.5752
. 1651 . 9860 2 . 0140 -1.9177
. 1273 .9891 2 .0109 -2.0544
.6017 .9346 1 . 0654 1.8354
. 8974 .8117 2 . 1833 -.4007
.9720 .e367 2' . 1633 —.4945
.9542 .8587 2 .1413 -.5870
.5262 . 9462 2' .0538 -1.1634
.8388 .7898 2 .2102 -.3262
.4842 . 9520 1 . 0480 2.0130
.7746 . 9026 2 . 0974 -.8159
. 8823 .8778 1 . 1222 1.4615
. 3967 .5341 2 . 4659 .3178
.6754 .7164 2 .2836 -.1108
.8168 . 8934 1 . 1066 1.5451
.5863 .6672 1 .3328 .7692
.3578 . 9675 2 .0325 -1.4492
.4546 . 5794 1 . 4206 . 5656
. 1772 . 9850 r> .0150 -1.8791
.6116 . 6B19 1 .3181 .8056
.3069 . 9729 2 .0271 -1.5514
.2160 . 9B16 1 .0184 2.5506
. 1844 .9844 2 .0156 -1.8569
.7765 .9022 2 .0978 -.8135
.5326 .9452 -> .0548 —1.1537
. 2732 .9763 1 . 0237 2.4093
.6344 1 . 3656 .6910
.2928 .9744 1 . 0256 2.3655
. 50B9 . 94B6 1 .0514 1.9739
.3242 .9711 2 .0289 -1.5154
.6107 .6814 2 .3186 -.0205
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Canonical Discriminant Function 1
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Histogram for ungrouped cases
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No. of Predicted Group Membership
Actual Group Cases 1 2
Group 1 62 51 11
No 82.37. 17.77.
Group 2 25 6 19
Yes 24.07. 76.07.




Percent of "grouped" cases correctly classified: 80.467.
Classification Processing Summary 
224 Cases were processed.
0 Cases were excluded for missing or out-of—range group codes. 
129 Cases had at least one missing discriminating variable.
95 Cases were used for printed output.
Appendix D1 - SAVOIR Shell
SAVOIR is an  expert system shell of the type known as an  advice lan­
guage. It is designed to produce expert systems which conduct a question and 
answer session and give advice. It has the facilities to implement many other 
types of expert system applications.
A SAVOIR model is written by a  programmer or knowledge engineer who 
obtains the information on the subject area from the domain expert. SAVOIR is 
a  batch compiled system. The rules which make up the application are entered 
into the computer using any normal text editor. They are then complied using 
the SAVOIR compiler and further checked using the FV check programme which 
performs a series of checks on the model for consistency and completeness. The 
outcome of this compilation process is an  object model which is represented in 
an  interpretable pseudo code, j  Then pseudo code is executed by SAVOIR’s run  
time programme.
SAVOIR comes with the facility of a combination of features which in­
clude:
n Forward chaining 
a  Backward chaining 
Q Demons
Q Values held as ranges 
a  Made variables
Datatypes:
A SAVOIR’s model can be looked a t as divided into two parts, a  passive 
and an  active part. The passive part of the model describes the expert’s domain 
knowledge whereas the active part describes how he goes about using this knowl­
edge in  an  advice giving session. There are four types of variable:
NUMBER; Held as a num ber pair.
PROBABILITY: Held as a  pair and an  a  priori
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CONDITION: Either True, False or Unknown.
STRING: Either an alphanumeric string or unknown.
The variables in the inference net can be looked a t as forming a series or 
tree structures, each variable points to the variables from which it is derived. The 
leaf nodes of these trees are usually questions. Their values can be derived either 
by asking the user for the values, calling another programme or reading the 
values from a  file or data base.
There are six types of questions in the SAVOIR language:
CERT. Accepts reply on a certainty scale of -5 to 5.
YESNO: Accepts a reply or Y (yes) N (no) or ! (don’t know). This reply is con­
verted into a condition.
NUMERIC: Accepts a  real num ber as a  reply.
CONFIRM: This is a  restricted form of yesno question which only accepts yes 
as an  answer.
INTEGER: A  restricted form of the numeric question.
ALPHA: Accepts an alphanumeric string as an  answer.
Actions:
The active part of the model is implemented by means of ACTIONS. An 
action is a  group of statements which say ’Do something as soon as some con­
dition becomes true’. Every time the model acquires a  new item of information it 
fully jupdates its knowledge base so as to enable any relevant actions to be ex­
ecuted as soon as possible.
External function calls:
SAVOIR contains facilities for calling external functions. These are pro­
gramme modules written in a conventional algorithmic language. Param eters can 
be passed in both directions.
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Appendix D2 - TEDEX programme listing
^**************************** j j 89-my05.xpt}
J  * * *  aft %  4 c  *  4 c  *  4 c  * * * * *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  *  # #  *  * *  *  *  *  * * * *  *  * * * *  * * * * * *  *  *  * *  * *  *  *  * *  * *  * *  J
Functions CertFun(Prob):Num CondProb(Cond,CondJNum):Prob NumProb(Num,Num):Prob 
ProbNum(Prob):Num Member(Num, Num, Num, Num, Num, Num):Prob Votes(Any):Cond 
Cat(String,String):String DefineWindow(Num ,Num ,Num ,Num ,Num ,Cond, Num ,Num
,Num ,Num ,Num ,Cond ) :  Null System(Any): Null SField(Num ,Num ,Num ,Num): Null 
CField(Num ,Num ,Num) :  Null NField(Num ,Num Jvfum ,Num ,Num) :  Null
{+++++++++++++++++++++++++++++++++++++++■>■ H  ■+++++++++++++ I I I 4 ++ 4 4 ++++++++-H -+4
+} INCLUDE mywindo.wdf INCLUDE 89_loade.xpt
{++++++++++++ ++4-+ ++++ +++++ ++4++ +++-H H - H - H  H  1-++-H-++ ++ -H  4 t i l l  i 4  t i < ■>■■>■++++++++++
+} INCLUDE 89_add.xpt
{+++-H -++++++++++-f+++++-H -+-i-++-H -+++++++++-f+++++++++++++++++4+4-++++++++++++-M -+4
+}
CONDITION last_visit_report ’ ’ MADE CONDITION please_get ’ ’ MADE CONDITION
please_obtain ’ ’ MADE CONDITION pleasejoad’ ’ MADE
CONDITION a_begin’ ’ MADE CONDITION b_begin’ ’ MADE CONDITION 
c_begin’ ’ MADE CONDITION clinical_finished ’ ’ MADE CONDITION clinical_report ’
’ MADE CONDITION medium_report’ ’ MADE CONDITION validate_finished ’ ’ MADE
CONDITION please_save ’ ’ MADE CONDITION please_sheel ’ * MADE CONDITION 
please_store ’ * MADE
STRING f_a_s_who_are_you ’ ’ MADE STRING m_a_s_who_are_you ’ ’ MADE 
NUMBER m_a_i_user_experience ’ ’ MADE NUMBER f_a_i_user_experience ’ ’ MADE 
[       .]
INVESTIGATE a_c_tedex_user a_s_who_are_you a_i_user_experience 
ASSOONAS AT_START
MAKE m_a_s_who_are__you a_s_who_are_you ASSOONAS ANSWERED a_s_who_are_you
MAKE m_a_i_user_experience a_i_user_experience ASSOONAS ANSWERED a_i_user_experience
[ ]
MAKE a_begin TRUE
ASSOONAS (ANSWERED a_c_tedex_user AND ANSWERED a_s_who_are_you AND 
ANSWERED a_i_user_experience)
[ .] SCRATCHPAD SAVE
(a_s_hospital_number?) CLEAR REPORTLIST STOP ALL CLEAR ALL
[MAKE please_get TRUE] MAKE b_begin FALSE [ MAKE bbegin TRUE]
MAKE a_begin FALSE MAKE a_begin TRUE
ASSOONAS (a_i_final_menu = 3) [-
MAKE pleaseJoad FALSE MAKE pleaseobtain FALSE MAKE pleasc_get FALSE
MAKE validate_finished FALSE MAKE clinical_report FALSE MAKE medium_report
FALSE MAKE clinical_finished FALSE MAKE z.begin FALSE
STOP p_mal_nerve p_mal_muscles
MAKE please_save FALSE MAKE please_sheel FALSE MAKE please_store FALSE
MAKE b_begin TRUE MAKE c_begin FALSE [SCRATCHPAD WIPE
(1,200) for the time being this made problems ]
ASSOONAS a_begin 
[.   .]
INVESTIGATE a_i_main_menu a_s_hospital_number?
ASSOONAS bbegin
[----------------------------------------------------------- -------------] MAKE last_visit_report TRUE
ASSOONAS ANSWERED a_i_main_menu AND (a_i_main_menu = 3) AND please_load
DISPLAY REPORTLIST CLEAR REPORTLIST ASSOONAS last_visit_report 
ASK a_i_main_menu ASSOONAS last_visit_report AND (a_i_main_menu = 3)
[         .]
DISPLAY ’follow up visit #m_a_s_who_are_you# #m_a_i_user_experience# ’ ASSOONAS 
(ANSWERED a_i_main_menu AND (a_i_main_menu = 2)) AND please_load
[   ]
MAKE c.begin TRUE ASSOONAS (ANSWERED a_s_hospital_number? AND ANSWERED 
a_i_main_menu AND NOT (a_i_main_menu = 4))
*^******************************************* ************************* J
[.------------------------ LOAD FILE--------------------------  ] QUESTION obtain?’ob ’ YESNO
MAKE please_load TRUE ASSOONAS please_obtain
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MAKE please_obtain TRUE SCRATCHPAD LOAD (a_s_hospital_number?) ASSOONAS (please_get 
AND ANSWERED a_s_hospital_number? ) OR ( ANSWERED obtain?
AND obtain?)
MAKE please_get TRUE ASSOONAS ( ((a_i_main_menu = 2) OR (a_i_main_menu = 3))
AND ANSWERED a_s_hospital_number? )
[++44H -++++++4^-++++++-H --H -++-K -+++4++++++++-H -++++++++-H --H -+-f4-f+++4-4+++-H -+4+++4+4
+ + ] '
INVESTIGATE g_histoiy p_diplopia_symptom_now p_diplopia_symptom_change
p_diplopia_on_examination_now g_diplopia_on_examination_change
a_i_proptosis_now p_proptosis_now p_proptosis_change p_snellen_now
p_snellen_change p_lid_lag p_lid_retraction p_lid_eodema_now
p_lid_eodema_change p_chemosis_now p_chemosis_change p_comea_now
p_comea_change n_IOP_dif a_i_pupill_now c_coroidal_folds
p_disk_eodima a_c_any_invest? i_stop_cont? c_nerve_invest?
c_field_of_vision? c_100_hue? p_test_mal_nerve g_validate_nerve_answers
c_muscles_invest? c_Hess_chart? c_ultra_sound? c_CTscan?
c_MRIscan? p_test_mal_muscles g_validate_muscles_answers a_i_final_menu
MAKE last_visit_report FALSE ASSOONAS c_begin
|*********************************************************************j DISPLAY 
REPORTLIST CLEAR REPORTLIST ASSOONAS medium.report
MAKE medium_report TRUE MAKE clinical_report TRUE ASSOONAS clinical_finished
MAKE clinical_finished TRUE ASSOONAS ANSWERED a_i_disk_eodema
^* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * j
{---------------------- WHICH WAY TO-GO?----------------------------- }
QUESTION a_c_any_invest?’#13,13,13,13,13,13# #13# Do you have any investigation results 
ready?#13# #13# ’
YESNO ONLY {..............................................  }
NUMBER i_stop_cont?’ stop_cont variable’ a_i_stop_cont? IF (ANSWERED a_c_any_invest? AND 
NOT a_c_any_invest?) ELSE 2
QUESTION a_i_stop_cont? ’ #13# #13,13# Now ..#13# #13# The clinical data enquiry is completed 
and #13# no investigation results are available #13# #13# Do you want to: #13# #13# (l)Stop at 
this stage untill you get the #13# investigation results. #13# OR#13# (2) Continue without
investigations.’
INTEGER 1 2 ONLY
{..............................     } CONDITIONc_nerve_invest? ’ ’ a_c_nerve_invest? IF
(ANSWERED a_c_any_invest? AND a_c_any_invest?) ELSE FALSE





CONDITION c_field_of_vision? ’ ’ a_c_field_of_vision? IF (ANSWERED c_nerve_invest? AND 
c_nerve_invest?) ELSE FALSE
DO SYSTEM(’cls\ ’pause*) ASSOONAS (ANSWERED a_c_field_of_vision? AND 
a_c_field_of_vision?)
QUESTION a_c_field_of_vision?’ #13,13,13# Which results are available:#13,13# - Field of vision. 
#13# #27#[0;30;47m #27#[l;30m- 100-Hue test #13# #13,13# #27#[0;30;47m Field of vision? 
(Y/N)* YESNO ONLY {....................................................................... )
CONDITION c_100_hue? ’ ’ a_c_100_hue? IF (ANSWERED c_nerve_invest? AND c_nerve_invest?) 
ELSE FALSE
QUESTION a_c_100_hue?’ #13,13,13# Which results are available:#13# #13# - Field of vision. #13# 
- 100-Hue test. #13# #13# #13# 100-Hue test? (Y/N) ’ YESNO ONLY
{   . }
CONDITION c_muscles_invest? ’ ’ a_c_muscles_invest? IF (ANSWERED a_c_any_invest? AND 
a_c_any_invest?) ELSE FALSE
QUESTION a_c_muscles_invest?’ #13# #13# #13,13,13,13,13# Do you have Extraocular Muscle 
investigation#13# results available?
YESNO ONLY {.......................................................................}
CONDITION c_Hess_chart? ’ ’ a_c_Hess_chart? IF (ANSWERED a_c_muscles_invest? AND 
a_c_muscles_invest?) ELSE FALSE
QUESTION a_c_Hess_chart?’ #13# #13,13# Which results are available:#13,13# - Hess chart. #13# 
- Oibitalulrasound.#13# - CT scan. #13# - MRI scan. #13# #13# #13# Hess chart? (Y/N) ’ 
YESNO ONLY {..........................................      }
CONDITION c_ultra_sound? ’ ’ a_c_ultra_sound? IF (ANSWERED a_c_muscles_invest? AND 
a_c_muscles_invest?) ELSE FALSE
QUESTION a_c_ultra_sound?’#13# #13# #13# Which results are available:#13,13# - Hess chart 
#13# - Orbital ulrasound. #13# - CT scan. #13# - MRI scan. #13# #13# #13# Ultrasound?
(Y/N)’YESNO ONLY {....................................................  }
CONDITION c_CTscan? ’ ’ a_c_CTscan? IF (ANSWERED a_c_muscles_invest? AND 
a_c_muscles_invest?) ELSE FALSE
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QUESTION a_c_CTscan?’ #13# #13,13# Which results are available:# 13,13# - Hess chart. #13# - 
Orbital ulrasound. #13# -C T  scan. #13# - MRI scan. #13# #13# CT scan? (Y/N) ’ YESNO 
ONLY{.......................................................................}
CONDITION c__MRIscan? ’ ’ a_c_MRIscan? IF (ANSWERED a_c_muscles_invest? AND 
a_c_muscles_invest?) ELSE FALSE
QUESTION a_c_MRIscan?’ #13# #13,13# Which results are available:# 13,13# - Hess chart. #13# - 
Orbital ulrasound. #13# - CT scan. #13# - MRI scan. #13# #13# MRI scan? (Y/N) ’
YESNO ONLY
{  }
{--------------------------------------------------------------------------) CLEAR REPORTLIST MAKE
clinical_report FALSE ASSOONAS validate_finished
MAKE validate_finished TRUE ASSOONAS
(( (p_sug_mal_nerve < 0.499) OR (NOT a_c_nerve_invest?) OR ( (ANSWERED a_i_field_now 
OR NOT a_c_field_of_vision?) AND (ANSWERED a_i_100_hue_now OR NOT 
a_c_100_hue? ) AND (NOT c_nerve_sug_test_dif OR (a_i_validate_nerve_answers = 4))
) ) AND ( (p_sug_mal_muscles < 0.499) OR (NOT a_c_muscles_invest?) OR ( (ANSWERED 
a_i_Hess_chart_now OR NOT a_c_Hess_chart? ) AND (ANSWERED a_i_ultra_sound OR 
NOT a_c_ultra_sound? ) AND (ANSWERED a_i_CTscan OR NOT a_c_CTscan? ) 
AND (ANSWERED a_i_MRIscan OR NOT a_c_MRIscan? ) AND (NOT
c_muscles_sug_test_dif OR (a_i_validate_muscles_answers =4)) ) )) OR (ANSWERED
a_i_stop_cont? AND ( a_i_stop_cont?= 2 ) )




&&&«&&&&&&&&&&&&&&} REPORT (99)’ #13# #13# Optic Nerve: #13# __________ .#13#
#13# From the clinical data there is #13# no evidence to suggest optic #13# nerve compression. ’
ASSOONAS(clinical_report) AND( ANSWERED p_sug_mal_nerve AND
(p_sug_mal_nerve < 0.299) )
REPORT(98) ’ #13# #13# Normally no further investigat-#13# ions of the visual functions are #13# 
required. However, it is #13# recommended to proceed with base-#13# line tests for future 
reference. ’
ASSOONAS (NOT ANSWERED c_show_final_menu) AND clinical_finished AND ( 
ANSWERED p_sug_mal_nerve AND (p_sug_mal_nerve < 0.299) )
{????????????????????????????????????????????????????????????????????????} REPORT (99) ’ #13#
#13# Optic Nerve: #13#   #13# #13# From the clinical data there is #13# no
conclusive evidence to suggest #13# optic nerve compression. ’
ASSOONAS(clinical_report) AND ( ANSWERED p_sug_mal_nerve AND
(p_sug_mal_nerve > 0.3) AND (p_sug_mal_nerve < 0.499 ) )
REPORT (98)’ #13# #13# Further investigations of visual #13# functions are strongly recommended. ’ 
ASSOONAS (NOT ANSWERED c_show_final_menu ) AND clinical_finished AND ( 
ANSWERED p_sug_mal_nerve AND (p_sug_mal_nerve > 0.3) AND (p_sug_mal_nerve < 0.499 )
) {??????????????????????????????????????????????????????????????????????} REPORT (99) ’ #13#
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#13# Optic Nerve: #13# ___________#13# #13# From the clinical examination, #13# there is a
highly suggestive #13# evidence that the optic nerve #13# is compressed.’
ASSOONAS(clinical_report) AND( (p__sug_mal_nerve > 0.5) AND (p_sug_mal_nerve <
0.699) AND ANSWERED p_sug_mal_nerve )
REPORT (98) ’ #13# #13# Investigations are urgently req-# 13# uired to confirm this diagnosis #13# 
before starting the treatment #13# plan. These are 100-Hue, Field #13# of vision, ultrasound, MRI 
and #13# CT scan. ’
ASSOONAS (NOT ANSWERED c_show_final_menu ) AND clinical_finished AND ( 
(p_sug_mal_nerve > 0.5) AND (p_sug_mal_nerve < 0.699) AND ANSWERED
P_sug_mal_nerve )
{??????????????????????????????????????????????????????????????????????} REPORT (99) ’ #13#
Optic Nerve: #13#  #13# #13# From the clinical data, there #13# a conclusive
evidence of optic #13# nerve compression. ’
ASSOONAS(clinical_report) AND( (p_sug_mal_nerve > 0.7) AND ANSWERED
P_sug_mal_nerve )
REPORT (98) ’ #13# #13# Investigations are urgently #13# required to confirm this #13# 
diagnosis before starting the #13# treatment plan, which are #13# 100-Hue, field of vision, 
#13# ultrasound and CT scan. ’
ASSOONAS (last_visit_report AND (nnnn = 4)) OR ( (NOT ANSWERED 
c_show_final_menu ) AND clinical_finished AND ( (p_sug_mal_nerve > 0.7 ) AND 
ANSWERED p_sug_mal_nerve ) )
{??????????????????????????????????????????????????????????????????????}
{---------    VALIDATION------------------------   }
{     }
GROUP g_yalidate_nerve_answers n_sug_mal_nerve n_test_mal_nerve 
c_nerve_sug_test_dif i_validate__nerve_answers
NUMBER i_validate_nerve_answers ’ ’ a_i_yalidate_nerve_answers IF (c_nerve_sug_test_dif AND 
(ANSWERED a_i_field_now OR ANSWERED a_iJo0_hue_now)) ELSE 4
QUESTIONa_i_validate_nerve_answers ’ #13# #27#[l;5;31m #27#[31m A T T E N T I O N
..! #13# #27#[30m #13# #27#[0;30;47m #27#[lm Sorry.. there is marked discrepancy# 13# 
between clinical data and test results
#13# Do you think it is necessary to#13# #13# 1 - Repeat the clinical assessment
#13# 2 -Repeat the investigations. #13,13# 3 -Repeat both. #13# OR#13# 4 -You are
satisfied with the results# 13# and will continue the session.
#13# #13# #13# ’ INTEGER 1 4
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[???????] CONDITION c_nerve_sug_test_dif ’to get difference between p_sug_mal_nerve and 
P_test_mal_nerve ’ ( (n_sug_mal_nerve - n_test_mal_nerve) = 0.3) OR (
(n_test_mal_nerve - n_sug_mal_nerve) = 0.3) [?????????????]
NUMBER n_sug_mal_nerve ’to transfer probability to number n sug. mal nerve ’ PROBNUM( 
P_sug_mal_nerve)
[???????]
NUMBER n_test_mal_nerve ’to transfer probability to number * PROBNUM( p_test_mal_nerve)
{ -RESET & RESTART-----------------------------}
{  } CLEAR a_i_disk_eodema CLEAR




{---------------  } CLEAR a J_field_now CLEAR
a_i_field_change CLEAR a_i_l00_hue_now CLEAR a_i_ 100_hue_change {CLEAR 
a_p_charts_comment} CLEAR a_c_color_blind
CLEAR a_i_validate_nerve_answers
ASSOONAS a_i_validate_nerve_answers = 2 
{    }
CLEAR a_i_disk_eodema CLEAR a_c_coroidal_folds CLEAR a_i_snellen_now {CLEAR 
a_i_snellen_change} {CLEAR a_i_temprac_now} {CLEAR a_i_temprac_change} CLEAR 
a__i_field_now CLEAR a_i_field_change CLEAR a_i_100_hue_now CLEAR a_i_100_hue_change 
{CLEAR a_p_charts_comment} CLEAR a_c_color_blind
CLEAR a_i_validate_nerve_answers




CONDITION anti_all ’ ’ anti_steroids AND anti_surgery AND anti_radio
{----------------------------------------------- ---------------------------- }{----------------------- ANTI-STEROIDS
START------------------------------ }-{-----------------------------------------------------------------------------}
QUESTION a_c_peptic_ulceration ’ #13# #13,13,13,13,13# Does the patient have
any previous history#13# #13# of peptic ulceration?’
YESNO
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QUESTION a_c_history_anti_steroids ’#13,13,13,13# #13# #13# Does the patient have any 
previous side#13,13# effects due to systemic steroid treatment? #13# ’ YESNO 
{.......................................................................... }CONDmONanti_steroids ’ ’ c_anti_steroids
CONDITION c_anti_steroids ’ ’ ( a_c_peptic_ulceration OR
a_c_history_anti_steroids OR ((a_s_patient_sex =/ T )  AND (i_patient_age 45)) OR 
(a_c_Diabetic?) OR (a_i_thyroid_status = 3) OR a_c_Hypertensive? )
DISPLAY’ #13##13##13##13##13# #27#[l;33m#13# IS  S Y S T E M I C  S T E R O I D S  
#13##13# C O N T R A - I N D I C A T E D  I N T H IS#13##13# P A R T I C U L A R  P 
ATIENT?#13#*INVESTIGATE c_anti_steroids ASSOONAS ( (a_i_treat_nerve = 1) OR 
((cccc=4) AND (nnnn=4)) ) AND ( validate_finished OR (z_begin[ AND anti_steroids]))
{ ..................................................................... ) DISPLAY ’ #13##13,13# #13# #13# Considerably
high dosese of oral systemic steroids#13# are usually required in such case (120 milligrams of# 13# 
prednisolone or equivalent is the usual starting dose).#13,13# It is recommend that a physican should 
be involved# 13# in patient management.#13,13,27#[31m#13,13,13# Note: This high dose can only 
be given to the# 13# patient while in hospital.’
ASSOONAS ( (a_i_treat_nerve = 1) OR ((cccc=4) AND (nnnn=4)) ) AND NOT c_anti_steroids 
AND ( validate_finished OR (z_begin[ AND anti_steroids]))
{ ...     }
STRING s_Diabetic ’ ’ ’ #13# - Diabetic. ’ IF (ANSWERED a_c_diabetic?) AND (a_c_diabetic?) 
ELSE ”
STRING s_Hyper_tensive ’ ’ * #13# - Hypertensive.’ IF (ANSWERED a_c_Hypertensive?) AND 
(a_c_Hypertensive?) ELSE ’ *
STRING s_female_over45 ’ ’ ’ #13# - being at risk of oteoporosis.’ IF (ANSWERED a_s_patient_sex) 
AND (ANSWERED i_patient_age) AND ((a_s_patient_sex =/ T )  AND (i_patient_age 45))
ELSE ”
STRING s_steroids_side_effect ’ ’ ’ #13# -the presence of previous steroid treatment #13# side 
effects.’ IF (ANSWERED a_c_history_anti_steroids) AND a_c_history_anti_steroids ELSE ’ ’
STRING s_peptic_ulceration ’ ”  #13# - the risk of bleeding or perforation of the #13# peptic ulcer.’ 
IF (ANSWERED a_c_peptic_ulceration) AND a_c_peptic_ulceration ELSE ’ ’
DISPLAY’#13# #13# #13# In this particular patient it is preferred #13# not to use systemic 
steroids and to consider #13# other options if possible. As the patient#s_Diabetic# 
#s_thyroid_status##s_Hyper_tensive##s_female_over45##s_steroids_side_effect##s_peptic_ulceration# 
#13# #13# The availability of other options and your #13# judgements should be the deceicive
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factors #13# in reaching the final decision. #13# ’ ASSOONAS ( (a_i_treat_nerve = 1) OR 
((cccc=4) AND (nnnn=4))) AND c_anti_steroids AND ( validate_finished OR
(z_begin[ AND anti_steroids])) AND (NOT anti_all)
{------------------  _ .} { ------------------------ ANTI-STEROIDS
{---------------------------------------------------------------------------- }{----------------------- ANTI-SURGERY
QUESTION a_c_contra_anasthesia? ’#13,13,13,13,13# #13# Are there any contra-indications #13# 
#13# for surgery under general anasthesia? ’
YESNO ONLY
CONDITION anti_surgery ’ ’ c_anti_surgery 
CONDITION c_anti_surgery ’ * a_c_contra_anasthesia?
INVESTIGATE c_anti_surgery ASSOONAS ( (a_i_treat_nerve = 2) OR (a_i_lid_tars_leng_deco = 3)
) OR ( c_muscles_troubles AND (NOT c_any_other_troubles) AND (ANSWERED c_stable AND 
c_stable) ) AND ( validate_finished OR (z_begin[ AND anti_surgery]))
{...........    ...} DISPLAY’#13,13,13,13,13,13# #13# Apperantly
there is no contraindications to #13# orbital surgical decompression. ’
ASSOONAS ( (a_i_treat_nerve = 2) OR (a_i_lid_tars_leng_deco = 3)) AND NOT
c_anti_surgery AND ( validate_finished OR (z_begin[ AND anti_surgery]))
{........................................................................... ) DISPLAY’#13,13,13,13,13,13,13# #13#
Apperantly there are contraindications to #13# to orbital surgical decompression. It is #13# 
recommended to use alternative treatment #13# modaliy. *
ASSOONAS ( (a_i_treat_nerve = 2) OR (a_i_lid_tars_leng_deco = 3 ) )  AND c_anti_surgery
AND ( validate_finished OR (z_begin[ AND anti_surgery])) AND (NOT anti_all)
{----------------------------------------------------------------------------}{-------------------------ANTI-SURGERY
e n d   } {---------------------------------------------------------------------------- }
ANTI-RADIOTHERAPY START—  ------------------—) ^
{---------------   } CONDITION anti_radio ’ ’ c_anti_radio
CONDITION c_anti_radio ’ ’ ( (a_c_Radiotherapy?) AND NOT (a_i_Radiotherapy_effect? = 1) )
INVESTIGATE c_anti_radio ASSOONAS((a_i_treat_nerve = 3) OR ( (cccc=4)AND(nnnn=4)AND 
anti_steroids))AND ( validate_finished OR (z_begin[ AND anti_radio]))
{ }
DISPLAY ’ #13,13,13,13,13,13# #13# Apparently there are no contraindications #13# to Orbital
Radiotherapy in thid particular #13# patient ’ ASSOONAS((a_i_treat_nerve = 3)OR ( (cccc=4) AND
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(nnnn=4) AND anti_steroids))AND b
validate_finished OR (z_begin[ AND anti_radio]))
NOTc anti_radio AND (
DISPLAY ’ #13# #13# #13,13,13# #13# #13# #13# This patient had previous unsuccessful Orbital 
#13# Radiotherapy course. Therefore, radiotherapy #13# should not be repeated.







REPORT (91)’ #13# #13# Extraocular Muscles: #13# ___________________ #13# #13# From the
clinical data, there is #13# no evidence to suggest extraocular #13# muscle dysfunction. ’
ASS OONAS (clinical_report) AND( ANSWERED p_sug_mal_muscles AND
(p_sug_mal_muscles < 0.299) )
REPORT(90)’ #13# #13# Normally, No further investigat- #13# ions are required. However, It is #13# 
recommended to proceed with the #13# following base-line tests for #13# future reference: Hess 
chart, #13# Field of single binocular vision. ’ ASSOONAS (NOT ANSWERED c_show_final_menu ) 
AND clinical_finished AND ( ANSWERED p_sug_mal_muscles AND (p_sug_mal_muscles
<0.299) )
{????????????????????????????????????????????????????????????????????????) REPORT (91) ’ #13#
#13# Extraocular mucsles: #13#  #13# #13# From the clinical data there is
#13# evidence suggesting extraocular #13# muscle dysfunction. ’
ASSOONAS(clinical_report) AND( ANSWERED p_sug_mal_muscles AND
(p_sug_mal_muscles > 0.3) AND (p_sug_mal_muscles < 0.499) )
REPORT(90) ’ #13# #13# The following investigations of #13# ocular motility investigations #13# 
are recommended: Hess chart, #13# Field of single binocular vision. ’
ASSOONAS (NOT ANSWERED c_show_final_menu) AND clinical_finished AND (
ANSWERED p_sug_mal_muscles AND (p_sug_mal_muscles > 0.3 ) AND (p_sug_mal_muscles < 
0.499) )
{??????????????????????????????????????????????????????????????????????) REPORT (91) ’ #13#
#13# Extraocular Muscles: #13# ___________________ #13# #13# The clinical data strongly
#13# suggests that there is muscles #13# dysfunction.’
ASSOONAS(clinical_report) AND( (p_sug_mal_muscles > 0.5) AND
(p_sug_mal_muscles < 0.699) AND ANSWERED p_sug_mal_muscles )
anti_all) {----------------------------
ANTI-RADIOTHERAPY END
c_anti_radio AND ( validate_finished OR (z_begin[ AND anti_radio])) AND (NOT
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REPORT (90)’ #13# #13# The following investigations are #13# strongly required to confirm this 
#13# diagnosis before starting the #13# treatment plan: Hess chart, Field #13# of single binocular 
vision. ’
ASSOONAS (NOT ANSWERED c_show_final_menu ) AND clinical_finished AND ( 
(p_sug_mal_muscles > 0.5) AND (p_sug_mal_m uscles < 0.699) AND
ANSWERED p_sug_mal_muscles )
{??????????????????????????????????????????????????????????????????????) REPORT (91) ’ #13#
#13# Extraocular Muscles: #13#  #13# #13# The clinical data provides a
#13# conclusive evidence of extraocular #13# muscles dysfunction. ’
ASSOONAS(clinical_report) AND( (p_sug_mal_muscles > 0.7) AND ANSWERED
p_sug_mal_muscles )
REPORT (90)’ #13# #13# The following investiggations are #13# required: Hess chart, Field of #13# 
single binocular vision. ’
ASSOONAS (NOT ANSWERED c_show_final_menu) AND clinical_finished AND( 
(p_sug_mal_muscles > 0.7) AND ANSWERED p_sug_mal_muscles )
{??????????????????????????????????????????????????????????????????????) GROUP 
g_validate_muscles_answers n_sug_mal_muscles n_test_mal_muscles 
c_muscles_sug_test_difi_validate_muscles_answers
NUMBER i_validate_muscles_answers ’ ’ a_i_validate_muscles_answers IF ( c_muscles_sug_test_dif 
AND (ANSWERED a_i_Hess_chart_now OR ANSWERED a_i_ultra_sound
OR ANSWERED a_i_CTscan OR ANSWERED a_i_MRIscan ) )
ELSE 4
QUESTION a_i_validate_muscles_answers ’#27#[lm #13# #27#[5m #27#[31mA T T E N T
IO N  ..!#13,27#[0;30;47m#13,27#[30;47m Sorry. . there is marked discrepancy 
#13,27#[0;30;47m between clinical#27#[5;47m data and test results. #13# #13# Do you think it is 
necessary to: #13# #13# (1) Repeat the clinical assessment. #13# #13# (2) Repeat the
investigations. #13,13# (3) Repeat both. #13# OR #13# (4) You are satisfied with the results,
#13# and continue the session. #13# #13# ’ INTEGER 1 4
[???????] CONDITION c_muscles_sug_test_dif ’to get difference between p_sug_mal_muscles and 
p_test_mal_muscles ’ ( (n_sug_mal_muscles - n_test_mal_muscles) = 0.3) OR (
(n_test_mal_muscles - n_sug_mal_muscles) = 0.3) [?????????????]
NUMBER n_sug_mal_muscles ’to transfer probability to number n_sug_mal_muscles * PROBNUM( 
P_sug_mal_muscles)
[???????]
NUMBER n_test_mal_muscles ’to transfer probability to number ’ PROBNUM( p_test_mal_muscles )
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{------------- -RESET & RESTART-
CLEAR a_i_diplopia_symptom_now CLEAR a_i_diplopia_symptom_change CLEAR 
a_i_diplopia_on_examination_now CLEAR a_i_diplopia_on_examination_change CLEAR 
a_i_proptosis_opinion CLEAR a_i_proptosis_now CLEAR a_i_proptosis_change
CLEAR a_i_validate_muscles_answers
ASSCX)NAS a_i_validate_muscles_answers =1
CLEAR a_i_Hess_chart_now CLEAR a_i_Hess_chart_change CLEAR a_i_ultra_sound CLEAR 
a_i_CTscan CLEAR a_i_MRIscan
CLEAR a_i_validate_muscles_answers
ASSOONAS a_i_validate_muscles_answers = 2 
{   }
CLEAR a_i_diplopia_symptom_now CLEAR a_i_diplopia_symptom_change CLEAR 
a_i_diplopia_on_examination_now CLEAR a_i_diplopia_on_examination_change CLEAR 
a_i_proptosis_opinion CLEAR a_i_j)roptosis_now CLEAR a_i_proptosis_change CLEAR 
a_i_Hess_chart_now CLEAR a_i_Hess_chart_change CLEAR a_i_ultra_sound CLEAR a_i_CTscan 
CLEAR a_i_MRIscan
CLEAR a_i_validate_muscles_answers
ASSOONAS a_i_validate_muscles_answers = 3 
{???????????????????????????????????????????????????????????????????????} 
{??????????????????????????????????????????????????????????????????????}
REPORT(96)’ #13# #13# Cornea: #13#  ____ #13# #13# Normal cornea. ’
ASSOONAS(clinical_report) AND ( ANSWERED p_mal_comea AND (
p_mal_comea < 0.299) )
REPORT(96) ’ #13# #13# Cornea: #13# ______ #13# #13# Superficial Punctate Keratopathy. ’
ASSOONAS(clinical_report) AND ( ANSWERED p_mal_comea AND
(p_mal_comea > 0.3) AND (p_mal_comea < 0.499) )
REPORT(96) ’ #13# #13# Cornea: #13# ______ #13# #13# Exposure problem. ’
ASS OON AS (clinical_report) AND ( ANSWERED p_mal_comea AND
(p_mal_comea > 0.5) AND (p_mal_comea < 0.699) )
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REPORT(96)’ #13# #13# Cornea: #13# ______ #13# #13# Ulceration. ’
ASSOONAS(clinical_report) AND ( ANSWERED p_mal_comea AND (
p_mal_comea > 0.7) )
{$$$$$$$$$$$$$$$$$$$$$$$$$$ J
REPORT(93) ’ #13# #13# Right Eyelid* #13# ;____________ #13# #13# Only lid retraction
(and/or) #13# lidlag. No coverage problem. *
ASSOONAS(clinical_report) AND ( ANSWERED p_mal_lid AND ( p_mal_lid <
0.299) ) REPORT(93) ’ #13# #13# Righ Eyelid: #13# ____________#13# #13#
Mild lid coverage problem. ’
ASSOONAS(clinical_report) AND ( ANSWERED p_malJid AND (p_malJid >
0.3) AND (p_mal_lid< 0.499) )
REPORT(93) ’ #13# #13# Right Eyelid: #13#  _______ _  #13##13# Moderate lid shortage. ’
ASSOONAS(clinical_report) AND ( ANSWERED p_mal_lid AND (p_mal_lid
> 0 .5 ) AND (p_mal_lid< 0.699) )
REPORT(93) * #13# #13# Right Eyelid: #13# #13# #13# Severe lid shortage. ’
ASSOONAS(clinical_report) AND ( ANSWERED p_mal_lid AND ( p_mal_lid >
O ?)  ^ {??????????????????????????????????????????????????????????????????????}
1^  ^ ^^^^  ^ ^ S^^ ^ ^  ^ ^  ^ ^^  ^^ s ss s s $ $ $ $ $ SS $ ^ $$ $ $$$ $$ $ 51
INCLUDE 89_saver.xpt
MAKE please_save TRUE ASSOONAS a_save? OR AT_QUIT OR ATJEND 
MAKE please_sheel TRUE ASSOONAS please_save 
MAKE please_store TRUE ASSOONAS please_sheel
QUESTION a_save?’#13,13,13,13,13,13# #13# Do you like to save? ’ YESNO
QUESTION a_daa?’da a ’ YESNO
SCRATCHPAD S AVE(a_s_hospital_number?) ASSOONAS please_store OR a_daa?
’ validate finished ’ ASSOONAS validate finished
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{ patient personal information-------------------} {10 -19}
STRING f_a_s_patient_name ’ ’MADE NUMBER f_a_i_patient_DOB ’ ’MADE STRING 
f_a_s_patient_sex ’ ’MADE
{--------------------------- general health (history)------------------ }
{20-39}
CONDITION f_a_c_Diabetic? ’ ’MADE CONDITION f_a_c_Hypertensive? ’
’MADE CONDITION f_a_c_Renal? ’ ’MADE CONDITION f_a_c_Pulmonaric?
’MADE CONDITION f_a_c_GI? ’ ’MADE CONDITION f_a_c_peptic_ulceration
’MADE CONDITION f_a_c_history_anti_steroids ’ ’MADE CONDITION 
f_a_c_contra_anasthesia? ’ ’MADE CONDITION f_a_c_Hart_disease ’ ’MADE
{-------— -------------history of thyroid treatment----------------------}
{40-49}
NUMBER f_a_i_thyroid_status ’ ’MADE CONDITION f_a_c_Radioactive_iodine? ’ ’MADE 
CONDITION f_a_c_Thyroidectomy? ’ ’MADE CONDITION f_a_c_Carbimazol? ’ ’MADE
{ eye troubles and complains-----------  }
{50-69}
CONDITION f_a_c_lacrimination? ’ ’MADE CONDITION f_a_c_photophobia?
’MADE CONDITION f_a_c_visual_blurring? ’ ’MADE CONDITION f_a_c_double_vision? 
’ ’MADE CONDITION f_a_c_pain? ’ ’MADE NUMBER
f_a_ijpatient_most_troublesome ’ ’MADE NUMBER f_a_i_patient_appearance ’ ’MADE
{--------------  previous eye treatment---------------------------  }
{70-99}
NUMBER f_a_i_eye_disease_duration ’ ’MADE CONDITION f_a_c_Eye_lubricants? ’ 
’MADE CONDITION f_a_c_Tr_for_comeal_ulcer? ’ ’MADE CONDITION 
f_a_c_Lid_lengthening? ’ ’MADE CONDITION f_a_c_Tarsorhaphy? ’ ’MADE
CONDITION f_a_c_Systemic_steroids? ’ ’MADE CONDITION f_a_c_Radiotherapy?
’MADE CONDITION f_a_c_decompression? ’ ’MADE CONDITION f_a_c_Prisms_occlusion?
’ ’MADE CONDITION f_a_c_Muscle_surgery? ’ ’MADE
{ CONDITION f_a_c_lubricants_effect ’ ’MADE CONDITION f_a_c_Tr_ulcer_effect
’MADE CONDITION f_a_c_Lid_lengthening_effect ’ ’MADE CONDITION 
f_a_c_Tarsorahphy_effect ’ ’MADE CONDITION f_a_c_Systemic_steroids_effect ’ ’MADE 
CONDITION f_a_c_Radiotherapy_effect ’ ’MADE CONDITION f_a_c_decompression_effect




NUMBER f_a_i_disk_eodema ’ ’MADE CONDITION f_a_c_coroidal_folds
’MADE NUMBER f_a_i_snellen_now ’ ’MADE NUMBER f_a_i_field_now
’MADENUMBER f_aj_100_hue_now ’ ’MADECONDITION f_a_c_color_blind
’ ’MADE NUMBER f_a_i_diplopia_symptom_now ’ ’MADE NUMBER 
f_a_i_diplopia_on_examination_now ’ ’MADE NUMBER f_a_i_proptosis_opinion ’ ’MADE 
NUMBER f_a_i_proptosis_now ’ ’MADE NUMBER f_a_i_Hess_chart_now
’MADE NUMBER f_a_i_ultra_sound ’ ’MADE CONDITION f_a_c_lid_lag
’MADE NUMBER f_a_i_lid_retraction ’ ’MADE NUMBER f_a_i_comea_now
’ ’MADE NUMBER f_a_i_lid_eodema_now ’ ’MADE NUMBER f_a_i_chemosis_now 
’ ’MADENUMBER f_n_IOP_dif ’ ’MADE
{-------------------------- -—FINDINGS---------------------------- — } {130-140 }
NUMBER f_m_i_nerve_condition * ’MADE NUMBER f_m_i_muscles_condition ’ ’MADE 
NUMBER f_m_i_comea_condition ’ ’MADE NUMBER f_m_i_lid_condition ’ ’MADE
NUMBER m_i_nerve_condition ’ ’MADE NUMBER m_i_muscles_condition ’ ’MADE 
NUMBER m_i_comea_condition ’ ’MADE NUMBER m_i_lid_condition ’ ’MADE
{------------  . . .  REQUIRED INVESTIGATIONS----------------------- } { 140 -160}
CONDITION f_m_c_field_of_vision ’ ’MADE CONDITION f_m_c_100_hue_test 
’MADE CONDITION f_m_c_Hess_chart ’ ’MADE CONDITION f_m_c_ultra_sound
’ ’MADE
[ ’ ’MADE ’ ’MADE ]
CONDITION m_c_field_of_vision ’ ’MADE CONDITION m_c_100_hue_test ’ ’MADE
CONDITION m_c_Hess_chart ’ ’MADE CONDITION m_c_ultra_sound
’MADE
{--------------. . . . . .  -ACTIONS-  ------------  } { 160-165}
NUMBER f_m_i_action ’ ’MADE
NUMBER mJLaction ’ ’MADE
{---------------------------MEDICAL TREATMENT--------------------------} { 165 - 180}
CONDITION f_m_c_eye_lubricants * ’MADE CONDITION f_m_c_systemic_steroids
’ ’MADE CONDITION f_m_c_raise_head_w_dioretics ’ ’MADE CONDITION 
f_m_c_raise_head_w_no_dioretics ’ ’MADE CONDITION f_m_c_occlusion_or_prism 
’MADE CONDITION f_m_c_Radiotherapy ’ ’MADE CONDITION
f_m_c_anti_glaucoma_medications ’ ’MADE
CONDITION m_c_eye_lubricants ’ ’MADE CONDITION m_c_systemic_steroids
’ ’MADE CONDITION m_c_raise_head_w_dioretics ’ ’MADE CONDITION 
m_c_raise_head_w_no_dioretics ’ ’MADE CONDITION m_c_occlusion_or_prism 
’MADE CONDITION m_c_Radiotherapy ’ ’MADE CONDITION
m_c_anti_glaucoma_medications ’ ’MADE
{-------------------------- SURGICAL TREATMENT------------------------} { 180 -190 }
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CONDITION f_m_c_tarsoraphy ’ ’MADE CONDITION f_m_c_lidjenghthen ’ ’MADE 
CONDITION f_m_c_decompression ’ ’MADE CONDITION f_m_c_muscles_surgery ’ ’MADE
CONDITION m_c_tarsoraphy ’ ’MADE CONDITION m_c_lid_lenghthen ’ ’MADE 







{------------------ —  patient personal information-------------------- } {10-19}
SCRATCHPAD GET (10,f_a_s_patient_name) SCRATCHPAD GET (11 rf_a_i_patient_DOB)
SCRATCHPAD GET (13/_a_s_patient_sex) ASSOONAS please_load
{--------------------------- general health (history)-------------------} {20-39}
SCRATCHPAD GET (21£_a_c_Diabetic?) SCRATCHPAD GET (22,f_a_c_Hypertensive?) 
SCRATCHPAD GET (23£_a_c_Renal?) SCRATCHPAD GET (24/_a_c_Pulmonaric?) SCRATCHPAD 
GET (25,f_a_c_GI?) SCRATCHPAD GET (26,f_a_c_peptic_ulceration) SCRATCHPAD GET 
(27X_a_c_history_anti_steroids) SCRATCHPAD GET (28,f_a_c_contra_anasthesia?) SCRATCHPAD 
GET (29 /_a_c_Hart_disease) ASSOONAS please_load
{up to 39} {--------------------— history of thyroid treatment--------------------- } {40-49}
SCRATCHPAD GET (40/_a_i_thyroid_status) SCRATCHPAD GET (41,f_a_c_Radioactive_iodine?) 
SCRATCHPAD GET (42,f_a_c_Thyroidectomy?) SCRATCHPAD GET (43£_a_c_Carbimazol?)
ASSOONAS please_load
{----------------------eye troubles and complains-------------------------} {50-69}
SCRATCHPAD GET (50/_a_c_lacrimination?) SCRATCHPAD GET (51 Jf_a_c_photophobia?) 
SCRATCHPAD GET (52,f_a_c_visual_blurring?) SCRATCHPAD GET (53,f_a_c_double_vision?) 
SCRATCHPAD GET (54/_a_c_pain?) SCRATCHPAD GET (55/_a_i_patient_most_troublesome) 
SCRATCHPAD GET (56/_a_i_patient_appearance) ASSOONAS please_load
{--------------- previous eye treatment ------------------- } {70-99}
SCRATCHPAD GET (70, f_a_i_eye_disease_duration) SCRATCHPAD GET (71, 
f_a_c_Eye_lubricants?) SCRATCHPAD GET (72, f_a_c_Tr_for_comeal_ulcer?) SCRATCHPAD GET 
(73, f_a_c_Lid_lengthening?) SCRATCHPAD GET (74, f_a_c_Tarsorhaphy?) SCRATCHPAD GET (75, 
f_a_c_Systemic_steroids?) SCRATCHPAD GET (76, f_a_c_Radiotherapy?) SCRATCHPAD GET (77, 
f_a_c_decompression?) SCRATCHPAD GET (78, f_a_c_Prisms_occlusion?) SCRATCHPAD GET (79, 
f_a_c_Muscle_surgery?) ASSOONAS pleasejoad
{ SCRATCHPAD GET (85, f_a_c_lubricants_effect) SCRATCHPAD GET (86, f_a_c_Tr_ulcer_effect) 
SCRATCHPAD GET (87, f_a_c_Lid_lengthening_effect) SCRATCHPAD GET (88, 
f_a_c_Tarsorhaphy_effect) SCRATCHPAD GET (89, f_a_c_Systemic_steroids_effect) SCRATCHPAD
D2-16
GET (90, f_a_cJRadiotherapy_effect) SCRATCHPAD GET (91, f_a_c_decompression_effect) 
SCRATCHPAD GET (92, f_a_c_Prisms_occlusion_effect) SCRATCHPAD GET (93, 
f_a_c_Muscles_surgery_effect) ASSOONAS pleasejoad}
[SCRATCHPAD GET 0]
{----------------------------clinical examinations —*-----------   J
SCRATCHPAD GET (100, f_a_i_disk_eodema) SCRATCHPAD GET (101,f_a_c_coroidal_folds) 
SCRATCHPAD GET (102, f_aJLsnellen_now) SCRATCHPAD GET (103, f_a_i_field_now) 
SCRATCHPAD GET (104, f_a_i_100_hue_now) SCRATCHPAD GET (105, f_a__c_color_blind) 
SCRATCHPAD GET (106, f_aJ_diplopia_symptom_now) SCRATCHPAD GET (107, 
f_a_i_diplopia_on_examination_now) SCRATCHPAD GET (108, f_a_i_proptosis_opinion) 
SCRATCHPAD GET (109, f_a_i_proptosis_now) SCRATCHPAD GET (110,f_a_i_Hess_chart_now) 
SCRATCHPAD GET (lll,f_a_i_ultra_sound) SCRATCHPAD GET (112,f_a_c_lid_lag) 
SCRATCHPAD GET (113, f_aJJid_retraction) SCRATCHPAD GET (114, f_a_i_comea_now) 
SCRATCHPAD GET (115, f_a_i_lid_eodema_now) SCRATCHPAD GET (116, f_a_i_chemosis_now) 
SCRATCHPAD GET (117, f_nJOP_dif) ASSOONAS pleasejoad {UP TO 150}
{----------------— _—FINDINGS — -—  ----------------------------} {130-140}
SCRATCHPAD GET (130, f_m_i_nerve_condition) SCRATCHPAD GET (131, 
f_m_i_muscles_condition) SCRATCHPAD GET (132, f_m_i_comea_condition) SCRATCHPAD GET 
(133, f_mJJid_condition) ASSOONAS please_load {----------------------- REQUIRED
INVESTIGATIONS----------------------- } {140 -160}
SCRATCHPAD GET (140, f_m_c_field_ofvision) SCRATCHPAD GET (141, f_m _cJ00Jiuejest) 
SCRATCHPAD GET (142, f_m_c_Hess_chart) SCRATCHPAD GET (143, f_m_c_ultra_sound) 
ASSOONAS pleasejoad {-------------------------------ACTIONS-------------------------------} {160 -165}
SCRATCHPAD GET (160, f m  J_action) ASSOONAS pleasejoad {-------  MEDICAL
TREATMENT----------------  } {165-180}
SCRATCHPAD GET (165, fm_c_eyejubricants) SCRATCHPAD GET (166, 
f_m_c_systemic_steroids) SCRATCHPAD GET (167, f_m_c_raise_head_w_dioretics) SCRATCHPAD 
GET (168, f_m_c_raiseJiead_w_no_dioretics) SCRATCHPAD GET (169, f_m_c_occlusion_or_prism) 
SCRATCHPAD GET (170, f_m_c_Radiotherapy) SCRATCHPAD GET (171, 
f_m_c_anti_glaucoma_medications) ASSOONAS pleasejoad {--------------------------- SURGICAL
TREATMENT------------------------ } { 180-190}
SCRATCHPAD GET (180, f_m_c_tarsoraphy) SCRATCHPAD GET (181, f_m_cjidjenghthen) 




MAKE f_a_s_who_are_you a_s_who_are_you MAKE f_aj_user_experience aj_user_experience 
ASSOONAS please_save
SCRATCHPAD PUT (3, f_a_s_who_are_you) SCRATCHPAD PUT (4, f_aj_user_experience) 
ASSOONAS please_sheel
{ patient personal information--------------------} {10-19}
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MAKE f_a_s_patient_name a_s_patient_name MAKE f_a_i_patient_DOB a_i_patient_DOB 
MAKE f_a_s_patient_sex a_s_patient_sex ASSOONAS please_save
SCRATCHPAD PUT (10,f_a_s_patient_name) SCRATCHPAD PUT (1 l,f_a_i_patient_DOB) 
SCRATCHPAD PUT (13,f_a_s_patient_sex) ASSOONAS please_sheel
{--------------------------- general health (history)-------------------}
{20-39}
{MAKE f_a_i_thyroid_status a_i_thyroid_status} MAKE f_a_c_Diabetic? a__c_Diabetic? 
MAKE f_a_c_Hypertensive? a_c_Hypertensive? MAKE f_a_c_Renal? a_c_Renal? MAKE 
f_a_c_Pulmonaric? a_c_Pulmonaric? MAKE f_a_c_GI? a_c_GI? MAKE
f_a_c_peptic_ulceration a_c_peptic_ulceration MAKE f_a_c_history_anti_steroids 
a_c_history_anti_steroids MAKE f_a_c_contra_anasthesia? a_c_contra_anasthesia?
MAKE f_a_c_Hart_disease a_c_Hart_disease ASSOONAS please_save
{SCRATCHPAD PUT (20/_a_i_thyroid_status)} SCRATCHPAD PUT (21,f_a_c_Diabetic?) 
SCRATCHPAD PUT (22,f_a_c_Hypertensive?) SCRATCHPAD PUT (23,f_a_c_Renal?) 
SCRATCHPAD PUT (24,f_a_c_Pulmonaric?) SCRATCHPAD PUT (25/_a_c_GI?) SCRATCHPAD 
PUT (26,f_a_c_peptic_ulceration) SCRATCHPAD PUT (27,f_a_cJiistory_anti_steroids) 
SCRATCHPAD PUT (28,f_a_c_contra_anasthesia?) SCRATCHPAD PUT (29/_a_c_Hart_disease) 
ASSOONAS please_sheel
{up to 39}
{-----------------------history of thyroid treatment ---------------}
{40-49}
MAKE f_a_i_thyroid_status a_i_thyroid_status MAKE f_a_c_Radioactive_iodine? 
a_c_Radioactive_iodine?MAKE f_a_c_Thyroidectomy? a_c_Thyroidectomy?MAKE 
f_a_c_Carbimazol? a_c_Carbimazol? ASSOONAS please_save
SCRATCHPAD PUT (40/_a_i_thyroid_status) SCRATCHPAD PUT (41,f_a_c_Radioactive_iodine?) 
SCRATCHPAD PUT (42,f_a_c_Thyroidectomy?) SCRATCHPAD PUT (43 ,f_a_c_Carbimazol?) 
ASSOONAS please_sheel
{--------------------- eye troubles and complains------------------------ }
{50-69}
MAKE f_a_c_lacrimination? a_c_lacrimination? MAKE f_a_c_photophobia?
a_c_photophobia? MAKE f_a_c_visual_blurring? a_c_visual_bluning? MAKE 
f_a_c_double_vision? a_c_double_vision? MAKE f_a_c_pain? a_c_pain? MAKE
f_a_i_patient_most_troublesome a_i_patient_most_troublesome MAKE f_a_i_patient_appearance 
a_i_patient_appearance ASSOONAS please_save
SCRATCHPAD PUT (50,f_a_c_lacrimination?) SCRATCHPAD PUT (51,f_a_c_photophobia?) 
SCRATCHPAD PUT (52,f_a_c_visual_blurring?) SCRATCHPAD PUT (53,f_a_c_double_vision?) 
SCRATCHPAD PUT (54,f_a_c_pain?) SCRATCHPAD PUT (55tf_a_i_patient_most_troublesome ) 
SCRATCHPAD PUT (56,f_a_i_patient_appearance) ASSOONAS please_sheel
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{--------------- previous eye treatment — }
{70-99}
MAKE f_a_i_eye_disease_duration a_i_eye_disease_duration
MAKE f_a_c_Eye_lubricants? (a_c_Eye_lubricants? OR c_tr_ulcer_lubrication 
OR c_tr_comea_lid_lubrication)
MAKE f_a_c_Tr_for_comeal_ulcer? (a_c_Tr_for_comeal_ulcer? OR c_tr_ulcer OR 
c_tr_ulcer_lubrication)
MAKE f_a_c_Lid_lengthening? (a_c_Lid_lengthening? OR c_tr_lid_lengthening)
MAKE f_a_c_Tarsorhaphy? (a_c_Tarsorhaphy? OR c_tr_tarsoraphy)
MAKE f_a_c_Systemic_steroids? (a_c_Systemic_steroids? OR c_tr_ulc_nerv_w_steroids OR 
c_tr_ulc_nerv_critical ORc_tr_nerve_w_steroids)
MAKE f_a_c_Radiotherapy? (a_c_Radiotherapy? OR c_tr_ulc_nerv_w_radiotherapy 
OR c_tr_nerve_w_radiotherapy)
MAKE f_a_c_decompression? (a_c_decompression? OR c_tr_nerve_w_decompression OR 
c_tr_lid_drcompress OR c_do_deco_first_muscles )
MAKE f_a_c_Prisms_occlusion? (a_c_Prisms_occlusion? OR c_prism_or_occlussion)
MAKE f_a_c_Muscle_surgery? (a_c_Muscle_surgery? OR c_do_muscles_surgery 
OR c_do_muscles_surgery_w_care)
ASSOONAS please_save
SCRATCHPAD PUT (70, f_aJ_eye_disease_duration) SCRATCHPAD PUT (71, 
f_a_c_Eye_lubricants?) SCRATCHPAD PUT (72, f_a_c_Tr_for_comeal_ulcer?) SCRATCHPAD PUT 
(73, f_a_cJLid_lengthening?) SCRATCHPAD PUT (74, f_a_c_Tarsorhaphy?) SCRATCHPAD PUT (75, 
f_a_c_Systemic_steroids?) SCRATCHPAD PUT (76, f_a_c_Radiotherapy?) SCRATCHPAD PUT (77, 
f_a_c_decompression?) SCRATCHPAD PUT (78, f_a_c_Prisms_occlusion?) SCRATCHPAD PUT (79, 
f_a_c_Muscle_surgery?) ASSOONAS please_sheel
{MAKE f_a_c_lubricants_effect a_c_lubricants_effect MAKE f_a_c_Tr_ulcer_effect
a_c_Tr_ulcer_effect MAKE f_a_c_Lid_lengthening_effect a_c_Lid_lengthening_effect MAKE
f_a_c_Tarsorahphy_effect a_c_Tarsorahphy_effect MAKE f_a_c_Systemic_steroids_effect
a_c_Systemic_steroids_effect MAKE f_a_c_Radiotherapy_effect a_c_Radiotherapy_effect MAKE
f_a_c_decompression_effect a_c_decompression_effect MAKE f_a_c_Prisms_occlussion_effect 
a_c_Prisms_occlussion_effect MAKE f_a_c_Muscles_surgery_effect a_c_muscles_surgery_effect 
ASSOONAS please_save
SCRATCHPAD PUT (85, f_a_c_lubricants_effect) SCRATCHPAD PUT (86, f_a_c_Tr_ulcer_effect) 
SCRATCHPAD PUT (87, f_a_c_Lid_lengthening_effect) SCRATCHPAD PUT (88, 
f_a_c_Tarsorhaphy_effect) SCRATCHPAD PUT (89, f_a_c_Systemic_steroids_effect) SCRATCHPAD 
PUT (90, f_a_c_Radiotherapy_effect) SCRATCHPAD PUT (91, f_a_c_decompression_effect) 





MAKE f_a_i_disk_eodema a_i_disk_eodema MAKE f_a_c_coroidal_folds
a_c_coroidal_folds MAKE f_a_i_snellen_now a_i_snellen_now MAKE f_a_i_field_now
a_i_field_now MAKE f_a_i_l 00_hue_now a_i_100_hue_now MAKE f_a_c_color_bbnd
a_c_color_blind MAKE f_a_i_diplopia_symptom_now a_i_diplopia_symptom_now MAKE 
f_a_i_diplopia_on_examination_now a_i_diplopia_on_examination_now MAKE 
f_a_i_proptosis_opinion a_i_proptosis_opinion MAKE f_a_i_proptosis_now 
a_i_proptosis_now MAKE f_a_i_Hess_chart_now a_i_Hess_chart_now MAKE
f_a_i_ultra_sound a_i_ultra_sound MAKE f_a_c_lid_lag a_c_lid_lag MAKE
f_a_i_lid_retraction a_i_lid_retraction MAKE f_a_i_comea_now a_i_comea_now
MAKE f_a_i_lid_eodema_now a_i_lid_eodema_now MAKE f_a_i_chemosis_now
a_i_chemosis_nowMAKE f_n_IOP_dif n_IOP_difASSOONAS please_save
SCRATCHPAD PUT (100, f_a_i_disk_eodema) SCRATCHPAD PUT (101, f_a_c_coroidal_folds) 
SCRATCHPAD PUT (102, f_a_i_snellen_now) SCRATCHPAD PUT (103, f_a_i_field_now) 
SCRATCHPAD PUT (104, f_aJL100_hue_now) SCRATCHPAD PUT (105, f_a_c_color_blind) 
SCRATCHPAD PUT (106, f_a_i_diplopia_symptom_now) SCRATCHPAD PUT (107, 
f_a_i_diplopia_on_examination_now) SCRATCHPAD PUT (108,f_a_i_proptosis_opinion) 
SCRATCHPAD PUT (109, f_a_i_proptosis_now) SCRATCHPAD PUT (110, f_aJ_Hess_chart_now) 
SCRATCHPAD PUT (111, f_a_i_ultra_sound) SCRATCHPAD PUT (112, f_a_c_lid_lag) 
SCRATCHPAD PUT (113, f_a_i_lid_retraction) SCRATCHPAD PUT (114, f_a_i_comea_now) 
SCRATCHPAD PUT (115, f_a_i_lid_eodema_now) SCRATCHPAD PUT (116, f_a_i_chemosis_now) 
SCRATCHPAD PUT (117, f_n_IOP_dif) ASSOONAS please.sheel
[UP TO 150}
{----------------------------- -FINDINGS----------------— ---------} {130-140}
MAKE f_m_i_nerve_condition m_i_nerve_condition MAKE f_m_i_muscles_condition 
m_i_muscles_condition MAKE f_m_i_comea_condition m_i_comea_condition MAKE 
f_m_i_lid_condition m_i_lid_condition ASSOONAS please_save
SCRATCHPAD PUT (130, f_m_i_nerve_condition) SCRATCHPAD PUT (131, 
f_m_i_muscles_condition) SCRATCHPAD PUT (132, f_m_i_comea_condition) SCRATCHPAD PUT 
(133, f_m_i_lid_condition) ASSOONAS please_sheel
{..----------------------REQUIRED INVESTIGATIONS } { 140 -160}
MAKE f_m_c_field_of_vision m_c_field_of_vision MAKE f_m_c_ 100_hue_test 
m_c_100_hue_testMAKE f_m_c_Hess_chart m_c_Hess_chartMAKE f_m_c_ultra_sound
m_c_ultra_sound ASSOONAS please_save
{ MAKE MAKE }
SCRATCHPAD PUT (140, f_m_c_field_of_vision) SCRATCHPAD PUT (141, f_m_c_100_hue_test) 
SCRATCHPAD PUT (142, f_m_c_Hess_chart) SCRATCHPAD PUT (143, f_m_c_ultra_sound) 
ASSOONAS please_sheel
{---------. . . . . . ----------------ACTIONS---------------------  } { 160-165}
MAKE f_m_i_action m_i_action ASSOONAS please_save
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SCRATCHPAD PUT (160, f_m_i_action) ASSOONAS please_sheel
{-------- ------------------ MEDICAL TREATMENT-------------------------- } { 165 - 180 }
MAKE f_m_c_eye_lubricants m_c_eye_lubricants MAKE f_m_c_systemic_steroids
m_c_systemic_stcroids MAKE f_m_c_raise_head_w_dioretics m_c_raise_head_w_dioretics MAKE 
f_m_c_raisc_head_w_no_dioretics m_c_raise_head_w_no_dioretics MAKE 
f_m_c_occlusion_or_prism m_c_occlusion_or_prism MAKE f_m_c_Radiotherapy 
m_c_Radiotherapy MAKE f_m_c_anti_glaucoma_medi cations m_c_anti_glaucoma_medications 
ASSOONAS please_save
SCRATCHPAD PUT (165, f_m_c_eye_lubricants) SCRATCHPAD PUT (166, 
f_m_c_systemic_steroids) SCRATCHPAD PUT (167, f_m_c_raise_head_w_dioretics) SCRATCHPAD 
PUT (168, f_m_c_raise_head_w_no_dioretics) SCRATCHPAD PUT (169, f_m_c_occlusion_or_prism) 
SCRATCHPAD PUT (170, f_m_c_Radiotherapy) SCRATCHPAD PUT (171, 
f_m_c_anti_glaucoma_medications) ASSOONAS please_sheel
{-------------------------- SURGICAL TREATMENT  ------------------ } { 180 -190}
MAKE f_m_c_tarsoraphy m_c_tarsoraphy MAKE f_m_c_lid_lenghthen m_c_lid_lenghthen 
MAKE f_m_c_decompression m_c_decompression MAKE f_m_c_muscles_surgery 
m_c_muscles_surgery ASSOONAS please_save
SCRATCHPAD PUT (180, f_m_c_tarsoraphy) SCRATCHPAD PUT (181, f_m_c_lid_lenghthen) 
SCRATCHPAD PUT (182, f_m_c_decompression) SCRATCHPAD PUT (183, f_m_c_muscles_surgery) 
ASSOONAS please_sheel
{ . . . -------------------------------------------------------------}
j THIS IS A
NEW VERSION OF ADD99.XPT AFTER JL20 1988 } { THE OLD ONE IS KEPT UNDER 
ADD99 OLD} (***********************************************************************}
DISPLAY’#13,27#[0;31;46m#13,27#[0;34;46m #13# #35,35,35,35,35,35,35,35#
#353535,35,35,35,35# #35353535# #35,35,35,35,35,3535# #3535# #35,35# #13# #35,35#
#3535# #3535# #3535# #35,35# #35,35# #3535,13# #35,35# #3535353535#
#3535# #3535# #3535,35,35,35# #353535,13# #3535# #35,35# #3535# #35,35#
#3535# #35,35# #3535,13# #3535# #3535,35353535,35# #35,35,35,35#
#353535,35,35,35,35##3535# #35,35,13##13,27#[30m#13# W e lc o m e  to  T E D E X
#13#  #13# #13# TEDEX is an expert system which advises #13#
on management of patients with dysthyroid #13# eye disease. ’
ASSOONAS AT_START
GROUP gjiistory g patient personal g patient complaint history
{-------------------------------------------   }---------{-introduce tedex to
novice user----------------------}
QUESTION a_c_tedex_user ’ #13# #13,13,13,13,13# Have you used TEDEX before ? ’ YESNO
QUESTION a_i_novice_user_intro ’ #13# There is a wide range of supporting #13# information 
that can be given. #13# #13# 1 - The aim and purpose of the system. #13# 2 - How to'make best
use of it. #13# 3 - The limitations. #13# 4 - The assumptions made. #13# 5 - Glossary of terms
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used #13# 6 -Expert systems and how they work.# 13# #13# 0 - No more,thank you. #13# #13# (
pressing h key will bring you back here) ’ INTEGER 0 6
DISPLAY ’ #13# TEDEX will ask you questions about your #13# patient in order to come to a
conclusion. #13# #13# TEDEX is knowledgeable about dysthyroid #13# eye disease, its
reasoning is mainly #13# based on a long term follow up study of #13# 224 patients treated in the
Tennent Institute #13# of Ophthalmology, Glasgow, UK. #13# Also a critical review of the 
literature #13# in this area completed the qualifications to #13# build such a system. #13# #13# 
TEDEX is crurrently under testing and #13# evaluation in real life clinical set up. #13# #13# #13# 
Please do not take its conclusions in preference #13# to advice from experienced specialist.’ 
INVESTIGATE a_i_novice_user_intro ASSOONAS NOT a_c_tedex_user
DISPLAY’ #13# 1 - My aim and purpose. ’ CLEAR a_i_novice_user_intro ASSOONAS
a_i_novice_user_intro =1
DISPLAY’ #13# 2 - How to make best use of me. ’ CLEAR a_i_novice_user_intro ASSOONAS
a_i_novice_user_intro = 2
DISPLAY’ #13# 3 - My limitatioms. ’ CLEAR a_i_novice_user_intro ASSOONAS
a_i_novice_user_intro = 3
DISPLAY’ #13# 4 - The assumptions I make. * CLEAR a_i_novice_user_intro ASSOONAS
a_i_novice_user_intro = 4
DISPLAY’ #13# 5 - Glossary of terms I use. ’ CLEAR a_i_novice_user_intro ASSOONAS
a_i_novice_user_intro = 5
DISPLAY’ #13# 6 - Expert systems and how they work.’ CLEAR a_i_novice_user_intro
ASSOONAS a_i_novice_user_intro = 6
DISPLAY ’ #13# Now we start work ’ ASSOONAS a_i_novice_user_intro = 0
J * * lie * 4c * * a|c % * 4c * * * 4c * % * % * % 4c * * % * * * * * 4c * 4c * * * % * * * * * * * * * * * 4c * * * * * * * * * * % * * * % * * * 4c * 4c j
{--------------------- USER PERSONAL INFORMATION------------------------- }
GROUP g_user_personaI a_s_who_are_you a_i_user_experience
QUESTION a_s_who_are_you ’#13,13,13,13# First..#13##13# Please type in 
#27#[0;30;47myour name ? ’ ALPHA
QUESTION a_i_user_experience ’ #13# #13# Are you.. #13# #13# (1) Consultant Ophthalmologist 
#13# (2) Senior Registrar in Ophthalmology. #13# (3) Registrar in Ophthalmology. #13# (4)
Senior House Officer/House officer. #13# (5) Endocrinologist. #13# (6) GP.#13##13# (7)
Student. #13# (8) Patient. ’ INTEGER 1 7
STRING s_Dr ’ ’ ”  IF (a_i_user_experience = 7) ELSE ’Dr.’
DISPLAY ’#13,13,13,13# #13# Now #s_Dr# #a_s_who_are_you# #13# #13# Please type in the 
personal information and the #13# medical history of your patient ’ ASSOONAS ANSWERED 
a_i_user_experience AND NOT (a_i_user_experience = 7)
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DISPLAY * #13# #13# #13,13,27#[5;31m I am very sorry #13,27#[0;30;46m#13# #13,13#
#13# THIS PROGRAM IS NOT FOR PATIENTS ’ MAKE AT_END TRUE ASSOONAS
ANSWERED a_i_user_experience AND (a_i_user_experience = 7)
I******************************************************************** J J . ,  __ _
PATIENT PERSONAL INFORMATION------------------}
GROUP g patient personal a_s_patient_name a_i_patient_DOB i_patient_age 
a_s_patient_sex
QUESTION a_s_patient_name ’#13,13,13,13,13,13# Enter patient” s name ?’ SCRATCHPAD 10 
ALPHA
QUESTION a_i_patient_DOB ’#13,13,13# #13# #13# Enter patient” s year of birth ? #13#
(19 ) #13# #13# ’ SCRATCHPAD 11 NUMERIC 0 99
NUMBER i_patient_age’ ’ 89 - a_i_patient_DOB
{ QUESTION a_i_patient_age ’#13,13,13,13,13,13# Enter patient” s age ?#13,13# (in 
years)#13,13#’ SCRATCHPAD 12 INTEGER 1 90}
QUESTION a_s_patient_sex ’#13,13,13,13# #13,13# What is the patient” s sex ? (M/F) #13,13# ’ 
SCRATCHPAD 13 ALPHA 1 1
£ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * j
  ------   PATIENT COMPLAIN & HISTORY-------------------------- }
GROUP g patient complaint history g_patient_complaint a_i_patient_most_troublesome 
a_i_eye_disease_duration a_i_thyroid_status a_i_thyroid_disease_duration 
g previous sys conditions g previous thyroid treatment g_previous_eye_treatment 
a_i_patient_appearance
GROUP g_patient_complaint a_c_lacrimination? a_c_photophobia? 
a_c_visual_blurring? a_c_double_vision? a_c_pain?
{ .}
QUESTION a_c_lacrimination? ’#13^7#[0m#13,27#[30;47m Patient complaint#27#[30m:#13,13# 
#27#[5m #27#[0;30;47ml #27#[30m-#27#[30m
#27#[0;5;31;47mL#27#[5;31 ;47ma#27#[3 lmc#27#[3 lmrimation#27#[0;30;47m.#13# 
#27#[l;30m2#27#[30m-Photophobia.#13# 3 - Blurring of vision.#13# 4 - Double vision.#13# 5 - 
Pain.#13,13,13,27#[0;30;47m Does the patient suffer from#13,13,27#[l;31m #27#[5;31m 
#27#[0;31;47mLacrimation#27#[0;5;30;47m?#27#[5m(Y/N)#27#[0;5m#13,13,27#[47m#27#[30m 
#27#[30;47m ’ YESNO
{     }
QUESTION a_c_photophobia? ’#13,13# Patient complaint:#13,13,27#[lm 1 -#27#[lm
#27# [0; 1 ;30;47mL#27#[ lmacrimati#27#[lmon.#27#[0;30;47m #27# [0;47m #13 ^ 7# [30m 
#27#[0;30;47m2-#27#[31mPhotophobia.#27#[0;30;47m#13,27#[0;30;47m #27#[lm3 - Blurring of 
vision.#13# 4 - Double vision.#13# 5 - Pain.#13,13,13# #27#[0;30;47m Does the patient suffer 
from#13,13,27#[0;35;47m #27#[0;5;31 ;47mPhotophobia #27#[0;5;30;47m? 




QUESTION a_c_visual_bluiring? ’ #13,27#[30;47m#13# Patient complaint#13,13,27#[lm 
l#27#[0;30;47m #27#[l;47m- Lacrimation.#27#[0;47m#13,27#[30m #27#[lm #27#[30m2#27#[30m - 
Ph#27#[30motophobia.#13,27#[0;47m #27#[30m3 - #27#[31mBlurring of 
vision.#27#[0;30;47m#13,27#[lm #27#[30;47m 4 - Double vision.# 13,27#[lm 5 - 
Pain.# 13,27#[30m# 13,27#[30m# 13,27#[0;30;47m Does the patient suffer form #13,13#
#27#[0;31 ;47mBluning of vision #27#[0;5;30;47m? #27#[5m(Y/N)#27#[0;5;47m #27#[34m 
#13,27#[47m #27#[30m #27#[30;47m #13#’ YESNO
{     }
QUESTION a_c_double_vision? ’#13##13,27#[30;47m Patient complaint: #13,13# #27#[lm 
l#27#[0;30;47m #27#[l;47m- Lacrimation#27#[0;30;47m.#27#[0;47m #13# #27#[l;30m2#27#[30m - 
Ph#27#[30motophobia.#13# 3 -#27#[0;l;5;31;47m #27#[0;l;30;47mB#27#[lmlurring of 
vision.#13,27#[30;47m #27#[0;30;47m4 - #27#[0;5;31;47mDouble vision#27#[0;30;47m.#13# 
#27#[lm5-Pain.#13,13##13# #27#[0;30;47mDoes the patient suffer from#13,13#
#27#[0;31 ;47mDouble vision #27#[5;30;47m?#27#[5m (Y/N)#27#[0;5;47m #27#[34m #13,27#[47m 
#27#[30m #27#[30;47m #13#’ YESNO
Question a_c_j)ain?’#13,27#[30;47m#13# Patient complaint: #13# #13,27#[lm l#27#[0;30;47m
#27#[l;47m- Lacrimation.#27#[0;47m #13,27#[lm #27#[30m2#27#[30m - 
#27#[30mPhotophobia.# 13# 3 - Blurring of vision.#27#[0;30;47m#13,27#[l;30;47m 4 - Double 
vision.#13# #27#[0;30;47m 5 - #27#[31mPain.#13,13,13# #27#[30mDoes the patient suffer 
from#13,13# #27#[31mPain #27#[5;30;47m? #27#[5m(Y/N)#27#[0;5m#13,27#[47m #27#[34m 
#13,27#[47m #27#[30m #27#[30;47m #13#’ YESNO
QUESTION a_i_patient_most_troublesome’#13# #13# Which symptom is the most 
troublesome# 13,13# to the patient ?
#13,13# #13# (1) Cosmetic appearance.#13,13# (2) Blurring of vision.
#13# (3) Double vision.# 13# #13# (4) Pain/lacrimation/photophobia. ’ INTEGER 1 4
{  diplopia }
QUESTION a_i_eye_disease_duration ’ #13,13,13,13,13# How long is it since the patient” s#13,13# 
first eye symptom ? #13# (in months) ’ SCRATCHPAD 70 INTEGER 1 120
QUESTION a_i_thyroid_status ’#13# #13,13# What is the status of the thyroid ?#13,13# #13#
(1) Hyperthyroid. #13# #13# (2) Hypothyroid. #13# #13# (3) Euthyroid. ’ INTEGER 1 3
QUESTION a_i_thyroid_disease_duration’#13# #13,13,13# #13# How long is it since the first 
#13,13# thyroid disease symptoms ? #13,13# (in month) ’ SCRATCHPAD 40
[SHOULD BE 41] INTEGER 1 300
{-------------------- ------------------------------------------------------- } GROUP g_previous_sys_conditions
a_c_Diabetic? a_c_Hypertensive? a_c_Renal? a_c_Pulmonaric? a_c_GI?
QUESTION a_c_Diabetic?’#13# #13,13,13# Systemic conditions #13# #13# #27#[lm
#27#[0;30;47ml - #27#[31mDiabetes.#27#[5;34m #13# #27#[0;l;30;47m2#27#[30m - Hypertension.
D2-24
#13# 3 - Renal disease. #13# 4 - Pulmonary disease. #13# 5 - GI disease. #13,13,13,27#[lm
#27#[0;30;47mIsthepatient#27#[31m#27#[0;31;47mDiabet#27#[31mic#27#[34m 
#27#[30m?#27#[5;30m (Y/N)#27#[0;30;47m’ YESNO ONLY
QUESTION a_c_Hypertensive?’ #13,13,13,13# Systemic conditions #13# #13,27#[lm 1-
Diabetes. #13# #27#[0;30;47m 2 - #27#[31mHypertension.#27#[5;34m
#13# #27#[lm#27#[0;l;30;47m3#27#[l;30;47m-Renal disease. #13# 4 - Pulmonary disease.
#13# 5 - GI disease. #13,13,13,27#[lm #27#[0;30;47mls the patient
#27#[0;31 ;47mH#27#[3lmypertensive #27#[30m?#27#[5;30m (Y/N)’ YESNO ONLY
QUESTION a_c_Renal?’#27#[30m #13,13,13,13# Systemic conditions #13# #13# #27#[lml -
Diabetes. #13# 2 - Hypertension. #13# #27#[0;30;47m3 - #27#[3 ImRenal disease.#27#[5;34m
#13# #27#[l;30m#27#[0;l;30;47m4#27#[l;30m-Pulmonary disease. #13# 5 -GI disease.
#13,13,13,27#[lm #27#[0;30;47mDoes the patient suffer from any #13#
#27#[0;31;47mr#27#[31menal disease #27#[30m? #27#[5;30m(Y/N)’ YESNO ONLY
QUESTION a_c_Pulmonaric?’#27#[30;47m #27#[0m#13,13,27#[30;47m#13,13# Systemic 
conditions #13,27#[lm#13,27#[l;5m #27#[0;l;30;47ml#27#[lm - Diabete#27#[47ms.
#13# 2 - Hypertension. #13# 3 - Renal disease.#13,27#[30m #27#[0;30;47m4#27#[30m -
#27#[3lmPulmonary disease.#27#[0;30;47m #13,27#[30m #27#[0;l;30;47m5 - GI
disease.#13,13,13,27#[l;30;47m #27#[47m #27#[47m #27#[0;30;47mDoes the patient suffer from any 
#13# #27#[0;34;47m #27#[31mpulmonaiy diseases #27#[30m?#27#[5;30m (Y/N)’ YESNO ONLY
QUESTION a_c_GI?’#13,13,13,13# Systemic conditions #13# #13# #27#[lm 1 - Diabetes. #13#
2 - Hypertension. #13# 3 - Renal disease. #13# 4 - Pulmonary disease. #13# #27#[0;30;47m 5
- #27#[31mGI disease.#27#[0m#13,13,13,27#[30;47m #27#[lmDoes the patient suffer from any #13# 
#27#[0;31 ;47mg#27#[3lmastero-intestinal disease#27#[30m ?#27#[5;30m (Y/N)’ YESNO ONLY




’#27#[0;30;47m#13# #13,13# Previous thyroid treatment: #13# #13# #27#[33m
#27#[36m #27#[30ml - #27#[31mRadioactive iodine.#27#[0;30;47m #13# #27#[lm2-
Thyroidectomy. #13# 3 - Carbimazole. #13# #13# #27#[0;30;47m Has the patient been treated
by#13# #27#[0;31;47mR#27#[31madioactive Iodine #27#[30m?#27#[5;30m(Y/N)#27#[0;30;47m’
YESNO
{       }
QUESTION a_c_Thyroidectomy? ’#13# #13# #13# Previous thyroid treatment: #13# #13#
#27#[30m #27#[0;30;47ml#27#[47m #27#[l;30;47m- Radioactive iodine.#13# 2 - 
#27#[31mT#27#[31mhyroidectomy.#27#[0;30;47m #13# 3 - Carbimazole. #13# #13#
#27#[0;30;47mHas the patient been treated by #27#[0;35;47m#13# #27#[31mThyroidectomy 
#27#[5;30m? (Y/N)#27#[0;30;47m ’ YESNO {............................................................................ }
QUESTION a_c_Carbimazol? ’#27#[47m#13# #13# #13# Previous thyroid treatment:
#13# #13# #27#[lm 1 - Radioactive iodine. #13# 2 - Thyroidectomy. #13# #27#[0;30;47m 3 -
#27#[3lmCarbimazole.#27#[0;30;47m# 13# #13,27#[lm #27#[0;30;47m Has the patient been treated 
by #13# #27#[0;35;47m #27#[31mCarbimazole #27#[5;30m? (Y/N)#27#[0;30;47m#13#’ YESNO
D2-25
{----------------------------------------------------------  } GROUP g_thyroid_bicx: hem is try a_i_T3
a_i_T4 a_i_TSH
QUESTION a_i_T3 ’ #13# #13,13# #13# #13# Enter the T3 (Tri-iodo-thyronine)#13# #13# 
blood level?’ INTEGER 1 50
QUESTION a_i_T4 ’#13,13,13,13,13# Enter The T4 (Thyroxin)#13# #13# blood level ? ’
INTEGER 1 50
QUESTION aJLTSH ’#13# #13,13,13,13# Enter the TSH (Thyroid Stimulation Hormone)#13# #13# 
assay result ? ’ INTEGER 1 50






a_i_Prisms_occl_effect? a_c_Muscle_surgery? a i Muscle, surg_effect?
{      }
QUESTION a_c_Eye_lubricants? ’ Previous eye treatment: #13# #13# 1-
#27#[5;31mE#27#[31mye lubricants.#27#[0;30;47m #13# 2 - Treatment for comeal ulcer. #13# 3
- Lid lengthening procedure. #13# 4 - Tarsorrhaphy. #13# 5 -Systemic steroids. #13# 6 -
Radiotherapy of the orbit #13# 7 - Decompression. #13# 8 -Prisms/occlusion. #13# 9 -
Muscle surgery. #13# #13# Did the patient use #27#[31mE#27#[31mye lubricants 
#27#[0;30;47m(#27#[5mY/N#27#[0;30;47m)#27#[30;47m ?#27#[0;5m#13,27#[0;l;32;47m *
SCRATCHPAD 71 YESNO
{       }QUESTIONaJ_Eye_lub_effect? ’#27#[lm
Previous eye treatment: #13,13# 1 -#27#[0;l;5;31;47mE#27#[31mye
lubricants#27#[5m.#27#[0;30;47m #13# #27#[lm2 - Treatment for comeal ulcer. #13# 3 - Lid
lengthening procedure.# 13# 4 - Tarsorrhaphy. #13# 5 - Systemic steroids. #13# 6 -
Radiotherapy of the orbit #13# 7 - Decompression. #13# 8 -Prisms/occlusion.# 13# 9 -
Muscle surgery. #13,13,27#[0;30;47m What was the result of #27#[31mEye lubricant 
#27#[30mtreatment?#13,27#[0;30;47m#13# 1 - Sucess (improvement).# 13# 2 - Failure (or
minimal effect).#13# 3 - Side effects.’
INTEGER 1 3 IF a_c_Eye_lubricants? ELSE 0 
{•••    }
QUESTION a_c_Tr_for_comeal_ulcer? ’ Previous eye treatment: #13# #13# 1 - Eye lubricants.
#13# 2 #27#[0;30;47m-#27#[30;47m #27#[5;31mT#27#[31mreatment for comeal
ulcer.#27#[0;30;47m #13# 3 -Lid lengtheningprocedure.#l3# 4 - Tarsorrhaphy. #13# 5 -
Systemic steroids. #13# 6 - Radiotherapy of the orbit #13# 7 - decompression. #13# 8 - Prisms
/occlusion.# 13# 9 - Muscle surgery. #13,13# Did the patient recieve treatment for# 13#





Previous eye treatment: #13# #13# 1 - Eye lubricants. #13# 2#27#[lm
#27#[0;l;30;47m-#27#[30;47m #27#[l;5;31mT#27#[31mreatment for comeal ulcer.#27#[0;30;47m 
#13,27#[lm 3 - Lid lengthening procedure.# 13# 4 - Tarsorrhaphy. #13# 5 - Systemic steroids.
#13# 6 - Radiotherapy of the orbit. #13# 7 - decompression. #13# 8 - Prisms /  occlusion.#13#
9 - Muscle surgery. #13,13,27#[0;30;47m What was the result of #27#[31mComeal ulcer 
#27#[30mtreatment?#27# [0;5m# 13*27# [30;47m #27#[0m#l 3,27# [30;47m 1 - Sucess
(improvement).#13# 2 - Failure (or minimal effect).#13# 3 - Side effects.’
INTEGER 1 3 IF a_c_Tr_for_comeal_ulcer? ELSE 0 
{       )
QUESTION a_c_Lid_lengthening? ’ Previous eye treatment: #13# #13# 1 - Eye lubricants. #13#
2 - Treatment for corneal ulcer. #13# 3 - #27#[5;31mL#27#[31mid lengthening
procedure.#27#[0;30;47m#13# 4 - Tarsorrhaphy. #13# 5 - Systemic steroids. #13# 6 -
Radiotherapy of the orbit #13# 7 - decompression. #13# 8 -Prisms/occlusion.# 13# 9 -
Muscle surgery. #13,13# Does the patient have previous #27#[31mL#27#[31mid




Previous eye treatment: #13,13# 1 - Eye lubricants. #13# 2 - Treatment for comeal ulcer. #13#
3 - #27#[5;31mL#27#[31mid lengthening procedure.#27#[0;30;47m#13,27#[lm 4 - Tarsorrhaphy. #13#
5 - Systemic steroids. #13# 6 -  Radiotherapy of the orbit #13# 7 -decompression. #13# 8 -
Prisms/occlusion.# 13# 9 - Muscle surgery. #13,13,27#[0;30;47m What was the result of the
#27#[31mLid#27#[0;30;47mprocedure?#13,13# 1 - Sucess (improvement).#13# 2 -
Failure (or minimal effect).# 13# 3 - Side effects.’
INTEGER 1 3 IF a_c_Lid_lengthening? ELSE 0 
{       )
QUESTION a_c_Tarsorhaphy? * Previous eye treatment: #13# #13# 1 - Eye lubricants. #13#
2 - Treatment for comeal ulcer. #13# 3 -Lid lengthening procedure.# 13# 4 -
#27#[5;31mT#27#[31marsorrhaphy.#27#[0;30;47m#13# 5 - Systemic steroids. #13# 6 - Radiotherapy
of the orbit #13# 7 - decompression. #13# 8 -Prisms/occlusion.#13# 9 - Muscle surgery.
#13,13# Did the patient have previous
#27#[31mT#27#[31marsorrhaphy#27#[0;30;47m(#27#[5mY/N#27#[0;30;47m)#27#[30;47m?#27#[30;47m 
#27#[0;5;47m #27#[47m #13# ’
SCRATCHPAD 74 YESNO
{......... ...................................................................) QUESTIONa_i_Tarsorhaphy_effect?
’#27#[lm Previous eye treatment #13# #13# 1 - Eye lubricants. #13# 2 - Treatment for comeal
ulcer. #13# 3 - Lid lengthening procedure.#13# 4 -
#27#[5;31mT#27#[31marsorrhaphy.#27#[0;30;47m#13,27#[lm 5 - Systemic steroids. #13# 6 -
Radiotherapy of the orbit #13# 7 - decompression. #13# 8 - Prisms /  occlusion.# 13# 9 -
Muscle surgery. #13,13,27#[0;30;47m What was the result of #27#[31mT#27#[31marsorrhaphy 
#27#[0;5m#13,27#[0;30;47m #27#[0m#13,27#[0;30;47m 1 - Sucess (improvement).# 13# 2 -
Failure (or minimal effect).# 13# 3 - Side effects.*
INTEGER 1 3 IF a_c_Tarsorhaphy? ELSE 0
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{ }
QUESTION a_c_Systcmic_steroids? ’ Previous eye treatment: #13# #13# 1 - Eye lubricants.
#13# 2 - Treatment for comeal ulcer. #13# 3 -Lid lengthening procedure.# 13# 4 -
Tarsorrhaphy. #13# 5 - #27#[5;3 lmS#27#[3 lmystemic steroid.#27#[0;30;47m#13# 6 -
Radiotherapy of the orbit #13# 7 -decompression. #13# 8 - Prisms /  occlusion.# 13# 9 -




Previous eye treatment: #13# #13# 1 - Eye lubricants. #13# 2 - Treatment for comeal ulcer. #13#
3 - Lid lengthening procedure.# 13# 4 - Tarsorrhaphy. #13# 5 - #27#[5;31mS#27#[31mystemic
steroid.#27#[0;30;47m#13,27#[lm 6 - Radiotherapy of the orbit #13# 7 - decompression. #13# 8 -
Prisms /occlusion.# 13# 9 - Muscle surgery. #13,13,27#[0;30;47m What was the result of
#27#[31mSystemic steroid #27#[30mcourse?#13##27#[0;5m#13,27#[0;30;47m 1 - Sucess
(improvement).# 13# 2 - Failure (or minimal effect).#13# 3 - Side effects.’
INTEGER 1 3 IF a_c_Systemic_steroids? ELSE 0 
{     }
QUESTION a_c_Radiotherapy? ’ Previous eye treatment #13# #13# 1 - Eye lubricants. #13#
2 - Treatment for comeal ulcer. #13# 3 - Lid lengthening procedure.# 13# 4 - Tarsorrhaphy. #13#
5 - Systemic steroids. #13# 6 - #27#[5;3 lmR#27#[3 lmadiotherapy of the orbit#27#[0;30;47m#13# 7
- decompression. #13# 8 - Prisms /  occlusion.# 13# 9 - Muscle surgery. #13,13# Did the patient




’#27#[l;30m Previous eye treatment #13# #13# 1 - Eye lubricants. #13# 2 - Treatment for
comeal ulcer. #13# 3 - Lid lengthening procedure.#13# 4 - Tarsorrhaphy. #13# 5 - Systemic
steroids. #13# 6 - #27#[5;31mR#27#[3lmadiotherapy of the orbit#27#[0;30;47m#13,27#[0;l;30;47m
7 - decompression. #13# 8 - Prisms /  occlusion.# 13# 9 - Muscle surgery. #13,13,27#[0;30;47m
What was the result of #27#[3lmR#27#[3 lmadiotherapy #27#[0;5m#13,27#[0;30;47m
#13# 1 - Sucess (improvement).# 13# 2 - Failure (or minimal effect).#13# 3 -
Side effects.’
INTEGER 1 3 IF a_c_Radiotherapy? ELSE 0 
{   }
QUESTION a_c_decompression? ’ Previous eye treatment: #13# #13# 1 - Eye lubricants. #13#
2 - Treatment for comeal ulcer. #13# 3 - Lid lengthening procedure.#13# 4 - Tarsorrhaphy. #13#
5 - Systemic steroids. #13# 6 - Radiotherapy of the orbit #13# 7 -
#27#[5;31md#27#[31mecompression.#27#[0;30;47m #13,27#[30;47m 8 - Prisms /  occlusion.# 13#




{............................................................................ } QUESTION a_i_decompression_effect?
’#27#[lm Previous eye treatment: #13,13# 1 - Eye lubricants. #13# 2 - Treatment for corneal
ulcer. #13# 3 - Lid lengthening procedure.# 13# 4 - Tarsorrhaphy. #13# 5 - Systemic steroids.
#13# 6 - Radiotherapy of the orbit. #13# 7 - #27#[5;3 lmd#27#[3 lmecompression.#27#[0;30;47m
#13,27#[l;30;47m 8 - Prisms /  occlusion.#13# 9 - Muscle surgery. #13,13,27#[0;30;47m What
was the result of #27#[3 lmD#27#[3 lmecompression #27#[0;5m#13,13,27#[0;30;47m 1 - Sucess 
(improvement).# 13# 2 - Failure (or minimal effect).# 13# 3 - Side effects. ’
INTEGER 1 3 IF a_c_decompression? ELSE 0 
{     }
QUESTION a_c_Prisms_occlusion? ’#27#[30m Previous eye treatment #13# #13# 1 - Eye
lubricants. #13# 2 -Treatment for comeal ulcer. #13# 3 - Lid lengthening procedure.# 13# 4 -
Tarsorrhaphy. #13# 5 - Systemic steroids. #13# 6 -Radiotherapy of the orbit #13# 7 -
decompression. #13# 8 - #27#[5;31 mP#27#[31 mrisms /  occlusion.#27#[0;30;47m#13,27#[30;47m 9 -
Muscle surgery. #13,13# Did the patient have previously used #13# #27#[31mp#27#[31mrisms /  
occlusion #27#[0;30;47m(#27#[5mY/N#27#[0;30;47m) ? #27#[0;5m’
SCRATCHPAD 78 YESNO
{............. ............................................................... ) QUESTIONa_LPrisms_occl_effect? ’#27#[lm
Previous eye treatment: #13# #13# 1 - Eye lubricants. #13# 2 - Treatment for comeal ulcer. #13#
3 - Lid lengthening procedure.#13# 4 - Tarsorrhaphy. #13# 5 - Systemic steroids. #13# 6 -
Radiotherapy of the orbit #13# 7 - decompression. #13# 8 - #27#[5;31 mP#27#[31 mrisms /
occlusion.#27#[0;30;47m# 13,27#[30;47m #27#[lm9 - Muscle surgery. #13,13,27#[0;30;47m What isthe 
result of #27#[31mprisms/occlusion#27#[30mtreatment?#27#[0;5m#13,27#[30;47m 1-
Sucess (improvement).#13# 2 -Failure (or minimal effect).#13# 3 - Side effects.’
INTEGER 1 3 IF a_c_Prisms_occlusion? ELSE 0
 —      .....}
QUESTION a_c_Muscle_surgery? ’ Previous eye treatment: #13# #13# 1 - Eye lubricants.
#13# 2 - Treatment for comeal ulcer. #13# 3 - Lid lengthening procedure.#13# 4 -
Tarsorrhaphy. #13# 5 - Systemic steroids. #13# 6 - Radiotherapy of the orbit #13# 7 -
decompression. #13# 8 - Prisms /  occlusion.# 13# 9 - #27#[5;3 lmM#27#[3 lmuscle
surgery.#27#[0;30;47m#13,13,27#[30;47m Did the patient have extra ocular #27#[31mMuscle# 13# 
#27#[31msurgery#27#[0;30;47m(#27#[5mY/N#27#[0;30;47m)?#27#[0;5m#13,27#[30;47m’
SCRATCHPAD 79 YESNO
          } QUESTIONa_i_Muscle_surg_effect? ’#27#[lm
Previous eye treatment: #13# #13# 1 - Eye lubricants. #13# 2 - Treatment for comeal ulcer. #13#
3 -Lid lengthening procedure.# 13# 4 - Tarsorrhaphy. #13# 5 - Systemic steroids. #13# 6 -
Radiotherapy of the orbit #13# 7 - decompression. #13# 8 -Prisms/occlusion.# 13# 9 -
#27#[5;31mM#27#[3lmuscle surgery.#27#[0;30;47m#13,13# What was the result of #27#[31mMuscle 
surgery #27#[30m? #27#[0;5m#13,27#[0;30;47m
#13# 1 - Sucess (improvement).# 13# 2 - Failure (or minimal effect).#13# 3 -
Side effects.’
INTEGER 1 3 IF a_c_Muscle_surgery? ELSE 0
D2-29
{ }
QUESTION a_i_patient_appearance ’ #13# #13# #13# In your view, how bad is the effect of #13# 
the eye condition on the patient” s #13# appearance ? #13# #13# ( On a scale from 1 to 10)
#13# 1 .... normal #13# 10.... abnormal #13# ’ NUMERIC 1 10
£%**************************%************************************************}
{-----------------------START CLINICAL-TEST-------------------------------- } QUESTION a_i_main_menu
’#27#[30;47m#13,13##13# O P E N IN G  M ENU#13# ------------------------#13#
#13,13# (1) New patient #13,13# (2) Follow up visit #13,13# (3) Print last session
report #13,13# (4) Teaching session. #13# *
INTEGER 1 4
QUESTION a_i_teaching_menu ’#13,13# #13# Teaching Menu #13# #13# #13# 1 -
---------------.#13# 2 - Treatment directly. #13# 3 -------------------- .#13# 4 -
  --------.#13#’
INTEGER 1 4
INVESTIGATE a_i_teaching_menu AS SOONAS (a_i_main_menu = 4)
( > * * * * * * * * * * * * * * * * * * * * * * * % * * * * * * * * * * * * * * * * * * * * * * * * % * * * * * * * * * * * * % * * % * * * * * * * * * * l
QUESTION a_s_hospital_number?’#13,13,13,13,13# #13# Enter the patient” s#13# #13# 
Hospital Number ?’ ALPHA 9 9
^ * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * j
QUESTION a_c_Hart_disease ’#13,13,13,13# Is the patient suffering from any#13,13# heart
disease ? ’ YESNO
D2-30
I* * * * * 4c * * 4c * * * * * * * * * * * * * * * * ** * ** * ★ * * * * * * * * * * * * * 4c * * * * * * * * * * * * * * * * * * * * * * * * * ** J









PROBABILITY p_mal_nerve ’to assess how bad the present nerve condition ’
{**************p_previous_nerve_treatment 0.2 LN 10.0***********} {
P_sug_mal_nerve LS 10.0 LN 0.2 } { p_test_mal_nerve LS 20.0 LN 0.2 }
{ PRIOR 0.2} MAX ( p_sug_mal_nerve, p_test_mal_nerve )
{&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&&&&&&&&&&&&&&&&&}
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
{ PROBABILITY p_previous_nerve_treatment ’ to assess the effect of previous
nerve treatment on its present condition ’
*********************************** previous nerve treatment previous
p_mal_nerve) }
{70707070707070 7070707070 70 707070 707070707070 707070707070707070707070707070 7o 70 70 7070707c 70 70 70 70707070 
%%%%%%%%%%%%%%%%%%%%%}
PROBABILITY p_sug_mal_nerve ’ to consider doctor observations on nerve
condition by looking into the patient eye and by commenting on charts tests results. Here
I am considering the human experience dimension, where the comment of
more experienced doctor will be more weighted in a confidential manna-’ MAX(
p_disk_eodima ,p_visual_acuity_drop [, p_indirect_sug_mal_nerve ] )
{ ** p_indirect_sug_mal_nerve variable should be weighted before put here }
PROBABILITY p_test_mal_nerve ’ to consider machine -reading & evaluation- to
chart results on nerve condition. Here I am considering only the machine evaluation
dimension, which will be constantly weighted compared to human
evaluation * { This variable should condition by a questionD o  you have automatic reading information 
- scanner or db3+or....}
MAX ( p_field_of_vision , p_100_hue_test {,p_charts_comment})
D2-31
{ the 100_hue_test should be conditioned b y t h e  patient should not be color blind, these 3 p_variables 
are converted/originated from numerical questions}
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%%%%}
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
PROBABILITY p_disk_eodima ’to know how bad doctor finds disk_eodima ? ’
pl_disk_eodima LS 34 LN 1 IF c_coroidal_folds ELSE
pl_disk_eodima LS 30 LN 1 PRIOR 0.2
PROBABILITY pl_disk_eodima ’to transfer the numeric question to probability ’ MEMBER( 
a_i_disk_eodema, 0.035 , 0.9 , 3 .1 ,98 ,99)
QUESTION a_i_disk_eodema ’ #13# #13# Right Optic Disc #13# #13# On Ophthalmoscopy
#13#----------------------#13# #13# #13# (l)Nopapilloedema.#13##13# (2) Suspected disc
oedema. #13# #13# (3) Definite disc oedema. ’ INTEGER 1 3
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
CONDITION c_coroidal_folds ’#13# On ophthalmoscopy:#13,13# #13# Can you detect any 
choroidal-folds ?#13#’ a_c_coroidal_folds
QUESTION a_c_coroidal_folds ’ #13# #13# Right Fundus: #13# #13# On Ophthalmoscopy #13# 
-----------------# 13# #13# #13# Can you detect any choroidal folds ? ’
YESNO ONLY
{—    )
QUESTION a_i_pupill_now’ #13# #13# #13# Pupillary reaction: #13# #13# #13# 1 - Normal.
#13# #13# 2 - Afferent pupillary defect ’ INTEGER 1 2
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
PROBABILITY p_visual_acuity_drop ’ to investigate the - suggestive - effect of patient
visual acuity drop on nerve mal-functioning ? ’
pl_visual_acuity_drop LS 45 LN 0.1 IF c_coroidal_folds ELSE
pl_visual_acuity_drop LS 35 LN 0.17 PRIOR 0.2
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
PROBABILITY pl_visual_acuity_drop ’to get the patient visual acuity drop, including 
both snellen” s and temporal acuities ’ p_snellen_acuity_drop




p_snellen_now LS 380 LN 1 {adjust} p_snellen_change LS 380
LN 1 {adjust}
PRIOR 0.05 {!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_snellen_now ’OOOOOOOOOOOOOOOO’ MEMBER( a_i_snellen_now, 0.05 ,3 .9 , 
17.1,98 , 99)
QUESTION a_i_snellen_now ’#13# What is the best corrected Visual Acuity ?
#13# 1 -6 /5  #13# 2 - 6 /6  9 - 5/60#13# 3 -6 /9  10-4/60#13# 4 -6 /1 2
11 -3/60#13# 5 -6 /1 8  12-2 /60  #13# 6 - 6/24 13 - 1 /60#13# 7-6 /36#13#
8 -6 /6 0  #13# #13# 1 4 -Counting fingures #13# 15-Hand movement (H.M.) #13# 16 - Perception 
of light (PX.)# 13# 17-N o Perception of light (NPX.) ’
INTEGER 1 17
{........................................................................ } PROBABILITY p_snellen_change
’OOOOOOOOOOOOOOOO’ pl_snellen_change IF NOT (a_i_main_menu = 1) ELSE 0.05
PROBABILITY pl_snellen_change ’OOOOOOOOOOOOOOOO’ MEMBER( a_i_snellen_change, 
0.05,0 .001,5 .1 ,98 ,99 ) IF NOT KNOWN f_aJ_snellen_now ELSE MEMBER( (a_i_snellen_now - 
f_a_i_snellen_now + 1 8 ), 0.05,18.00,23.00,98 ,9 9 )
QUESTION a_i_snellen_change ’ #13# How many lines does the Right Visual Acuity #13# differe 
from that of last visit? #13# #13# #13# (0) No difference #13# (1) One line #13# (2) Two
lines #13# (3) Three lines #13# (4) Four lines #13# (5) Five lines ’ INTEGER 0 5
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!} 
{PROBABILITY p_temprac_acuity_drop ’ooooooo’
p_temprac_now LS 10 LN 1 p_temprac_change LS 30 LN 1
PRIOR 0.1
PROBABILITY p_temprac_now ’OOOOOOOOOOOOOOOO’ MEMBER( a_i_temprac_now, 0 .1 ,0 .9 ,
6 .1 ,9 8 ,9 9 )
QUESTION a_i_temprac_now ’#13# Enter the patient temprac” s acuity drop #13#
#13# 1 #13# 2 #13# 3 #13# I
#13# I #13# 6 ’ INTEGER 1 6
D2-33
PROBABILITY p_temprac_change ’OOOOOOOOOOOOOOOO’ MEMBER( a_i_temprac_change, 
0.1,0.9 ,5 .1 ,9 8 ,9 9  ) IF NOT (a_i_main_menu = 1)
QUESTION a_i_temprac_change ’#13# Enter the patient temprac” s acuity drop #13#
change compared to last visit acuity drop ? #13# #13# 1 line
#13# 2 lines #13# 3 #13# I #13# I
#13# 5 ’ INTEGER 1 5  }
PROBABILITY p_vision_dummy ’ dummy vision constant ’ 0.8 PRIOR 0.8 PROBABILITY 
p_field_of_vision ’to get machine evaluation to patient field of vision test ’
p_field_now LS 60 LN 0.6 P_field_change LS 90 LN 0.6 IF
(ANSWERED a_c_field_of_vision? AND a_c_field_of_vision?) ELSE OPPOSITE (p_vision_dummy)
{ This variable should be obtained from numerical questions, for the time being - temporarily - it will be 
obtained from probability questions}
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!} PROBABILITY p_field_now ’To transfer 
the numeric question to probability variable ’ MEMBER( a_i_field_now ,0 .02 ,0 .9 ,4 .1 ,
9 8 ,9 9 )
QUESTION a_i_field_now ’ #13# Right eye #13# #13# Enter your comment on the latest #13#
#13# Field of Vision #13#--------------------#13# #13# #13# (1) Normal field. #13# #13# (2)
Only general constriction. #13# (3) Central of paracentral scotoma. #13# #13# (4) Arcuate
scotomata and/or (2) or (3). ’ INTEGER 1 4
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_field_change ’To transfer the numeric question to probability 
variable ’ pl_field_change IF NOT (a_i_main_menu = 1) ELSE 0.02
PROBABILITY pl_field_change ’OOOOOOOOOOOOO’ MEMBER( a_i_field_change ,0.02,1.9 ,5.1 
, 9 8 ,9 9 )  IF NOT KNOWN f_a_i_field_now ELSE MEMBER( (ajJield_now  - f_a_i_field_now + 5 ) 
,0 .0 2 ,5 .9 ,9 .1 ,9 8 ,9 9 )
QUESTION a_i_field_change ’ #13# COMPARING Right Vision Field #13#
 # 13# # 13# with the previous one, do #13# you believe that it is: #13# #13#
1 - Significantly better, #13# 2 - Minimal improvement, #13# 3 - Much the same, #13# 4 -
Minimal deterioration or #13# 5 - Significantly worse ? ’ INTEGER 1 5
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_100_hiie_test ’to get machine evaluation to patient field of vision
test ’
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p_100_hue_now LS 6 LN 1 P_100_hue_change LS 9 LN 1
IF (ANSWERED a_c_100_HUE? AND a_c_100_HUE?) ELSE OPPOSITE (p_vision_dummy)
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_100_hue_now ’To transfer the numeric question to probability 
variable ’ MEMBER( a_i_100_hue_now ,0.1,0.9 , 4.1,998 , 999)
{ MADE MAKE (p_100Jiue_now = MEMBER(a_i_100_hue_now,0 .1 ,0 .9 ,4 .1 ,9 9 8 ,9 9 9 ))
ASSOONAS age=l
MEMBER( a_i_100_hue_now ,0.1,0.9 ,4 .1 ,998 ,999  ) IF age = 1 
MEMBER( a_i_100_hue_now ,0 .1 ,0 .9 ,4 .1 ,998 ,999  ) ELSE IF age = 2 
MEMBER( a_i_100_hue_now ,0 .1 ,0 .9 ,4 .1 ,998  ,999) ELSE IF age = 3 
MEMBER( a_i_100_hue_now ,0 .1 ,0 .9 ,4 .1 ,9 9 8 ,9 9 9 ) ELSE IF age = 4
MEMBER( a_i_100_hue_now ,0 .1 ,0 .9 ,4 .1 ,9 9 8 ,9 9 9 ) ELSE IF age = 5 }
QUESTION aj_100_hue_now ’ #13# #13# #13# Right eye #13# #13# #13# Enter the latest
#13# 100-Hue test error score #13#  ’
INTEGER 0 500
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!} PROB ABILITYp_100_hue_change 
’To transfer the numeric question to probability variable ’ pl_100_hue_change IF NOT
(a_i_main_menu = 1) ELSE 0.1
PROBABILITY pl_100_hue_change ’ooooooooooooooooo’ MEMBER ( (a_i_100_hue_now - 
a_i_100Jiue_change + 501), 0.1,0.9,500.1,998,999) IF NOT KNOWN
f_a_i_100_hue_now ELSE MEMBER ( (a_i_100_hue_now - f_a_i_ 100_hue_now + 501), 
0.1,0.9,500.1,998,999)
QUESTION a_i_100_hue_change ’ #13# Right eye #13# #13# #13# Enter #13# previous
100-Hue test error score #13#  ’
INTEGER 0 500
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
{Illlllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll} {PROBABILITYp_charts_comment’to know doctor opinion after 
seeing test charts ?’ MEMBER( a_j>_charts_comment ,0 .1 ,0 .9 ,4 .1 ,9 8 ,9 9  )
D2-35
QUESTION a_p_charts_comment ’ #13# How you interpret nerve condition #13# from reading
charts?
#13# #13# 1 - Normal field. #13# 2 -Probably
normal. #13# 3 - Probably nerve compression. #13# 4 -Typical
nerve compression. ’ INTEGER 1 4 }
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
QUESTION a_c_color_blind ’ #13,13,13# #13# Is the patient colour blind ? ’ YESNO ONLY
{ DISPLAY ’ O. K. ’ ASSOONASp.mal.nerve >0.8 }
PROBABILITY p_mal_muscles ’to assess how bad the present muscles
condition ’
{ p_sug_mal_muscles LS 10.0 LN 0.2 } { p_test_mal_muscles LS
20.0 LN 0.2 } { PRIOR 0.1 } [************** p_previous_muscles_treatment LS 0.2 LN 
10 0* * * * * * * * * * * ]
MAX ( p_sug_mal_muscles, p_test_mal_muscles)
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%%%%%%%%)
{ PROBABILITY p_previous_muscles_treatment ’ to assess the effect of previous
muscles treatment on its present condition *
previous_muscles_treatment, previous. p_mal_muscles ) }
PROBABILITY p_sug_mal_muscles ’to assess the effect of eye proptosis
and diplopia on muscles condition’ MAX( p.diplopia, p_proptosis)
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
% % % % % % % % % % % % % % % % % % % % % % % % % }
PROBABILITY p_test_mal_muscles ’ to consider doctor comment on test results
(hess chart and ultra sound image) on muscles condition *
MAX ( p_Hess_chart, p_ultra_sound, p.CTscan, p.MRIscan)
D2-36
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%%%%%%%%)
PROBABILITY p.diplopia ’to investigate diplopia considering patient 
complain and doctor examination '
MAX ( p_diplopia_symptom, p_diplopia_on_examination )
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_diplopia_symptom ’to ’




PROBABILITY p_diplopia_symptom_now ’to transfer the numeric question to 
probability variable ’ MEMBER( a_i_diplopia_symptom_now, 0 .1 ,0 .9 ,4 .1 ,9 8 ,9 9 )
QUESTION a_i_diplopia_symptom_now * #13# #13# How does the patient describe #13# his
diplopia ? #13# #13# #13# (1) No diplopia. #13# #13# (2) Mild ( or only in extreme gaze). #13#
(3) Moderate. #13# #13# (4) Severe (close to mid line) ’ INTEGER 1 4
PROBABILITY p_diplopia_symptom_change ’to transfer the numeric question to 
probability variable ’ pl_diplopia_symptom_change IF NOT (a_i_main_menu = 1) ELSE 0.1
PROBABILITY pl_diplopia_symptom_change ’oooooooooooooooooo’ MEMBER( 
a_i_diplopia_symptom_change, 0 .1 ,0 .9 , 3 .1 ,9 8 ,9 9 )  IF NOT KNOWN 
f_a_i_diplopia_symptom_now ELSE MEMBER( (a_i_diplopia_symptom_now - 
f_a_i_diplopia_symptom_now + 5 ) , 0 .1 ,5 .9 ,9 .1 ,9 8  ,9 9 )
QUESTION a_i_diplopia_symptom_change’ #13# #13# Does the patient feel that #13# double
vision is #13# #13# (1) Getting better, #13# #13# (2) As before or #13# #13# (3) Getting
worse ? ’ INTEGER 1 3
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_diplopia_on_examination ’to *
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p_diplopia_on_examination_now LS 10 LN 1 p_diplopia_on_examination_change 




’to transfer the numeric question to probability variable ’ MEMBER(
a_i_diplopia_on_examination_now, 0.1, 0 .9 ,3 .1 ,9 8 ,9 9 )
QUESTION a_i_diplopia_on_examination_now’ #13# #13# On examination of the ocular motility
#13# Diplopia is: #13# #13# #13# (1) Absent. #13# #13# (2) In extreme gaze. #13# #13#
(3) On elevation/depression. #13# (4) On adduction/abduction. #13# #13# (5) Close to midline. ’
INTEGER 1 5
{"I:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::} GROUP g_diplopia_on_examination_change 
p_diplopia_on_examination_change c_six_month_stable_diplopia
PROBABILITY p_diplopia_on_examination_change’to transfer the numeric question
to probability variable ’ pl_diplopia_on_examination_change IF NOT (a_i_main_menu = 1) ELSE 0.1
PROBABILITY p 1 _diplopia_on_examination_change ’PPPPPPPPPPPP’ MEMBER( 
aJLdiplopia_on_examination_change, 0.1, 0 .9 ,3 .1 ,9 8 ,9 9 )  IF NOT KNOWN 
f_a_i_diplopia_on_examination_now ELSE MEMBER( ( a_i_diplopia_on_examination_now - 
f_a_i_diplopia_on_examination_now + 6 )  , 0 .1 ,6 .9 ,12 .1 , 9 8 ,9 9 )
QUESTION a_i_diplopia_on_examination_change’ #13# Comparing today” s examination with the
#13# previous one, Diplopia i s : #13# ------- #13# #13# #13# (1) Decreasing. #13#
#13# (2) Stable. #13# #13# (3) Increasing. ’ INTEGER 1 3
CONDITION c_six_month_stable_diplopia ’ this is to get the value of 
a_c_six_month_stable_diplopia QUESTION ’ a_c_six_month_stable_diplopia IF 
((a_i_diplopia_on_examination_change = 2) AND (NOT (a_i_main_menu = 1)))
QUESTION a_c_six_month_stable_diplopia’#13# #13,13,13# Is extra ocular motility stable over 
#13# at least the last six months ( Y ^ ) ? ’
YESNO ONLY
{ INVESTIGATE a_c_six_month_stable_diplopia ASSOONAS ( 
a_i_diplopia_on_examination_change = 2 ) }
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
PROBABILITY p_proptosis ’To get - suggestive - proptosis effect on muscles mal
functioning ’




PROBABILITY p_proptosis_now ’ to transfer the mm. measured proptosis to 
probability value ’ MEMBER(a_i_proptosis_opinion , 0 .1 ,0 .9 ,3 .1 ,9 8 ,9 9  )
QUESTION a_i_proptosis_opinion ’ #13# Considering: #13# #13# - patient race, #13# - facial
configuration and#13# -errors of refraction (high myopes)#13##13##13# Do you regard 




QUESTION a_i_proptosis_now ’ #13,13# Enter Exophthalmometry reading in mm.. 
#13,13,13,13,13,13# #13,13,13,13# (Make a note of the base reading if# 13# using Hertelor 
Keeler-Please use the# 13# same base for all subsequent measures)
’INTEGER 12 40
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_proptosis_change ’ to transfer the mm. measured proptosis to 
probability value ’ pl_proptosis_change IF NOT (a_i_main_menu = 1) ELSE 0.1
PROBABILITY pi_proptosis_change ’ oooooooooooooo’ MEMBER( a_i_proptosis_change, 0.1,
0 .001,10 .1 ,98 ,99  ) IF NOT KNOWN f_a_i_proptosis_now ELSE MEMBER( ( a_i_proptosis_now - 
f_a_i_proptosis_now + 29 ) ,  0 .1,29.001,39.01,98 ,9 9 )
QUESTION a_ijproptosis_change ’ #13# Right Exophthalmometry #13#    #13#
How does this reading differ from #13# the previous one ? #13# #13# If No difference enter (0) 
#13# OR #13# Enter the difference in mm. #13# #13# #13# #13# #13# (Please use the previous 
base reading) #13# #13# ’ INTEGER 0 10
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)
PROBABILITY p_Hess_chart ’to consider doctor comment on hess-chart result in
- eye muscles - condition ’
p_Hess_chart_now LS 30 LN 1 p_Hess_chart_change LS 90 LN 1 
IF(ANSWERED a_c_Hess_chart? AND a_c_Hess_chart?) ELSE OPPOSITE (p_hess_dummy)
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!} PROBABILITYp_Hess_chart_now 
’to consider doctor comment on hess-chart result in - eye muscles - condition ’
MEMBER(a_i_Hess_chart_now, 0 .1 ,0 .9 ,9 .1 ,9 8 ,9 9 )
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QUESTION a_i_Hess_chart_now ’ #13# #13# Enter #13# Hess chart/orthoptic report conclusion:
#13# ----------------- ;--------------------- #13# 1 - Normal motility. #13# 2 - Restricted up gaze.
#13# 3 - Restricted down’gazc. #13# 4 -Restricted up and down gaze. #13# 5 -Restricted
abduction. #13# 6 - Restricted adduction. #13# 7 - Restricted abduction and adduction. #13#
8 - Combination of restrictions. #13# 9 - Fixed eye. ’ INTEGER 1 9
{!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_hess_dummy ’dummy hess constant ’ 0.9 PRIOR 0.9
PROBABILITY p_Hess_chart_change ’to consider doctor comment on hess-chart result in
- eye muscles - condition ’ pl_Hess_chart_change IF NOT (a_i_main_menu = 1) ELSE 0.1
PROBABILITY p 1 _Hess_chart_change ’ooooooooooo* MEMBER(a_i_Hess_chart_change, 0 .1 ,0 .9 ,
3 .1 ,98 ,99  ) IF NOT KNOWN f_aJ_Hess_chart_now ELSE MEMBER( ( a_i_Hess_chart_now - 
f_a_i_Hess_chart_now + 10), 0 .1 ,10 .9 ,19 .1 , 9 8 ,9 9 )
QUESTION a_i_Hess_chart_change ’#13# #13#
(today)#13# with the previous ones. #13,13#
#13,13# (1) Getting better. #13#
#13# (3) Getting worse. *
INTEGER 1 3 {!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!}
PROBABILITY p_ultra_sound ’to consider doctor comment on ultra sound images in
- eye muscles - condition ’ MEMBER(a_i_ultra_sound ,0.1,0.001,4.1,98 ,99) IF(ANSWERED 
a_c_ultra_sound? AND a_c_ultra_sound?) ELSE 0.1
QUESTION a_i_ultra_sound’ #13# #13# Enter your comment on: #13# #13# Right Orbital
Ultrasonography #13#  #13# #13# #13# (1) E.O.M. normal #13# #13#
(2) The muscles are moderately thickened. #13# (3) Markedly swollen. #13# #13# (4) Swollen
and crowded at orbital apex. ’
INTEGER 1 4
(llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll} PROBABILITY p_CTscan ’to consider doctor
comment on C.T.scan images in - eye muscles - condition ’ MEMBER(a_i_CTscan ,0.1
,0.001,4.1,98,99) IF(ANSWERED a_c_CTscan? AND a_c_CTscan?) ELSE 0.1
QUESTION a_i_CTscan’ #13# #13# Enter your comment on Right Orbital #13# #13# MRIscan
#13# #13# #13# 1 - E.O.M. normal. #13# #13# 2 - The muscles are moderately thickened. #13#
3 - Markedly swollen. #13# #13# 4 - Swollen and crowded at orbital apex. ’
INTEGER 1 4
PROBABILITY p_MRIscan ’to consider doctor comment on MJR.I. images in
- eye muscles - condition ’ MEMBER(a_i_MRIscan ,0.1,0.001,4.1,98,99) IF(ANSWERED 
a_c_MRIscan? AND a_c_MRIscan?) ELSE 0.1
Comparing motility assesment 
Motility is: #13#
(2) Stable (minimal or no change).
D2-40
QUESTION a_i_MRIscan’ #13# #13# Enter your comment on Right Orbital #13# #13# MRIscan
#13# #13# #13# 1- E.O.M. normal. # 13# # 13# 2 - The muscles are moderately thickened. #13#









PROBABILITY p_mal_lid ’to assess how bad the present lid condition ’
{***********p_previous_lid_treatment LS 0.2 LN io .O*********} p_uncoverage 




{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%}
{ PROBABILITY p_previous_lid_treatment ’ to assess the effect of previous lid
treatment on its present condition ’
previous_lid_treatment, previous_ p_mal_lid ) }
{%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% % % % % % % % % % % % % % % % % % }
PROBABILITY p_uncoverage ’to see the degree of eye uncoverage’ MIN( p_lid_retraction,
p_lid_lag)
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%)
{lllllllllllllllllllllllllllllllllllllllllilllllllllllllllllllllllllll}
PROBABILITY p_lid_lag ’to get the probability of lid lag’ CONDPROB(a_c_lid_lag 
,ANSWERED a_c_lid_lag, 0.1)
QUESTION a_c_lid_lag ’#13,13,13,13# Is there any Right Lid Lag ? ’ YESNO ONLY
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PROBABILITY p_lid_rctraction ’to see the effect of lid retraction on eye coverage ’
MEMBER( a_iJid_retraction, 0 .1 ,0 .9 ,4 .1 , 98 ,99 )
QUESTION a_i_lid_retraction ’ #13# #13# #13# Right Eye Lid: #13# #13# #13# (1)
Normal. #13# #13# (2) Mild retraction. #13# (3) Moderate retraction. #13# #13# (4) Severe








PROBABILITY p_mal_comea ’to assess how bad the present cornea condition ’
{***********p_previous_cornea_treatrnent l s  o.2 LN io .O*********} p_comea 






{ PROBABILITY p_previous_comea_treatment ’ to assess the effect of previous
cornea treatment on its present condition ’
previous_comea_treatment, previous_ p_mal_comea ) }
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %  
% % % % % % % % % % % % % % % % % % % % % % % }  PROBABILITY p_comea ’ to get the precise cornea 
condition ’




PROBABILITY p_comea_now * to get the present cornea condition ’ MEMBER(a_i_comea_now, 0.1, 
0 .9 ,5 .1 ,9 8 ,9 9 )
QUESTION a_i_comea_now ’#13# #13# Right Cornea: #13,13#
#13# (1) Clear. #13# #13# (2) Stippling. #13# #13# (3) Ulcer.




PROBABILITY p_comea_change ’ to compare present cornea condition with its 
previous one ’ pl_comea_change IF NOT (a_i_main_menu =1) ELSE 0.1
PROBABILITY pl_comea_change ’ oooooooooooo ’ MEMBER(a_i_comea_change , 0.1 ,0 .9 ,3.1 ,
98,99 ) IF NOT KNOWN f_a_i_comea_now ELSE MEMBER( (a_i_comea_now - f_a_i_comea_now 
+ 6 ) ,  0 .1 ,6 .9 ,11 .1 ,98 ,99 )
QUESTION a_i_comea_change ’#13,13# #13# How do you find the condition of the#13#
Right Cornea compared to last visit ? #13# #13# (1) Improving.








GROUP g_soft_tissue p_lid_eodema p_chemosis
{&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&&&&&&&&&&&&&&&&&&&}
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%%%%%%)
PROBABILITY p_lid_eodema’to gerthe probability of eye lid eodema’
p_lid_eodema_now LS 10 LN 1 p_lid_eodema_change LS 30 LN 1 
PRIOR 0.1
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%%%%%%}
PROBABILITY p_lid_eodema_now ’to get the present condition of eye lid eodema’ MEMBER( 
a_i_lid_eodema_now, 0 .1 ,0 .9 ,4 .4 ,98 ,99 )
QUESTION a .i Jid_eodema_now ’ #13# #13# #13# Right Eye Lid: #13# #13# #13# (1) No lid




PROBABILITY p_lid_eodema_change ’to compare the present lid eodema condition 
with the previous one ’ pl_lid_eodema_change IF NOT (a_i_main_menu =1) ELSE 0.1
PROBABILITY pl_lid_eodema_change ’OOOOOOOOOOOO’ MEMBER( a_i_lid_eodema_change, 
0.1,0.9 , 3.1,98 ,99 ) IF NOT KNOWN f_a_iJid_eodema_now ELSE MEMBER( 
(a_i_lid_eodema_now - f_a_i_lid_eodema_now + 5 ), 0 .1 ,5 .9 ,9 .1 ,98 ,
99)
QUESTION a_i_lid_eodema_change ’#13# #13# Do you find Right Lid Oedema 
#13# #13# (1) Decreasing, #13# #13# (2) As before or
#13##13# (3) Increasing? ’ INTEGER 1 3
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllilllllllllllllllll}
{ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
% % % % % % % % % % % % % % % % % % % % % % % }
PROBABILITY p_chemosis ’to get the probability of eye chemosis’
p_chemosis_now LS 10 LN 1 p_chemosis_change LS 30 LN 1 
PRIOR 0.1
[ % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % % %
%%%%%%%%%%%%%%%%%%%%%%%}
{llllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllll}
PROBABILITY p_chemosis_now ’to get the present condition of eye chemosis’ MEMBER( 
a_i_chemosis_now, 0 .1 ,0 .9 ,4 .4 ,98 ,99 )
QUESTION a_i_chemosis_now ’ #13# #13# #13# Right Conjunctiva #13# #13# #13# (1)
No chemosis. #13# #13# (2) Mild chemosis. #13# (3) Moderate chemosis. #13# #13# (4)
Severe chemosis. * INTEGER 1 4
{llllllllllilllllllllllllllllllllllllllllllllllllilllllllllllllllllllllllll}
PROBABILITY p_chemosis_change ’to compare the present chemosis condition with
the previous one ’ pl_chemosis_change IF NOT (a_i_main_menu = 1) ELSE 0.1
PROBABILITY pl_chemosis_change ’OOOOOOOOOOOOOOOOOOO’ MEMBER( 
a_i_chemosis_change, 0 .1 ,0 .9 ,3 .1 ,98 ,99 ) IF NOT KNOWN f_a_i_chemosis_now ELSE 
MEMBER( (aJL.chemosis_.now - f_aJ_chemosis_now + 5 ) , 0.1 ,5 .9 ,9 .1 ,9 8 ,9 9 )
QUESTION aJ_chemosis_change ’#13# #13# Do you find Right Chemosis
#13# #13# (1) Decreasing, #13,13# (2) As before or
#13# (3) Increasing ? ’ INTEGER 1 3
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{Illlllllllllllllllllllllllllllllllllll}
NUMBER n_IOP_dif ’ to get the difference in IOP straight ,up pressure ’ ESSAY ’ #13# (1)
Nonpositional intraocular pressure changes in #13# thyroid eye disease #13# #13#
#13# Braily and Eyre (1901) were the first to #13# report cases with
hyperthyroidism and #13# exophthalmos who had evidence of glaucoma by #13# 
palpation. The studies during the first half of #13# the twentieth century were reviewed
by #13# Pohjanpelto (1968), who emphasized the lack of #13# agreement on the 
question of the link between #13# intraocular pressure and thyroid dysfunction. #13# 
However, tonometry was poorly developed during #13# that period. #13# #13#
Interest in the relation between thyroid #13# function and intraocular pressure was
renewed #13# during the 1960” s by the study of Mclenachan and #13# Davis (1965) 
and Beker et. al. (1966). #13# #13# Vasilieva (1965), studied 53 patients with
#13# hyperthyroidism and found that all had increased #13# intraocular pressure which 
correlated directly #13# with thyroid hormone levels. #13# #13# Other
investigator, paying close attention to #13# eye position when performing tonometry, have 
#13# failed to corroborate these findings. Ching and #13# Perkings (1967), found only two 
cases of glaucoma #13# in a group of 155 patients with thyroid disease. #13# This 
prevalence is the same for all individuals #13# over 40 years of age (2.00 to 2.4%). #13#
#13# #13# (2) Positional intraocular pressure changes in #13# thyroid disease
#13# #13# #13# Positional intraocular pressure changes in #13# patients with
Graves” ophthalmopathy occur in #13# other positions of gaze, although most commonly
#13# demonstrated in upward direction. #13# #13# This observation was first
referred toby #13# Wessely (1918) and later its significance was #13# recognized by 
Braley (1953). #13# #13# Lyons (1971), Zappia (1971) and Gamblin et.al. #13#
(1983), have suggested that the measurement of #13# positional intraocular pressure changes 
may be #13# clinically useful in the detection of orbital #13# involvement in 
Graves” disease as well as in #13# monitoring the progression of ophthalmopathy. #13#
#13# Lyons (1971), in a study of 36 patients with #13# Graves” ophthalmopathy found that 
all demonstrated #13# significant (= 3 mm. Hg) intraocular pressure #13# increases 
on upgaze. Additionally, of nine #13# patients with Graves” disease with lid retraction
#13# only, four had abnormal pressure readings. #13# #13# The presence of
intraocular pressure #13# abnormalities in most patients without clinical #13#
Graves” s eye disease is consistent with orbital #13# ultrasonographic (Werner et. al., 1974)
and CT #13# studies (Enznann et. al , 1979) which also #13# indicated frequent 
subclinical ophthalmopathy. #13# #13# Pressure changes seem to correlate well with
#13# severity of ophthalmopathy as suggested by Draeger #13# and Schneider (1975).
#13# #13# In cross-sectional studies it has been noted #13# that the percentage of
Graves” disease patients #13# with ophthalmopathy - as judged by positional #13# 
intraocular pressure readings - increased with #13# time elapsed from the diagnosis of Graves”
disease #13# and was nearly universal after 10 years (Gamblin #13# et. al.,1984).
#13# #13# It should be recognized that the presence of #13# positional intraocular
pressure changes is not #13# specific for Graves” ophthalmopathy. Both orbital #13# 
myositis and orbital fracture with inferior rectus #13# entrapment have been shown to cause
intraocular #13# pressure changes in upgaze (Zappia et. al., 1971). *
( a_i_IOP_straight - a_i_IOP_up)
QUESTION a_i_IOP_up ’ #13# #13# #13# #13# Enter Interocular pressure in up gaze *
AMPLIFY ’ #13# Applanation tonometry using Perkins or Draeger 
#13# hand-held tonometer, allows for accurately 
#13# following the curve of the cornea when positional
#13# changes are being measured. #13# #13# By careful head positioning, slit lamp mounted
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#13# Goldmann applanation tonometer can be used to
#13# measure the intraocular pressure in straight, up 
#13# and down directions of gaze while still
#13# applanating the central area of the cornea. ’
INTEGER 10 50












MAKE z_begin TRUE ASSOONAS (a_i_teaching_menu=2)





NUMBER cccc ’ ’ ccc_? IF z_begin ELSE cccc_converted
NUMBER cccc_converted ’ ’ 4 IF validate_finished AND (p_mal_comea > 0.7) ELSE cccc_converted_a
NUMBER cccc_converted_a ’ ’ 3 IF validate_finished AND ((p_mal_comea > 0.5) AND (p_mal_comea
< 0.699)) ELSE cccc_converted_b
NUMBER cccc_converted_b ’ ’ 2 IF validate_finished AND ((p_mal_comea > 0.3) AND (p_mal_comea
< 0.499)) ELSE cccc_converted_c
NUMBER cccc_converted_c ’ ’ 1 IF validate_finished AND ((p_mal_comea < 0.299))
{     ) NUMBER nnnn’ ’ nnn_? IF z_begin ELSE
nnnn_converted
NUMBER nnnn_converted ’ ’ 4 IF validatejmished AND (p_mal_nerve > 0.7) ELSE nnnn_converted_a
NUMBER nnnn_converted_a ’ ’ 3 IF validate_finished AND ((p_mal_nerve > 0.5) AND (p_mal_nerve
< 0.699)) ELSE nnnn_converted_b
NUMBER nnnn_converted_b ’ ’ 2 IF validate_finished AND ((p_mal_nerve > 0.3) AND (p_mal_nerve
< 0.499)) ELSE nnnn_converted_c
NUMBER nnnn_converted_c ’ ’ 1 IF validate_finished AND ((p_mal_nerve < 0.299))
U..........  .}
NUMBER m i’ ’ 111_? IF z_begin ELSE llll_converted
NUMBER llll_converted * ’ 4 IF validate_finished AND (p_mal_lid > 0.7) ELSE lHl_converted_a
NUMBER llll_converted_a ’ ’ 3 IF validate_finished AND ((p_mal_lid > 0.5) AND (p_mal_lid <
0.699)) ELSE UU_converted_b
NUMBER llll_converted_b ’ ’ 2 IF validate_fmished AND ((p_mal_lid > 0.3) AND (p_mal_lid <
0.499)) ELSE llll_converted_c
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NUMBER llU_converted_c ’ ’ 1 IF validate_finished AND ((p_mal_lid < 0.299))
{ }
NUMBER mmmm ’ * mmm_? IF z_begin ELSE mmmm_converted
NUMBER mmmm_converted ’ ’ 4 IF validate_finished AND (p_mal_muscles > 0.7) ELSE 
mmmm_converted_a
NUMBER mmmm_converted_a ’ ’ 3 IF validate_finished AND ((p_mal_muscles > 0.5) AND 
(p_mal_muscles < 0.699)) ELSE mmmm_converted_b
NUMBER mmmm_converted_b ’ ’ 2 IF validate_finished AND ((p_mal_muscles > 0.3) AND 
(p_mal_muscles < 0.499)) ELSE mmmm_converted_c
NUMBER mmmm_converted_c ’ * 1 IF validate_finished AND ((p_mal_muscles < 0.299))
{......................................................................} NUMBER prop’ ’ pro_? IF z_begin ELSE
prop_converted
NUMBER prop_converted ’ ’ 3 IF validate_flnished AND (p_proptosis > 0.7) ELSE prop_converted_a
NUMBER prop_converted_a ’ ’ 2 IF validate_finished AND ((p_proptosis > 0.3) AND (p_proptosis < 
0.699)) ELSE prop_converted_b
NUMBER prop_converted_b ’ ’ 1 IF validate_finished AND (p_proptosis < 0.299)
{&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&&&&&&&&&&&&&&&&&}
QUESTION ccc_? ’ enter cccc ’ INTEGER 14 
QUESTION nnnj? ’ enter nnnn ’ INTEGER 14 
QUESTION 1U_? ’ enter 1111’ INTEGER 14 
QUESTION mmm_? ’ enter mmmm ’ INTEGER 14 
QUESTION pro_? ’ enter prop ’ INTEGER 1 3
MAKE s_lid_already_said * * MAKE s_already_said ’ reported before ’ ASSOONAS 
(validate_finished OR z_begin)
INVESTIGATE 111_? mmm_? pro_? ccc_? nnn_? ASSOONAS (a_i_teaching_menu = 2)
{ )
{........................... ACTIONS REQUIRED............................. ) CONDITION c_announce_action’ *
c_start_treatment
{       ' )
NUMBER i_choose_action_l ’ ’ 1 IF (cccc=4) ELSE i_choose_action_2
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NUMBER i_choose_action_2 * ’ 2 IF (nnnn=4) ELSE i_choose_action_3 
NUMBER i_choose_action_3 ’ * 3 IF (nnnn=3) ELSE i_choose_action_4
NUMBER i_choose_action_4 ’ ’ 4 IF (mmmm=4) OR (nnnn=2) OR (cccc=3) OR (1111=3) OR (1111=4) 
ELSE i_choose_action_5
NUMBER i_choose_action_5 ’ ’ 5 IF (mmmm=3) OR (cccc=2) OR (1111=2) ELSE i_choose_action_ 6  
NUMBER i_choose_action_ 6  ’ ’ 6  IF (mmmm=2) ELSE i_choose_action_7 
NUMBER i_choose_action_7 ’ ’ 7 IF (mmmm=l) ELSE i_choose_action_ 8  
NUMBER i_choose_action_ 8  ’ ’ 8 IF (cccc=l) OR (nnnn=l) OR (1111=1)
INVESTIGATE i_choose_action_l ASSOONAS c_announce_action 
{... -      }
REPORT (70)’ #13# #13# ACTION (70) 1 #13# _________#13##13# Urgent admission. ’
ASSOONAS (i_choose_action_l = 1) AND ((a_i_fmal_menu = 1) OR (a_i_final_menu = 2))
REPORT (70)’ #13# #13# ACTION (70) 2 #13# _________#13# #13# Admission. ’ ASSOONAS
(i_choose_action_l =2) AND ((a_i_final_m enu = 1) OR (a_i_final_menu = 2))
REPORT (70)’ #13# #13# ACTION (70) 3 #13# _________ #13# #13# Two weeks. ’ ASSOONAS
(i_choose_action_l =3) AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
REPORT (70)’ #13# #13# ACTION (70) 4 #13# ________ _#13##13# One month. ’ ASSOONAS
(i_choose_action_l =4) AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
REPORT (70)’ #13# #13# ACTION (70) 5 #13#  _________ #13# #13# Three month. ’
ASSOONAS (i_choose_action_l =5) AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
REPORT (70)’ #13# #13# ACTION (70) 6  #13# #13# #13# Six month. ’ ASSOONAS
(i_choose_action_l =6 ) AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
REPORT (70)’ #13# #13# ACTION (70) 7 #13#  _______ #13# #13# Eight months to one year. ’
ASSOONAS (i_choose_action_l =7) AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
REPORT (70)’ #13# #13# ACTION (70) 8  #13# #13# #13# No further appointment ’
ASSOONAS (i_choose_action_l =8) AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
DISPLAY ’ start_treatment ’ ASSOONAS c_start_treatment
CONDITION c_start_treatment’ ’ TRUE IF ((ANSWERED nnnn) AND (ANSWERED cccc) AND 
(ANSWERED 1111) AND (ANSWERED mmmm) AND (ANSWERED prop)) AND (validate_finished 
OR z_begin) ELSE FALSE
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DISPLAY * no_ulcer ’ ASSOONAS c_no_ulcer
CONDITION c_no_ulcer ’ ’ TRUE IF ((cccc 3)ANDc start treatment) ELSE FALSE
{.......................................................................... } {QUESTION anti_steroids * anti_steroid ’ YESNO
QUESTION anti.surgery ’antijsurgery ’ YESNO 
QUESTION anti_radio ’ anti_radio * YESNO
INVESTIGATE anti_steroids ASSOONAS (a_i_treat_nerve = 1) OR ((cccc=4) AND (nnnn=4))
INVESTIGATE anti_surgery ASSOONAS (a_i_treat_nerve = 2) OR (a_i_lid_tars_leng_deco = 3) OR ( 
c_muscles_troubles AND (NOT c_any_other_troubles) AND (ANSWERED c_stable AND c_stable)
[AND ((prop=2)OR(prop=3))] )




{............TREAT ULCER HRST.> COME BACK AFTER HEALING................ }
REPORT(21)’ #13# #13# RECOMENDED TREATMENT #13# ___________________ ’
ASSOONAS (a_i_final_menu = 1) OR (a_i_final_menu = 2)
REPORT(20) * #13# #13# The corneal ulcer requires urgent #13# treatment. ’ ASSOONAS c_tr_ulcer
CONDITION c_tr_ulcer * ’ c_start_treatment AND (cccc=4) AND ((a_i_final_menu = 1) OR 
(a_i_final_menu = 2 ))
REPORT(19) ’ #13# #13# During such treatment of the #13# cornea should be kept well #13# 
protected and lubricated until #13# the ulcer heals, when the lid #13# condition will receive 
appropriate #13# procedure. ’ ASSOONAS c_tr_ulcer_lubrication AND ((a_i_fmal_menu =1) OR 
(a_i_final_menu = 2 ))
CONDITION c_tr_ulcer_lubrication ’ ’ c_start_treatment AND ((cccc=4) AND ((llll=3)OR(llll=4)))
{   }
REPORT(16) * #13# #13# Systemic steroids may be used for #13# optic neuropathy untill the #13# 
comeal ulcer heals when other #13# options will be possible. ’ ASSOONAS c_tr_ulc_nerv_w_steroids 
AND ((a_i_fmal_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_tr_ulc_nerv_w_steroids * ’ c_start.treatment AND ( (NOT anti.steroids) AND
((nnnn=4) AND (cccc=4)) )
REPORT(16) ’ #13# #13# Orbital radiotherapy can be used #13# for optic neuropathy untill the 
#13# comeal ulcer heals when other #13# options may be possible. ’ ASSOONAS 
c_tr_ulc_nerv_w_radiotherapy AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
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CONDITION c_tr_ulc_nerv_w_radiotherapy ’ ’ c_start_treatment AND ( (NOT anti.radio) AND
anti_steroids AND ((nnnn=4) AND (cccc=4)) )
REPORT(16) ’ #13# #13# It is recomended to postpone #13# orbital decompression untill the 
#13# comeal ulcer heals while radio-#13# therapy is out of question now. #13# #13# Although 
there are definite #13# contrandications in this #13# particular patient to the use of #13# 
systemic steroids, this is the #13# only choice available. #13# #13# It recommended to start a 
#13# systemic steroid course under #13# strict medical supervision. ’ ASSOONAS 
c_tr_ulc_nerv_critical AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_tr_ulc_nerv_critical ’ ’ c.start.treatment AND anti.radio AND anti.steroids AND
((nnnn=4) AND (cccc=4» {................................ ........................................) {QQQQQQQQQQQQ
QQQQQQQQQQ QQQQQQQQQQQ QQQQQQQQQQQQQQQQQ QQQQQQ)
STRING s_proptosis ’ ’ ’also proptosis is severe’ IF (prop=3) ELSE sl_proptosis 
STRING sl_proptosis ’ ’ ’also proptosis is moderate’ IF (prop=2) ELSE s2_proptosis 
STRING s2_proptosis * ’ ’also proptosis is mild’ IF (prop= 1)
{     } STRING s_anti_steroids ’ ’ ’ #13# #13# Systemic
steroids is contraindicated.* IF (ANSWERED anti.steroids AND anti.steroids) ELSE ’ ’
STRING s_anti_surgery ’ * ’ #13# #13# Surgical decompression is contraindicated. ’ IF (ANSWERED 
anti_surgery AND anti_surgery) ELSE ’ ’
STRING s_anti_radio * ’ ’ #13# #13# Orbital radiotherapy is out of question.’ IF (ANSWERED 
anti_radio AND anti_radio) ELSE ’ *
{— ------------------------------------  ...-------------------------- }.{.............. .TEDEX.choice is to show
TEDEX opinion...;..................}
STRING s_TEDEX_choice ’ * ’systemic steroids.’ IF (ANSWERED c_TEDEX_choice AND 
c_TEDEX_choice) ELSE sl_TEDEX_choice
STRING sl_TEDEX_choice * ’ ’surgical decompression.’ IF (ANSWERED cl_TEDEX_choice AND 
c l_TEDEX_choice) ELSE s2_TEDEX_choice
STRING s2_TEDEX_choice ’ ’ ’orbital radiotherapy.’ IF (ANSWERED c2_TEDEX_choice AND 
c2_TEDEX_choice)
[\\\\\\\\\\\\\W
CONDITION c_TEDEX_choice’ ’ TRUE IF c_no_ulcer AND ( (prop=l) OR ( ((prop=2)OR(prop=3)) 
AND anti_surgery) )  AND ((NOT ANSWERED anti_steroids)OR(NOT anti.steroids)) ELSE FALSE
CONDITION cl_TEDEX_choice’ ’ TRUE IF c_no_ulcer AND ( ((prop=3)OR(prop=2)) OR ( (prop=l) 
AND anti.steroids AND anti.radio) ) AND ((NOT ANSWERED anti_surgery)OR(NOT
anti.surgery)) ELSE FALSE
CONDITION c2_TEDEX_choice’ ’ TRUE IF c_no_ulcer AND ( ((prop=l) AND anti.steroids ) OR ( 
((prop=2) OR (prop=3)) AND anti.steroids AND anti.surgery) )AND ((NOT
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ANSWERED anti_radio)OR(NOT anti.radio)) ELSE FALSE
STRING s_choose_steroids ’ ’ ’ ’ IF (ANSWERED anti.steroids AND anti.steroids) ELSE * #13#
Enter 1 ...forsteroids. ’ STRINGs_choose_decompression ”  * ’ IF(ANSWEREDanti.surgery AND 
anti_surgery) ELSE ’ #13# Enter 2 ...for decompression. ’ STRING s_choose_radiotherapy ’ ”  ’ IF 
(ANSWERED anti.radio AND anti.radio ) ELSE ’ #13# Enter 3 ...for radiotherapy. ’
{     .}
QUESTION a_i_treat_nerve’ #13# As#s_already_said#this patient is #13# almost definitly suffering 
from optic #13# nerve compression, this is an emergent #13# case,
(#s_proptosis#).#s_anti_steroids##s_anti_surgery##s_anti_radio# #13# #13# My first choice is 
#s_TEDEX_choice# #13# #13# Considering availability and your #13# preference, what is your 
choice? #13##s_choose_steroids##s_choose_decompression##s_choose_radiotherapy#’
INTEGER 1 3
INVESTIGATE s_anti_steroids s_anti_surgery s.anti.radio s_choose_steroids
s_choose_decompression s_choose_radiotherapy s_TEDEX_choice INVESTIGATE
a_i_treat_nerve ASSOONAS c_no_ulcer AND (nnnn=4) AND (s_already_said = ’ reported before ’)
INVESTIGATE s_anti_steroids s_anti_surgery s_anti_radio s_choose_steroids
s_choose_decompression s_choose_radiotherapy s_TEDEX_choice
ASK a_i_treat_nerve ASSOONAS (NOT(ANSWERED anti_steroids AND anti_steroids AND 
ANSWERED anti.surgery AND anti_surgery AND ANSWERED antijradio AND anti_radio 
)) AND ((ANSWERED a_c_your_choice_bad? AND NOT a_c_your_choice_bad?))
{ }^\\\\\\\\\\\\\\\\\^^^^
STRING s_contra_indications ’ ’ ’contraindications to systemic steroids’ IF (a_i_treat_nerve = 1) AND 
(ANSWERED anti.steroids AND anti.steroids) ELSE sl_contra_indications
STRING sl_contra_indications ’ ’ ’contraindications to general anaethesis’ IF (a_i_treat_nerve = 2 )
AND (ANSWERED anti_surgery AND anti_surgery) ELSE s2_contra_indications
STRING s2_contra_indications ’ ’ ’conrtaindications to radiotherapy’ IF (a_i_treat_nerve = 3 ) AND 
(ANSWERED anti.radio AND anti.radio)
QUESTION a_c_your_choice_bad? ’ #13# I do not fully agree with you because #13# there are: #13# 
#s_contra_indications# #13# in this particular patient #13# #13# NOW.. #13# #13# Do you want 
me to continue using #13# your choice? (Y)# 13# OR #13# Look for other choices? (N)# 13#
#13# #13# Enter (Y) for Continue #13# Enter (N) for Other choices ’ YESNO ONLY
MAKE s_already_said ’ mentioned previously ’ INVESTIGATE s_contra_indications ASK 
a_c_your_choice_bad? ASSOONAS (NOT(ANSWERED anti.steroids AND anti.steroids AND 
ANSWERED anti.surgery AND anti.surgery AND ANSWERED anti.radio AND anti_radio 
)) AND ( ( (anti_steroids) AND (a_i_treat_nerve = 1)) OR ( (anti.surgery) AND (a_i_treat_nerve = 2 )) 
OR ( (anti_radio) AND (a_i_treat_nerve = 3 )) )
{............................ .....}ft\\\\\\\\\\\\\m
STRING s_critical_choice ’ ’ ’ systemic steroids ’ IF (anti.steroids AND anti.surgery AND
anti_radio) AND (prop = 1) ELSE sl_critical_choice
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STRING sl_critical_choice ’ ’ ’orbital decompressions’ IF (anti_steroids AND anti_surgery AND 
anti_radio) AND ((prop = 2)OR(prop = 3) )
QUESTION a_i_critical_choice ’ #13# #13# This is a critical situation. This patient #13# has 
contraindications for systemic steroids #13# treatment, orbital radiotherapy and surgical #13# 
decompression. However, I recommend #13# #s_critical_choice# treatment with utmost #13# 
medical care and very close close follow up. #13# #13# Considering the availability, your preference 
#13# and the above conclusion, what is your final #13# choice? #13# #13# 1- Systemic
steroids #13# 2 - Surgical decompression #13# 3 - Orbital radiotherapy ’
INTEGER 1 3
INVESTIGATE a_i_critical_choice ASSOONAS anti_steroids AND anti_surgery AND anti_radio
{------- -------------------------------------------------------------------— — }{........................TREAT
NERVE...................................... } REPORT(12) ’ #13# #13# It is recommended to start a #13#
systemic steroid course. #13# Considerably high dose is #13# required in such cases 
(80-120mg #13# Prednisone or equivalent). #13# #13# A physician should preferably be #13# 
involved in the management of #13# this patient ’ ASSOONAS c_tr_nerve_w_steroids AND 
((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_tr_nerve_w_steroids ’ ’ (nnnn=4) AND ( (  (NOT anti_steroids) AND
(a_i_treat_nerve = 1) )OR ( ( anti_steroids) AND (a_c_your_choice_bad?) AND (a_i_treat_nerve =
1))OR ( a_i_critical_choice = 1) )
REPORT(12) ’ #13# #13# Arrangements are required for #13# orbital decompression. ’ 
ASSOONAS c_tr_nerve_w_decompression AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_tr_nerve_w_decompression * ’ (nnnn=4) AND (
( (NOTanti_surgery)AND(a_i_treat_nerve =  2 ) )OR( ( anti_surgery)AND 
(a_c_your_choice_bad?) AND (a_i_treat_nerve = 2 ))OR ( a_i_critical_choice = 2 )
)
REPORT(12) ’ #13# #13# Arrangements for a course of #13# orbital radiotherapy are required. 
#13# The usual dose is 20Gy of super- #13# voltage x-ray divided into 10 #13# fractions over 2 
weeks. ’ ASSOONAS c_tr_nerve_w_radiotherapy AND ((a_i_final_menu = 1) OR (a_i_final_menu =
2 ))
CONDITION c_tr_nerve_w_radiotherapy ’ ’ (nnnn=4) AND (
( (NOT anti_radio) AND (a_i_treat_nerve = 3 ) )OR( ( anti_radio) AND 
(a_c_your_choice_bad?)AND (a_i_treat_nerve =3 ))OR ( a_i_critical_choice = 3 )
{--------------------------------------------------------------------------------- }{.........................TREAT
LID........................................ )
CONDITION c_start_treating_lid * ’ [NEW AT 29 OCT 8 8 ] ((1H1=3)0R(1111=4)) AND(
( NOT (nnnn=4)) OR ( (nnnn=4) AND (NOT ANSWERED c_tr_nerve_w_decompression) AND ( 
ANSWERED c_tr_nerve_w_steroids OR ANSWERED c_tr_nerve_w_radiotherapy)) )
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CONDITION c_do_not_decompress’ ’ ((nnnn=4) AND ((prop=2)OR(prop=3)) AND NOT
ANSWERED c_tr_nerve_w_decompression) {........................................................................} STRING
s_lid_condition’ ’ ’moderate lid shortage’ IF (1111=3) ELSE sl_lid_condition
STRING sl_lid_condition’ * ’severe lid shortage’ IF (1111=4)
STRING s_lid_A_TEDEX_choice’ ’ ’surgical decompression’ IF ((NOT ANSWERED anti_surgery) 
OR (NOT anti_surgeiy)) ELSE sl_lid_A_TEDEX_choice
STRING sl_lid_A_TEDEX_choice’ ’ ’lid lengthening procedure* IF (1111=4) AND anti_surgery ELSE 
s2_lid_A_TEDEX_choice
STRING s2_lid_A_TEDEX_choice’ ’ ’Temporary tarsoraphy ’ IF (1111=3) AND anti_surgery
STRING s_lid_choose_decomp ’ ’ ’ ’ IF (ANSWERED anti_steroids AND anti_steroids) ELSE
’Enter 3 d ...for decompression’
{       ) QUESTIONa_i_lid_tars_leng_deco’#13# As
#s_lid_already_said# there is # 13# #s_lid_condition# #13# #sjproptosis# #13# #s_anti_surgery# 
#13,13# My first choice is: #13,13# #s_lid_A_TEDEX_choice##13##13# Considering 
treatment availability and #13# your preference, what is your choice ? #13,13# 1 - Lid lengthening.
#13# 2 - Tarsoraphy. #13# #s_lid_choose_decomp# ’ INTEGER 1 3
INVESTIGATE a_i_lid_tars_leng_deco ASSOONAS ( c_start_treating_lid) AND ( NOT 
c_do_not_decompress) AND ((1111=3) OR (1111=4)) AND ((prop=2)OR(prop=3))
ASK a_Llid_tars_leng_deco ASSOONAS ( (ANSWERED a_c_lid_bad_choice) AND (NOT 
a_c_lid_bad_choice))
{........................................       ) QUESTIONa_c_lid_bad_choice’# 13# I  do not fully
agree with you because this#13# is a high risk patient for general anaethesia. #13# #13,13# NOW 
#13,13# Do you want me to continue using #13# your choice? #13# OR#13# Look for
other choices ? #13,13# #13# Enter (y) for CONTINUE#13# Enter (n) for OTHER
CHOICES#13#’ YESNO ONLY
INVESTIGATE a_c_lid_bad_choice MAKE s_lid_already_said ’already said’ ASSOONAS 
(anti_surgery) AND (a_i_lid_tars_leng_deco = 3)
{..     }
STRING s_lid_B_TEDEX_choice’ ’ ’Temporary tarsorrhaphy’ IF (1111=3) ELSE 
sl_lid_B_TEDEX_choice
STRING sl_lid_B_TEDEX_choice’ ’ ’Lid lengthening procedure’ IF (1111=4)
QUESTION a_i_lid_tarso_length’ #13# #13# #13# My choice is: #s_lid_B_TEDEX_choice# #13# 
#13# #13# What is yours ? #13# #13# 1 - Lid lengthening. #13# or #13# 2 -
Tarsorrhaphy. #13# #13# ’ INTEGER 12 ONLY
INVESTIGATE a_i_lid_tarso_length ASSOONAS (ANSWERED a_i_critical_choice AND NOT 
(a_i_critical_choice =2) )OR( (c_start_treatingjid) AND ((1111=3) OR (1111=4)) AND ( (prop=l) OR ( 
((prop=2)OR(prop=3))AND ( c_do_not_decompress) ) )  )
{   ) REPORT(9) ’#13##13# Surgical decompression
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is #13# indicated to correct the #13# mechanical problem which cuases #13# lid shortage. ’ 
ASSOONAS c_tr_lid_drcompress AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_tr_lid_drcompress ’ ’ (c_start_treating_lid) AND ( (a_i_lid_tars_leng_deco = 3) AND( 
(NOT anti_surgery)OR(a_c_lid_bad_choice)) )
REPORT(9) ’ #13# #13# You can proceed to lid lengthening #13# procedure. ’ ASSOONAS 
c_tr_lid_lengthening AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_tr_lid_lengthening ’ ’ (c_start_treating_lid) AND ( (a_i_lid_tarso_length = 1) OR 
(a_i_lid_tars_leng_deco = 1) )
REPORT(9) ’ #13# #13# You can arrange for temporary #13# tarsorrhaphy. ’ ASSOONAS 
c_tr_tarsoraphy AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_tr_tarsoraphy ’ ’ (c_start_treating_lid) AND ( (a_i_lid_tarso_length = 2) OR 
(a_i_lid_tars_leng_deco = 2 ) )
REPORT(9)’ #13# #13# It is recommended to postpone any #13# lid surgery until decompression 
#13# is performed, then the lid #13# condition will be reassessed. #13# #13# The cornea 
should be kept #13# protected and lubricated all the #13# time untill the lid problem is #13# 
dealt with. ’ ASSOONAS c_postpone_lid_tr AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITIONc_postpone_lid_tr ’ ’ ((1111=3)OR(1111=4 )) AND((c_tr_lid_drcompress)OR 
(c_tr_nerve_w_decompression))
REPORT(9) ’ #13# #13# Frequent application of artificial #13# tears is all what you need for #13# 
this patient at this stage. ’ ASSOONAS c_tr_comea_lid_lubrication AND ((a_i_final_menu = 1) OR 
(a_i_final_menu = 2 ))
CONDITION c_tr_comea_lid_lubrication’ ’ c_start_treatment AND ((1111=2) OR ((cccc=2) OR 
(cccc=3)) )
{------------------_--------     ){ ........................TREAT
MUSCLES....................................) DISPLAY ’ c_start_treating_muscles ’ ASSOONAS
c_start_treating_muscles
CONDITION c_start_treating_muscles’ ’ ( ( NOT (nnnn=4)) OR ( (nnnn=4) AND
(ANSWERED c_tr_nerve_w_decompression OR ANSWERED c_tr_nerve_w_steroids OR 
ANSWERED c_tr_nerve_w_radiotherapy)))
AND ( GU1=1) OR (ANSWERED c_tr_comea_lid_lubrication AND
c_tr_comea_lid_lubrication) OR ( ANSWERED c_start_treating_lid AND ( (NOT 
c_start_treating_lid)OR( c_start_treating_lid AND ( c_tr_lid_drcompress OR c_tr_lid_lengthening OR 
c_tr_tarsoraphy OR c_postpone_lid_tr ) ) )
) ■ ■ ) {    }
CONDITION c_stable ’ ’ ANSWERED a_c_six_month_stable_diplopia AND 
a_c_six_month_stable_diplopia
INVESTIGATE c_stable ASSOONAS (validate_finished OR z_begin) AND c_start_treating_muscles 
AND c_muscles_troubles AND (NOT c_any_other_troubles)
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CONDITION c_coping * * NOT (a_i_patient_most_troublesome=3)
INVESTIGATE c_coping ASSOONAS (validate_finished OR z_begin) AND (c_start_trcating_muscles 
AND c_postpone_muscles_surgery )
CONDITION c_do_not_decomp_muscles’ ’ c_start_treating_muscles AND (ANSWERED 
c_do_not_decompress AND c_do_not_decompress) OR ( ((llll=3)OR(llll=4)) AND 
((prop=2)OR(prop=3)) AND (ANSWERED a_i_lid_tars_leng_deco AND NOT 
(a_i_lid_tars_leng_deco=3)) )
{       }
CONDITION c_any_other_troubles ’ ’ c start treating, muscles AND (1111=2) OR (nnnn=2) OR 
(cccc=2 )
CONDITION c_musclcs_troubles ’ ’ c start treating_muscles AND c_start_treatment AND (mmmm=3)
{   .) [ INVESTIGATE anti_surgery c_muscles_troubles
AND NOT c_any_other_troubles ] { ................................................... )
REPORT(6 ) ’ #13# #13# Before contemplating any muscle #13# surgery, orbital decompression is 
#13# first required followed by #13# reassessment of ocular motility. ’ ASSOONAS 
c_do_deco_first_muscles AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_do_deco_first_muscles ’ ’ (NOT anti_surgery) AND ( c_muscles_troubles AND NOT 
c_any_other_troubles AND (ANSWERED c_stable AND c_stable) AND(
((prop=2)OR(prop=3)) AND NOT c_do_not_decomp_muscles) )
REPORT(6 )’ #13# #13# Extraocular muscle surgery is #13# required. ’ ASSOONAS 
c_do_muscles_surgery AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_do_muscles_surgery ’ ’ (NOT anti_surgery) AND ( c_muscles_troubles AND NOT 
c_any_other_troubles AND (ANSWERED c_stable AND c_stable) AND ( (
((prop=2)OR(prop=3))ANDc_do_not_decomp_muscles) OR (prop=l) ) )
REPORT(6 ) ’ #13# #13# Extraocular muscle surgery is #13# required. ’ ASSOONAS 
c_do_muscles_surgery_w_care AND ((a_i_finaljmenu = 1) OR (a_i_final_menu = 2))
CONDITION c_do_muscles_surgery_w_care ’ ’ (anti_surgery) AND ( c_muscles_troubles AND NOT 
c_any_other_troubles AND (ANSWERED c_stable AND c_stable) AND ( (
((prop=2)OR(prop=3))ANDc_do_not_decomp_muscles) OR (prop=l) ) )
REPORT(6) ’ #13# #13# cjx)stpone_muscles_surgery ?????? #13# ?????????????? ’ ASSOONAS 
c_postpone_muscles_surgery AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
CONDITION c_postpone_muscles_surgery ’ ’ (cccc=4) OR ( (c_start_treatment AND (mmmm=2)) OR 
c_muscles_troubles) AND (c_any_other_troubles OR NOT c_stable) AND(
(ANSWERED c_do_deco_first_muscles AND NOT c_do_deco_first_muscles) AND (ANSWERED 
c_do_muscles_surgery AND NOT c_do_muscles_surgery) )
REPORT(5) ’ #13# #13# Occlusion of one eye or the use #13# of prisms is required at this #13# 
stage. * ASSOONAS c_prism_or_occlussion AND ((a_i_final_menu = 1) OR (a_i_final_menu = 2))
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CONDITION c_prism_or_occlussion ’ ’ c_postpone_muscles_surgery AND (ANSWERED c_coping 
AND NOT c_coping)
REPORT(5) ’ #13# #13# No treatment is required for the #13# ocular motility disturbance at #13# 
this stage. ’ ASSOONAS c_do_nothing_for_muscles AND ((a_i_final_menu = 1) OR (a_i_final_menu = 
2))
CONDITION c_do_nothing_for_muscles ’ ’ c_postpone_muscles_surgery AND (ANSWERED 
c_coping AND c_coping)
{........................................................................ } QUESTIONaJJinaLmenu ’ #13# #13# #13# C
lo s in g  M e n u  #13# -------------------------#13# #13# (1) - DISPLAY final report. #13#
#13# (2 )-PRINT final report. #13# #13# (3) - RE-START new patient #13# #13# (4)-




ASK a_i_final_menu ASSOONAS (ANSWERED a_i_final_menu) AND (NOT 
((a_i_final_menu = 3) OR (a_i_final_menu = 4)) )
DISPLAY ’ GOOD BYE ’ MAKE AT_END TRUE ASSOONAS (aj_final_menu = 4)
DISPLAY REPORTLIST CLEAR REPORTLIST MAKE clinical_report FALSE MAKE clinical_report 
TRUE ASSOONAS (a_i_final_menu = 1)
PRINT REPORTLIST CLEAR REPORTLIST MAKE clinical_report FALSE MAKE clinical_report 
TRUE ASSOONAS (a_i_final_menu = 2) {...................................................................... }
CONDITION c_show_final_menu ’ ’ (c_start_treating_muscles AND ( (mmmm=l) OR ( (mmmm=2) 
AND ( c_do_deco_first_muscles OR c_do_muscles_surgery OR c_do_muscles_surgery_w_care
OR c_prism_or_occlussion OR c_do_nothing_for_muscles) ) ) )
{&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&
&&&&&&&&&&&&&&&&&&&} {------------------------------ final report start----------------------------- }
REPORT(120)’ 1 #13# #13# TEDEX FINAL REPORT #13#
_________________ #13#
#13*****************************************************************************
#13#* * #13#* TEDEX is an experimental expert thyroid
eye disease. *#13#* system which provides an extra The clinician involved must still*
#13#* piece of information about the make the final decision, and must * #13#* assesment and
management of carry the responsibility of that * #13#* patients suffering from dys- decision.
* #13#* *
# 13******************************************************************************
REPORT (118)’ 2 #13# #13# Examiner: Dr.#a_s_who_are_you# (#s_user_experience#) #13#
   #13# #13# Hospital No.:
#a_s_hospital_number?# #13# #13# Name : #a_s_patient_name# #13# Sex :
#a_s_patient_sex# #13# Year of Birth: #a_i_patient_DOB# (#i_patient_age# years old) #13# ’
REPORT(l 16)* 3 #13# #13# History: #13# _______#13# #13# The patient is complaining #13#
mainly of:#13##s_lacrimination##s_photophobia##s_blurring##s_double_vision##s_pain# #13# #13#
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for #a_i_eye_disease_duration# months. #13# ’ ASSOONAS (a_i_final_menu = 1) OR (a_i_final_menu 
= 2)
REPORT(l 14)’ 4 #13# #13# Relevant present and past history: #13#





#s_Prisms_occlussion?##s_Prisms_occl_effect# #s_ Muscle. surgery?##s. Muscle surg_effect# #13# 
#13# * Diagnosis of #s_thyroid_status# has been made #13# #a_i_thyroid_disease_duration# months 
ago. #13# #13# *  Thyroid dysfunction treated by: #s_Radioactive_iodine# #s_Thyroidectomy# 
#s_Carbimazol# #13,13# #13# ’ REPORT(l 12)’ 5 #13# #13# Clinical findings: Right eye
Left eye #13# __________________#13# #13# Snellens acuity - #s_snellen_now#
#13# Lid retraction - #s_lid_retract# - .......#13# Lid lag -#s_lid_lag#
#13# #13# #13# Soft-tissues changes: #13#  #13# #13# Lid eodema
- #s_lid_eodema# - .......#13# Chemosis - #s_chemosis# - .......#13# Cornea
-#s_comea# - ........#13# Pupillary reactions -#s_pupill# - .......#13# #13# #13#
’ ASSOONAS (a_i_final_menu = 1) OR (a_i_final_menu = 2)
REPORT(110)’6 #13# Ophthalmoscopy #13# _________ _ # 1 3 # # 1 3 #
#s_disk_eodema# - ........#13# - #s_coroidal_fld# - ..........#13# #13# Intraocular
Pressure: #13# ___________________ #13# #13# Straight - #a_i_IOP_straight#
 #13# In up gaze - #a_i_IOP_up# -  #13# Delta I.O P -#n_IOP_dif#
 -.....#13# Exophalmometrty - #a_i_proptosis_now# - .....#13# #13# #13# #13#
Extra-ocular motility: #s_diplopia_on_examination# #13# #13# #13# Effect of the eye problem on the 
#13# patient’ ’s appearance: #s_cosmetic_appearance# #13# #13# ’
REPORT(108)’7 #13# #13# Results of the most recent investigations #13#
______________________ ________________ #13# #13# #13# #13# VISUSL FUNCTIONS: #13#
_______________ #13# #13# Field of vision: - #s_field_comment# - s_field #13# Colour vision
: -aJLhue -a_i_hue#13# (100-Hue score) #13# #13# #13# #13# ORBITAL IMAGING:
#13# ______________ #13# #13# Ultrasound: - #s_ultra_sound_comt# - ......... #13#
C.T.scan: - #s_CTscan_commenter# - .........#13# MPJ.scan: - #s_MRIscan_commentr#
 -........#13#’
REPORT(106)’ 8  #13# #13# Thyroid Biochemistry: #13# ___________________ #13# #13#
Serum T3: - #a_i_T3# #13# Serum T4: - #a_i_T4# #13# #13# T.S.H:
#a_i_TSH# #13# ’ ASSOONAS (a_i_final_menu = 1 ) OR (a_i_fmal_menu = 2)
TREATMENT MODULE AT OCTOBER 16 1988)
s_user_experience’ ’ ’Consultant Ophthalmologist’ IF (ANSWERED m_a_i_user_experience AND 
(m_a_i_user_experience = 1)) ELSE sl_user_experience
STRING sl_user_experience’ * ’Senior Registrar ’ IF (ANSWERED m_a_i_user_experience AND 
(m_a_i_user_experience = 2 )) ELSE s2_user_experience
STRING s2_user_experience* ’ ’Registrar * IF (ANSWERED m_a_i_user_experience AND 
(m_a_i_user_experience = 3 )) ELSE s3_user_experience
STRING s3_user_experience’ ’ ’Endocrinologist ’ IF (ANSWERED m_a_i_user_experience AND 
(m_a_i_user_experience = 4 )) ELSE s4_user_experience
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STRING s4_user_experience’ ’ ’GP ’ IF (ANSWERED m_a_i_user_experience AND 
(m_a_i_user_experience = 5 )) ELSE s5_user_experience
STRING s5_user_experience* ’ ’Student ’ IF (ANSWERED m_a_i_user_experience AND 
(m_a_i_user_experience = 6 ) )
) STRING s_lacrimination’ ’ ’#13# 
lacrimination ’ IF (ANSWERED a_c_lacrimination? AND a_c_lacrimination?) ELSE 9 9
STRING s_photophobia’ ’ ’#13# -photophobia ’ IF (ANSWERED a_c_photophobia?
AND a_c_photophobia?) ELSE ’ ’
STRING s_blurring’ ’ ’#13# - blurring ’ IF (ANSWERED a_c_visual_bliming? AND
a_c_visual_bluning?) ELSE ’ ’
STRING s_double_vision’ ’ ’#13# - double vision ’ IF (ANSWERED a_c_double_vision?
AND a_c_double_vision?) ELSE ’ ’
STRING s_pain* ” #13# -pain ’ IF (ANSWEREDa_c_pain? ANDa_c_pain?) ELSE 9 9
{I:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::} CONDITION c_more_than_2_symtoms’ ’
V OTES (2,a_c_lacrimination?,a_c_photophobia? ,a_c_visual_blurring?, 
a_c_double_vision?,a_c_pain?)
STRING s_Eye_lubricants? ’ ’ ’#13# - Eye lubricants’ IF (ANSWERED a_c_Eye_lubricants?
AND a_c_Eye_lubricants? ) ELSE ’ ’
{   - - )
STRING s_Tr_f_cr_ulcer? ’ ’ ’#13# - Treatment for ulcer’ IF (ANSWERED
a_c_Tr_for_comeal_ulcer? AND a_c_Tr_for_comeal_ulcer?) ELSE ’ ’
{ :   }
STRING s_Lid_lengthening? ’ ’ ’#13# - Lid lengthening operation’ IF (ANSWERED
a_c_Lid_lengthening? AND a_c_Lid_lengthening?) ELSE ’ ’
{..       -...}
STRING s_Tarsoraphy? ’ ’ ’#13# - Tarsoraphy’ IF (ANSWERED a_c_Tarsorhaphy? AND
a_c_Tarsorhaphy?) ELSE ’ ’
{       )
STRING s_Systemic_steroids? ’ ’ ’#13# - Systemic steroids’ IF (ANSWERED
a_c_Systemic_steroids? AND a_c_Systemic_steroids?) ELSE ’ ’
(   )
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STRING s_Radiotherapy? * ’ ’#13# - Radiotherapy’ IF (ANSWERED a_c_Radiotherapy?
AND a_c_Radiotherapy?) ELSE ’ ’
{   }
STRING s_decompression? ’ ’ ’#13# - decompression’ IF (ANSWERED a_c_decompression?
AND a_c_decompression? ) ELSE ’ ’
{............................}
STRING s_Prisms_occlussion? ’ * ’#13# - PrismsNocclussion’ IF (ANSWERED
a_c_Prisms_occlusion? AND a_c_Prisms_occlusion? ) ELSE ’ *
{     )
STRING s_Muscle_surgery? ’ ’ ’#13# - Muscle surgery’ IF (ANSWERED
a_c_Muscle_surgery? AND a_c_Muscle_surgery?) ELSE ’ ’
{I:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::} STRINGs_Eye_lub_effect? * ’ ’ (This proved to 
be successful)’ IF (ANSWERED a_i_Eye_lub_effect? AND (a_i_Eye_lub_effect? = 1)) ELSE 
s l_Eye_lub_effect?
STRING sl_Eye_lub_effect? ’ ’ ’ (This proved to be unsuccessful)’ IF (ANSWERED 
a_i_Eye_lub_effect? AND (aJLEye_lub_effect? = 2 )) ELSE s2_Eye_lub_effect?
STRING s2_Eye_lub_effect? ’ * ’ (This resulted in side effect)’ IF (ANSWERED a_i_Eye_lub_effect? 
AND (a_i_Eye_lub_effect? = 3 )) ELSE ’ ’ {........................................................   }
STRING s_Tr_c_ulcer_effect ’ ’ ’ (This proved to be successful)’ IF (ANSWERED
a_i_Tr_c_ulcer_effect? AND (a_i_Tr_c_ulcer_effect? = 1)) ELSE sl_Tr_c_ulcer_effect
STRING sl_Tr_c_ulcer_effect ’ ’ ’ (This proved to be unsuccessful)’ IF (ANSWERED 
a_i_Tr_c_ulcer_effect? AND (a_i_Tr_c_ulcer_effect? = 2)) ELSE s2_Tr_c_ulcer_effect
STRING s2_Tr_c_ulcer_effect ’ ’ ’ (This resulted in side effect)’ IF (ANSWERED
a_i_Tr_c_ulcer_effect? AND (a_i_Tr_c_ulcer_effect? = 3)) ELSE ’ ’
{..       )
STRING s_Lid_leng_effect * ’ ’ (This proved to be successful)’ IF (ANSWERED 
a_i_Lid_length_effect? AND (a_i_Lid_length_effect? = 1)) ELSE sl_Lid_leng_effect
STRING sl_Lid_leng_effect ’ ’ ’ (This proved to be unsuccessful)’ IF (ANSWERED 
a_i_Lid_length_effect? AND (a_i_Lid_length_effect? = 2)) ELSE s2_Lid_leng_effect
STRING s2_Lid_leng_effect ’ ’ ’ (This resulted in side effect)’ IF (ANSWERED 
a_i_Lid_length_effect? AND (a_i_Lid_length_effect? = 3)) ELSE ’ ’
{     }
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STRING s_Tarsor_effect ’ ’ ’ (This proved to be successful)’ IF (ANSWERED 
a_i_Tarsorhaphy_effect? AND (a_i_Tarsorhaphy_effect? = 1)) ELSE sl_Tarsor_effect
STRING sl_Tarsor_effect ’ ’ ’ (This proved to be unsuccessful)’ IF (ANSWERED 
a_i_Tarsorhaphy_effect? AND (a_i_Tarsorhaphy_effect? = 2)) ELSE s2_Tarsor_effect
STRING s2_Tarsor_effect ’ ’ ’ (This resulted in side effect)’ IF (ANSWERED 
a_i_Tarsorhaphy_effect? AND (a_i_Tarsorhaphy_effect? = 3)) ELSE ’ ’
{     )
STRING s_steroids_effect ’ ’ ’ (This proved to be successful)’ IF (ANSWERED
a_i_Sys_steroids_effect? AND (a_i_Sys_steroids_effect? = 1)) ELSE sl_steioids_effect
STRING sl_steroids_effect ’ ”  (This proved to be unsuccessful)’ IF (ANSWERED
a_i_Sys_steroids_effect? AND (a_i_Sys_steroids_effect? = 2)) ELSE s2_steroids_effect
STRING s2_steroids_effect ’ ’ ’ (This resulted in side effect)’ IF (ANSWERED
a_i_Sys_steroids_effect? AND (a_i_Sys_steroids_effect? = 3)) ELSE ’ ’
{     )
STRING s_Radiotherapy_effect ’ * ’ (This proved to be successful)’ IF (ANSWERED
a_i_Radiotherapy_effect? AND (a_i_Radiotherapy_effect? = 1)) ELSE sl_Radiotherapy_effect
STRING sl_Radiotherapy_effect ’ ’ ’ (This proved to be unsuccessful)’ IF (ANSWERED
a_i_Radiotherapy_effect? AND (a_i_Radiotherapy_effect? = 2)) ELSE s2_Radiotherapy_effect
STRING s2_Radiotherapy_effect ’ ’ ’ (This resulted in side effect)’ IF (ANSWERED
a_i_Radiotherapy_effect? AND (a_i_Radiotherapy_effect? = 3)) ELSE ’ ’
{     }
STRING s_decompression_effect ’ ’ ’ (This proved to be successful)’ IF (ANSWERED
a_i_decompression_effect? AND (a_i_decompression_effect? = 1)) ELSE sl_decompression_effect
STRING sl_decompression_effect ’ . ”  (This proved to be unsuccessful)’ IF (ANSWERED
a_i_decompression_effect? AND (a_i_decompression_effect? = 2)) ELSE s2_decompression_effect
STRING s2_decompression_effect ’ ’ ’ (This resulted in side effect)’ IF (ANSWERED
a_i_decompression_effect? AND (a_i_decompression_effect? = 3)) ELSE ’ ’
{   -      }
STRING s_Prisms_occl_effect ’ ’ ’ (This proved to be successful)’ IF (ANSWERED 
a_i_Prisms_occl_effect? AND (a_i_Prisms_occl_effect? = 1)) ELSE sl_Prisms_occl_effect
STRING sl_Prisms_occl_effect ’ ’ ’ (This proved to be unsuccessful)’ IF (ANSWERED 
a_i_Prisms_occl_effect? AND(a_i_Prisms_occl_effect? = 2))ELSEs2_Prisms_occl_effect
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STRING s2_Prisms_occl_effect ’ ’ ’ (This resulted in side effect)’ IF (ANSWERED 
a_i_Prisms_occl_effect? AND (a_i_Prisms_occl_effect? = 3)) ELSE ’ *
{............................ }
STRING s_Muscle_surg_effect ’ ’ ’ (This proved to be successful)’ IF (ANSWERED
a_i_Muscle_surg_effect? AND (a_i_Muscle_surg_effect? = 1)) ELSE sl_Muscle_surg_effect
STRING sl_Muscle_surg_effect ’ ’ ’ (This proved to be unsuccessful)’ IF (ANSWERED
a_i_Muscle_surg_effect? AND (a_i_Muscle_surg_effect? = 2)) ELSE s2_Muscle_surg_effect
STRING s2_Muscle_surg_effect ’ ’ * (This resulted in side effect)’ IF (ANSWERED
a_i_Muscle_surg_effect? AND (a_i_Muscle_surg_effect? = 3)) ELSE ’ *
{..       ..}
STRING s_thyroid_status ’ ’ ’Euthyroid’ IF (ANSWERED a_i_thyroid_status AND 
(a_i_thyroid_status = 2)) ELSE sl_thyroid_status
STRING sl_thyroid_status ’ ’ ’Hyperthroid’ IF (ANSWERED a_i_thyroid_status AND 
(a_i_thyroid_status = 3)) ELSE s2_thyroid_status
STRING s2_thyroid_status ’ ’ ’Hypothyroid’ IF (ANSWERED a_i_thyroid_status AND 
(a_i_thyroid_status = 1))
STRING s_Radioactive_iodine ’ ’ ’#13# - Radioactive iodine’ IF (ANSWERED
a_c_Radioactive_iodine? AND a_c_Radioactive_iodine?) ELSE ”
{.....................  ......}
STRING s_Thyroidectomy ’ ’ ’#13# - Thyroidectomy’ IF (ANSWERED
a_c_Thyroidectomy? AND a_c_Thyroidectomy?) ELSE ’ ’
{       }
STRING s_Carbimazol ’ ’ ’#13# - Carbimazol ’ IF (ANSWERED a_c_Carbimazol?
AND a_c_Carbimazol?) ELSE ’ ’
{I::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::} STRINGs_snellen_now’ ” 6/5 ’ IF
(ANSWERED a_i_snellen_now AND (a_i_snellen_now = 1)) ELSE sl_snellen_now
STRING sl_snellen_now ’ ’ ’6 /6  * IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
2 )) ELSE s2_snellen_now
STRING s2_snellen_now ’ * ’6/9 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
3 )) ELSE s3_snellen_now
STRING s3_snellen_now ’ ’ *6/12 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
4 )) ELSE s4_snellen_now
D2-62
STRING s4_snellen_now ’ ’ *6/18 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
5 )) ELSE s5_snellen_now
STRING s5_snellen_now ’ ’ *6/24 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
6 ) )  ELSE s6_snellen_now
STRING s6_snellen_now ’ ’ *6/36 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
7 )) ELSE s7_snellen_now
STRING s7_snellen_now ’ * ’6/60 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
8) )  ELSE s8_snellen_now
STRING s8_snellen_now ’ ’ *5/60 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
9 )) ELSE s9_snellen_now
STRING s9_snellen_now * ’ *4/60 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now =
10)) ELSE slO_snellen_now
STRING slO_snellen_now ’ ’ *3/60 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now
= 11)) ELSE sll_snellen_now
STRING sll_snellen_now * '* *2/60 * IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now
= 12) ) ELSE sl2_snellen_now
STRING sl2_snellen_now * * *1/60 ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now
= 13)) ELSE sl3_snellen_now
STRING sl3_snellen_now ’ ’ ’Coun. fingers’ IF (ANSWERED a_i_snellen_now AND
(a_i_snellen_now = 14)) ELSE sl4_snellen_now
STRING sl4_snellen_now ’ ’ *M.H. ’ IF (ANSWERED a_i_snellen_now AND
(a.Lsnellen^now = 15)) ELSE sl5_snellen_now
STRING sl5_snellen_now ’ ’ ’P.L. ’ IF (ANSWERED a_i_snellen_now AND (a_i_snellen_now
= 16)) ELSE sl6_snellen_now
STRING sl6_snellen_now * ’ ’N.P.L. ’ IF (ANSWERED a_i_snellen_now AND
(a_i_snellen_now = 17))
{I::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::} STRING sjidjretract ’ ’ ’-(1.5 - 2.0) ’ IF
(ANSWERED a_i_lid_retraction AND (a_i_lid_retraction = 1)) ELSE sl_lid_retract
STRING sl_lid_retract ’ ’ ’(0.00) ’ IF (ANSWERED a_i_lid_retraction AND (a_i_lid_retraction =
2)) ELSE s2_lid_retract
STRING s2_lid_retract ’ ’ ’(1.0 - 3.0) ’ IF (ANSWERED a_i_lid_retraction AND (a_i_lid_retraction =
3)) ELSE s3_lid_retract
STRING s3_lid_retract ’ ’ ’(4.0 - 6.0) ’ IF (ANSWERED a_i_lid retraction AND (a_i_lid_retraction =
4))
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STRING s jid ja g  ’ ’ ’YES ’ IF (ANSWERED a_cJidJag AND a_c_lid_lag) ELSE sl_lid_lag
STRING si JidJag ’ ” N 0 ’ IF (ANSWERED a_cJidJag AND NOT a_cJidJag)
STRING s_lid_eodema ’ ’ ’No eodema ’ IF (ANSWERED aJJid_eodema_now AND 
(aJJid_eodema_now = 1)) ELSE si Jid_eodema
STRING si Jid_eodema * ’ ’Mild ’ IF (ANSWERED aJJid_eodema_now AND
(aJJid_eodema_now = 2)) ELSE s2Jid_eodema
STRING s2Jid_eodema ’ ’ ’Moderate * IF (ANSWERED aJJid_eodema_now AND
(aJJid_eodema_now = 3)) ELSE s3Jid_eodema
STRING s3_lid_eodema ’ ’ ’Severe ’ IF (ANSWERED aJJid_eodema_now AND 
(aJJid_eodema_now = 4))
STRING s_chemosis ’ ’ ’No eodema ’ IF (ANSWERED aj_chemosis_now AND (aJ_chemosis_now
= 1)) ELSE sl_chemosis
STRING sl_chemosis ’ ’ ’Mild ’ IF (ANSWERED aJ_chemosis_now AND (aJ_chemosis_now =
2)) ELSE s2_chemosis
STRING s2_chemosis ’ ’ ’Moderate ’ IF (ANSWERED aJ_chemosis_now AND (aJ_chemosis_now
= 3)) ELSE s3_chemosis
STRING s3_chemosis ’ ’ ’Severe ’ IF (ANSWERED aJ_chemosis_now AND (aJ_chemosis_now =
4))
{I:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::}
STRING s_comea ’ ’ ’Clear ’ IF (ANSWERED aJ_comea_now AND (aJ_comea_now = 1)) ELSE
sl_comea
STRING sl_comea ’ ’ ’Stippl. ’ IF (ANSWERED aJ_comea_now AND (a_i_comea_now = 2)) ELSE
s2_comea
STRING s2_comea* ’ ’Ulcer ’ IF (ANSWERED aJ_comea_now AND (aJ_comea_now = 3))
ELSE s3_comea
STRING s3_comea ’ ’ ’Nec/Perf IF (ANSWERED aJ_comea_now AND (aJ_comea_now = 4))
ELSE s4_comea
STRING s4_comea * ’ ’Scarring’ IF (ANSWERED aJ_comea_now AND (a_i_comea_now = 5))
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STRING s_pupill ’ ’ ’Normal ’ IF (ANSWERED aJLpupiUnow AND (a_i_pupiU_now = 1)) ELSE
sl_pupill
STRING sl_pupill * ’ ’Afferent’ IF (ANSWERED a_i_pupill_now AND (a_i_pupill_now = 2))
{I:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::}
STRING s_disk_eodema ’ ’ ’No eodema ’ IF (ANSWERED a_i_disk_eodema AND
(a_i_disk_eodema = 1)) ELSE sl_disk_eodema
STRING sl_disk_eodema ’ ’ ’Suspected * IF (ANSWERED a_i_disk_eodema AND
(a_i_disk_eodema = 2)) ELSE s2_disk_eodema
STRING s2_disk_eodema ’ ’ ’Definite ’ IF (ANSWERED a_i_disk_eodema AND
(a_i_disk_eodema = 3)) ELSE s3_chemosis
STRING s_coroidal_fld ’ ’ ’Normal ’ IF (ANSWERED a_c_coroidal_folds AND
a_c_coroidal_folds) ELSE sl_coroidal_fld
STRING sl_coroidal_fld ’ ’ ’Afferent ’ IF (ANSWERED a_c_coroidal_folds AND NOT
a_c_coroidal_folds)
I::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::}
STRING s_diplopia_on_examination ’ ’ ’Absent ’ IF(ANSWERED
a_i_diplopia_on_examination_now AND (a_i_diplopia_on_examination_now =
1)) ELSE sl_diplopia_on_examination
STRING sl_diplopia_on_examination ’ ’ ’On elevation/depression ’ IF (ANSWERED
aJ_diplopia_on_examination_now AND (a_i_diplopia_on_examination_now =
2)) ELSE s2_diplopia_on_examination
STRING s2_diplopia_on_examination ’ ’ ’On adduction/abduction ’ IF (ANSWERED
a_i_diplopia_on_examination_now AND (a_i_diplopia_on_examination_now =
3)) ELSE s3_diplopia_on_examination
STRING s3_diplopia_on_examination * ’ ’Close to mid line ’ IF (ANSWERED
a_i_diplopia_on_examination_now AND (a_i_diplopia_on_examination_now =
4)) ELSE s4_diplopia_on_examination
STRING s4_diplopia_on_examination ’ ’ ’In extreme gaze ’ IF (ANSWERED
a_i_diplopia_on_examination_now AND (a_i_diplopia_on_examination_now =
5))
(I:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::} STRING s_cosmetic_appearance ’ ’ 
’s_cosmetic_appearance’ IF ANSWERED a_i_patient_appearance
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STRING s_field_comment * * ’Normal * IF (ANSWERED a_i_field_now AND (a_i_field__now =
1)) ELSE sl_field
STRING sl_field ’ ’ ’Prob. normal ’ IF (ANSWERED a_i_field_now AND (a_i_field_now = 2))
ELSE s2_field
STRING s2Jield ’ ’ ’Suggestive ’ IF (ANSWERED aJLfield_now AND (aJ_field_now = 3)) 
ELSE s3_field
STRING s3_field ’ ’ ’Typical ’ IF (ANSWERED a_i_field_now AND (a_i_field_now = 4)) ELSE
’No data
STRING s_ultra_sound_comt ’ ’ ’No data ’ IF (ANSWERED a_i_ultra_sound AND
(a_i_ultra_sound = 0)) ELSE sl_ultra_sound
STRING sl_ultra_sound ’ ’ ’Normal thickened ’ IF (ANSWERED a_i_ultra_sound AND
(a_i_ultra_sound = 1)) ELSE s2_ultra_sound
STRING s2_ultra_sound ’ ’ ’Moderate thickened’ IF (ANSWERED a_i_ultra_sound AND
(a_i_ultra_sound = 2)) ELSE s3_ultra_sound
STRING s3_ultra_sound ’ * ’Markedly thickened’ IF (ANSWERED a_i_ultra_sound AND
(a_i_ultra_sound = 3)) ELSE s4_ultra_sound
STRING s4_ultra_sound ’ ’ ’Swollen ’ IF (ANSWERED a_i_ultra_sound AND (a_i_ultra_sound
= 4)) ELSE’No data
{I:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::}
STRING s_CTscan_commenter ’ ’ ’No data ’ IF (ANSWERED a_i_CTscan AND (a_i_CTscan
= 0)) ELSE sl_CTscan
STRING sl.CTscan ’ ’ ’Normal ’ IF (ANSWERED a_i_CTscan AND (a_i_CTscan = 1)) ELSE
s2_CTscan
STRING s2_CTscan ’ ’ ’Moderate thickened’ IF (ANSWERED a_i_CTscan AND (a_i_CTscan = 2))
ELSE s3_CTscan
STRING s3_CTscan ’ * ’Markedly thickened’ IF (ANSWERED a_i_CTscan AND (a_i_CTscan = 3))
ELSE s4_CTscan
STRING s4_CTscan ’ ’ ’Swollen ’ IF (ANSWERED aJ_CTscan AND (a_i_CTscan = 4)) ELSE
’No data
STRING s_MRIscan_commentr ’ * ’No data ’ IF (ANSWERED a_i_MRIscan AND
(a_i_MRIscan =1)) ELSE sl_MRIscan
D2-66
STRING sl_MRIscan ’ ’ ’Normal ’ IF (ANSWERED a_i_MRIscan AND (a_i_MRIscan = 2))
ELSE s2_MRIscan
STRING s2_MRIscan ’ ’ ’Moderate thickened’ IF (ANSWERED a_i_MRIscan AND (a_i_MRIscan =
3)) ELSE s3_MRIscan
STRING s3_MRIscan ’ ’ ’Markedly thickened’ IF (ANSWERED a_i_MRIscan AND (a_i_MRIscan =
4)) ELSE s4_MRIscan
STRING s4_MRIscan ’ ’ ’Swollen * IF (ANSWERED a_i_MRIscan AND (a_i_MRIscan = 5))
ELSE’No data ’
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Appendix D4 - Validation results print out
n z u i
No Name 
Variable(s)
29 f a p patient appearance 
0.5000
197 p diplopia symptom now 
0.0313
19B p diplopia symptom change 
0.0455
199 p diplopia on examination now 
0.0455
202 p proptosis now 
0.0455
203 p proptosis change 
0.0000
204 p snellen now 
0.0000
205 p snellen change 
0.0000
206 p lid 1ag 
0.0000
207 p lid retraction 
0.0313
20B p lid eodema now 
0.02B6
209 p lid eodema change 
0.0455
210 p chemosis now 
0.02B6
211 p chemosis change 
0.0455
212 p cornea now 
0.023B
213 p cornea change 
0.0455
217 p disk eodima 
0.2060 
223 p test mal nerve 
0.2000 
230 p test mal muscles 
0.1000 
247 p sug mal nerve 
0.2060 
252 p sug mal muscles 
0.1000
259 p mal nerve 
0.2060
260 p visual acuity drop 
0.2000
261 p field of vision 
0.2000
262 p 100 hue test 
0.2000
263 pi disk eodima 
0.0455
265 pi visual acuity drop 
0.0500
266 p snellen acuity drop 
0.0500
26B pi snellen change 
0.0000 
270 p vision dummy 
0.B000
Condition Value
Ans True Ans 0.5000 0.5000
Ans True Not Ans 0.1000 0.96BB
Not Ans Unknown Not Ans 0. 1000 0.9545
Ans True Not Ans 0. 1000 1.0000
Ans True Not Ans 0.1000 0.9545
Not Ans Unknown Not Ans 0.1000 0.9901
Ans True Not Ans 0.0500 0.9924
Not Ans Unknown Not Ans 0.0500 0.9B04
Ans True Not Ans 0.1000 1.0000
Ans True Not Ans 0.1000 0.9688
Ans True Not Ans 0. 1000 0.8857
Not Ans Unknown Not Ans 0. 1000 0.9545
Ans True Not Ans 0. 1000 0.8857
Not Ans Unknown Not Ans 0. 1000 0.9545
Ans True Not Ans 0. 1000 0.9762
Not Ans Unknown Not Ans 0.1000 0.9545
Not Ans Unknown Not AnSj 0.2000 0.8730
Ans True Ans 0. 2000 0 .2000
Ans true Ans 0.1000 0 .1 000
Ans True Not Ans 0.2000 0.9183
Ans True Not Ans 0.1000 0.9656
Ans True Not Ans 0.2000 0.9183
Not Ans Unknown Not Ans 0.2000 0.9183
Not Ans Fal se Ans 0.2000 0 .2000
Not Ans Fal se Ans 0.2000 0 .2 000
Ans True Not Ans 0.0350 0.9545
Ans True Not Ans 0.0500 0.999B
Ans True Not Ans 0.0500 0.9998
Ans True Not Ans 0.0500 0.9S04
Ans True Ans O.BOOO 0.B000
271 p -field now 
0.0313
272 P -field change 
0.0000
273 pi -field change 
0.0000
275 p 100 hue now 
0.0000
276 P 100 hue change 
0.0000
277 pi 100 hue change 
0.0000
280 p mal muscles 
0.1000 
2B1 p diplopia 
0.1000
282 p proptosis 
0.1000
283 p Hess chart 
0.1000
284 p ultra sound 
0.1000
285 p CTscan 
0.1000
286 p MRIscan 
0.1000
287 p diplopia symptom 
0.1000
288 p diplopia on examination 
0 .1000
290 pi diplopia symptom change 
0.0455
292 p diplopia on examination.change 
0.0455
295 pi diplopia on examination change 
0.0455 
299 pi proptosis change 
0.0000
301 p Hess chart now 
0.0122
302 p Hess chart change 
0.0455
303 p hess dummy 
0.9000
304 pi Hess chart change 
0.0455
306 p mal lid 
0.0217
307 p uncoverage 
0.0000
310 p mal cornea 
0.1000
311 p cornea 
0.1000
313 pi cornea change 
0.0455
316 p lid eodema 
0 .1000
317 p chemosis 
0.1000
319 pi lid eodema change 
0.0455 
322 pi chemosis change 
0.0455
Ans True Not Ans 0. 02(1)0 0.9688
Not Ans Unknown Not Ans 0.0200 0.9688
Ans True Not Ans 0.0200 0.9688
Ans True Not Ans 0.1000 1.0000
Not Ans Unknown Not Ans 0.1000 1.0000
Ans True Not Ans 0.1000 1.0000
Ans True Not Ans 0.1000 0.9656
Ans True Not Ans 0.1000 0.9656
Ans True Not Ans 0.1000 0.9648
Not Ans Fal se Ans 0.1000 0 .1000
Not Ans Fal se Ans 0.1000 0.1000
Not Ans False Ans 0.1000 0.1000
Not Ans Fal se Ans 0.1000 0.1000
Ans True Not Ans 0.1000 0.9628
Ans True Not Ans 0.1000 0.9656
Ans True Not Ans 0 .1O00 0.9545
Not Ans Unknown Not Ans 0.1000 0.9545
Ans True Not Ans 0 .1000 0.9545
Ans True Not Ans 0.1000 0.9901
Ans True Not Ans 0.10O0 0.9878
Not Ans Unknown Not Ans 0.1000 0.9545
Ans True Ans 0.9000 0.9000
Ans True Not Ans 0 . 1000 0.9545
Ans True Not Ans 0.1000 0.5064
Ans True Not Ans 0 .1000 0.9688
Ans True Not Ans 0.1000 0.9961
An 5 True Not Ans 0.1000 0.9961
Ans True Not Ans 0 .1000 0.9545
Ans True Not Ans 0 .1000 0.9545
Ans True Not Ans 0. 1000 0.9545
Ans True Not Ans 0. 1000 0.9545
Ans True Not Ans 0.1000 0.9545
19 -f a- i thyroid status Ans True Ans Unknown
28 f a i patient most troublesome Ans True Ans Unknown
30 -F a i eye disease duration Ans True Ans Unknown
40 -f a i disk eodema Ans True Ans Unknown
42 f a i snellen now Ans True Ans Unknown
43 f a i -field now Ans True Ans Unknown
44 f a i 100 hue now Ans True Ans Unknown
46 -F a i diplopia symptom now Ans True Ans Unknown
47 -F a i diplopia on examination now Ans True Ans Unknown
48 -f a i proptosis opinion Ans True Ans Unknown
49 f a i proptosis now Ans True Ans Unknown
50 f a i Hess chart now Ans True Ans Unknown
51 -f a i ultra sound Ans True Ans Unknown
53 -F a i lid retraction Ans True Ans Unknown
54 F a i cornea now Ans True Ans Unknown
55 f a i lid eodema now Ans True Ans Unknown
56 -f a i chemosis now Ans True Ans Unknown
57 f n I0P di-f Ans True Ans Unknown
58 i fn i nerve condition Ans True Ans Unknown
59 -f m i muscles condition Ans True Ans Unknown
60 -f m i cornea condition Ans True Ans Unknown
61 f m i lid condition Ans True Ans Unknown
62 m i nerve condition Ans True Ans Unknown
63 m i muscles condition Ans True Ans Unknown
64 m i cornea condition Ans True Ans Unknown
65 m i lid condition Ans True Ans Unknown
74 F m i action Ans True Ans Unknown
75 m i acti on Ans True Ans Unknown
192 m a i user experience Ans True Ans Unknown
193 f a i user experience Ans True An 5 Unknown
214 n I OP di-f Ans True Not Ans 40.00
40. 00
219 i stop cont? Not Ans Fal se Ans 2 .0 0
2. 00
335 nnnn Ans Unknown Ans Unknown
336 n sug mal nerve Ans True Not Ans 0.92
0.21
337 n test mal nerve Ans True Ans 0 .2 0
0 .20
338 i validate nerve answers Not Ans Fal se Ans 4.00
4. 00
345 cccc Ans Unknown Ans Unknown
347 cccc converted Not Ans Unknown Not Ans 4 . 00
1.00
348 cccc converted a Not Ans Unknown Not Ans 3. 00
1.00
349 cccc converted b Not Ans Unknown Not Ans 2 .0 0
1.00
350 cccc converted c Not Ans Unknown Not Ans 1. 00
1.00
nnnn converted Not Ans Unknown Not Ans 4 .00
1.00
353 nnnn converted a Not Ans Unknown Not Ans 3. 00
1.00
354 nnnn converted b Not Ans Unknown Not Ans 2 .0 0
1.00
355 nnnn converted c Not Ans Unknown Not Ans 1.00
1.00
356 1111 Ans Unknown Ans Unknown
358 1111 converted Not Ans Fal se Not Ans 3.00
1.00
359 1111 converted a Not Ans Unknown Not Ans 3.00
1.00
360 1111 converted b Not Ans Unknown Not Ans 2 .0 0
1.00





365 mmmm converted a
1.00
366 mmmm converted b
1.00





371 prop converted a
1.00
372 prop converted b
1.00
377 i choose action 1
378 i choose action 2
379 i choose action 3
380 i choose action 4
381 i choose action 5
382 i choose action 6
383 i choose action 7
384 i choose action 8
632 n sug mal muscles 
0. 10
633 n test mal muscles 
0. 10
634 i validate muscles answers 
4.00
10 ■f a c Diabetic?
11 ■f a c Hypertensi ve?
12 •f a c Renal?
13 •f a c Pulmonari c?
14 •f a c GI?
15 f a c peptic ulceration
16 -f a c history anti steroids
17 ■f a c contra anasthesia?
18 ■f a c Hart disease
20 ■f a c Radioactive iodine?
21 •f a c Thyroi dectomy?
22 •f a c Carbimazol?
23 -f a c 1acrimi nati on?
24 f a c photophobi a?
25 ■f a c visual blurring?
26 ■F a c double vision?
->'7 ■F a c pain?
31 f a c Eye lubricants?
•f a c Tr -for corneal ulcer?
33 ■F a c Lid lengthening?
34 •f a c Tarsorhaphy?
35 •f. a c Systemic steroids?
36 •f a c Radiotherapy?
37 f a c decompressi on?
38 •f a c Pri sms occlusion?
39 -f a c Muscle surgery?
41 •f a c coroidal -folds
45 ■f a c color blind
52 -f a c lid 1ag
66 ■f m c ■field o-f vision
67 •f m c 100 hue test
68 ■f m c Hess chart
Not Ans Unknown Not Ans 1.00
Ans Unknown Ans Unknown
Not Ans Unknown Not Ans 4.00
Not Ans Unknown Not Ans 3.00
Not Ans Unknown Not Ans 2.00
Not Ans Unknown Not Ans 1.00
Ans Unknown Ans Unknown
Not Ans Unknown Not Ans 3.00
Not Ans Unknown Not Ans 2.00
Not Ans Unknown Not Ans 1.00
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans True Not Ans 0.97
Ans True Ans 0 .
Ans Fal se Ans 4.
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Un known
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
69 -f m c ultra sound Ans True Ans Unknown
70 m c field of vision Ans True Ans Unknown
71 m c 100 hue test Ans True Ans Unknown
72 m c Hess chart Ans True Ans Unknown
73 m c ultra sound Ans True Ans Unknown
76 f m c eye lubricants Ans True Ans Unknown
77 f m c systemic steroids Ans True Ans Unknown
78 f m c raise head w dioretics Ans True Ans Unknown
79 f m c raise head w no dioretics Ans True Ans Unknown
80 f m c occlusion or prism Ans True Ans Unknown
81 f m c Radiotherapy Ans True Ans Unknown
82 f m c anti glaucoma medications Ans True Ans Unknown
83 m c eye lubricants Ans True Ans Unknown
84 m c systemic steroids Ans True Ans Unknown
85 m c raise head w dioretics Ans True Ans Unknown
86 m c raise head w no dioretics Ans True Ans Unknown
87 m c occlusion or prism Ans True Ans Unknown
88 m c Radi otherapy Ans True Ans Unknown
89 m c anti glaucoma medications Ans True Ans Unknown
90 f m c tarsoraphy Ans True Ans Unknown
91 f m c lid lenghthen Ans True Ans Unknown
92 f m c decompressi on Ans True Ans Unknown
93 f m c muscles surgery Ans True Ans Unknown
94 m c tarsoraphy Ans True Ans Unknown
95 m c lid lenghthen Ans True Ans Unknown
96 m c decompressi on Ans True Ans Unknown
97 m c muscles surgery Ans True Ans Unknown
99 please load Ans True Ans Unknown
178 1 ast. visit report Ans True Ans Unknown
179 please get Ans True Ans Unknown
ISO please obtain Ans True Ans Unknown
1B1 a begin Ans True Ans Unknown
182 b begin Ans True Ans Unknown
183 c begi n Ans True Ans Unknown
184 clinical -Finished Ans True Ans Unknown
185 firs;t report Ans True Ans Unknown
186 validate finished Ans True Ans Unknown
187 please save Ans True Ans Unknown
188 please sheel Ans True An 5 Unknown
189 pi ease store Ans True Ans Unknown
195 2 begin Ans True Ans Unknown
216 C coroidal folds Ans True Not Ans Unknown
220 C nerve invest? Nat Ans Fal se Ans Fal se
221 C field of vision? Ans Fal se Ans False
222 C 100 hue? Ans Fal se Ans Fal se
225 C muscles invest? Not Ans Fal se Ans False
226 C Hess chart? Not Ans False Ans Fal se
227 C ultra sound? Not Ans Fal se Ans False
228 c CTscan? Not Ans Fal se Ans Fal se
229 c MRI scan? Not Ans Fal se Ans Fal se
250 c nerve sug test dif Ans True Not Ans Unknown
257 c muscles sug test dif Ans True Not Ans Unknown
294 c si:>: month stable diplopia Not Ans Unknown Not Ans Unknown
327 c show final menu Ans True Not Ans Unknown
375 c announce action Ans True Ans Unknown
376 c start treatment Ans Unknown Ans Unknown
396 c .no ulcer Ans Unknown Ans Unknown
398 c tr ulcer Ans True Ans Unknown
400 c tr ulcer lubrication Ans True Ans Unknown
402 c tr ulc nerv w steroids Ans True Not Ans Unknown
403 anti steroi ds Ans True Not Ans Unknown
405 c tr ulc nerv w radiotherapy Ans True Not Ans Unknown
406 anti radio Ans True Not Ans Unknown
408 c tr ulc nerv critical
414 anti surgery
417 c TEDEX choice
419 cl TEDEX choice
421 c2 TEDEX choice
438 c tr nerve w steroids
440 c tr nerve w decompression
442 c tr nerve w radiotherapy
443 c start treating lid
444 c do not decompress 
461 c tr lid drcompress 
463 c tr lid lengthening 
465 c tr tarsoraphy
467 c postpone lid tr
469 c tr cornea lid lubrication
471 c start treating muscles
472 c stable
474 c muscles troubles
475 c any other troubles
476 c coping
478 c postpone muscles surgery
479 c do not decomp muscles 
481 c do deco first muscles 
483 c do muscles surgery
485 c do muscles surgery w care
488 c prism or occlussion
490 c do nothing for muscles
542 c more than 2 symtoms
606 c anti steroids
616 c anti surgery
620 c anti radio
7 f a s patient name
8 f a s patient DOB
9 f a s patient se::
190 f a  s who are you
191 m a s who are you
343 s already said




412 s anti steroids
413 s anti surgery
415 s anti radio
416 s TEDEX choice 
418 si TEDEX choice 
420 s2 TEDEX choice
422 s choose steroids 
.for steroi. . .
423 s choose decompression 
.for decomp•..
424 s choose radiotherapy 
-for radiot...
429 s contra indications
430 si contra indications
431 s2 contra indications
433 5 critical choice
434 si critical choice
445 s lid condition
446 si lid condition
447 s lid A TEDEX choice
Ans True Not Ans. Unknown
Ans True Not Ans Unknown
Not Ans Unknown Not Ans, Unknown
Not Ans Unknown Not Ans Unknown
Not Ans Unknown Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not An s Unknown
Ans True Not Ans Unknown
Ans True Ans Unknown
Ans True Not Ans Unknown
Ans True Ans False
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Ans Fal se
Ans True Ans Fal se
Ans True Ans Fal se
Ans True Ans False
Ans True Ans Fal se
Ans True Ans False
Ans True Not Ans Unknown
Ans True Not Ans Unknown
Ans True Mot Ans Unknown
Ans True Not Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans True Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Not Ans Fal se Ans
Not Ans Fal se Ans
Not Ans Fell se Ans
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans False Ans Unknown
Not Ans Fal se Ans Enter 1 s
Not Ans Fal se Ans Enter 2 d
Not Ans Fal se Ans Enter 3 r
Nbt Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Unknown Not Ans Unknown
Not Ans Unknown Not Ans Unknown
Ans Unknown Ans Unknown
Ans Unknown Ans Unknown
Not Ans True Ans Surgi cal
pressi an
448 sl lid A TEDEX choice Not Ans Unknown Not Ans Unknown
449 s2 lid A TEDEX choice Not Ans Unknown Not Ans Unknown
450 s lid choose decomp Not Ans Fal se Ans Enter 3
or decompre...
456 s lid B TEDEX choice Ans Unknown Ans Unknown
457 sl lid B TEDEX choice Ans Unknown Ans Unknown
496 s user experience Ans Unknown Ans Unknown
497 s 1acri mi nati on Not Ans False Ans
498 s photophobia Not Ans Fal se Ans
499 s blurring Not Ans Fal se Ans
500 s double visi on Not Ans False Ans
501 c pain Not Ans Fal se Ans
503 s Eye lubricants? Not Ans Fal se Ans
504 s Tr f cr ulcer? Not Ans Fal se Ans
505 5 Lid lengthening? Not Ans Fal se Ans
506 S Tarsoraphy? Not Ans False Ans
507 S Systemic steroids? Not Ans Fal se Ans
508 £ steroids effect Not Ans Fal se Ans
509 s Radi otherapy? Not Ans Fal se Ans
510 E Radiotherapy effect Not Ans Fal se Ans
511 S decompression? Not Ans Fal se Ans
512 5 decompression effect Not An5 Fal se Ans
513 5 Prisms occlussion? Not Ans Fal se Ans
514 Muscle surgery? Not Ans Fal se Ans
515 S thyroid status Not Ans Fal se Ans Unknown
516 s Radioactive iodine Not Ans Fal se Ans
517 s Thyroidectomy Not Ans Fal se Ans
518 s Carbi mazol Not Ans False Ans
519 s T3 Not Ans Fal se Ans
520 s T4 Not Ans Fal se Ans
521 s snellen now Not Ans Fal se Ans Unknown
522 s lid retract Not Ans Fal se Ans Unknown
523 s lid 1ag Not Ans Fal se Ans Unknown
524 s lid eodema Not Ans Fal se Ans Unknown
525 s chemosis Not Ans Fal se Ans Unknown
526 ■ s cornea Not Ans Fal se Ans Unknown
527 s pupill Not Ans Fal se Ans Unknown
529 s disk eodema Not Ans Fal se Ans Unknown
530 s coroidal fid Not Ans Fal se Ans Unknown
531 s diplopia on examination Not Ans Fal se Ans Unknown
532 s cosmetic appearance Not Ans False Ans Unknown
jjj s field Not Ans * False Ans No data
534 s ultra sound Not Ans Fal se Ans No data
535 s CTscan Not Ans False Ans No data
536 5 MRIscan Not Ans False Ans No data
537 sl user experience Ans Unknown Ans Unknown
538 s2 user experience Ans Unknown Ans Unknown
539 s3 user experience Ans Unknown Ans Unknown
540 s4 user experience Ans Unknown Ans Unknown
541 s5 user experience Ans Unknown Ans Unknown
543 sl steroids effect Not Ans False Ans
544 s2 steroids effect Not Ans False Ans
545 sl Radiotherapy effect Not Ans Fal se Ans
546 Radiotherapy effect Not Ans False Ans
547 si decompression effect Not Ans False Ans
548 s2 decompression effect Not Ans False Ans
549 sl thyroid status Not Ans Fal se Ans Unknown
550 s2 thyroid status Not Ans False Ans Unknown
551 sl snellen now Not Ans Fal se Ans Unknown
552 s2 snellen now Not Ans Fal se Ans Unknown
553 s3 snellen now Not Ans Fal se Ans Unknown
554 s4 snellen now Not Ans Fal se Ans Unknown
s5 snellen now Not Ans Fal se Ans Unknown
557 s7 snellen now 
55S sB snellen now
559 s9 snellen now
560 slO snellen now
561 sll snellen now
562 sl2 snellen now
563 sl3 snellen now
564 sl4 snellen now
565 sl5 snellen now
566 sl6 snellen now
567 sl lid retract
568 s2 lid retract
569 s3 lid retract
570 sl lid lag
571 sl lid eodema
572 s2 lid eodema









582 sl disk eodema
583 s2 disk eodema
584 sl coroidal fid
585 sl diplopia on examination Not Ans Fal se Ans Unknown
586 s2 diplopia on examination Not Ans Fal se Ans Unknown
587 So diplopia on examination Not Ans Fal se Ans Unknown
588 s4 diplopia on examination Not An5 Fal se Ans Unknown
589 sl field Not Ans Fal se Ans No data
590 s2 field Not Ans Fal se Ans No data
591 s3 field Not Ans Fal se Ans No data
592 sl ultra sound Not Ans Fal se Ans No data
593 s2 ultra sound Not Ans Fal se Ans No data
594 s3 ultra sound Not Ans Fal se Ans No data
595 s4 ultra sound Not Ans Fal se Ans No data
596 sl CTscan Not Ans Fed se Ans No data
597 s2 CTscan Not Ans Fal se Ans No data
598 s3 CTscan Not Ans Fal se Ans No data
599 s4 CTscan Not Ans Fal se Ans No data
600 sl MRIscan Not Ans Fal se Ans No data
601 s2 MRIscan Not Ans Fal se Ans No data
602 5 3 MRIscan Not Ans Fal se Ans No data
603 s4 MRIscan Not Ans Fal se Ans No data
609 s Diabetic Not Ans Fal se Ans
610 s Hyper tensive Not Ans Fal se Ans
611 s female over45 Not Ans Fal se Ans
612 s steroids side effect Not Ans Fal se Ans
613 s peptic ulceration Not Ans Fal se Ans
Juesti on is)
141 a p patient appearance Ans True Not Ans 0.0100 1
). 0000
115 a i novice user intro Ans True Not Ans 6 .0
0 .00
126 a i user experience Ans True Not Ans 7.6'
1.00
131 a i patient age Ans True Not Ans 90. O'
1.00
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans False Ans Unknown
Not Ans False Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans False Ans Unknown
Not Ans False Ans Unknown
Not Ans False Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans Fal se Ans Unknown
Not Ans False Ans Unknown
Not Ans Fal se Ans Unknown




i patient most troublesome Ans True Not Ans 4 . 00
135 a 
1. 00
i eye disease duration Ans True Not Ans 120.00
136 a 
1.00
i thyroid status Ans True Not Ans 3. 00
137 a 
1.00
i thyroid disease duration Ans True Not Ans 300.00
15S a 
1. 00
i T3 Ans True Not Ans 50.00
159 a 
1.00
i T4 An 5 True Not Ans 50. 00
160 a 
1.00
i TSH Ans True Not Ans 50. 00
166 a
0.00
1 Sys steroids e-f-fect? Not Ans Unknown Not Ans 3. 00
168 a 
0.00
i Radiotherapy e-f-fect? Not Ans Unknown Not Ans 3. 00
170 a 
0.00
i decompression e-f-fect? Not Ans Unknown Not Ans 3. 00
173 a 
1.00
i main menu Ans True Not Ans 4 .  00
174 a 
1.00
i teaching menu Ans True Not Ans 4 . 00
201 a 
12.00
i proptosis now Ans True Not Ans 40.00
215 a 
1.00
i pupill now Ans True Not Ans 2 . 00
232 a 
1.00
i ■final menu Ans True Not Ans 4.00
©
1.00
i disk eodema Ans True Not Ans 3.00
236 a 
1.00
i stop cont? Ans True Not Ans 2 .0 0
248 a 
1.00
i ■field now Ans True Not Ans 4. 00
249 a 
0.00
i 100 hue now Ans True Not Ans 500.00
251 a 
1.00
i validate nerve answers Ans True Not Ans 4 . 00
253 a 
1.00
i Hess chart now Ans True Not Ans 9. 00
254 a 
0. 00
i ultra sound Ans True Not Ans 4.00
*Lm wJ wj Cl 
0.00
i CTscan Ans True Not Ans 4. 00
256 a
0. 00
i MRIscan Ans True Not Ans 4. 00
258 a 
1.00
i validate muscles answers Ans True Not Ans 4 .00
267 a 
1.00
i snellen now Ans True Not Ans 17.00
269 a 
0. 00
i snellen change Ans True Not Ans 5.00
274 a 
1.00
i -field change Ans True Not Ans 5. 00
278 a 
0.00
i 100 hue change Ans True Not Ans 500.00
289 a 
1.00
i diplopia symptom now Ans True Not Ans 4. 00
291 a 
1.00
i diplopia symptom change Ans True Not Ans 3. 00
293 a i diplopia on examination now Ans True Not Ans 5. 00
1.00
296 a i 
1.00
diplopia on examination change Ans True Mot Ans 3. 00
298 a i 
1.00
proptosis opinion Ans True Not Ans 3. 00
300 a i 
0 .00
proptosis change Ans True Not Ans 10. 00
305 a i 
1. 00
Hess chart change Ans True Not Ans 3. 00
309 a i 
1.00
lid retraction Ans True Not Ans 4. 00
312 a i 
1. 00
cornea now Ans True Not Ans 5. 00
314 a i 
1.00
cornea change Ans True Not Ans 3. 00
318 a i 
1.00
lid eodema now Ans True Not Ans 4.00
320 a i 
1.00
lid eodema change Ans True Not Ans 3.00
321 a i 
1.00
chemosis now Ans True Not Ans 4.00
323 S i 
1.00
chemosi s change Ans True Not Ans 3.00
324 a 1 
10.00
I0P straight Ans True Not Ans 50. 00
325 a i 
10.00
I OP up Ans True Not Ans 50. 00
346 ccc 
1.00
Ans True Not Ans 4 .00
351 nnn 
1.00
"-> Ans True Not An 5 4.00
357 111 
1.00
r> Ans True Not Ans 4.00
363 mmm 
1.00
Ans True Not Ans 4.00
369 pro 
1.00
7 Ans True Not Ans 3.00
425 a i 
1*00
treat nerve Ans True Not Ans 3.00
435 a i 
1.00
critical choice Ans True Not Ans 3.00
451 a i 
1.00
lid tars leng deco Ans True Not Ans 3.00
453 a i 
1.00
lid tarso length Ans True Not Ans 2 .0 0
114 a c tedex user Ans True Not Ans Unknown
142 a c lacrimination? Ans True Not Ans Unknown
143 a c photophobi a? Ans True Not Ans Unknown
144 a c visual blurring? Ans True Not Ans Unknown
145 a c double vision? Ans True Not Ans Unknown
146 a c pai n? Ans True Not Ans Unknown
147 a c Diabeti c? Ans True Not. Ans Unknown
148 a c Hypertensi ve? Ans True Not Ans Unknown
149 a c Renal? Ans True Not Ans Unknown
150 a . c Pulmonaric? Ans True Not Ans Unknown
151 a c GI? Ans True Not Ans Unknown
152 a c Radioactive iodine? Ans True Not Ans Unknown
153 a c Thyroi dectomy? Ans True Not Ans Unknown
154 a c Carbi mazol? Ans True Not Ans Unknown
155 a c T3? Ans True Not Ans Unknown
156 a c T4? Ans True Not Ans Unknown
161 a c Eye lubricants? Ans True Not Ans Unknown
162 a c Tr for corneal ulcer? Ans True Not Ans Unknown
163 a c Lid lengthening? Ans True Not Ans Unknown
164 a c Tarsorhaphy? Ans True Not Ans Unknown
165 a c Systemic steroids? Ans True Not Ans Unknown
167 a c Radi otherapy? Ans True Not Ans Unknown
169 a c decompression? Ans True Not Ans Unknown
171 a c Prisms occlusion? Ans True Not Ans Unknown
172 a c Muscle surgery? Ans True Not Ans Unknown
177 a c Hart disease Ans True Not Ans Unknown
218 a c any invest? Ans True Not Ans Unknown
237 a c nerve invest? Ans True Not Ans Unknown
238 a c •field o-f vision? Ans True Not Ans Unknown
239 a c 100 hue? Ans True Not Ans Un known
240 a c muscles invest? Ans True Not Ans Unknown
241 a c Hess chart? Ans True Not Ans Unknown
242 a c ultra sound? An 5 True Not Ans Unknown
243 a c CTscan? Ans True Not Ans Unknown
244 a c MRIscan? Ans True. Not Ans Unknown
264 a c coroidal folds Ans True Not Ans Unknown
279 a c col or bli nd Ans True Not Ans Unknown
297 a c si>: month stable diplopia Ans True Not Ans Unknown
308 a c 1 id 1ag Ans True Mot Ans Unknown
428 a c your choice bad? Ans True Not Ans Unknown
454 a c lid bad choice Ans True Not Ans Unknown
604 a c peptic ulceration Ans True Not Ans Unknown
605 a c history anti steroids Ans True Not Ans Unknown
615 a c contra anasthesia? Ans True Not Ans Unknown
671 a save? Ans True Nat Ans Unknown
674 a daa? Ans True Not Ans Unknown
125 a 5 who are you Ans True Not Ans Unknown
129 a S patient name Ans True Nat Ans Unknown
130 a S patient DOB Ans True Not Ans Unknown
132 a E patient sex Ans True Not Ans Unknown
176 a S hospital number? Ans True Not Ans Unknown
Acti on <s)
98 <Action 98> Ans Unknown Ans
100 <Acti on 100 > Ans Unknown Ans
101 <ActionlOl> Ans Unknown Ans
102 <Action 102> Ans Unknown Ans
103 <Actionl03> Ans Unknown Ans
104 <Action104> Ans Unknown Ans
105 <ActionlC)5> Ans Unknown Ans
106 <Action106> Ans Unknown Ans
107 <Action 107> Ans Unknown Ans
108 <Action 108> Ans Unknown Ans
109 <Acti on109> Ans Unknown Ans
110 <Acti on 110> Not Ans Unknown Not Ans
116 <Actionll6> Not Ans Unknown Not Ans
117 <Acti on 117> Not Ans Unknown Not Ans
118 <Acti on 118> Not Ans Unknown Not Ans
119 <Action 119> Not Ans Unknown Not Ans
120 <Act i on 120 > Not Ans Unknown Not Ans
121 <Actionl21> Not Ans Unknown Not Ans
122 <Actionl22> Not Ans Unknown Not Ans
123 <Action 123> Not Ans Unknown Not Ans
127 <Action127> Nat Ans Fal se Not Ans
128 <Action 128> Not Ans Fal se Not Ans
175 <Actionl75> Not Ans Unknown Not Ans
194 <Acti on 194> Not Ans Unknown Not Ans
196 <Action196> Not Ans Unknown Not Ans
233 <Action233> Ans Unknown Ans
234 <Action234> Not Ans Fal se Not Ans
245 <Action245> Ans Unknown Ans
246 <Action246> Not Ans Unknown Not Ans
326 <Action326> Not Ans Fal se Not Ans
328 <Action328> Not Ans Fal se Not Ans
3 2 9 < A c t  i or»32?> N o t Ans F a l  se N o t Ans
3 3 0 < A c t i o n 3 3 0 > N o t Ans F a l  se N o t Ans
331 < A c t 1 o n 3 3 1 > N o t Ans F a l  se N o t Ans
3 3 2 < A c t i  o n 3 3 2 > N o t Ans F a l  se N o t Ans
3 3 3 < A c t i  o n 3 3 3 > N o t Ans F a l  se N o t Ans
3 3 4 < A c t i  o n 3 3 4 > N o t Ans Unknown N o t Ans
3 3 9 < A c t i  o n 3 3 9 > N o t Ans Unknown N o t Ans
3 4 0 < A c t  i  o n 3 4 0 > N o t Ans Unknown N o t Ans
341 < A c t i o n 3 4 1 > N o t Ans Unknown N o t Ans
3 4 2 < A c t i o n 3 4 2 > N o t Ans Unknown N o t Ans
3 7 3 < A c t i o n 3 7 3 > Ans Unknown Ans
3 7 4 < A c t i o n 3 7 4 > N o t Ans Unknown N o t Ans
3 3 5 < A c t i  o n 3 3 5 > Ans Unknown Ans
3 8 6 < A c t i  o n 3 3 6 > Ans Unknown Ans
3 3 7 < A c t i  o n 3 S 7 > Ans Unknown Ans
3 3 3 < A c t i  o n 3 S 3 > Ans Unknown Ans
3 3 9 < A c t i  o n 3 8 9 > Ans Unknown Ans
3 9 0 < A c t  i  o n 3 9 0  > Ans Unknown Ans
391 < A c t i  o n 3 9 1 > Ans Unknown Ans
3 9 2 < A c t i  o n 3 9 2 > Ans Unknown Ans
3 9 3 < A c t i  o n 3 9 3 > Ans Unknown Ans
3 9 4 < A c t i  o n 3 9 4 > Ans Unknown Ans
3 9 5 < A c t i o n 3 9 5 > Ans Unknown Ans
3 9 7 < A c t i o n 3 9 7 > Ans Unknown Ans
3 9 9 < A c t i o n 3 9 9 > Ans Unknown Ans
401 < A c t i  o n 4 0 1 > N o t Ans Unknown N o t Ans
4 0 4 < A c t i o n 4 0 4 > N o t Ans Unknown N o t Ans
4 0 7 < A c t i  o n 4 0 7 > N o t Ans Unknown N o t Ans
4 2 6 < A c t i o n 4 2 6 > Ans Unknown Ans
4 2 7 < A c t i  o n 4 2 7 > N o t Ans F a l  se N o t Ans
4 3 2 < A c t i o n 4 3 2 > N o t Ans Unknown N o t Ans
4 3 6 < A c t i  o n 4 3 6 > N o t Ans Unknown N o t Ans
4 3 7 < A c t i  o n 4 3 7 > N o t Ans Unknown N o t Ans
4 3 9 < A c t i  o n 4 3 9 > N o t Ans Unknown N o t Ans
441 < A c t i o n 4 4 1 > N o t Ans Unknown N o t Ans
4 5 2 < A c t i o n 4 5 2 > N o t Ans Unknown N o t Ans
4 5 3 < A c t i  o n 4 5 3 > N o t Ans F a l  se N o t Ans
4 5 5 < A c t i o n 4 5 5 > N o t Ans Unknown N o t Ans
4 5 9 < A c t . io n 4 5 9 > N o t Ans Unknown N o t Ans
4 6 0 < A c t i  o n 4 6 0 > N o t Ans Unknown N o t Ans
4 6 2 < A c t i o n 4 6 2 > N o t Ans Unknown N o t Ans
4 6 4 < A c t i o n 4 6 4 > N o t Ans Unknown N o t Ans
4 6 6 < A c t i  o n 4 6 6 > N o t Ans Unknown N o t Ans
4 6 3 < A c t i o n 4 6 8 > Ans Unknown Ans
4 7 0 < A c t i  o n 4 7 0 > N o t Ans Unknown N o t Ans
4 7 3 < A c t i o n 4 7 3 > N o t Ans Unknown N o t Ans
4 7 7 < A c t i o n 4 7 7 > N o t Ans Unknown N o t Ans
4 3 0 < A c t i  o n 4 8 0 > Ans F a l  se Ans
4 3 2 < A c t i o n 4 S 2 > Ans F a l  s e Ans
4 3 4 < A c t i  o n 4 S 4> Ans F a l  se Ans
4 3 6 < A c t i  o n 4 3 6 > N o t Ans Unknown N o t Ans
4 3 7 < A c t  i  o n 4 S 7 > Ans F a l  se Ans
4 8 9 < A c t i  o n 4 S 9 > Ans Fell se Ans
491 < A c t i  o n 4 9 1 > N o t Ans F a l  s e N o t Ans
4 9 2 <A c t i o n 4 9 2 > N o t Ans Unknown N o t Ans
4 9 3 < A c t i o n 4 9 3 > N o t Ans Un known N o t Ans
4 9 4 < A c t i  o n 4 9 4 > N o t Ans Unknown N o t Ans
4 9 5 < A c t i o n 4 9 5 > N o t Ans Unknown N o t Ans
5 0 2 < A c t i  o n 5 0 2 > N o t Ans Unknown N o t Ans
5 2 3 < A c t i  o n 523.> N o t Ans Unknown N o t Ans
6 0 7 < A c t i  o n 6 0 7 > N o t Ans Unknown N o t Ans
6 0 3 < A c t i o n 6 0 8 > N o t Ans Unknown N o t Ans
6 1 4 < A c t i o n 6 1 4 > N o t Ans Unknown N o t Ans
6 1 7 < A c t i o n 6 1 7 > N o t Ans Unknown N o t Ans
6i a Ac t i on 618 > Not Ans Unknown Not Ans
619 <Acti on619> Not Ans Unknown Not Ans
621 <Action621> Not Ans Unknown Not Ans
622 <Acti on622> Not Ans Unknown Not Ans
623 <Acti on623> Not Ans Unknown Not Ans
624 <Acti on624> Not Ans False Not Ans
625 <Acti on625> Not Ans Fal se Not Ans
626 <Acti on626> Not Ans Fal se Not Ans
627 <Action627> Mot Ans Fal se Not Ans
628 <Acti on628> Not Ans Fal se Not Ans
629 <Action629> Not Ans Fal se Not Ans
630 <Action630> Not Ans Fal se Not Ans
631 <Acti on631> Not Ans Fal se Not Ans
6^5 <Acti on635> Not Ans Unknown Not Ans
636 <Action636> Not Ans Unknown Not Ans
637 <Acti on637> Not Ans Unknown Not Ans
638 <Acti on638> Not Ans Fal se Not Ans
639 <Action639> Not Ans Fal se Not Ans
640 <Action640> Not Ans Fal se Not Ans
641 <Action641> Not Ans False Not Ans
642 <Action642> Not Ans Fal se Not Ans
643 ■•; Acti on643> Not Ans False Not Ans
644 <Action644> Not Ans Fal se Not Ans
645 •iActi on645> Not Ans Fal se Not Ans
646 <Acti on646> Ans Unknown Ans
647 <Acti on647> Ans Unknown Ans
648 <Acti on648> Ans Unknown Ans
649 <Acti on649> Ans Unknown Ans
650 <Acti on650> Ans Un known Ans
651 <Acti on651> Ans Unknown Ans
652 <Action652> Ans Unknown Ans
653 <Acti on653> Ans Unknown Ans
654 <Action654> Ans Unknown Ans
655 <Acti on655> Ans Unknown Ans
656 <Action656> Ans Unknown Ans
657 <Acti on657> Ans Unknown Ans
658 <Acti on658> Ans Unknown Ans
659 <Acti on659> Ans Unknown Ans
660 <Acti on660> Ans Unknown Ans
661 <Acti on661> Ans Unknown Ans
662 <Acti on662> Ans Unknown Ans
663 <Action663> Ans Unknown Ans
664 <Action664> Ans Unknown Ans
665 <Action665> Ans Unknown Ans
666 <Action666> Ans Unknown Ans
667 <Action667> Ans Unknown Ans
668 <Action668> Ans Unknown Ans
669 <Action669> Ans Unknown Ans
670 <Action670> Not Ans Unknown Not Ans
672 <Acti on672> Ans Unknown Ans
673 <Acti on673> Ans Unknown Ans
675 <Acti on675> Not Ans Unknown Not Ans
676 <Acti on676> Ans Unknown Ans
Group(s)
111 <Group111> Not Ans Unknown Not Ans
112 <Group 112> Not Ans Unknown Not Ans
113 <Group 113> Not Ans Unknown Not Ans
124 <Group 124> Not Ans Unknown Not Ans
133 <Group 133> Not Ans Unknown Not Ans
138 <Group 138> Not Ans Unknown Not Ans
139 <Group 139> Not Ans ■•Unknown Not Ans
140 <Group140> Not Ans Unknown Not Ans
157 <Group 157> Not Ans- Unknown Not Ans
200 <Group200> Not Ans Unknown Not Ans
224 <Group224> Not Ans Unknown Not Ans
231 <Group231> Not Ans Unknown Not Ans
315 <Group315> Not Ans Unknown Not Ans
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Appendix D5 - Model statistics
n s - i
Sum m ary o f  M o d e l
No Line Name Type
1 0 AT_START Questi on Condi ti on
2 0 AT_END Vari able Condi ti on
0 AT_QUIT Questi on Condi ti on
4 0 AT_HELP Variable Condi ti on
5 0 AT__RESTORE Questi on Condi ti on
6 0 AT_RESTART Questi on Condi ti on
7 30 f _a_5_pat i ent_,name Vari able String
8 31 •f _s_patient_D0B Variable Stri ng
9 Tr> f _a__s_pat i ent_se>: Vari able String
10 38 f _a_c_Di aibeti c? Vari able Condition
11 39 f _ a_c_Hypertensive? Vari able Condition
12 40 f _a_c_Renal? Variable Condition
.13 41 f _a_c_Pul rnonar i c? Variable Condition
14 42 f _a_c_GI? Vari able Conditi on
15 43 f _a_c_pepti c_ulcerati on Vari able Condi ti on
16 44 •f _a_c_hi 5tory_anti_5teroids Vari able Condi ti on
17 45 f_a_c_contra_anastheBia? Variable Conditi on
18 46 f _a_c_Hart__di sease Vari able Condi ti on
19 55 f _a_i_thyroid_status Variable Number
20 56 f _a_c_Radi oact i ve__i odi ne? Variable Condi ti on
21 57 ■f _B „c_Thyroidectomy? Vari able Condition
22 58 f _a _c_Carbimazol? Vari able Condi ti on
0"T 64 f _a._c_lacri mi nati on? Vari able Condi ti on
24 65 f _a__c_photophobi a? Vari able Condi ti on
25 66 •f _a_„c_vi sual_blurri ng? Vari able Condition
26 67 •f _a__c_double_visi on? Vari able Condition
27 68 f _a.„c_pai n? Vari able Condi ti on
28 69 f _a__i _pati ent_most_troublesome Vari able Number
29 70 f ,_a__p_pati ent._appearance Vari able Probabi1i ty
30 79 f _a__i __eye_di sease_durat i on Vari able Number
31 80 f _a__c_Eye_lubricants? Vari able Condi ti on
81 f __a__c_Tr_for_corneal\ulcer? Vari able Condition
33 8.2 f_a__c_Lid_lengthening? Vari able Condition
34 S3 f _a__c_Tarsorhaphy? Vari able Condition
35 84 f „a__c_Systemic_steroids? Vari able Condi ti on
36 85 f _a__c_Radiotherapy? Vari able Condition
37 86 * _a~_c_decompression? Vari able Condi ti on
38 87 f ,_a_c_Prisms_occlusion? Vari able Condi ti on
39 88 ,c_Muscle_surqery? Vari able Condition
40 109 f __a__i _di sk _eodema Vari able Number
41 110 f _a__c_coroidal_folds Vari able Condition
42 111 •f _a__i _snel 1 en_now Variable Number
43 .112 f _a__i _-f i el d_now Vari able Number
44 113 •f _a__i _ 100,_hue_now Vari able Number
45 114 ■f __a_c_color_blind Vari able Condi ti on
46 115 •f __a _i_dipiopia_symptom_now Vari able Number
47 116 •f_a__i _di piopi a_on_exarainat ion_now Vari able Number
43 117 •f _a_ i _proptosi s_opi ni on Vari able Number
49 118 f _a_ i_proptosis.now Vari able Number
50 119 •f _a_i _Hess__chart _now Vari able Number
51 120 f i _ul tra__sound Vari able Number
52 121 •f _a_,c_lid_lag Vari able Condi ti on
53 122 •f _a_ i _1 i d_.retract i on Vari able Number
54 123 -f _a_i _cornea..now Vari able Number
55 124 f ,„a_i ,_1 i d _eodema ...now Vari able Number
56 125 •f _a_i._chemosis now Vari able Number
57 126 •f n IOP dif Vari able Number
53 132 ■f„m_i _nerve__conditi on Oari able Number
59 133 ■f__m_i_mascles_condi ti on Vari able Number
60 134 •f„m_i _cornea_condi ti an Vari able Number
61 135 f_m_i _1i d_conditi on Vari able Number
62 '137 m_i_nerve_condition Vari able Number
63 133 m_i_muscles_condition Vari able Number
64 139 m_.i _cornea_..condi t i on Vari able Number
65 140 m_i _.l i d_condi t i on Vari able Number
66 143 f i el d_o-f _vi si on Var i ab1e Condi ti on
67 149 f_m_c_100__hue_test Vari able Condi ti on
63 150 f_(n_c_Hes5_chart Vari able Condi ti on
69 151 ■f tra_5aund Variable Condi ti on
70 156 m_c_-f i el d_o-f _vi si on Vari able Condi ti on
71 157 m_c_.100_hue_.test Variable Condi ti on
•jr> 153 m_c_Hess_chart Vari able Condi ti on
73 159 m_c_ultra_sound Vari able Condi ti on
74 165 •f'_m_i_action Vari able Number
75 167 m._i_.action Variable Number
76 173 f ’_m_c_eye_lubricants Vari able Condi ti on
77 174 •f._m_c_systemic_steroids Vari able Condi ti on
73 175 •f'_m_c_raise_head_w_di oreti cs Vari able Conditi on
79 176 f...m_c_rai se_head_w_no_di oreti cs Variable Condition
SO 177 •f._m_c_occlusion_or_prism Vari able Condi ti on
31 173 f._m_c_Radiotherapy Vari able Condition
82 179 ■f._m_c_anti _glaucoma_medi cati ons Variable Conditi on
83 181 m._c__eye_l ubri cants Vari able Condi ti on
34 132 m__c_systemic_steroids Vari able Conditi on
35 183 m._c_raise_head_w_dioretic5 Vari able Condi ti on
36 134 m _c_rai se _head _w._no_di oreti cs Vari able Condi ti on
37 185 m._c_occlusion_or_prism Vari able Condi ti on
S3 186 m__c_Radiotherapy Vari able Condi ti on
39 187 m„_c_anti_glaucoma_medications Vari able Condition
90 194 f ’_m_c_tarsoraphy Variable Conditi on
91 195 f._m_c_lid_lenghthen Variable Condition
92 196 f ._m_c_decompression Vari able Condi ti on
93 197 •f._m_c_mu5cles_surgery Vari able Conditi on
94 199 ro._c_tarsoraphy Vari able Condi ti on
95 200 m__c_li d_lenghthen Variable Condi ti on
96 201 m._c_decompression Variable Conditi on
97 202 m_. c_muscl es._surgery Vari able Condi ti on
93 213 Acti on Nul 1
. 00 2 2 2 Action Nul 1
01 237 Action Null
02 247 Acti on Nul 1
03 259 Acti on Nul 1
04 289 Acti on Nul 1
05 313 Action Nul 1
06 321 Acti on Null
07 329 Action Nul 1
03 334 Action Nul 1
09 345 Acti on Nul 1
10 374 Acti on Nul 1
11 396 9_.history Group Null
14 406 a_ c_tedex_user Questi on Condition
15 414 a_ i _novice_user_intro Questi on Number
16 434 Acti on Nul 1
17 467 Acti on Nul 1
IS 474 Acti on Nul 1
19 479 Acti on Null
20 484 Acti on N u l 1
21 489 Acti on Nul 1
2 2 494 A c t i o n Null
23 499 Action Null
24 5u7 <3._user_personal Group Nul 1
25 510 a _s  who are_you Quest!on Stri ng
2 6 51.6 a i u s e r  _e:-:peri enct? Questi on Num ber
127 530 Acti on Nul 1
128 539 Act i on Null
112 554 g_patient_personal Group Nul 1
129 559 a_s__pat i ent__name Question Stri ng
130 563 a_s_patient_DOB Questi on Stri ng
131 ’ 571 a_i _pati ent_ age Questi on Number
132 576 a_5_pat i ent_se>: Question Stri ng
113 587 g_.pat i ent._compl ai nt„.hi story Group Nul 1
133 596 g_patient_complal nt Group Null
142 601 a__c_l acr i mi nati on? Question Condition
143 612 a_c_photophobi a? Questi on Condi ti on
144 625 a_c__vi sual _blurr i ng? Questi on Condi ti on
145 639 a__c_doubl e_vi si on? Questi on Condi ti on
146 651 a_c_pai n? Questi on Condi tion
134 664 a_i __pati ent_most_troubl esome Question Number
135 682 a_i _eye_di sease__dur ati on Questi on Number
136 692 a__i _thyroi d_status Questi on Number
137 703 a_i _thyroi d__di sease_.durati on Questi on Number
138 719 g_previou5_sys_conditions Group Nul 1
147 723 a__c__Di abetic? Questi on Condi ti on
148 734 a_c_Hypertensive? Question Condi ti on
149 745 a_c_Renal? Questi on Condi ti on
150 757 a_c_Pulmonaric? Questi on Condition
151 767 a_c_GI? Questi on Condition
139 779 g_previous_thyroid_treatment Group Nul 1
152 784 a_c_Radioactive_iodine? Question Condition
153 800 a_c_Thyroidectomy? Questi on Condi ti on
154 815 a_c_Carbi mazol? Questi on Condi ti on
155 830 a_c_T3? Questi on Condi ti on
156 846 a_c_T4? Question Condi ti on
157 859 g_thyroi d_bi ochemi stry Group Null
158 862 a_i _T3 Quest .i on Number
159 866 a_i _T4 Questi on Number
160 871 a_i _TSH Questi on Number
140 875 g_previ ous_eye_treatment Group Null
161 887 a__c_.Eye_l ubri cant s? Questi on Condi ti on
162 908 ai_c_Tr_for_corneal _ul cer? Question Condi ti on
163 928 a_c_Li d__l engtheni ng? Questi on Condi ti on
164 948 a_c_Tarsorhaphy? Questi on Condi ti on
165 971 a_c_Systemic_steroids? Question Condition
166 990 a_i _Sys_steroi ds_e-f f ect? Questi on Number
167 1009 a_c .Radi otherapy? Questi on Condi tion
168 1028 a_i _Radi otherapy_e-f-f ect? Questi on Number
169 104-9 a_c_decompressi on? Question Condi ti on
170 1067 a_i _decompressi on_e-ff ect? Questi on Number
171 1086 a_c_Prisms_occlusion? Questi on Condi tion
172 1106 a_c_Muscle_surgery? Questi on Conditi on
141 1125 a__p__pati ent__appearance Questi on Probabi1i ty
173 1134 a_i_main_menu Question Number
174 1146 a_i _teachi ng__menu Questi on Number
175 1159 Acti on Nul 1
176 1164 a_s_hospi tal_number? Quest i on Stri ng
17"7 1170 a.._c_Hart_di sease Question Condi ti on
178 1177 1 ast_vi si t_report. Vari able Condi ti on
179 1178 please_get Vari able Condi ti on
ISO 1179 piease_obtain Vari able Condition
99 1180 piease_load Vari able Condi ti on
181 1182 a_.begi n Vari able Condi ti on
182 1183 b _begi n Vari able Conditi on
183 1184 c_begi n Vari able Condi ti on
184 1 185 clinical _-f ini shed Vari able Condi ti on
135 1186 f i rst_report Vari able Condi ti on
186 1187 val i date_-f ini shed Vari able Condition
137 1 189 piease_save Variable Condition
188 1 190 please_sheel Vari able Condi ti on
189 1191 please store Var i ab1e Condi ti on
190 1 193 ■f._ a w h o _ a r e _ y a u Vari able Stri ng
191 1194 m_a_ .s_who_are_you Var i ab1e Stri ng
192 1196 m_a_i _user_e>:per i ence Vari able Number
193 1197 f’_a_i _nser_e>:per i ence Vari able Number
194 1245 Acti on Nul 1
196 1323 Acti on Nul 1
1365 Action Nul 1
234 1371 Acti on Nul 1
218 1377 a_„c_any_invest? Questi on Condi ti on
219 1384 i._stop_cont? Vari able Number
236 1389 a__i _.stop_cont? Questi on Number
220 1403 c._nerve_i nvest? Variable Condi ti on
237 1408 a__c_nerve_invest? Questi on Condi ti on
1415 c._-f i el d_of _vi si on? Vari able Condi ti on
238 1420 a._c_-f i el d__o-f _vi si on? Questi on Condi ti on
1430 c__100_hue? Variable Condition
239 1435 a__c_100_hue? Questi on Condi t i on
225 1447 c__muscles_invest? Vari able Condi ti on
240 1453 a__c_muscles_i nvest? Question Condi ti on
226 1460 c._Hess_chart? Variable Condi ti on
241 1466 a__c_Hess_chart? Question Condition
227 1478 c__ultra_sound? Variable Condition
242 1484 a._c_ultra_sound? Questi on Condi ti on
228 1496 c__CT scan? Variable Condi ti on
243 1502 a _c_CTscan? Questi on Condi ti on
1514 c__MRIscan? Variable Condi ti on
244 1520 a__c__MRIscan? Question Condi ti on
245 1533 Acti on Nul 1
246 1537 Action Null
259 1575 P.._mal_nerve Variable Probabi1i ty
247 1601 P.._sug_mal_nerve Vari able Probabi1i ty
1616 P__test_mal_nerve Vari able Probabi1i ty
217 1636 P__di sk_eodi ma Vari able Probabi 1 i ty
263 1643 pl_di sk_eodi ma Vari able Probabi1i ty
235 1646 a__i _di sk_eodema Questi on Number
216 1660 c__coroi dal _-f ol ds Vari able Condition
264 1665 a_ c_corol dal _-f ol ds Questi on Conditi on
215 1675 a__i _pupi 11 _now Questi on Number
260 1688 P__vi sual_acui ty_drop Vari able Probabi1i ty
265 1700 pi._vi sual_acui ty_drop Vari able Probabi1i ty
266 1710 P_.snel1en_acui ty_drop Variable Probabi1i ty
204 1721 P_,snellen_now Variable Probabi1i ty
267 1726 a_ i _snel1en_now Questi on Number
205 1744 P_ snel1en_change Variable Probabi1i ty
268 1749 Pi_snel1en_change Variable Probabi1i ty
269 1756 a_ i_snel1en_change Questi on Number
270 1325 P_vi si on_dummy Vari able Probabi1i ty
261 1828 P_ ■f i el d_of _vi si on Vari able Probabi1i ty
271 1843 P_•field_now Vari able Probabi1i ty
248 1849 i_field_now Questi on Number
1865 p_•f i el d_change Variable Probabi1i ty
1871 pi_-f i el d_change Vari able Probabi1i ty
274 1879 3 i __-f i el d_change Question Number
262 1899 P_ 100_hue_test Variable Probabi1i ty
275 1915 P_ 100_hue_now Variable Probabi1i ty
249 1940 a_i _100__hue_now Question Number
276 1950 P_ 100_hue_change Vari able Probabi1i ty
277 1956 Pi_100_hue_change Vari able Probabi1i ty
278 1966 a_i _100_hue_change Questi on Number
279 1997 a_c_color_bli nd Questi on Condi ti on
280 2016 P_mal_muscles Variable Probabi1i ty
'-'cr'-O 2042 P_sug_mal_muscles Vari able Probabi1i ty
230 2052 P_test _.mal _muscl es Vari able Probabi1i ty
281 2065 P_di piopi a Vari able Probabi1i ty
287 2076 P._dipiopia_symptom Variable Probabi 1 :i ty
197 2083 P_diplopia symptom now Variable Probabi1i ty
2S9 2095 a_i _di pi op:L a_symptom_ now Questi on Number
193 2111 p_di piopi a_symptam_change Vari able Probability
290 2117 p 1 _di piopi a_symptom_change Vari able Probabi1i ty
291 2126 a_i __di pi opi a__symptom_ change Questi on Number
233 2141 p_diplopi a_on_e>:ami nati on Vari able Probabi 1 .i ty
199 2151 p_di pi opi a__on_exami nati on_now Vari able Probabi1i ty
293 2158 a_i _dipi opi a_on_exami nati on_now Question Number
200 2173 g__di pi opi a__on_e::aminati on_change Group Null
292 2176 p_di plopi a_on_e::ami nation_change Vari able Probabi1i ty
295 2182 pl_diplopi a_on_e>:ami nati on_change Vari able Probabi 1 ,i ty
296 2191 a_i _di piopi a_on_e>:ami nati on_change Questi on Number
294 2203 c__si >;_month_stabl e_di pi opi a Vari able Condi ti on
297 2209 a_c_si ;;_month_stabl e_d i p 1 op ict Questi on Condi ti on
232 2225 p_proptosis Vari able Probabi1i ty
202 2238 p_proptosi s_now Vari able Probabi1i ty
293 2245 a_i _proptoEi s_opi nion Questi on Number
201 2263 a_i _proptosi s_now Questi on Number
203 2277 p_proptosiE_change Vari able Probabi1i ty
299 2234 pl_proptosis_change Variable Probabi1i ty
300 2294 a_i _proptosi 5_change Questi on Number
233 2317 p_Hess_chart Variable Probabi 1 i ty
301 2330 p_Hess_chart_now Variable Probabi1i ty
253 2336 a__i _Hes5_chart_now Questi on Number
303 2352 p_he55_dummy Vari able Probabi1i ty
302 2357 p..Hes5_chart_change Vari able Probabi1i ty
304 2364 p 1__Hess_chart_change Vari able Probabi1i ty
305 2372 a_i _Hes5...chart_change Question Number
284 2391 p_ultra_sound Vari able Probabi1i ty
254 2399 a_i _ultra_50und Questi on Number
235 2418 p_CTscan Vari able Probabi1i ty
255 2426 a_i _CT scan Questi on Number
236 2441 p_MRIscan Vari able Probabi1i ty
256 2449 a _i _MRI scan Questi on Number
306 2467 p_mal_1i d Vari able Probabi1i ty
307 2490 p_uncoverage Vari able Probabi1i ty
206 2499 P_1id_lag Vari able Probabi1i ty
303 2504 a_c_li d_lag Questi on Condi ti on
207 2513 p_li d_retracti on Vari able Probabi1ity
309 2513 a_i _1i d_retraction Questi on Number
310 2537 p__mal _cornea Vari able Probabi1i ty
311 2553 p_cornea Var i ab1e Probabi1i ty
212 2569 p_cornea_now Vari able Probabi1i ty
312 2572 a_i _cornea_now Questi on Number
213 2590 p_cornea_change Vari able Probabi1i ty
313 2596 pl_cornea_change Vari able Probabi1ity
314 2604 a_i_cornea_change Questi on Number
315 2625 g_so-f t_ti BELIE Group Null
316 2633 p_lid_eodema Vari able Probabi1i ty
203 2644 p_li d_eodema_now Vari able Probabi1i ty
318 2643 a._i _1 id_BodE/na_now Questi on Number
209 2661 P...1 i d _eodema_change Vari able Probabi 1 i ty
319 2667 p1_1i d_eodema_change Vari able Probabi1i ty
320 2675 a_i _1i d_eodema_change Questi on Number
317 2692 p_chemosi e Vari able Probabi1i ty
210 2703 p._chemosi s_now Variable Probabi1i ty
321 2707 a_i _chemoEis_now Questi on Number
211 2723 p_chemosi s_change Variable 1Probabi1i ty
322 2730 pl_chemosi Exchange Variable Probabi1i ty
323 2737 a _i _chemos:i s_change Questi on Number
214 2750 n_I0P_dif Vari able Number
325 2341 a_i _I0P_up Questi on Number
324 2867 a_ i _I0P_straight Questi on Number
326 2376 Action Nul 1
323 2339 Acti on Null
329 2903 Action Nul 1
330 271.3 Act i on Nul 1
331 2931 Acti on Nul 1
2945 Acti on Nul 1
337T 2953 Acti on Nul 1
334 2973 Acti on Nul 1
224 2990 g.val idate_nerve._ answers Group Nul 1
333 2993 i _vali date_nerve_ answers Vari able Number
251 3000 a__i _val i date_ner\’e_answers Questi on Number
250 3017 c _n er ve__ sug .test ..dif Vari able Condi ti on
336 3023 n_sug_..mal _nerve Variable Number
337 3023 n_test_mal ,_nerve Vari able Number
339 3033 Acti on Nul 1
340 3046 Acti on Nul 1
341 3059 Acti on Nul 1
195 3033 z_begin Variable Condi ti on
342 3035 Acti on Nul 1
343 3088 s_al ready__sai d Variable Stri ng
344 3039 s_l i d__al ready_sai d Variable String
345 3094 cccc Variable Number
347 3100 cccc_CDnverted Vari able Number
343 3106 cccc_converted_a Variable Number
349 3113 cccc_converted _b Vari able Number
350 3120 cccc_converted_c Variable Number
335 3125 nnnn Vari able Number
352 3131 nnnn_converted Var i a b 1e Number
3137 nnnn .converted ..a Variable Number
354 3144 nnnn__con verted _b Variable Number
355 3151 nnnn_converted_c Vari able Number
356 3157 1111.’ Vari able Number
353 3163 1 111_converted Variable Number
359 3169 1111 _.converted_a Variable Number
360 3176 1 1 1 1 ..converted _b Vari able Number
361 3133 1 111_converted_c Vari able Number
362 3139 mmmm Vari able Number
364 3195 mmmm_converted Variable Number
365 3201 mmmm _ converted _a Vari able Number
366 3208 mmmm_.converted__b Vari able Number
367 3215 mmmm_converted_c Vari able Number
363 3219 prop Variable Number
370 3225 prop converted Vari able Number
371 3231 prop_converted_a Vari able Number
372 3233, prop__converted_b Vari able Number
346 3244 ccc_? Question Number
351 3247 nnn_ ? Questi on Number
357 3250 1111? Questi on Number
363 3253 mmm _.? Questi on Number
369 3256 pro_? Questi on Number
T7? 3259 Action Nul 1
374 3266 Action Nul 1
"t -7 rr 3271 c _announce_acti on Vari able Condi tion
377 3276 .i __choose_act i on_l Vari able Number
373 3234 i_choose._acti on _2 Vari able Number
379 3292 i _choose_acti on_3 Vari able Number
330 3300 i _choosG_act i on _4 Variable Number
331 3303 i _choose__acti on _5 Variable Number
332 3316 i .choose ...acti on_6 Var i a b 1e Number
333 3324 i _choase._acti on_7 Vari able Number
334 3332 i _choose...acti on_S Vari able Number
335 3339 Action Nul 1
336 3344 Acti on Null
337 Acti on Nul 1
333 3360 Acti on Nul 1
339 3363 Acti on Nul 1
390 3377 Acti on Nul 1
391 3335 Action Null
392 3393 Acti on Null
393 3400 Act. i on Nul 1
394 3410 Acti on Nul 1
376 3414 c_start_treatment Vari able Condi ti on
395 3422 Acti on Nul 1
396 3426 c_no_ul cer Vari able Condi ti on
397 3469 Acti on Nul 1
398 3475 c__tr_ulcer Vari able Condi ti on
399 3479 Acti on Nul 1
400 3490 c_tr__Lil cer_lubri cati on Vari able Condi t i on
401 3496 Acti on Nul 1
402 3504 c_tr_ulc_nerv_w_steroids Vari able Condi ti on
404 3508 Acti on Nul 1
405 3518 c_tr_ulc_nerv_w_radi otherapy Var i a b 1e Condi ti on
407 3522 Acti on Nul 1
408 3539 c_tr_ulc_nsrv_criti cal Vari able Condi ti on
409 3545 s_proptosis Variable Stri ng
410 3550 sl_propto£is Vari able String
411 3556 s2_propto5i s Vari able Stri ng
412 3561 s_anti_steroids Variable Stri ng
413 3571 s_anti_surgery Vari able Stri ng
415 3581 s__anti __radi o Vari able Stri ng
416 3592 s_TEDEX.choice Vari able Stri ng
418 3597 sl_TEDEX_choice Variable String
420 3602 s2_TEDEX.choice Variable Stri ng
417 3608 c_TEDEX_choice Vari able Condi ti on
419 3616 c 1 _TEDEX._choi ce Vari able Condi ti on
421 3625 c2_TEDEX_choice Vari able Condi ti on
422 3637 s_choo5e_steroids Vari able Stri ng
423 3647 s_choose_decompre.ssi on Vari able Stri ng
424 3656 s _choose_radiotherapy Vari able Stri ng
425 3664 a_i_.treat_nerve Question Number
426 3685 Acti on Nul 1
427 3699 Acti on Nul 1
429 3718 5_contra_indications Vari able Stri ng
430 3723 sl.contr a_i ndi cat i ons Vari able Stri ng
431 3728 s2_contra_i ndi cati ons Vari able Stri ng
428 3732 a_c_your_choi ce_taad? Question Condi ti on
432 3750 Action Nul 1
433 3769 s_.cri ti cal _.c:hoi ce Vari able Stri ng
434 3776 sl _cri ti cal _..choi ce Vari able String
435 3783 S-i ..c.ri ti cal _choi ce Question . Number
436 3SUO Acti on Nul 1
437 3807 Acti on Nul 1
438 3822 c__tr_nerve _w_steroi ds Vari able Condi ti on
439 3830 Acti on Null
440 3833 c_tr_nerve_w_decompre5Sion Vari able Condi ti on
441 3847 Acti on Nul 1
442 3857 c _tr _nerve_w_radi otherapy Variable Condi ti on
443 3369 c_start_treating_1id Vari able Condi ti on
444 3879 c_do._ not ...decompress Vari able Condi ti on
445 3882 s__l i d _c on d j. ti on Vari able Stri ng
446 3887 sl_1 i d._condi ti on Vari able String
447 3893 s_ 1 i d._A__TEDEX_chai ce Vari able String
448 3900 sl _1 i d_A..TEDEX_choi ce Vari a b l e . Stri ng
449 3907 s2...1 i d_..A._TEDEX _choi ce Vari able Stri ng
450 3912 s. 1 i d ..choose .decomp Vari able Stri ng
451 3918 a._ i ... 3. i d.. t a r s._ .1 e n g _. d e c o Questi on Number
452 3933 Acti on Nul 1
453 3938 Acti on Nul 1
454 3942 a_c_1 i d _bad._choi ce Questi on Condi t.i on
455 3953 Action Nul 1
456 3961 s . 1 i d .B_ TEDEX _choi ce Vari able String
457 3966 s 1 __ 1 i d _B... TEDEX ..choice Var .i ab 1 e Stri ng
458.3970 a._i ...1 i d _tarso .1 ength Question Number
459 3983 Action. Nul 1
460 3990 Acti on Nul 1
461 4000 c tr lid drcompress Variable Condition
462 4007 Act!on Nul 1
463 4015 c_.tr _1 i d_l engtheni ng Oari able Condi ti on
464 4021 A c t i on Nul 1
465 4028 c_tr_tarsoraphy Vari able Condi ti on
466 4035 Acti on Nul 1
467 4047 c_.postpone_l i d_.tr Vari able Condi t i on
468 4053 Acti on Nul 1
469 4062 c_ tr__cornea__l i d_l ubr i cat i on Vari able Condi ti on
470 4067 Act :i on Nul 1
471 4071 c_5tart_treating_muscles Vari able Condi ti on
472 4103 c_stable Vari able Condi ti on
473 4107 Acti on Nul 1
476 4116 c_.copi ng Var i aibl e Condi t.i on
477 4120 Action Nul 1
479 4125 c _do_not__decamp_.muscl es Vari able Condi ti on
475 4133 c_any..other_.troubl es Vari able Condi ti on
474 4137 c_muscles_troubles Vari able Condi ti on
480 4146 Act i on Nul 1
431 4152 c_do__deco_f i r st _muscl es Vari able Condi ti on
432 4160 Acti on Nul 1
483 4166 c__do_muscl eE_£urgery Variable Condi ti on
484 4177 Action Nul 1
485 4133 c_do_muscl es_5urgery_w_.care Variable Condi ti on
486 4192 Action Nul 1
478 4198 c_postpone_muscles_surgery Vari able Condi ti on
487 4207 Ac ti on Null
483 4213 c_prism_or_occlussion Vari able Condi ti on
489 4219 Action Nul 1
490 4225 c_do_nothing for_muscles Variable Condi t i on
232 4231 a_i _f i nal ..menu Questi on Number
491 4247 Acti on Nul 1
492 4252 Action Nul 1
493 4258 Action Nul 1
494- 4262 Action Null
327 4266 c_show_f i nal _menu Vari able Condi ti on
495 4279 Action Nul 1
502 4305 Action Null
528 4-338 Action Nul 1
496 4369 5_u5er_e:-:perience Vari able Stri ng
537 4374 sl_user_e>:per i once Vari able Stri ng
538 4379 s2_user_experience Variable String
539 4384 s3_ user _e>: peri ence Vari able String
540 4389 s4 user_e>:peri ence Vari able Stri ng
541 4394 s5__user_e>:per i ence Vari able Stri ng
497 4399 s._l acr i mi nat i on Variable Stri ng
493 4405 s_photcphobia Vari able Stri ng
499 4410 s_blurri ng Vari able String
500 4416 s__doubl e_vi si on Var i a b 1e Stri ng
501 4421 s.pain Variatble Stri ng
542 4428 c_more_than_2._symtams Var .i ab 1 e Condi ti on
503 4436 s _Eye_l ubr i cant s? Vari able Stri ng
504 4444 s_Tr _f _cr_,ul cer? Variable Stri ng
505 445.1 s_Li d__l engtheni ng? Variable Str .i ng
506 4458 s_Tarsoraphy? Variable String
507 4465 s_Systemi c..steroi ds? Variable Stri ng
509 4472 s_Radiotherapy? Variable String
511 4479 s_decompression? Vari able String
513 4486 s_Pri sms_ o c c 1ussi on? Variable Stri ng
514 4493 5_Muscle_Burgery? Vari able Stri ng
508 4500 s__,steroi ds_e?f f ect Vari able Stri ng
543 4505 si _ster oi ds _.ef f ect Variable Stri ng
544 4510 s2 _st.eroi ds ef f ect Vari able Stri ng
510 4518 s__Radi other£ipy_ effect Vari able Stri ng
54 5 4523 si ,_Radi otherapy effect Var i able Stri ng
546 4523 s2_Radiotherapy _effect Var i £ib 1 e String
512 4536 s decompression effect Variable Stri ng
547 4541 5l_deco(npressi on„e-f f ect Oar i a b 1e Stri ng
54 S 4546 e2 _ decompress! on_..ef f ect Variable Stri ng
515 4553 s_thyroi d._status Var i able Stri ng
54? 4553 si __thyro:i. d__status Vari able Str i ng
550 4563 s2_thvroi d._.status Vari able Stri ng
516 4571 s_Radi oact. i ve__i odi ne Vari able String
517 4573 s__Thyroi dect.omy Vari able Stri ng
51S 4535 e_Carbi macal Vari a b 1e Stri ng
519 4592 S..T3 Vari able String
520 4597 s_T4 Vari able Stri ng
521 4603 5_snel 1 en_now Variable Stri ng
1 4603 si _ enel 1 en_now Vari able Stri ng
errr'n 4613 s2_sne.l 1 en_now Vari able Stri ng
ercr*T
JJO 4613 s.3__snel 1 en_now Vari able String
554 4623 s 4 _ s n e l 1en_now Vari able String
555 4623 s5_snel 1 en._now Variable Stri ng
556 4633 s6_snellen_now Vari able Stri ng
557 4639 s7_snel .1 en_now Variable Stri ng
55S 4645 s S _ s n e l 1en_now Variable Stri ng
559 4651 s ?_snel1en_now Variable String
560 4657 sl0_ s n e l 1en_naw Variable Stri ng
561 4663 si 1_ s nel1en_now Variable String
562 466? sl2__snel 1 en__nsw Vari able Stri ng
563 4675 sl3__snel len_now Variable Stri ng
564 4631 sl4 _ s n e l 1en_now Variable Stri ng
565 4637 sl5_sne.l 1 en_now Vari able Stri ng
566 4692 s l 6 _ s n e l 1en_now Variable Stri ng
522 4697 s_lid_retract Variable Stri ng
567 4703 s l _ l 1d_retract Vari able Stri ng
56S 4709 s2_lid_retract Vari able Str i ng
569 4715 s3_lid_retract Vari able Stri ng
c-nT 4721 s__l i d__l ag Variable Stri ng
570 4726 si_1i d_lag Var i able Stri ng
524 4733 s_lid_eodema Vari able String
571 4739 si_1 i d__eodema Vari able String
572 4745 s2_l i d_eodema Vari able Stri ng
573 4752 s3_l id__eodema Variable String
525 4760 s __chemosi. s Variable Stri ng
574 4766 sl_chemosls Variable String
575 4772 s2 _ chemosis Vari able String
576 4779 s3_chemosis Variable Stri ng
526 4737 s_cornea Variable Stri ng
577 4793 sl_cornea Variable Stri ng
578 479? s2__cornea Variable Str i ng
579 4306 s3_cornea Vari able Stri ng
530 4312 s4_cornea Variable Stri ng
527 4320 s_pupill Var i a b 1e String
531 4326 sl_pupill Variable Stri ng
529 4333 s_disk_eodema Variable Stri ng
532 483? sl_di5k_eodema Variable Stri ng
533 4345 s2_di sk__eodema Variable Stri ng
530 4353 s_coroi dal _-f 1 d Vari able Stri ng
534 4359 si _coroi dal __-f 1 d Variable Stri ng
531 4363 s_di pi opi a_on_E>: ami nation Variable String
535 4375 si _di pi opi a__on_ei:ami nat i on Variable Stri ng
536 4332 s2__di p 1 opi a__on_e:: ami nat.i on Variable Stri ng
537 4390 s3_di pi opi a_on _e>: ami nat i on Varjable String
538 4397 s4__di pi opi a__on_e>:ami nati on Vari a b 1e Stri ng
4903 5_co5metic_appearance Vari able Stri ng
533 4910 s_.f i el d Vari able Stri ng
589 4916 si i el d Vari able Stri ng
590 4922 s2__field Vari able St.r i ng
59.1 4929 s3_f i eld Variable Stri ng
534 4939 s_ultra_sound Variable String
592 4945 si _ult.ra_sound Variable String
593 4951 s2 ultra sound Var i a b 1e String
594 4953 s3 _ul tra._. sound Variable Stri nq
595 4964 s4_ul tr a__sound Vari able String
535 4974 s__CTscan Vari able Stri ng
596 4 9 SO s l C T s c a n Vari able Stri ng
597 4986 s2__CT scan Var i able Stri ng
598 4993 s3_CTscan Variable Str i ng
599 4999 s4 __CT scan Vari able Stri ng
536 5003 s_MF: I scan Var i a b 1e String
600 5014 sl_MF;Iscan Vari able Stri ng
601 5020 s2_MF:I scan Variable String
602 5027 s3._MRIscan Variable Stri ng
603 5033 s4_MF: I scan Vari able Stri ng
604 5044 a ._c „ P e P 't i  c._.ul cerati on Question Condi ti on
605 5053 a._c_hi story_ant i _steroi ds Question Condi ti on
403 5061 anti _stero:i ds Variable Condi ti on
606 5064 c__ant i __steroi ds Vari abl e Condi t .i on
607 5072 Action Nul 1
60S 5031 Action Null
609 5097 s_Diabetic Variable Stri ng
610 5104 s__Hyper_tensi ve Variable Stri ng
61.1 5111 s_-f emal e_over45 Vari a b l e . Stri ng
612 5 119 s_steroi ds__si de_effect Vari able Stri ng
613 5127 s_pepti c__ul cerati on Vari able String
614 5135 Acti on Nul 1
615 5162 a_c_contra_anasthesia? Questi on Condi ti on
414 5170 a nti_ Burgery Vari able Condi ti on
616 5174 c._anti _surgery Vari able Condi ti on
617 5178 Acti on Null
618 5187 Action Nul 1
619 5196 Act i on Nul 1
406 5210 anti_radio Variable Condi ti on
620 5214 c_anti_j-adio Vari able Condi tion
621 5218 Acti on Nul 1
622 5224 Acti on Null
623 5236 Acti on Null
624 5255 Acti on Null
625 5268 Action Null
626 5280 Acti on Null
627 5293 Acti on Nul 1
628 5310 Acti on Nul 1
629 5326 Acti on Nul 1
630 5340 Acti on Null
631 5355 Action. Nul 1
231 5365 g _val i date _muscl es__ answers Group Null
634 5368 i ....val i date_muscl es_answers Vari able Number
258 5330 a__i __val i d a t e _m u s e 1es_answers Questi on Number
257 5399 c _musci es_.sug_t est _di f Vari able Condi ti on
632 5405 n_5Lig_mal ...muse 1 es Vari able Number
633 5410 n_test_mal_muscl es Vari able Number
635 5418 Acti on Nul 1
636 5432 Action Null
637 5443 Action Null
638 5465 Acti on Nul 1
639 5474 Action Nul 1
640 5482 Action Nul 1
64.1 5491 Action Null
642 5504 Action Nul 1
643 5512 Acti on Null
644 5522 Acti on Null
645 5532 Action Null
646 5548 Acti on Nul I
64-7 5553 Action Nul 1
648 5560 Action Null
649 5565 Acti on Null
650 5575 Acti on Nul 1
651 5590 ' Action Mull
652 5609 Action Nul 1
653 5616 Action Null
654 5626 Acti on Nul 1
655 5635 Action Nul 1
656 5648 Acti on Nul 1
657 5694 Acti on Nul 1
658 5748 Action Nul 1
659 5769 Action Null
660 5801 Acti on Nul 1
661 5808 Action Null
662 5817 Acti on Nul 1
663 5827 Action Nul 1
664 5837 Acti on Null
665 5840 Action Nul 1
666 5846 Action Nul 1
667 5856 Action Nul 1
668 5869 Action Null
669 5875 Action Nul 1
670 5887 Action Null
672 5891 Action Null
673 5894 Action Nul 1
671 5898 a__save? Question Condi ti on
674 5901 a_daa? Question Condi ti on
675 5904 Action Nul 1
676 5908 Acti on Nul 1
Statistics of Model.
(Maximum is 2250) 
(Maximum is 65500)
SAVOIR Prior Value Checker NO errors found.
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Appendix D6-NEXPERT
NEXPERT OBJECT is an  Artificial Intelligence library written in the C 
language. It is designed for integration of applications into operational environ­
m ents written in C, FORTRAN, ADA, COBOL and PASCAL.
Development and delivery of expert system applications are possible on 
the VAX, IBM/AT, IBM-386, MAC II and Unix workstations with full cross com­
patibility.
NEXPERT comprises a hybrid of expert system building tools, obj ect and 
rule-oriented representation routines and an  incremental compiler. It has a 
powerful and user-friendly graphics interfaces which provides the following fa­
cilities:
n Graphics Knowledge Editors.
o Windows.
Q Graphics Knowledge Browsers.
Q Custom End-User Interface.
The shell has an  open architecture which means that it can be integrated 
with the following environments:
1 -External programmes.
2- DBase in, Lotus 1-2-3 and Data base Queries
3 - Multitasking environments.
The facilities which are available in this tool were only available on ex­
pensive LISP machines.
D6-1
Appendix E - Details of equipment and trade-marks
Equipment: _______________________ ___________
EGA-Wonder display card:
Has connectors for EGA and RGB colour monitors, TTL and Composite 
Momochrome Monitors. It supports the following graphics modes:
B IBM VGA 640x560
B High resolution MultiSync graphics 800x560,752x410 and 640x480
B IBM EGA and CGA graphics
B Hercules graphics
NEC MULTISYNC II Monitor:
Is a 1 4 M MultiSynic high resolution monitor which offers automatic synchronisation 
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TEDEX USER’S  INSTRUCTION
INTRODUCTION: _______ _____________ _____________
TEDEX is an experimental prototype expert system which provides advice about the di­
agnosis and management of thyroid ophthalmopathy. Expert systems are computer sys­
tems, comprising both hardware and software that mimic the expert’s thought process 
to solve complex problems in a given field.
TEDEX is a ’disease-specific’ expert system, i.e., it is designed to handle only patients 
who have been provisionally diagnosed as suffering from thyroid ophthalmopathy. It is 
not designed to give lists of differential diagnoses or to deal with other ophthalmic dis­
ordered.
The treatment options which are provided by the system are kept simple and included 
only the widely accepted and proven lines of treatment. Avoiding controversial or ex­
perimental therapeutic approaches served several purposes: The project could be fin­
ished in the allocated time, testing and modifications were readily done and the user ac­
ceptability was enhanced.
TEDEX is designed with the following intended users in mind: General Ophthalmolog­
ists, Endocrinologists, General Practitioners and perhaps medical students at a later stage. 
System performance should be determined with respect to the intended user.
HOW TO USE TEDEX:______________ ______________________
(1) Turn the computer on.
(2) In the DOS prompt load the system by typing [TEDEX] then press the ’Enter’ key.
(3) After the display of the logo and introductory screens, the opening menu will appear 
on the screen (Figure Q. 1). Type [1] followed by pressing the ’Enter’ key to select ’New 
patient’.
(4) The dialogue with the system continues in the form of questions and answers. Ques­
tions my require a string (e.g., patient name), a number (e.g., year of birth), or a selec­
tion from a multiple choice question where only one item is chosen. Some questions are 
of the yes/no type and require a Y or N.
(5) Entering [B] will take you one step back by displaying the previous question, as long 
as no action has been fired (i.e., no conclusion has been reached by pursuing this par­
ticular line of reasoning). Entering [B] again will take you one more step back. This fa­
cility is intended to allow the user to change his mind or to correct a wrong entry.
(6) Entering [H] will take you to a list of general help function keys.
TEDEX USER’S  INSTRUCTION
(7) Entering [A] will give you an amplification on the current question. This facility is 
only provided for questions which are deemed by the developers to be prone to misin­
terpretation.
(8) Entering [E] will provide an explanation of the system’s conclusion (i.e., why a di­
agnosis has been made or a management plan has been provided). This includes the ra­
tionale behind the conclusions and the most important information relevant to this par­
ticular conclusion.
(9) The system gives its conclusions in the form of two reports. The first report is dis­




(3) Print Last Session Report
CLOSING MENU
(1) Display Final Report
(2) Print Enal Report
(3) Re-Start New Session
Figure Figure
Q1 Q2
final report is provided after the results of the requested investigations have been en­
tered. This report is stored on the computer hard disk at the end of the session.
(10) After the final report is displayed, the closing menu appears (Figure Q.2). This gives 
you the choice of printing the final report of the current session. You can choose either 
to start another session or to quit the system.
"TEDEX" THYROID EYE DISEASE EXPERT 
SYSTEM — AN EXAMPLE OF AN OPTHALMIC 
INTEGRATED CLINIC AUTOMATION’ SYSTEM
A. Wail Mussa, T.S. Durrani, University of 
Strathclyde, UK 
M.H.Zeini, G.N. Dutton, University of Glasgow, UK
Keywords: Expert systems, clinic automation, ophthalmology, 
thyroid eye disease, charts reading.
Abstract:
Most general ophthalmologists lack expertise 
in the management of dysthyroid eye disease 
due to the rarity of the condition. This may 
result in an incorrect or delayed diagnosis 
and unsatisfactory treatment. "TEDEX" is an 
expert system designed to assist ophthalmolo­
gists, endocrinologists, general practitio­
ners, and medical students in the diagnosis,
management, and treatment of this disease.
TEDEX is designed to work in a clinical 
environment (whilst the patient is present).
In order to emulate the clinician, TEDEX 
performs several modular functions: data
acquisition, measure-ment interpretation, 
diagnosis, treatment planning, and patient 
follow-up. To perform these functions, TEDEX 
has interfaces to a data base (patient files), 
a scanner (ophthalmic chart reader), and 
"TEMPRAC" (temporal visual assessment tester), 
thereby integrating an assembly to create a 
'clinic automation' system.
1 INTRODUCTION
In the early 1970's researchers at several institutions simultaneously 
began to investigate the potential of clinical applications of symbolic 
reasoning techniques. It was the landmark paper by Gorry et al (Ref. 1) in 
1973, that first critically analysed the hitherto conventional approaches to 
computer-based clinical decision making and outlined his reasons for turning 
to the newer symbolic techniques. His conclusions included the following 
four points: (i) Clinical judgement is based less on detailed knowledge than 
it is on gross 'chunks' of knowledge, along, with a good deal of experience;
(ii) Clinicians know facts, but their knowledge is also largely judgemental;
(iii) Clinicians recognize levels of belief or certainty associated with 
many of the rules; and (iv) It is easier for experts to state their rules in 
response to perceived misconceptions rather than it is for them to generate
such decision criteria a priori. It was perhaps inevitable that some medical 
researchers would divert to the expert systems field for new methodologies 
due to the limitations of the older techniques.
Medicine was a pioneering of expert systems applications (for example 
Mycin (Ref. 2), Casnet (Ref. 3) ). Nevertheless, strong reservations were 
made about the clinical usefulness of many of these systems, and few have 
become truly operational. "TEDEX" Thyroid Eye Disease Expert System is a 
modular ophthalmic expert system designed to work on a microcomputer. It can 
work as a stand-alone system. However it is designed to be interfaceable and 
integratable with other clinic systems such as the patient file data base, 
an ophthalmic charts reader, and a temporal visual assessment tester 
"TEMPRAC", thereby forming a prototype for a modular clinic automation 
system which can be used -without extravagancy - in the every day ophthalmic 
clinical environment. It may also open the road for future expansion to 
create other ophthalmic expert systems to constitute a comprehensive 
ophthalmic clinic automation system.
1.1 Thyroid Eve Disease and the Potential for an Expert System
Thyroid disease and consequently thyroid eye disease (T.E.D.) situation 
is complex since different parts of the human organism and its metabolism 
interact,with each other on multiple levels and follow several feedback 
patterns. These interactions and feedback patterns become even more complex 
when the effects of other systemic conditions and the external environment 
are considered. These phenomena culminate in the following conditions:
1- The disorder is uncommon.
2- Its course is variable.
3- The outcome is unpredictable.
4- There is a large number of diagnostic and management parameters.
5- Management is uncertain.
6- Treatment is primarily empirical.
In addition to the above, the number of T.E.D. cases is small resulting in 
limited expertise among general ophthalmologists. There is therefore a major 
role for the design of an expert system to assist with diagnosis and 
management of this disorder.
In building TEDEX, our main source of data and expertise has been 
the 'Tennent Institute of Ophthalmology', Glasgow, where a large collection 
of patients with thyroid eye disease have been followed up for as long as 25 
years. The expert system shell chosen to build our model is SAVOIR (Ref. 
4, 5, 6).
2 TEDEX GENERAL DESCRIPTION
The objective of the design of TEDEX is to select the knowledge 
representation model along with a control strategy which closely mimics the 
ophthalmic clinician's consultation cycle in treating thyroid eye disease. 
The clinician already has a conceptual model of what he is doing, even 
though it may not be explicit. The selection of the knowledge representation 
model closest to the clinician's world lends itself to easier encoding of 
the knowledge. In addition, debugging and testing the expert system will not 
be so cumbersome with a knowledge representation model that naturally mimics 
the clinician's view point.
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Fig. 1 TEDEX modules and diagnose-treat-response loop
2.1 The Clinician's Consultation Cycle
1 - At the patient's first visit, a new file is opened with a new hospital
number. The clinician starts with direct interaction with the patient 
collecting (i) administrative and personal information about the 
patient, Eg name, age, sex,., etc. ; and (ii) the clinical history.
2 - The clinician then examines the patient, looking for the symptoms and
signs that enable him to make his diagnosis. He may carry out further 
investigations to add weight to his preliminary diagnosis.
3 - Having made his diagnosis, the clinician makes up his mind to devise
necessary treatment or therapy, prescribes it and assigns the next visit 
appointment.
4 - A medical report is dictated, and the file is closed. The next patient
is then called.
The above cycle is repeated with every patient. But when the patient 
comes for a follow-up visit there is some difference. Here, the cycle starts 
from step 2 . Some attention will also be directed towards observing any
changes that happened since last visit.
2.2 TEDEX Cvcle
To represent the above cycle, the model has been reduced into six 
modules, each of these represents one cluster of knowledge with distinct 
features. As shown in Figure 1, these modules, comprise the Data-base 
module, the Data-acquisition module, the Measurement-interpretation module, 
the Diagnosis module, the Risk-prediction module, and the Treatment module.
"Diagnosis" and "Treatment" modules are intelligent (data driven) 
modules. They are master modules. Other modules are mechanistic. They carry 
no intelligence, and are driven by the master modules when required. Since 
the nature of thought processes in diagnosis differs from the thought 
process for devising treatment, the two master modules have distinct
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characteristics . In diagnosis the clinician starts with the answers (the 
symptoms) to abstract the reasons (the causes), but in treatment the 
clinician starts with the reasons (the causes) and searches for the answers 
(the treatment). The knowledge representation and the inference mechanism 
of each module is consequently different. The following are TEDEX
corresponding cycle steps:
- TEDEX starts its session by enquiring about the user name and experience.
The main menu then appears to enable TEDEX to know whether (i) the patient
is new; (ii) the patient is coming for a follow-up visit; or (iii) a
report about a patient is needed.
- The hospital number is the next thing to be inquired about.
- A new file is opened if the patient is new. Otherwise the patient file is 
retrieved for consultation or reporting. (Patients' file are stored in the 
Data-base module).
- The above steps are carried out by the Data-acquisition module through 
communication with either the Data-base module or directly with the user.
- The real work of the Diagnosis module then starts by examining the 
patient. Having made the diagnosis, a report appears informing the user 
about the findings and the recommended investigations.
- If these investigations are available, Measurement-interpretation module 
activates the chart reader. The appropriate chart is then scanned, 
recognised, processed, and transformed into an information vector. The 
vector is fed into the Data-acquisition module, then into the Diagnosis 
module. The same procedure may be followed for the TEMPRAC tester.
- The Treatment module is now activated. It has its inputs mainly from the 
Diagnosis module and the Risk-prediction module. Its outputs are 
partitioned into treatment and action.
- When treatment is made, a report is displayed or printed.
- The key information for this session is saved in the data base.
- Finally, an "EXIT" or "NEW SESSION" may be chosen when the main menu 
appears again.
3 TEDEX IN DETAIL
In this section, a brief description of the medical management of 
T.E.D. is presented. This description (Ref. 7) is to lay out a background 
for the sections that follow.
Patient evaluation: Evaluation of a patient with T.E.D. begins with a 
comprehensive general medical assessment of the patient. How severe a 
threat do the medical disorders pose to life and well being? Are there any 
contra-indications, or side effects of steroids, radiotherapy, or surgery? 
When the general medical status of the patient is known, the definition of 
the thyroid status is the next priority; namely either hyperthyroidism or 
hypothyrodism. What treatment has been directed towards the thyroid gland in 
the past? To what extent has it been successful? After the patient's 
general medical and thyroid status have been defined, the next step is to 
obtain a full history of the past therapy to the eyes, the success or lack 
of efficacy of that therapy, and the side effects resulting from it. Then 
attention can be turned to an assessment of the current eye status. How long 
is it since the first eye symptoms developed? Are the symptoms stable or 
progressive? What is the status of the cornea, optic nerve, eye lid, and 
extraocular muscles?
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Patient management: The above evaluation, allows the clinician to assess 
treatment options for the eye condition in the context of the patient's 
general health and against the record of previous treatment successes, 
failures, and side effects. A balanced assessment of relative risks from 
various forms of treatment is considered in the context of continuity of 
care and observations.
3.1 Data-base Module
The Data-base module is only a place for storing patients' files. 
Files are indexed according to patient hospital number. A patient file 
contains all the available information about the patient. A patient file is 
retrieved and saved by the Data-acquisition module.
3.2 Measurement-interpretation Module
This module is activated by the Data-acquisition module in order to get 
in return a qualitative description to either an ophthalmic chart or TEMPRAC 
tester. Ophthalmic charts and the TEMPRAC test are used by clinicians to 
obtain diagnostic bits of evidence.
TEMPRAC: is a test made to assess the time taken to achieve each level of 
Snellen acuity. It is employed as one of the clinical routine examinations. 
When Measurement-interpretation module invokes TEMPRAC, the test starts to 
run. When completed the test results are fed back to the Measurement- 
interpretation module in the form of an information vector.
Ophthalmic charts: In ophthalmic practice, a wide range of charts are
routinely used to diagnose and document various disorders of the human eye 
and visual processing. (Eg the field of vision chart, and the 100-Hue test 
chart). When the current module is activated, it invokes in due course an 
external programme that scans and reads the existing chart, extracts the 
desired diagnostic features, then encodes it to a summary feature vector and 
feeds it back to the invoker Measurement-interpretation module.
By receiving the fed back vector in either case, the Measurement-
interpretation module converts it into a qualitative description, and then
feeds it into the requesting Data-acquisition module.
3.3 Data-acquisition Module
Whenever data are required, this module is invoked by either the 
Diagnosis module, the Risk-prediction module, or the Treatment module, i.e. 
it interfaces TEDEX with the outside world. To perform this interfacing, 
the Data-acquisition module has to do the following: (i) acquire data from 
the human user, the data base files, TEMPRAC tester, or chart reader; (ii) 
check and validate inputed data before accepting it; and (iii) whenever 
accepted, convert acquired data to the form accepted by the invoker. The 
following is a brief description of its three interfaces:
Human user interface: The interaction with the human user (man/machine
interface) occurs through direct questioning with the user. Figure 2 shows 
an example of a question a_i_disk_oedima (to ask about right eye disc nerve
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PROBABILITY pl_disk_oedema 'to transfer the numeric
question to prodab i1i t y ’
MEMBER <a_i _disk_oedema , 0.035 , 0.9 , 3.1 , 98 ,99)
“QUESTION a_ i_disk_oedema ’
#13# Right Optic Disc
#13# On Ophthalmoscopy ?
#13#
#13# (1) No diplopia.
#13# (2) Suspected disk oedema.
#13# (3) Definite disk oedema. ’
INTEGER 1 3
Fig. 2 An example of TEDEX questions to get the right eye
optic nerve condition, expressed in SAVOIR language.
condition, where 'a' stands for ask question, 'i' stands for integer, and 
'disk' stands for optic nerve disc). The chosen integer answer is converted 
to an uncertainty probability variable pl_disk_oedima which is suitable to 
be fed into the Diagnosis module.
Data base interface: At the start of a session, the identified patient's
file is retrieved and kept in the memory for interrogation when needed. At 
the end of the session, the file is updated and saved for follow-up and 
future reference.
Measurement interpretation interface: The Measurement-interpretation module
is activated in order to get in return a qualitative description of an 
ophthalmic chart or of the results of the TEMPRAC tester as explained 
earlier.
3.4 Diagnosis Module
In order to make a diagnosis, the clinician is actually trying to draw 
out of a chunk of input information (symptoms) an abstracted description 
(conclusions) to the causes of disorder . So diagnosis is actually an 
abstraction thought process, and can be defined as: Identifying causes of 
given symptoms. Symptoms as well as disorder causes are of judgemental 
(uncertain) nature that depend to a great extent on the experience of the 
clinician. User experience proportionally strengthens TEDEX belief in the 
answer of some crucial judgemental questions. To cope with the uncertain 
nature of the diagnostic process, probability variables have been used in 
the knowledge tree representation of the Diagnosis module.
In TEDEX, symptoms are collected through direct personal questions, 
patient complaints, medical history, thorough examination, investigation, 
and are inputed from Data-acquisition module. Disorder causes (the goals of 
the present module) are the status or the condition of the following eye 
tissues: the cornea, the optic nerve, the eye lid and the extraocular 
muscles as well as the degree of proptosis . In TEDEX jargon, they are the 
malfunction probability of the eye tissue abbreviated as : p_mal_cornea,
p_mal_nerve, p_mal_lid, p_proptosis, p_mal_muscles, p_mal_chemosis and 
p_mal_lid_oedima. These goals - when ready - are outputted to the Treatment 
module.
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Fig. 3 Part of the knowledge tree representation to abstract 
the right optic nerve condition.
To represent the T.E.D. diagnosis model, the condition of each eye 
tissue is broken down into subconditions (at a lower level in the knowledge 
tree). The subconditions resulting are again broken down until no further 
subdivision is necessary (the lowest level). This lowest level, represents 
the symptoms collection level.
In Figure 3, an example is shown of how the condition of the optic 
nerve is abstracted, abbreviated as "p-mal-nerve" (the malfunction 
probability variable of the right eye nerve, where p stands for probability 
variable, and mal stands for malfunctioning). This variable is divided into 
two subvariables: (1) p_test_mal_nerve, the nerve malfunction probability 
assessed from investigations; and (2) p_sug_mal_nerve, the nerve malfunction 
probability assessed from the clinician's personal examination. Subvariable 
p_test_mal_nerve is again divided into (1) p_visual_acuity_drop; and (2) 
p_disk_oedima. Subvariable p_disk_oedima is further stepped down to be
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pl_disk_oedima using Bayesian probability: LS 34 LN 1 if there are coroidal 
folds, and LS 30 LN 1 if there are no coroidal folds. pl_disk_oedima is the 
probability conversion of a direct question a_i_disk_oediraa, explained 
earlier in the Data-acquisition module.
A similar representation is performed for p_mal_cornea, p_mal_lid, 
p_mal_proptosis, p_mal_muscles, p_mal_chemosis and p_mal_lid_oedima. The 
knowledge tree of each eye tissue is not segregated from other trees as it 
may appear from above description: they have some common metarules and
leaves (the lowest level).
The above is the static representation of diagnostic thought process. 
To emulate the clinician while he is establishing his diagnosis, a "Forward" 
chaining control strategy has first been implemented. This is to keep the 
order followed by clinicians in examining patients. Having completed a 
patient examination, "Forward and backward" chaining takes over until 
the diagnostic reasoning is complete. The system generally starts by
collecting symptoms (the knowledge tree leaves), then proceeds upwards to
reach the abstracted disorder causes (the goals).
3.5 Risk-prediction Module
The function of this module is to infer likely consequent disorders, in 
the context of patient current ocular and general health conditions. It 
acquires its inputs from Data-acquisition module. Its output is fed to the
Treatment module to help in devising the treatment.
The prediction process is mechanistic. Risk prediction factors are 
calculated by applying formulae which . have been derived from discriminant 
function analysis of the series of patients studied in the Tennent 
Institute.
3.6 Treatment Module
The Treatment module output has 40 possible treatment items. It 
compromises two types: (i) treatment which stands for medicine, surgery,
prisms or occlusion (32 out of 40 treatment items); and (ii) action which 
stands for assigning the next visit date. (8 out of 40 treatment items).
The Treatment module input has (i) 13 inputs from the Diagnosis module; and
(ii) 88 other possible inputs from the Risk-prediction module and Data- 
acquisition module.
After completing its job, the Diagnosis module, activates the 
Treatment module. In the meantime it feeds the Treatment module with the 13
probability variables that abstract current eye status. These probability
variables are converted to integer variables (ranging from 1 to 4 ) so that: 
probability ( <= 0.25 ) becomes integer 1
probability ( > 0.25 to <= 0.50 ) becomes integer 2
probability ( > 0.50 to <= 0.75 ) becomes integer 3
probability ( >0.75 ) becomes integer 4
Only the proptosis variable ranges from 1 to 3. The combination of these 
integer variables creates a pattern that can be defined as 'snapshots' of 
the states which represent the eye status of this particular patient at this 
particular visit. The pattern in question can be expressed in the following
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pTable 1 Diagnostic pattern and its possible values.
diagnosis pattern 
form
< left eye j right eye > 




1 1 1 1 1 1 1 1 1  
2 2 2 2 2 2 2 2 2  
3 3 3 3 3 3 3 3 3  
4 4 4 4 4 4 4
form: (c, n, p, 1, m, 1, p, n, c), as explained in Table 1. This nine-items 
pattern is the necessary minimum information that the Treatment module must 
start with. It may not be enough to reach the desired goals. In this case 
more information has to be collected about the patient from the "Data 
acquisition" or the "Risk prediction" modules using a "Backward and Forward 
chaining" control strategy.
Before proceeding any further, the treatment thought process will be 
analysed. After diagnosing the causes of the disorder, the clinician starts 
by devising a treatment therapy, and the goal in his mind is to effect 
partial or complete health improvement. Clinicians work on the premise that 
for the majority of diagnostic patterns, there is a treatment pattern (i.e. 
for each problem there is a solution). Knowing the diagnostic pattern, the 
clinician searches for the treatment pattern. The search is not a 
straightforward matter. It requires experience. The response of the patient 
to treatment proves how efficient or correct the treatment administered has 
been. Expert clinicians more commonly find and prescribe the correct 
effective treatment.
To emulate the expert clinician in planning and prescribing treatment, 
the Treatment module has been designed to be search intensive, and pattern 
directed. It deals with one or more disorder simultaneously while 
considering the whole amount of information about the patient . The 
Treatment module does not simply generate the treatment prescription; it 
analyzes and presents the best possible treatment with advice and 
recommendations. To emulate the search thought process, the Treatment module 
knowledge representation has been modeled in the shape of paths that 
transform the known diagnostic pattern into a treatment pattern. A path 
consists of production rules connected through predicate calculus relations. 
As an example, Figure 4 shows a typical treatment path searching for an 
item of the treatment pattern called 'c_tr_nerve_w_steroids’, which stands 
for 'treat nerve with steroids', where c stands for condition variable, tr 
stands for treat, and w stand for ’with'. *anti_steroids' is a condition 
variable which becomes true if the patient has side effects or 
contraindications to steroids (there is another path to get *anti_ steroids' 
which is not shown here). ’n~4' is a diagnostic pattern item which means 
that the optic nerve is severely affected. Now ’a_i_treat_nerve',
’ a_i_critical_choice' and ’a_c_your_choice_bad' are questions asked of the 
clinician to consult him about TEDEX choice in this treatment item. If he 
agrees, TEDEX continues working. But if not, an alternative treatment is 
tried. The reasons for considering the clinician's opinion are (i) this is 
an on-line decision support system; (ii) the suggested treatment may not be 
available; (iii) the clinician may personally prefer one treatment to
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another, and (iv) TEDEX leaves action responsibility to the clinician. 
However for future reference both choices (TEDEX and clinician) are
recorded.
The example just explained shows a path that deals with an optic nerve 
disorder, sketched in Figure 5 . Looking at the disorder pattern as a whole, 
we can generalize that diagnosis-treatment-response is a recursive cycle 
that stops when the patient is completely recovered. Risk prediction
factors on the one hand, and patient responses to the prescribed treatment 
on the other, are the main factors that count in assigning the next visit 
date (abbreviated as "action" in TEDEX). In emergency cases, patients are 
kept under continuous observation.
Before leaving the Treatment module it is worth while stating that due
to T.E.D. complexity mentioned in item 1.1 above, the mechanism of
treatment function in Thyroid eye disease is different from the usual 
treatment function. In the usual treatment, the clinician is trying to 
bring about a partial or complete improvement in the patient's health. The
purpose of the next visit is to see the effect of the treatment. In thyroid
eye disease, this is not the case. Here, due to the marked variability of 
the disease course and to its self limiting nature, the eye clinician is not 
able to predict the possible outco'me for the patient's eye. What he is
trying to do is to observe the patient, and to prevent the outcome from
irreparably damaging the eye, i.e. he is not directly dealing with the
thyroid eye disease, he is dealing with its range of consequences. The goal
in his mind is to avoid such damaging effects. The appointment for the next
visit is arranged to observe the eye condition and to make sure that nothing
urgent needs to be done. His role stops when both the thyroid disease and 
the thyroid eye disease become stable.
4 CONCLUSION
The present paper explains some features of TEDEX, the Thyroid Eye 
Disease Expert System, and highlights two main points.
The first is the emulation of the ophthalmic clinician's thought process in 
diagnosing and treating T.E.D.. It has been shown how the diagnosis can be 
considered as an abstraction thought process, whilst treatment is a search 
thought process. An example has been given to explain the relevant 
knowledge representation of each. The control strategy for each module has 
also been presented.
The second is the emulation of the clinical environment. This is to create a 
"clinic automation" system, where file saving or retrieval, reading and 
interpretation of ophthalmic charts, and encoding of temporal visual 
assessment are done automatically in such a way that it matches the work 
habits of the' clinicians. This has been achieved by breaking TEDEX apart 
into six interfaceable modules, each of which is performing^ a well 
recognized clinical function. These modules are controlled by the 
intelligence of the "diagnosis" and "treatment" modules.
There is an important difference between TEDEX and other diagnostic 
expert systems. These systems emulate and help the clinician only in 
diagnosis and treatment of disease, whereas TEDEX emulates the general 
ophthalmic clinician in the whole consultation cycle. It helps him to do
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F i g . ^ The knowledge representation of a path searching 
for an optic nerve treatment pattern item.











Fig. 5 Diagnosis-treatment-response recursive loop for the.right 
eye optic nerve.
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what he is used to do in a fast and accurate way. Moreover, it gives him the 
expert advice he requires. From the medical point of view , this system has 
many advantages: (i) the appropriate action is to be taken at the right time 
and (ii) specialised,centres will deal only with the appropriately referred 
patients. From the financial point of view, these medical advantages will 
lead to increased savings.
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